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Abstract 
Osteoarthritis (OA) is a leading cause of pain and disability in the UK for which there is, at 
present, no effective pharmacological treatment and no cure. Given the prevalence of the 
disease, there is increasing interest in the impact of nutrition and its potential to contribute 
both to prevention and treatment. Existing data in this area is both inconsistent and 
limited.  This research investigates associations in two large population based cohorts, in 
cross-sectional and longitudinal settings, with a particular focus on biological pathways 
known to contribute to disease development. 
Data available contained radiographic OA and pain variables in the TWINS-UK cohort, and 
clinician classified OA and pain variables in the EPIC-Norfolk cohort. Both groups had data 
on serum lipids and information on dietary exposure obtained through the use of food 
frequency questionnaires. Genetic data were also available in the EPIC-Norfolk cohort. A 
cross-sectional analysis was performed in 20517 adults from the EPIC-Norfolk cohort and in 
8351 females from the TWINS-UK cohort. Longitudinal analysis investigated incidence and 
change in hip and knee pain over time in EPIC-Norfolk. Key associations were explored 
further in a Mendelian randomisation analysis in an attempt to clarify the potential causal 
relationships between putative exposures and outcomes. 
The main finding from the FFQ cross-sectional analysis in TWINS-UK is that a ‘Traditional 
English’ dietary pattern showed a 28% increase in the risk of hand OA. An unexpected 
result was that the ‘Fruit and Vegetable’ dietary pattern was suggested to increase the risk 
of knee OA by 19%. Further analysis into the Mediterranean dietary pattern revealed a 
protective association with OA decreasing the risk of radiographic hand OA by 12%. 
Analysis of serum lipid levels showed that triglycerides increased the risk of hip OA, hand 
OA, elbow and forearm pain, and chronic widespread pain. Cholesterol and LDL were also 
consistently found to increase the risk of OA/pain and the LDL component apoB1 was 
found to significantly increase the risk of hand OA. 
Findings from the case-control and longitudinal analysis in EPIC-Norfolk, revealed that 
increased BMI is strongly associated with hip and knee OA (p<0.0001) and with onset of hip 
pain (p<0.0001) and knee pain (p=0.0001). Triglycerides were also found to increase knee 
OA (p=0.023) and knee pain (p<0.0001) in the case-control analysis and were found to 
increase knee pain in females (p=0.0013). Findings also showed that cholesterol levels 
increased the risk of future knee pain (p=0.016) and increased vegetable consumption was 
inversely associated with change in hip pain. The findings from the Mendelian 
Randomisation study, using SNPs from FTO and APOA5 to investigate reverse causality 
between BMI and triglycerides and OA, showed no causal associations with OA.     
In conclusion, data from these two cohorts suggests that a diet high in saturated fats 
increases the risk of OA/pain as do the serum levels of lipids. Increased consumption of a 
Mediterranean diet is suggested to be protective of hand OA. Although BMI is strongly 
associated with hip and knee OA and incidence and change in hip/knee pain over time, 
both BMI and triglycerides were found not to be causal of OA when explained by genetic 
variants responsible for changes in these two exposures. Although wider replication is 
needed to confirm these observations, the results from this research suggest potential 
dietary modifications for prevention and treatment of OA and pain associated with OA that 
could be tested further in randomised trials. 
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1 Introduction. 
 
1.1 Chapter Overview 
 
This introductory chapter discusses Osteoarthritis (OA) and the mechanisms that affect its 
onset and progression. With an increasingly aged and obese population, this particular joint 
disease is becoming even more of a concern to public health. This chapter outlines the 
definitions of OA and pain, current treatments, the underlying biological mechanisms and 
the many risk factors. This is followed by a review of existing evidence for the role of 
nutrition as a potential preventative treatment, the contribution of known dietary patterns 
towards health and how lipid metabolism and genetics contribute to OA. OA can result in 
pain at joint sites which can also influence chronic widespread pain and at present there 
are limited effective treatments and no cure. Diet has, therefore, become the main focus of 
research as it is easily modified and has the potential to become a preventative treatment. 
Identifying dietary risk factors could, therefore, be of great importance for public health.   
1.2 The Ageing Population and Musculoskeletal Conditions  
 
The intrinsic process of ageing is continuous, irreversible and consistent with adverse 
changes which occur over time (Smita, Lange et al. 2016). With ‘wear and tear’ also seen 
over time the effects of ageing are masked (van Leeuwen, Vera et al. 2010). A major 
contributing factor to structural and functional changes that is seen with increased age is 
cellular damage (Smita, Lange et al. 2016) which leads to reduced physiological integrity 
with increased vulnerability resulting in deterioration (López-Otín, Blasco et al. 2013). 
Estimations by the World Health Organisation (WHO) suggest that a quarter of adults aged 
over the age of 65 years are sufferers of musculoskeletal conditions (Loveless and Fry 
2016).  
Joint disease and the accompanying musculoskeletal pain are, therefore, a global issue 
both for patients and health care systems (Nájera, González-Chávez et al. 2016) as are the 
many different musculoskeletal conditions which display increased incidence and 
prevalence as the population shows increased longevity. These conditions could be slowed, 
prevented or even reversed if we were able to gain a better understanding of the 
underlying mechanisms (Goljanek-Whysall, Iwanejko et al. 2016). A study which followed 
on from the global burden of disease studies (which investigated non-fatal health 
outcomes from disease and injuries) found that one of the major contributors to the 
number of years lived with disability (YLDs), on a global scale, was musculoskeletal 
disorders. Leading causes for YLDs included lower back pain and neck pain (Vos, Flaxman et 
al. 2013) and back pain has been found to be present in up to 27% of those aged 20-89 
years of age (Loveless and Fry 2016).  
Under the umbrella of musculoskeletal conditions, there exists many different types of 
arthritis: Osteoarthritis, Rheumatoid arthritis, Gout and Spondyloarthropathies (Psoriatic 
arthritis, ankylosing spondylitis etc.) (Oliviero, Spinella et al. 2015). Typically characterised 
as inflammation of the joints, all types of arthritis can become extremely debilitating for 
those who are diagnosed (Arden and Cooper 2005). Osteoarthritis, which is the main focus 
of this research, is associated with increasing age and BMI with onset typically occurring in 
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those middle aged. It is on the increase, found worldwide affecting approximately 240 
million people (around 10% male and 18% female over the age of 60) (Nelson 2018), is the 
leading cause of disability in the US (Control and Prevention 2013) and is within the top 
three reasons for visiting health care providers (Loveless and Fry 2016). It also carries 
comorbidities with obesity and cardiovascular disease (Oliviero, Spinella et al. 2015). Figure 
1 overviews the risk factors and pathogenesis of each of the above forms of arthritis which 
will be discussed more specifically for OA throughout this chapter. 
 
FIGURE 1. OVERVIEW OF THE PATHOGENESIS OF THE MOST COMMON FORMS OF ARTHRITIS 
(OLIVIERO, SPINELLA ET AL. 2015). 
 
Closely related to many age related diseases is the chronic condition commonly referred to 
as inflammaging: the characteristic low-grade inflammatory state which develops alongside 
the ageing process. Inflammaging is now recognised as a key risk factor for disease but 
despite the abundance of pro-inflammatory markers seen with the inflammaging process, 
some very elderly, living to over a century, have escaped the onset of disease. Further 
studies are therefore needed to understand the potential beneficial and detrimental 
effects of inflammaging and the complex network of mediators and regulators that create 
an inflammatory response (Cevenini, Monti et al. 2013). 
 
1.3 Defining and Classifying Osteoarthritis 
 
Osteoarthritis can be defined either pathologically, radiographically or clinically for the 
purpose of investigating the joint disease through epidemiological studies (Zhang and 
Jordan 2010). The Osteoarthritis Research Society International (OARSI) define OA as “a 
disorder involving movable joints characterized by cell stress and extracellular matrix 
degradation initiated by micro- and macro-injury that activates maladaptive repair 
responses including pro-inflammatory pathways of innate immunity. The disease manifests 
first as a molecular derangement (abnormal joint tissue metabolism) followed by anatomic 
13 
 
and/or physiologic derangements (seen in Figure 2 below) which is characterized by 
cartilage degradation, bone remodelling, osteophyte formation, joint inflammation and loss 
of normal joint function) that can culminate in illness” 
(http://oarsi.org/research/standardization-osteoarthritis-definitions). 
 
 
FIGURE 2. A COMPARISON BETWEEN A HEALTHY JOINT AND UNHEALTHY JOINT ENVIRONMENT IN 
OSTEOARTHRITIS (WIELAND, MICHAELIS ET AL. 2005). 
 
Although multiple ways to define radiographic osteoarthritis exist, the most commonly 
used method is the Kellgren and Lawrence grading system (Spector, Hart et al. 1993). This 
scoring system judges the severity of OA and gives a grade based on the advancement of 
osteophyte formation, joint space narrowing, sclerosis and the destruction of cartilage 
(Kellgren and Lawrence 1957), discussed further in Chapter 5.3.2.  
Due to the aetiology of OA being unclear, there have been different ways in which OA has 
been defined (Tanna 2004). Clinical definitions suggest that those who suffer joint 
symptoms and pain may be more relevant as those with radiographic OA may not have 
clinical joint disease and those that suffer joint symptoms may not have radiographic OA 
(Zhang and Jordan 2010). Chronic musculoskeletal pain is therefore an important clinical 
feature that defines OA and there are multiple interactive pathways shown in the 
biopsychosocial framework (Figure 3) that are believed to determine pain in OA. It is 
important to consider all biological factors, psychosocial factors (including self-efficacy and 
pain catastrophizing) and social factors (including social support and pain communication) 
to be able to improve knowledge and understanding of the pain experience (Hunter, 
Guermazi et al. 2013).   
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FIGURE 3. MODEL OF THE BIOPSYCHOSOCIAL FACTORS LEADING TO THE EXPERIENCE OF PAIN 
(HUNTER, GUERMAZI ET AL. 2013). 
 
Chronic musculoskeletal pain affects a third of the adult population and is considered a 
major public health problem. In order for early intervention and prevention of 
musculoskeletal pain, the key is to identify the main risk factors involved (Bergman 2007). 
CWP is defined as “pain of a duration of at least 3 months in an axial distribution, plus pain 
on both the left and the right side of the body and above and below the waist” (Üçeyler, 
Valenza et al. 2006). Chronic pain is a clinical condition associated with specific structural 
disorders (Smith, Macfarlane et al. 2007) such as OA. Studies have investigated CWP by 
using the stricter ‘Manchester definition’ of CWP (CWP-M) from which findings indicate an 
impaired health status in those with chronic pain (Bergman 2005). 
Osteoarthritis incidence and prevalence has been difficult to assess due to the differences 
in definitions of the disease. A study that used differing definitions to estimate prevalence 
in different countries around the world, found that the radiographic definition gave the 
highest prevalence estimates and that self-reported and symptomatic OA definitions 
showed similar estimates. This study found that hand OA had the highest prevalence 
estimates but that knee OA was the most studied (Pereira, Peleteiro et al. 2011) which is 
consistent with the statistic that 83% of the burden of OA, on a global scale, is due to knee 
OA (Vos, Flaxman et al. 2013). 
A recent global burden of disease study found that the prevalence of knee OA globally is 
3.8% with hip OA at 0.85%. There were no substantial changes in these figures between 
1990 and 2010 (Cross, Smith et al. 2014). Hand OA continues to be the most common. The 
US National Health and Nutrition Examination Survey showed a prevalence of 8% and the 
Framingham cohort showed a prevalence of 7% (Bortoluzzi, Furini et al. 2018). An American 
study found that hand OA prevalence differed based on ethnicity. Race-specific 
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symptomatic hand OA risk estimates were 41.4% in those of white ethnicity and 29.2% 
among African Americans. Gender was found to be increase the risk of developing 
symptomatic hand OA showing that almost for every one in two women were likely to 
develop hand OA by age 85 compared to one in every four males. This study also found 
that the lifetime risk of symptomatic hand OA was increased by 11% among obese 
individuals (47.1%) compared to non-obese individuals (36.1%) (Qin, Barbour et al. 2017).  
Osteoarthritis slowly develops across an individual’s lifetime and could therefore be 
prevented early on in the course of disease progression with regard to improving function 
and reducing pain, both of which enhance quality of life, alongside slowing the progression 
of disease (Ageberg and Roos 2015). These are primary targets to be focused on when 
treating OA in the absence of a cure. Not only intended for alleviating the symptoms of the 
patient, this approach also aims at reducing the number of cases needing joint replacement 
in the advanced stages (Bennell, Hall et al.). Clinical practice guidelines encourage and 
highlight the benefits of a patient driven approach. Key here is the idea that the patient 
focuses on ways in which they can help themselves in the treatment of OA in a non-drug 
and non-surgical treatment focused manner (Bennell, Hall et al.).  
A good example of this is weight loss, education and exercise in the treatment for 
degenerative knee disease. Exercise has been reported to reduce pain, improve function 
and delay the need for joint replacement. Strength training is of importance as muscle 
weakness is very common in individuals with OA. Greater quadriceps strength for instance 
protects from the development of OA and muscle strength may be linked to slower 
progression of OA. Outcomes of exercise as a treatment include improved cartilage matrix 
quality and improved function and stability as well as reductions in pain (Ageberg and Roos 
2015). It has been suggested that to optimise outcomes, programs should be designed for 
the individual. This is consistent with the general idea of personalised health care during 
the treatment of OA (Bennell, Hall et al.). 
With regard to other interventions and treatments, knee braces aim to improve symptoms 
and maintain joint structure (by reducing the load on the knee) and show potential for 
slowing the progression of OA. Needle and laser acupuncture has also been a treatment 
which can improve pain (Bennell, Hall et al.). Relief from pain by musculoskeletal injections, 
which can be either corticosteroid injections or local anaesthetic, have also been found to 
significantly reduce pain (Sucuoğlu, Özbayrak et al. 2016). 
Joint replacement is used as a treatment for end stage OA (Wang, Simpson et al. 2011) and 
is aimed at relieving pain. Joint replacement is seen to be on the increase worldwide 
(Wang, Simpson et al. 2009), as are prescriptions and visits to specialists and GPs (March 
and Bagga 2004). These increases are suggested to exist, among other reasons, because of 
the world wide population’s increased life expectancy (Zhang and Jordan, 2010). With this 
increasing demand it is essential that we build knowledge of potential ways to prevent 
and/or slow the progression of OA through easily modifiable factors and self-care in an 
attempt to reduce the demands and increase quality of life for those suffering. Therefore 
the next part of this chapter discusses the pathological progression and some of the 
underlying mechanisms to give an overview of what is occurring at a cellular level and to 
show potential targets for treating OA. 
With OA being on the rise and becoming such a major health issue and with there being no 
known cure at present, this chapter continues to explore the inflammatory pathways and 
16 
 
risk factors for OA of which those that are modifiable, specifically lifestyle factors such as 
diet, are of great interest. 
1.4 Osteoarthritis and Pain: Biological Mechanisms 
 
Pathologically, during the progression of OA, there are many changes within the joint. A 
few include the destruction and subsequent loss or ‘wearing away’ of cartilage, appearance 
of bone marrow lesions and remodelling, laxity of ligaments, stretching of the joint capsule 
and the weakening of periarticular muscle (Felson, McLaughlin et al. 2003). Synovitis, 
inflammation, mechanical imbalance and malalignment can then often follow (Pelletier, 
Martel‐Pelletier et al. 2001). As the joint disease progresses through its course, all tissues 
can be affected and the cross talk between these individual tissues is suggested to be a 
contributing factor to both the progression of OA and the development of pain (Malfait 
2016). 
In addition to biomechanical mechanisms, inflammation is now considered an important 
driver of the molecular mechanism underlying OA/pain. This is due to pro-inflammatory 
cytokines (such as Interleukin-1 (IL-1) and Tumor necrosis factor (TNF-α)) upregulating the 
production of factors such as nitric oxide and prostaglandin E2 which induce changes in 
chondrocytes seen in the progression of the disease (Hedbom and Häuselmann 2002).  
Cartilage is composed of a matrix of three major components type II collagen, aggrecan and 
water which provide the functional properties; smooth articular motion and shock 
absorption. Type II collagen and aggrecan are lost in the progression of OA and the 
abundance of the protein is seen to decrease due to the synthesis and activity of matrix 
metalloproteinases (MMPs) stimulated by chondrocytes when in the presence of a cytokine 
(Tanigawa, Aida et al. 2011). Chondrocyte proliferation occurs at nearby sites in an attempt 
to repair the damaged cartilage as a result of signs of focal erosion and ulceration which 
are associated with cell necrosis. OA results from dysregulation of a number of factors 
(Arden and Cooper 2005). The biomechanical stresses alongside factors such as pro-
inflammatory cytokines and chemokines, pro-inflammatory enzymes (such as MMPs) and 
changes in the extra cellular matrix (ECM) are all factors to which articular chondrocytes 
are readily exposed and are therefore subjected to a phenotypic shift. Due to chondrocytes 
providing the structural maintenance of cartilage, as their primary function is to secrete 
components of the ECM (Settembre, Arteaga-Solis et al. 2008), the changes in 
chondrocytes therefore result in a disturbance in cartilage homeostasis (Malfait 2016).  
There are many genes and proteins at a molecular level that are involved in the regulation 
of the environment surrounding the joint. Factors such as pro-inflammatory cytokines and 
MMPs are in turn regulated by the transcription factor NF-κB and it is suggested that any 
agent able to suppress these factors and the activation of NF-κB could have the potential to 
be successful as a treatment (Arden and Cooper 2005). The NF-κB pathway is, therefore, 
considered a master regulator of immunity. This transcription factor interacts with p50 and 
p52 NF-κB components and with Rel proteins and resides within the cytoplasm in order to 
bind to IκB proteins. Upon sensing danger, such as oxidative and genotoxic stress, the IκB 
proteins are phosphorylated, freeing up and allowing the NF-κB complexes to prompt 
expression of pro-inflammatory genes within the nucleus. As a result, upregulation of NF-
κB has been found to be strongly associated with ageing. 
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Different physiologic functions of the cyclooxygenases (COX-1 and COX-2) have also been 
identified by previous research. COX-1 is expressed in the majority of tissues and produces 
prostaglandins which are important for homeostatic functions. COX-2 however seems more 
specific in that its expression is very restricted and it is seen to be up-regulated during 
inflammation. Increased levels have also been seen in patients with rheumatoid arthritis.  
Animal models have shown increases in COX-2 to run parallel with increases in 
prostaglandin production. In vitro experiments, in cell types such as chondrocytes, 
osteoblasts and synoviocytes, have found increased expression and stimulation of pro-
inflammatory cytokines e.g. Interleukin-1 (IL-1) and tumor necrosis factor (TNF) (Crofford 
1997). The synthesis of the pro-inflammatory cytokine TNF plays a key role in many 
diseases and disorders involving inflammation (Van Gool, Galli et al. 2009).  
The interleukin family of cytokines alongside the ADAMTS family of catabolic enzymes, 
both being pro-inflammatory, are now used in lab studies to stimulate, in cell lines, what 
would normally be seen in the progression of OA in the human joint. Previous research has 
found ADAMTS 1, 5 & 9, part of the NF-κB complex RELA, the hyaluronic acid synthase 
HAS2 and the heparan sulphate sulfotransferase HS3ST3A1 to be genes related to ECM 
turnover and were more highly expressed in OA chondrocytes. With the mRNA reflecting 
the rate of degradation and synthesis, this study also compared mRNA in the transcriptome 
of healthy and unhealthy chondrocytes and found that mRNA half-life was shortened in OA 
chondrocytes (Malfait 2016).  
The regulatory system involving the zinc importer ZIP8 and the MTF1 transcription factor 
has also been investigated. MMP 9, 12 & 13 and ADAMTS-5 expression were all found to be 
upregulated in the presence of a ZIP8-mediated zinc influx. Overexpression of ZIP8 in mice 
resulted in OA related changes, such as cartilage damage, however Zip8 knock out mice 
showed less of these changes (Kim, Jeon et al. 2014). 
The Silent Information Regulator 2 (SIR2) gene was originally found to control genome 
instability and extend the replicative life span of budding yeast by 30% (Kaeberlein, McVey 
et al. 1999). SIR2 does this by having an impact on the processes associated with ageing 
such as playing a key role in the silencing of yeast telomeres (Smith and Boeke 1997), 
preventing recombinant DNA (rDNA) recombination and restricting toxic 
extrachromosomal rDNA circle formation (Kaeberlein, McVey et al. 1999).  
Since the 90’s SIR2-like genes known as sirtuins, of which there are seven (Frye 2000), have 
been found to induce changes at a molecular level, that promote health and survival, upon 
detection of stress, energy intake and daylight. Nicotinamide adenine dinucleotide (NAD+)-
dependent deacetylase reactions are carried out by sirtuins (Imai, Armstrong et al. 2000) 
and, as in the case of SIRT4, also have NAD+-dependent mono-ADP-ribosyltransferase 
activity (Haigis, Mostoslavsky et al. 2006). Sirtuins are thus categorized by this NAD+ 
binding and catalytic domain or sirtuin core domain (Frye 2000). Due to the differences in 
binding to substrates, enzyme activity and patterns of expression sirtuins have very diverse 
roles (Haigis and Guarente 2006). The sirtuin proteins are distinctive in their activity as they 
act based on the metabolic state of the cell and the mechanisms by which they act as 
substrate specific protein deacetylases in order to carry out deacetylation are also unique 
(Haigis and Sinclair 2010). 
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SIRT1 has more recently been found to regulate the immune system (Haigis and Sinclair 
2010), by way of being able to suppress inflammation (Yoshizaki, Milne et al. 2009) and 
inhibit transcription of NF-κB (Yeung, Hoberg et al. 2004). It has been found to bind to the 
aforementioned Rel proteins, specifically RelA/p65, which halts NF-κB transcription (Yeung, 
Hoberg et al. 2004). Sirtuins may also indirectly regulate NF-κB by interacting with FOXO 
proteins which can inhibit TNFα-induced activation of NF-κB (Peng 2007). Importantly, for 
this study, SIRT1 has been shown to impact on obesity and other metabolic disease due to 
it affecting lipid accumulation in adipocytes and supporting this was the finding that 
increased inflammation and expression of NF-κB existed in liver specific-SIRT1 null mice. 
This was due to the activity of peroxisome proliferators-activated receptor alpha (PPARα) 
which is involved in the response to fasting and in the absence of SIRT1 which is known to 
suppress PPARα signalling (Purushotham, Schug et al. 2009).  
Studies have, therefore, suggested that SIRT1 has beneficial effects on metabolic disorders 
and the associated state of chronic inflammation due to its ability to stop inflammation in 
adipocytes and macrophages. Lipid-induced inflammation was found in lower levels in a 
study that investigated SIRT1-overexpressing (and resveratrol treated) mice which showed 
reduced NF-κB activity and decreased TNFα and IL-6 expression (Baur, Pearson et al. 2006). 
These two pro-inflammatory cytokines, TNFα and IL-6, were found to be associated with 
change in pain whilst in a standing position and changes in TNFα were positively associated 
with change in total knee pain.  
Another inflammatory marker positively associated with a change in knee pain whilst in a 
sitting position or lying down was high sensitivity CRP (Stannus, Jones et al. 2013). SIRT6 is 
another sirtuin linked to ageing, genome stability and the immune response (Mostoslavsky, 
Chua et al. 2006). SIRT6, similarly, has been shown to interact with Rel proteins and stop 
expression of NF-κB targets (Kawahara, Michishita et al. 2009). SIRT6 null mice have 
showed increased signs of ageing (Mostoslavsky, Chua et al. 2006) along with other defects 
and increased expression of NF-κB targets (Kawahara, Michishita et al. 2009). SIRT6 has 
also been shown to regulate TNF production (Van Gool, Galli et al. 2009). 
As a result of the suggestion that inflammation plays a key role in OA, studies have focused 
their efforts on biomarkers of tissue inflammation in relation to the OA. The Rotterdam 
study investigated factors such as CRP found to be released from tissues by the activity of 
MMPs. This study found that biomarkers of tissue inflammation such as MMP-dependent 
degradation of CRP, the collagen biomarker C1M (a measure of soft tissue degradation) and 
established biomarkers of OA progression such as serum cartilage oligomeric protein 
(COMP) were found to be positively associated with progression of OA confirming that 
inflammation has pathological relevance in the disease (Hosnijeh, Siebuhr et al. 2016). 
Those biological mechanisms of importance when looking at the development of chronic 
pain include neurological, endocrine and immunological and genetic mechanisms (Smith, 
Macfarlane et al. 2007). Pain is produced by nociception where stimulation is repeated on 
unmyelinated and small myelinated fibres which processes stimuli that damage the joint 
and surrounding tissue (Felson 2005). Mechanoreceptors and nerve endings in the 
surrounding structures of the joint are then stimulated, excluding cartilage, resulting in the 
origin of joint pain (Haviv, Bronak et al. 2013). There is an absence of nociceptors and pain 
fibres in cartilage (Felson, Chaisson et al. 2001) which supports and gives an explanation for 
those suffering from radiographic OA, who have been diagnosed and given a Kellgren-
Lawrence score, but may not be able to feel pain (Zhang and Jordan 2010). As one the main 
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structural changes in OA is cartilage degradation, other potential explanations are 
discussed below as to why pain is felt and can become so severe 
Many other tissues affected by OA do have pain fibres present (Felson, Chaisson et al. 
2001) and inflammation lowers the threshold for nociception. Nociceptive fibres are found 
within the bone marrow and bone in the periosteum and bone marrow lesions (BMLs) have 
been shown to be strongly associated with the presence of pain in knee osteoarthritis 
(Felson, Chaisson et al. 2001).  
Osteoarthritic pain is diagnosed as either acute or chronic, however, the progression from 
acute to chronic pain is not well understood. Acute pain, which is a result of stimulation of 
mechanoreceptors and pain receptors, is believed to be protective by acting as a warning 
of continuous tissue damage and is a symptom of the disease process. Chronic pain, 
however, is a disease process where activation of N-methyl-D-aspartate (NMDA) receptors 
stimulates release of the neuropeptide substance P which has been found within many 
tissues in the joint and is thought to be involved in the activation of inflammatory cells and 
secretion of inflammatory mediators (Allen 2011). Knee pain is suggested to be due to 
inflammation within the synovium, potentially due to synovial fluid escaping due to 
swelling of the joint capsule (Haviv, Bronak et al. 2013)), putting pressure on the nerve 
endings, ligaments and joint capsule (Cuzdan Coskun, Ay et al. 2015). The growth of new 
nerve fibres have been seen to penetrate cartilage and osteophytes, which is helped by 
angiogenesis and which are also involved in mediating the pain described by osteoarthritic 
patients.  
Chronic peripheral pain stimuli relating to OA is suggested to lead to hyperexcitability of 
neurons (Kosek and Ordeberg 2000). Pain experienced that is not necessarily due to 
osteoarthritic changes can be a result of convergence pain where pain surrounding the 
knee originates from a different source due to nociceptors converging on the same pain 
projection neurons. Pain can also be due to tissue injury and problems with the regulation 
of the transmission of pain. Tissue repair eventually follows nerve sensitization but some 
individuals experience persistent pain due to transport of substance P within the neurons 
which is assisted by COX-2 upregulation. Therefore in patients with radiographic OA, the 
origin of pain can be due to many factors and not solely to radiographic features (Allen 
2011).  
FIGURE 4. PAIN TRANSMISSION PATHWAY SHOWING THE MOVEMENT OF PAIN SIGNALS FROM AN 
OSTEOARTHRITIC KNEE (HAVIV, BRONAK ET AL. 2013). 
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Central sensitisation is the process by which central pain processing pathways become 
more sensitive due to pain-inhibitory mechanisms malfunctioning and altered sensory 
processing in the brain. As a result of increased reactivity in the central nervous system, the 
regulatory pathways for the autonomic, endocrine and immune system can become 
disrupted. The nociceptive system is controlled by pain modulating pathways that suppress 
surrounding neuronal activity. In the case of central sensitisation and CWP there is a 
malfunctioning of these pain inhibitory pathways. For peripheral and central sensitisation 
to take place an ongoing source of pain is needed. Damage or inflammation of peripheral 
tissues that inflicts pain is capable of causing CWP (Meeus and Nijs 2007). 
There are several hypotheses regarding the pathophysiology of CWP including that of the 
potential role of cytokines. Levels of anti-inflammatory cytokines have been found to be 
reduced in patients with CWP (Üçeyler, Valenza et al. 2006). Previous research has found 
that, in the induction of neuropathic pain, there was a role for tumor necrosis factor-alpha 
(TNF-α) which activates p38 mitogen-activated kinase. (Schäfers, Svensson et al. 2003). 
Many studies have shown that pro-inflammatory cytokines are involved in the 
development of both neuropathic and inflammatory pain in both their ability directly 
(receptor-mediated) and by involving further mediators (Sommer and Kress 2004).  
1.5 Risk Factors of Osteoarthritis and Pain 
 
Having discussed OA and pain, as the main focus of this research, as well as the potential 
biological mechanisms underlying these, this chapter will overview to what extent the 
pathways and mechanisms at a cellular level are reflected in risk factors of OA/pain. 
A review into the epidemiology of OA identified aetiological factors involved in the 
development of the joint disease as old age, female gender, obesity, bone density, muscle 
weakness, joint laxity and injury to or repetitive use of joints (Zhang and Jordan 2010). 
Genetic factors also have an important contribution to the joint disease with regard to 
cartilage loss (Thakur, Dawes et al. 2013) and, specifically with regard to hand OA, it has 
been suggested that the effects of genes may be specific to the different pathways of 
pathological progression (Doherty, Spector et al. 2000). 
Although the aetiology is still not fully understood, age does appear to be the biggest 
contributing factor as the greatest incidence of OA is seen in women aged 50-59 years and 
in men aged 60-69 years (Sun, Gooch et al. 2007). Population based radiographic surveys 
also revealed that the prevalence of OA, whilst varying with geographical location, rises 
with age at all joint sites (Arden and Cooper 2005) and is found worldwide with prevalence 
of knee osteoarthritis having been reported at 64% for both genders and 74% for females 
(Vos, Flaxman et al. 2013).  However, OA can also occur in those of younger age, specifically 
knee OA, where traumatic injury (such as ligament rupture or meniscal tears) has occurred 
in the past, making previous injury a risk factor for accelerated development of knee OA 
(Ackerman, Kemp et al. 2017). A study looking into American athletes found that partial 
meniscectomy and reconstructive surgery of the anterior cruciate ligament in particular, 
are associated with knee OA in the elite (Smith, Nepple et al. 2016). Early onset of hip OA, 
however, can be seen when the patient has experienced developmental complications such 
as structural deformities e.g. femoroacetabular impingement syndrome (Ackerman, Kemp 
et al. 2017). Already having joint disease also seems to be a contributing factor and 
potentially influences OA at other sites. Hand OA, for instance, has been found to be 
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related to the occurrence of OA at other sites and was found to be strongly associated with 
the prevalence of total knee replacement, alongside BMI (Jonsson, Helgadottir et al. 2011). 
Obesity, measured by BMI, is also a major risk factor for OA (Elliott, Chapman et al. 2013). 
Studies have found a statistically significant association between radiographic hand OA and 
BMI and confirms that seen in many others. The relationship between hip and knee OA and 
an elevated BMI was traditionally thought to be due to the excess weight having a negative 
impact on the joint (Holliday, McWilliams et al. 2011). There are many studies and reviews 
surrounding weight management and the relationship between obesity and OA (De Luis, 
Izaola et al. 2012).  
Ethnic groups are another suggested potential risk factor due to differing results from 
cross-sectional studies. Hip OA, for instance, has been found to be lowest in Asians and 
highest in white Europeans (Lievense, Bierma‐Zeinstra et al. 2002). Dietary magnesium 
intake has been found to be associated with radiographic knee OA but this association was 
not found in African American ethnic groups (Qin, Shi et al. 2012). These differences could 
be due to variations in lifestyle factors such as diet. As a part of dietary patterns moderate 
alcohol consumption has been found to be associated with a higher KL grade and an 
increase in severity of OA but is was also significantly associated with double the odds of 
erosive hand OA (Haugen, Magnusson et al. 2017). This, alongside smoking, is a lifestyle 
choice and is a modifiable risk factor.  
Smoking is suggested to be pro-inflammatory but despite the success of campaigns it still 
remains prevalent (Dean and Gormsen Hansen 2012) and has been found to be linked with 
inflammation associated with OA (Amin, Niu et al. 2007). Male OA patients who smoke, for 
instance, experience more knee pain and cartilage loss than non-smoking males (Amin, Niu 
et al. 2007). Symptoms and function in older adults with knee OA has been seen to improve 
with moderate levels of physical activity such as yoga and aerobic/strengthening exercises 
(Cheung, Wyman et al. 2016) suggesting that the modifiable ‘inactive lifestyle’ risk factor 
also plays a key role in OA (Dean and Gormsen Hansen 2012).  
Many studies have produced differing results between males and females suggesting that 
gender is also a risk factor for OA. An epidemiological study including both males and 
females, which assessed the prevalence of mild and severe radiological OA in 22 joints, 
found that a higher proportion of severe radiological OA in most joints was found in 
females (Van Saase, Van Romunde et al. 1989). Females also seemed to have greater risk of 
knee OA in a GOAL study that looked at associations with body shape in each decade of life 
(Holliday, McWilliams et al. 2011). Hormones may explain these differences as they are 
thought to play a role in the development of OA due to the observed increase in OA in 
women at the time of menopause (Zhang and Jordan 2010). Higher rates of radiographic 
knee OA cases have also been found in women who had previously undergone a 
hysterectomy compared with those who had not (Spector, Hart et al. 1991). OA symptoms 
in females are typically seen around menopausal age and is more pronounced in the hand 
as opposed to the hip and knee joints (discussed further in Chapter 8). Research has found 
that women who have undergone ovariectomy or pharmacologically induced menopause 
experience increased knee and hand OA (Watt 2016).  
The risk factors affecting the progression of OA such as obesity, joint injury and physical 
activity all appear to be joint specific. A factor, therefore, might show no association with 
OA of one joint but could show an association with another (Arden and Cooper 2005). 
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Looking specifically within knee OA at the early stages of disease, results (using an elderly 
population from the first cohort within the Rotterdam Study) showed that genetic and 
biomechanical markers alongside questionnaire variables and the presence of OA at other 
joint sites did not predict knee OA incidence as strongly as minor radiographic degenerative 
X-ray features could. This has been suggested to be a hugely important finding due to the 
very minor and doubtful changes rarely being recorded by radiologists (Kerkhof, Bierma-
Zeinstra et al. 2014).  
Epidemiological studies over the last decade investigating chronic widespread 
musculoskeletal pain have found higher rates of complaints of this major health problem 
among women (Gran 2003). A study published in 2005 revealed different risk factors 
associated with musculoskeletal pain in men and women over the age of 72. From this 
Framingham study, pain in one or more regions was reported in 63% of women compared 
to 52% of men and widespread pain was prevalent in 15% of women compared to 5% of 
men (Leveille, Zhang et al. 2005).  
More recent studies have demonstrated that women are at substantially greater risk for 
many clinical pain conditions (Fillingim, King et al. 2009).  A Swedish study, conducted over 
a 3 year time period, looking at the development and persistence of chronic widespread 
pain investigated three groups (those with no chronic pain, chronic regional pain and CWP. 
Findings were that risk factors varied amongst individuals. A family history of chronic pain 
and higher age group was shown to predict the development of CWP but having personal 
social support and a habit of drinking alcohol on a weekly basis was shown to be protective 
(Bergman, Herrström et al. 2002).  
Pain has also been shown to be associated with disability, poorer health, and a history of 
back pain prior to 65 years of age in both men and women. BMI, systolic blood pressure 
and symptoms of depression were associated with pain in women but in men pain was 
associated with radiographic OA (Leveille, Zhang et al. 2005). CWP was shown to be 
associated with mortality in a study that followed a cohort over 12 years and showed 
higher rates of mortality in a group initially reporting CWP as opposed to other groups 
(Andersson 2004). 
The results of a study that investigated health status in the general population aged 20-74 
years, found that physical and mental health status are affected by musculoskeletal pain 
and predict the further development of pain (Bergman, Jacobsson et al. 2004). Other 
studies have investigated the strong association between CWP and psychosocial distress in 
particular to assess the impact of various factors on the development of new cases of CWP. 
Findings were that individuals that showed features of somatization, health seeking 
behaviour and poor sleep were at substantially increased odds of developing CWP (Gupta, 
Silman et al. 2007). In most cases pain is persistent in patients in clinic but in community 
derived patients only half experienced persistent pain and it was predominantly those with 
psychological distress. Studies have indeed showed that individuals are more likely to have 
persistent widespread pain when showing features of somatization and that prevalence 
increases with greater exposure to risk factors (McBeth, Macfarlane et al. 2001).  
Lower back pain and neck pain have both been reported as a consequence of previous 
disease/injury (Vos, Flaxman et al. 2013). Studies investigating chronic widespread pain 
using the stricter definition CWP-M found that factors such as education level, lower socio-
economic group, lower social support, immigrant status and living in a compromised 
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residential area all associated with CWP (Bergman 2005). Loneliness is also an established 
risk factor for musculoskeletal pain (Docking, Fleming et al. 2011) based on the theory that 
in socially isolated areas there is greater reporting of symptoms due to the lack of 
distractions (Docking, Beasley et al. 2015). It is also suggested that personality could be 
important as a recent study found that high neuroticism and low conscientiousness were 
associated with a high level of chronic pain (Bucourt, Martaillé et al. 2016). CWP-M was 
also found to be associated with psychological disturbance, low levels of self-care and the 
reporting of other symptoms (Hunt, Silman et al. 1999). CWP is also linked to fatigue and 
these are two of the symptoms involved in the diagnosis of Fibromyalgia which has been 
found to be associated with workplace stress,  bullying in the workplace and high workload 
suggesting that stress is an important contributing factor towards the development of pain 
(Kivimaki, Leino-Arjas et al. 2004).  
It is therefore important to consider these many factors involved in the development of OA 
and pain when conducting an investigation into pain associated with OA, as there are a 
number of factors that could potentially be involved in the development and progression of 
the disease. Having discussed how lifestyle factors can influence OA and how they act as 
risk factors for OA/pain, the next chapter will overview nutrition and why it has become 
such a major focus of OA research. 
1.6 The Evidence for the role of Nutrition in the development of 
Osteoarthritis 
 
Due to there being no known cure for OA, prevention is therefore of great importance and 
it is suggested that diet could be key to this. Dietary manipulation is one of the ways in 
which patients feel they can help themselves to relieve symptoms and the most common 
dietary approaches are vegan, vegetarian, Mediterranean and elemental diets (Rayman 
and Pattison 2008). The literature surrounding diet suggests that consumption mainly of 
meat with the use of animal fats combined with the typical lifestyle seen in a western 
culture (Landaeta-Diaz, Fernandez et al. 2013) is pro-inflammatory (Dean and Gormsen 
Hansen 2012). In contrast, a diet which is plant based, rich in fibre and fruit and vegetables 
and which favours olive oil (Landaeta-Diaz, Fernandez et al. 2013), seen typically in 
Mediterranean and African lifestyles, is suggested to be anti-inflammatory (Dean and 
Hansen, 2012).  
Nutrition has, therefore, become the main focus of research for its potential as a 
preventative treatment for OA. The theory that nutritional compounds have a ‘build up’ 
effect over time and therefore chronic diseases should benefit more from this than acute 
diseases (Ameye and Chee 2006) has been explored by many. In the past the idea of dietary 
manipulation has been dismissed by sceptic rheumatologists mainly due to a lack of 
evidence (Rayman and Pattison 2008). This chapter explores the current literature on diet 
and nutrition in relation to OA/pain with a focus on the Mediterranean style diet and the 
plant based compounds found within this dietary pattern. 
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 Mediterranean Diet and Hormesis 
 
The Mediterranean diet (Med diet) is reflective of the dietary pattern found in 
Mediterranean countries such as Greece, Italy and Spain in the 1960s (Rayman and Pattison 
2008). This dietary pattern is now considered an established healthy eating behaviour 
(Veronese, Stubbs et al. 2016) and is considered to be more of a way of life rather than 
simply a dietary pattern (Estruch and Bach-Faig 2018). The Med diet is rich in long chain ω-
3 PUFAs, nutrients known to have antioxidant properties and unrefined carbohydrates 
(Rayman and Pattison 2008) as it is made up of foods that are largely plant based (fruits, 
vegetables, wholegrain cereals, potatoes, beans, nuts and seeds) with locally sourced 
seasonal foods that have undergone minimal processing (e.g. fish and olive oil) as the main 
sources of fat. Low to moderate amounts of dairy products (mainly cheese and yoghurt), 
meat and meat products (poultry, eggs and red meat) and alcohol (usually in the form of 
red wine) are also found within this dietary pattern (Willett, Sacks et al. 1995). These foods 
characteristic of the Med diet are referred to as ‘functional foods’, known to have positive 
effects on health and wellbeing (Oliviero, Spinella et al. 2015). 
 
Changing an entire dietary pattern (as opposed to incorporating foods into an existing diet) 
is suggested to be a better approach to take in order to gain the benefits from a 
Mediterranean style diet. Multiple processes are targeted as a result of consuming a Med 
diet, so investigating the health impacts from the dietary pattern as a whole as opposed to 
evaluating the impact of single nutrients on the inflammatory process (Cevenini, Monti et 
al. 2013) is also suggested to be a better approach as synergistic effects of compounds 
within the dietary pattern are taken into account. This ‘whole diet’ approach is a strength 
of the NU-AGE dietary intervention study which found that adopting a Med diet is 
beneficial for improving the health of adults (Berendsen, van de Rest et al. 2018).  
 
The most reported and widely discussed beneficial effect of consuming a Mediterranean 
diet is on inflammation (Oliviero, Spinella et al. 2015). Adhering to a Med diet has been 
shown to be associated with healthy ageing in those middle aged which suggests that this 
dietary pattern would be a good option for maintaining good overall health (Assmann, 
Adjibade et al. 2017). Adherence to the Med diet has been shown to reduce the incidence 
of cardiovascular disease by approximately 30%, type-2 diabetes by 40% and metabolic 
syndrome by approximately 10% (Estruch, Ros et al. 2013). Some studies have drawn 
associations between a Med diet and reduction in cancer risk (Barak and Fridman 2017), 
however this conflicts with studies such as those using the EPIC cohort (Molina-Montes, 
Sánchez et al. 2017) so further research is needed to understand the effects of a Med diet 
on cancer.  
 
It has also been suggested that a diet rich in the foods found within the Med diet is 
protective of Alzheimer’s disease and Dementia (Solfrizzi, Frisardi et al. 2011) and of other 
neurodegenerative diseases (Liu, Gao et al. 2019). Results from the SUN project showed 
that adherence to the Med diet is associated with a better self-perceived mental and 
physical health related quality of life (Sánchez, Ruano et al. 2012). Other studies have 
shown that high adherence to this diet is related to better academic performance mediated 
by quality of sleep (Adelantado‐Renau, Beltran‐Valls et al. 2019) and shows protective 
effects for mood and mental health (Albaladejo-Blázquez, Ferrer-Cascales et al. 2018) for 
instance reduced odds of depression, anxiety and psychological distress (Sadeghi, Keshteli 
et al. 2019). Longitudinal studies have found that the Mediterranean diet is associated with 
lower incidence of frailty (‘increased vulnerability to stressors causing limited capacity to 
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maintain homeostasis’). This in turn affects the number of hospital admissions and 
institutionalisations usually seen with the transition from frailty to disability which implies 
that consuming a Med diet could indirectly reduce these adverse outcomes within a 
population (Veronese, Stubbs et al. 2018).   
 
When exploring OA specifically studies are limited with most being of cross-sectional design 
and with a focus on knee OA. Those studies that have investigated OA have found that 
adherence to a Med diet is associated with a better quality of life in terms of decreased 
pain, disability and symptoms of depression (Veronese, Stubbs et al. 2016). Cross-sectional 
studies have found that adherence to the Med diet is associated with lower prevalence of 
knee OA (Veronese, Stubbs et al. 2017). It is worth noting that in these studies the 
consistent factor was that those participants that had higher adherence to the Med diet 
also had lower BMI’s, were in good health medically speaking and had a higher level of 
education. A study that used MRI assessment to investigate knee cartilage found that high 
adherence to a Med diet is associated with a significant improvement in knee cartilage 
(Veronese, La Tegola et al. 2018) and a longitudinal study found that a Med diet is 
associated with a lower risk of radiographic symptomatic knee OA. Those with high 
adherence also reported lower risk of pain worsening (Veronese, Koyanagi et al. 2018). 
Although very few studies have investigated the association between adherence to a Med 
diet and OA a recent systematic review concluded that despite the lack of epidemiological 
evidence and the need for more long term interventions there does appear to be a 
relationship between adherence to a Med diet and OA (Morales-Ivorra, Romera-Baures et 
al. 2018). 
 
Despite the research emerging showing the beneficial effects of the Med diet, adherence to 
this dietary pattern is threatened by socioeconomic and lifestyle factors (Estruch, Ros et al. 
2013). For example items within the Med diet have a relatively low cost and are readily 
available in southern European countries but are only available to those within higher 
socioeconomic classes in northern European countries due to the increased cost (Veglia, 
Baldassarre et al. 2019). However, even in those traditional areas most suited to this 
dietary style, fewer people are adhering to it (Rizza, De Gara et al. 2016).  
 
Adherence to a Med diet has been investigated due to being particularly poor in young 
adolescents, who are perhaps influenced by the temptations of the modern westernized 
world. Fast paced lifestyles and successful marketing strategies result in consumption of 
highly processed snacks and fast foods. It has also been shown that greater feelings of 
loneliness result in poor adherence to the Med diet (Ferrer-Cascales, Albaladejo-Blázquez 
et al. 2018) and an addictive eating pattern high in sugars, salts and fats ensues. This 
association is thought to be indirect due to loneliness increasing stress levels and therefore 
the influential relationship between stress and eating behaviours becomes relevant (Ferrer-
Cascales, Albaladejo-Blázquez et al. 2018). Despite the Med diet having been recognised as 
promoting quality of life and lifelong wellbeing and now standing as a recommendation for 
primary and secondary prevention of major chronic diseases (Lichtenstein, Appel et al. 
2006), there still exists an increasing trend in a shift towards vegetarian, vegan and raw 
dietary options. Despite the available foods in Mediterranean countries the shift away from 
this traditional dietary pattern suggests that this diet needs adaptation in order to be a 
feasible option alongside new lifestyle, agricultural and environmental constraints (Estruch 
and Bach-Faig 2018). 
 
With the Med diet being made up mostly of plant based foods, it is important to 
understand and consider how, by consuming a Med diet, these foods confer a beneficial 
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effect. Polyphenols are natural chemicals produced by plants in response, and by way of 
adapting, to the stresses of the environment. Having the ability to move is a luxury plants 
do not possess however they are still able to avoid extreme exposure, dehydration and 
resist attack so the response to stress, although chemically similar to ours, is more complex 
and superior (Hooper, Hooper et al. 2010). Hormesis is the name given to the process 
whereby mild amounts of stress are undergone in small doses by being exposed to those 
factors which would normally be harmful if taken to the extreme (Rattan 2008). In 1538, 
Paracelsus was the first to theorise about this phenomenon known as mithridatism: “All 
things are poison and not without poison; only the dose makes the thing not a poison”. This 
was followed by Schulz in 1887 who demonstrated that there can be opposite effects from 
a toxic substance dependent on the dose. Pre-conditioning is the term given to the process 
whereby mild stressors activate and upregulate defence pathways at a cellular and 
molecular level. The successive adaptation and protective properties that this process 
results in is named post-conditioning. The hormesis paradigm conceptualises caloric 
restriction which is the most studied area within the area of nutrition and ageing (Martucci, 
Ostan et al. 2017). 
 
FIGURE 5. DOSE RESPONSE CURVE AS A RESULT OF HORMETIC STIMULI 
The stressors stimulate the cellular stress response and other pathways of repair in order 
to improve health, fitness and adaptability to our environment (Rattan 2008). These 
mechanisms include inflammation, antioxidant system activation, autophagy, heat shock 
protein response, unfolded protein response, DNA damage response and sirtuin response 
(Martucci, Ostan et al. 2017).    
There has been a lot of epidemiological research that shows that diets rich in flavonoids (a 
sub class of polyphenols) are associated with lower incidence of disease (Lu, Xiao et al. 
2013). Flavones, Flavonols, Flavanones, Flavanols, Isoflavones and Anthocyanidins are all 
classifications of Flavonoids in which the chemical structure contains at least one sugar 
group bound to phenolic groups by glycosidic linkages (see Figure 6 below) (Kinoshita, Lepp 
et al. 2006). Flavonoids are the most studied class (Chaaban, Ioannou et al. 2017) and there 
have been more than 6000 different flavonoids found. These are widely distributed in 
plants with hundreds having been found in edible plants (Falcone Ferreyra, Rius et al. 
2012). Flavonoids are believed to play a role in preventing disease due to their strong 
antioxidant properties as ROS are heavily involved in the pathogenesis of disease. However, 
it has been suggested that beneficial effects of flavonoids could be indirect. Their abilities 
are likely to include filtering UV light and acting as signalling molecules due to the low 
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bioavailability of exogenous flavonoids. Indeed many of the health benefits we see from 
consuming flavonoids can actually be explained biologically by the functions of their targets 
(Lu, Xiao et al. 2013). 
 
FIGURE 6. THE CHEMICAL STRUCTURES OF FLAVONOIDS (KINOSHITA, LEPP ET AL. 2006). 
 
It is suggested that the best sources of polyphenols are those foods grown in the wild 
where they have undergone more stress than those grown under controlled and ‘ideal’ 
conditions to increase yield (Hooper, Hooper et al. 2010). This is likely due to the effects of 
light and oxygen on antioxidant activity. It has been found that flavonoids in raw food are 
stable to light due to their protection by the food matrix whereas in processed foods 
flavonoids experience photo degradation although research is still to understand more 
about the effects of light and oxygen on antioxidant activity (Chaaban, Ioannou et al. 2017)   
Foods that seemingly produce high levels of polyphenols are highly recommended in diet 
plans and have gained the name SIRT foods for their ability to activate a family of genes 
called sirtuins. These are referred to as master regulators (Li 2013), due to sirtuin activity 
having been found to show a clear association with cell metabolism (Ghosh, George et al. 
2010). With the intake of a Med diet there are multiple mechanisms that are likely to be 
responsible for the resulting protective effect (Veglia, Baldassarre et al. 2019).   
The next section of this chapter outlines in depth previous research into many of the plant 
based compounds found within a Mediterranean dietary pattern that potentially act as 
hormetins and discusses the biological mechanisms through which they are suggested to 
have their protective effects.   
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 Diet and Osteoarthritis/Pain: Pathological and Epidemiological 
Evidence 
 
Epidemiological studies alongside intervention studies have focused their attention on diet 
and anti-inflammatory bioactive compounds. Many dietary compounds have been studied 
over the years particularly polyphenols: isoflavone, anthocyanin, quercertin, catechin and 
resveratrol (Rosa, Zulet et al. 2012). It is proposed and there is ever increasing evidence to 
support the suggestion that a western diet is pro-inflammatory and a plant based diet, seen 
typically in Mediterranean and African lifestyles, is anti-inflammatory (Dean and Gormsen 
Hansen 2012). The differences between these two lifestyles are the consumption mainly of 
meat and a proposed inactive lifestyle in western culture and the Mediterranean diet is 
largely plant based, rich in fibre and fruit and vegetables and favours olive oil over animal 
fats (Landaeta-Diaz, Fernandez et al. 2013). This part of the chapter explores dietary 
compounds and biological mechanisms through which they may confer their beneficial 
effects.  
1.6.2.1 The Importance of Dietary Compounds 
 
Studies have shown that up to 75% of patients believed that their condition is affected by 
the food they eat. Some foods are thought to exacerbate joint inflammation due to their 
acidity, actually alkalize the blood and ought to be included in a healthy diet due to being 
rich in micronutrients e.g citrus fruits which contain vitamin C and tomatoes which contain 
lycopene. Although randomised controlled trial results reflect amalgamated findings from a 
group of subjects they could be missing specific needs and therefore benefits on an 
individual level (Rayman and Pattison 2008). 
There has been much research into the effects of different chondroprotective agents on 
the degradation of cartilage in osteoarthritis. Williams et.al., studied the effect of dietary 
components on OA, in twins which identified diallyl disulphide (DADs), found in allium 
vegetables such as garlic to be associated with reduced hip OA occurrence as DADs blocked 
expression of key matrix-degrading proteases (Williams, Skinner et al. 2010). 
There are also reported effects of milk peptides, plant sterol and stanol, l-carnitine and α-
lipoic acid on inflammation (Rosa, Zulet et al. 2012). Previous studies have looked at these 
anti-inflammatory effects using plant agents such as the sterol guggulsterone (found in 
gum resin) which was found to down-regulate activation of NF-κB, showing potential for 
the treatment of joint disease (Khanna, Sethi et al. 2007). Intake of plant 
phytosterols/stanols has been found through intervention trials to significantly reduce lipid 
levels, such as cholesterol (Wu, Fu et al. 2009). The phytosterol stigmasterol has been 
found to bind to chondrocyte membranes and inhibit IL-1 induced MMP and ADAMTS4 
expression. This was confirmed by the reduction in cartilage degradation due to suppressed 
MMP expression, through intra articular injection of stigmasterol in rabbits (Chen, Yu et al. 
2012).  
Previous research has investigated the effects of the Isothiocyanate (ITC) known as 
Sulforaphane (SFN). ITCs are bioactive compounds found in a number of foods particularly 
cruciferous vegetables (Steck, Gammon et al. 2007) and are known to interfere with 
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multiple signalling pathways (Kim, Yeo et al. 2009). There are many structurally related ITCs 
such as allyl ITC, benzyl ITC, phenethyl ITC and SFN (Tang, Li et al. 2006). Each ITC is formed 
from the metabolism of a different glucosinolate as seen in Figure 6 (Steck, Gammon et al. 
2007), SFN being a good example (Gasper, Al-janobi et al. 2005).  
Hydrolysis of the glucosinolates to ITCs is dependent upon a glucohydrolase enzyme known 
as myrosinase of which activity is from plant enzymes and microflora of the intestines. 
There are many different glucosinolates found within cruciferous vegetables of which each 
produces a different ITC. Two of the most abundant glucosinolates in broccoli are 
glucoraphanin and glucoerucin and when hydrolysed these form SFN and the ITC 
metabolite erucin (ERN) (Clarke, Hsu et al. 2011). The naturally occurring ITC, SFN, is an 
inducer of phase 2 enzymes which gives it chemopreventative activity and anti-
inflammatory activity has also been identified.  
A study aiming to determine whether SFN has any influence over MMP production and its 
effect on the activation of MAP kinases and NF-κB found that lower concentrations of SFN 
within chondrocytes were not cytotoxic, but at 50 µM SFN the treatments caused 
chondrocyte death. Results from this investigation showed that SFN decreased NF-κB 
protein expression, downregulated NF-κB activation and inhibited MMP production and 
activation in chondrocytes (Kim, Yeo et al. 2009). This shows success in SFN’s ability and 
potential to become a treatment which has been investigated further by the Clark lab with 
a SFN feeding trial. This investigation involved participants with end stage OA consuming a 
high SFN diet for ten days before their joint replacement and it was found that there was a 
build-up of SFN and that it was indeed measurable within the joint after that ten day period 
(Davidson, Gardner et al. 2017). Similar results have been reported with ERN bioactivity 
and it is suggested that a better understanding of the bioavailability of bioactive ITCs is 
needed (Clarke, Hsu et al. 2011). Investigations into the effect of the bioactive compound 
SFN on the control of MMP synthesis and activity in chondrocytes has demonstrated it to 
be a chondroprotective agent and it is being targeted in an attempt to inhibit degeneration 
of cartilage in OA (Kim, Yeo et al. 2009). 
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Research into the chondroprotective effects of pomegranate extract have revealed 
cartilage-protective active compounds as well as green tea which has also been shown to 
have anti-arthritic effects (Khalifé and Zafarullah 2011). This is due to the catechins, also 
found in dark chocolate, which have been found to inhibit cartilage degradation in vivo 
(Adcocks, Collin et al. 2002). Epigallocatechin gallate and epicatechin gallate have also been 
shown to effectively inhibit ADAMTS-4 and -5 activity (Vankemmelbeke, Jones et al. 2003).   
Berries, containing anthocyanins (Manach, Scalbert et al. 2004), curcumin found in turmeric 
and resveratrol, found in the skin of red grapes, have all shown effects in improving pain 
and inflammation in OA.  
A recent study that investigated the effects of strawberries on pain and markers of 
inflammation found that in obese adults with radiographic knee OA, IL-1, IL-6 and MMP3 
were significantly decreased and pain was also reduced after 12 weeks of daily strawberry 
supplementation (Schell, Scofield et al. 2017). Resveratrol is an activator of Sirt1 (Lam, 
Peterson et al. 2013) which when deleted in mice causes an increased rate of development 
of OA (Matsuzaki, Matsushita et al. 2013). Resveratrol has been found to inhibit NF-κB in 
chondrocytes and is able to block inflammation and apoptosis (Lei, Wang et al. 2012). 
Resveratrol has also been found to have synergistic effects on chondrocytes with curcumin 
(Shakibaei, Mobasheri et al. 2011). Curcumin has been found to be an inhibitor of NF-κB, 
JNK, STAT and MAPK signalling, inhibiting MMP expression in cartilage (Innes, Fuller et al. 
2003), COX2 expression and other inflammatory mediators (Shakibaei, John et al. 2007).  
FIGURE 7. THE METABOLITES OF ITCS (GASPER, AL-JANOBI ET AL. 2005). 
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1.6.2.2 Micronutrients 
 
Epidemiological studies have looked at a variety of components within the diet in relation 
to radiographic OA. A study using the Hertfordshire Cohort, which looked at Vitamin D 
intake and Vitamin D Receptor Polymorphisms, showed Vitamin D intake to be associated 
with knee pain (Muraki, Dennison et al. 2011). It is suggested that Vitamin D has a direct 
effect on cartilage metabolism as it is believed to be a stimulant for the synthesis of 
proteoglycan in mature chondrocytes (Corvol, Dumontier et al. 1981). A Framingham 
Cohort Study revealed an increased risk of the progression of OA with lower Vitamin D 
intake (McAlindon, Felson et al. 1996) and a reduction in risk for radiographic OA with a 
higher consumption of Vitamin C (McAlindon, Jacques et al. 1996).  
Vitamin C is considered a highly effective antioxidant due to its ability to react with free 
radicals and ROS (Li, Zeng et al. 2016) and has been shown to prevent changes such as 
increased oxidative stress, loss of proteoglycan, apoptosis. It has been found to prevent 
increased levels of pro-inflammatory cytokines such as ILs, MMPs and TNF-α induced in an 
in vitro model using chondrocyte-like cells (Chiu, Hu et al. 2016). A reduction in the risk of 
knee OA in terms of reduced cartilage loss has been found with Vitamin C intake as well as 
reduced risk of the development of knee pain (McAlindon, Jacques et al. 1996) although 
more recently there have been some conflicting results from cross-sectional studies (Li, 
Zeng et al. 2016). Longitudinal studies have not found Vitamin C to be protective of 
progression of knee OA however multivariate analyses has shown that Vitamin C 
supplements have a protective effect on the development of knee OA (Peregoy and Wilder 
2011).  
Beta carotene, a precursor to Vitamin A (Maiani, Periago Castón et al. 2009), and Vitamin E 
were also seen to reduce the risk of OA progression (McAlindon, Jacques et al. 1996). 
Intake of other carotenoids, such as lutein and zeaxanthin, are associated with decreased 
risk of cartilage defects (Wang, Hodge et al. 2007) and Vitamin E is suggested to protect 
against changes in ECM gene expression when induced by hydrogen peroxide (Mehmood, 
Wajid et al. 2013). 
The Research on Osteoarthritis against Disability (ROAD) study was designed in 2005 in 
order to clarify both genetic and environmental risk factors of OA. Dietary nutritional 
factors and the prevalence of radiographic knee OA were investigated and Vitamin K intake 
was lower in those groups that had a higher Kellgren Lawrence grade suggesting that 
Vitamin K, which regulates mineralisation in bone and cartilage (Krüger, Westenfeld et al. 
2009), may have a protective role in OA (Oka, Akune et al. 2009). A study in Japan found 
that Vitamins K, B1, B2, B6 and C showed an association with minimum joint space width 
and Vitamins K, E, B1, B2, B3 (niacin) and B6 showed an association with osteophytes in 
females only (Muraki, Akune et al. 2014).   
1.6.2.3 Dietary Fatty Acids  
 
Fatty acids are essential nutrients and are involved in a number of biological processes. 
Fatty acids within the diet consist of saturated fats, trans-fatty acids, mono-unsaturated 
fatty acids (MUFAs) and poly-unsaturated fatty acids (PUFAs) (Tokuyama and Nakamoto 
2011). 
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As previously mentioned obesity is a major risk factor for OA (Elliott, Chapman et al. 2013) 
and excess weight can be due to diet and the saturated fats being incorporated into the 
adipose tissue along with MUFAs which can either be stored or oxidized for energy with the 
unsaturated fats (Lopez 2012).  
The main dietary polyunsaturated fatty acids (PUFAs) can be classified as either long chain 
ω-3 (n-3) or functional ω-6 (n-6). ω-3 Fatty acids (FAs) e.g. eicosapentaenoic acid (EPA) and 
α-linolenic acid (LA) are found in dietary sources such as fish oils, walnuts and canola oils 
whereas ω-6 FAs e.g. LA and arachidonic acid (AA) can be found in foods such as corn, 
soybean, sunflower oils and meats (Brenna, Salem et al. 2009).  
Fatty acids are suggested to be of great importance as palmitic, oleic and linoleic acids 
account for 85% of total fatty acid content in cartilage (Villalvilla, Gómez et al. 2013). The 
most abundant MUFA in the human diet is the ω-9 FA Oleic acid. Some MUFAs and 
saturated FAs can be synthesized from proteins and carbohydrates within the diet but the 
enzymes needed to form ω-3 or ω-6 FAs are lacking, ω-3 ALA and ω-6 LA cannot be 
produced and converting ALA into EPA and Docosahexaenoic acid (DHA) is limited in 
humans. Those who suffer from metabolic syndrome, iron, vitamin or mineral deficiencies, 
consume ω-6 FAs, trans-FAs and alcohol in excess or are on medications that are known to 
affect metabolism have decreased production of EPA and DHA metabolites from ALA 
(Brenna, Salem et al. 2009).  
Eicosanoids and docosanoids are the end products of the cyclooxygenase and 
lipooxygenase pathways (Lopez 2012) (which synthesize prostaglandins and leukotrienes 
(Villalvilla, Gómez et al. 2013)) as a result of the fatty acids EPA and DHA being utilised as a 
substrate and are known to have anti-inflammatory properties. However when the ω-6 FAs 
LA and AA are used, the end products instead have pro-inflammatory properties. ω-6 FAs, 
although important in other biological processes, when taken in excess levels to ω-3 FAs 
seem to shift the eicosanoid profile towards one that is pro-inflammatory (Lopez 2012). 
Unsurprisingly inhibition of cyclooxygenase has been found to lead to less inflammatory 
mediators (Villalvilla, Gómez et al. 2013). EPA and DHA are also very beneficial for 
cardiovascular, immune, cognitive and metabolic health alongside a positive contribution 
to muscular strength and function, mood and vision when ω-3 fish oil supplements rich in 
these PUFAs are consumed.  
Dietary lipids are thought to play an important role in carotenoid bioavailability despite 
their low lipids levels (Unlu, Bohn et al. 2005). De Roos et.al., conducted a study that found 
individuals, with serum levels of trans-beta-carotene and zeaxanthin were more likely to 
have knee OA whereas serum levels of the carotenoids lutein or beta-cryptoxanthin were 
70% less likely to have knee OA than the controls (De Roos, Arab et al. 2001). 
Saturated fatty acids and MUFAs are used as substrates for energy however PUFAs are 
metabolised to produce phospholipids and prostaglandins which have a number of 
biological functions. Dietary deficiencies in ω-6 LA and ω-3 ALA have been found to result 
in a number of different health problems (e.g. lowered immunity) showing their vital role 
(Tokuyama and Nakamoto 2011) which has earned them the term essential fatty acids as 
the human body can synthesize all but these two of the fatty acids it requires (Patterson, 
Wall et al. 2012). Human studies investigating the effect of the different fatty acids types 
on OA are limited to knee OA and are inconsistent (Loef, Ioan-Facsinay et al. 2019). The 
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figure below shows the metabolism of PUFAs within the diet (Tokuyama and Nakamoto 
2011). 
 
FIGURE 8. PUFAS AS PRECURSERS FOR COMPLEX AND INTERLINKED PATHWAYS OF METABOLISM 
(TOKUYAMA AND NAKAMOTO 2011). 
 Availability and Sources of Fatty Acids and Lipids 
 
Studies in the 1960s found that 0.5%-1% of human cartilage was made up of lipids 
(Stockwell 1967). Since then many studies have investigated lipid metabolism in relation to 
rheumatic signs and symptoms due to there being a link between inflammation, tissue 
repair, defence mechanisms and fluctuations in lipid levels (Esteve, Ricart et al. 2005). The 
status of cartilage and the general development of OA is known to be dependent upon the 
availability of lipids (Villalvilla, Gómez et al. 2013) and lipoproteins are suggested to play a 
crucial role in the process of acute and chronic inflammation (Oliviero, Nigro et al. 2012).  
As important nutrients in chondrocyte structure, signalling and metabolism, lipids are 
available to chondrocytes, which make up 2%-5% of total cartilage, through diffusion from 
surrounding tissues, e.g. synovial fluid, although availability is restricted by matrix 
permeability dependent upon the charge and size of molecules and also through de novo 
synthesis. Phospholipids are found within the cell membrane and the synovial fluid and are 
thought to play a key role in lubrication to protect cartilage surface.  
Phosphatidylethanolamine, phosphatidylcholine and sphingomyelin are all major 
components of cartilage boundary lubricant and free fatty acids may be incorporated by 
chondrocytes into these components as well as phosphatidylinositol and triacylglycerol. 
Extracellular fatty acids have been found to control lipid composition in chondrocytes and 
changes in lipid composition in cartilage have been found to be correlated with severity. In 
the advanced stages of OA there have been increases seen in total fatty acid content of as 
much as 440%. Both cholesterol biosynthesis and fatty acid metabolism occur in normal 
chondrocytes and lipids are required to travel through the complex matrix within cartilage. 
Fatty acids penetrate the ECM much more easily than larger complexes and research is 
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trying to understand exactly how this happens and how lipids then affect chondrocyte 
metabolism (Villalvilla, Gómez et al. 2013).  
Despite mature joints containing calcified cartilage which creates a potential barrier to lipid 
diffusion between calcified and non-calcified cartilage (Villalvilla, Gómez et al. 2013), both 
mature and immature joints are alike in their cartilage permeability for uncharged solutes 
(Torzilli, Grande et al. 1998). The matrix is negatively charged which stops movement of 
smaller negatively charged molecules but does allow movement of smaller positively 
charged solutes which means ability to move through cartilage depends on valency and 
molecule affinity for the matrix and larger molecules have altered movement through due 
to their charge (Maroudas 1976). In order to increase their solubility lipids exist as 
lipoproteins in blood plasma or bind to carrier proteins but becoming a larger molecule 
does then restrict their movement through cartilage. However, some larger molecules are 
able to separate in order to travel through tissues e.g. lauric acid separating from albumin 
at the surface of cartilage so that both can independently diffuse through (Arkill and 
Winlove 2006).  
It has been found that dietary lipid intake can affect fatty acid composition in cartilage (Xu, 
Watkins et al. 1994). Cartilage permeability increases with the progression of OA due to the 
increase in proteases (LOTKE and GRANDA 1971). Lipid movement through cartilage can, 
therefore, be easily achieved by diffusion from synovial fluid (Maroudas 1976) which 
contains proteins that can reach chondrocytes and initiate an inflammatory response 
(Sohn, Sokolove et al. 2012). Diffusion of molecules from the synovial fluid can be modified 
by repeated loading and compression (Villalvilla, Gómez et al. 2013) and due to the 
increased synovial permeability under inflammatory conditions and the ability of synovial 
fluid to filter plasma, lipoproteins are suggested to be able to diffuse from the circulation 
into the synovial fluid. Again this is thought to be determined by inflammation and vascular 
permeability of the synovium as well as the plasma concentrations of each lipid. In 
inflammatory arthritis, lipid levels have been found to be higher in synovial fluid except for 
HDL. The majority of serum lipid levels have been found to be higher specifically in OA as 
opposed to other inflammatory arthritides and fluctuations in these lipid levels are 
mediated by cytokines (Oliviero, Nigro et al. 2012) .  
Previous studies have also investigated whether subchondral bone also has the ability to 
provide lipids to cartilage. The transport of molecules from subchondral bone to cartilage in 
mice was found and suggested to be due to pores in non-mineralised regions of calcified 
cartilage allowing solute transport (Pan, Zhou et al. 2009). There have been suggestions of 
this same mechanism in humans but molecular transport has since been suggested to exist 
between bone and bone marrow vessels and calcified cartilage through the overlapping 
extensions of cartilage within the chondro-osseous region of mature cartilage (Lyons, 
McClure et al. 2006).  
The evidence throughout this chapter highlights the differences between dietary fatty acids 
and confirms the sources and role of lipids in OA. Lipid accumulation in cartilage, as a result 
of diet however, still needs clarification (Xu, Watkins et al. 1994).  
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1.7 Obesity and Osteoarthritis 
 
 Overnutrition 
 
Obesity and over eating is an existing problem which can lead to a variety of health issues 
and nutrition, when in excess, can bring on lipotoxic effects (Pottie, Presle et al. 2006). 
There is now a well-established link between obesity and OA however, the story of the role 
of excessive body weight in the development of OA is ongoing.  
Previously there have been many epidemiological studies that have investigated the effects 
of body mass on the main weight baring joints; the hip and the knee but with other joints 
such as the hand also at risk of OA comes the suggestion that obesity does not just have 
direct effects in terms of more weight loading on joints (Pottie, Presle et al. 2006) but that 
other biological mechanisms could be at work (Triantaphyllidou, Kalyvioti et al. 2013) there 
seems to be evidence for the existence of complex metabolic pathways in the pathology of 
rheumatic disease (Pottie, Presle et al. 2006). Studies have more recently found OA to be 
influenced by dietary fatty acid content (Wu, Jain et al. 2014). A study on obese patients 
with chronic OA using a 12 week weight reduction program revealed that a diet low in 
calories, with a commercial formula, was able to improve body weight, body fat, blood 
lipids and metabolic response. In addition patients with greater than 9% weight reduction 
reported a better quality of life (De Luis, Izaola et al. 2012). 
Changes in lipid metabolism are a suggested influence on OA (Triantaphyllidou, Kalyvioti et 
al. 2013) but the question remains as to whether this is a potential risk factor or a 
consequence of OA (Villalvilla, Gómez et al. 2013). This chapter will continue to discuss 
lipids, lipid metabolism and fatty acid associations with OA. 
 Obesity and Hand OA 
 
“Obese people do not walk on their hands” (Yusuf 2012). There is a definite link between 
obesity and the development of OA: a risk factor that has long been recognised (Felson, 
Lawrence et al. 2000). BMI has been found, in the Rotterdam Study, to be associated with 
osteoarthritis of the DIP, PIP and metacarpophalangeal joints in the hand (Hoeven, Kavousi 
et al. 2013). Osteoarthritis of the hip and knee can be attributed to the overloading of or 
increased stress as they are weight baring joints but occurrence of OA in the hand, a non-
weight baring joint, cannot be explained by an increase in weight. It is quite clear, therefore 
that other factors play a role in the development of hand OA.  
Osteoarthritis has been linked to fluctuations in hormones for over a century. Terms such 
as ‘menopausal arthritis’, ‘climacteric arthritis’, ‘endocrine arthritis’, ‘hypoglandular 
arthritis’, ‘chronic villous arthritis’ and ‘primary generalised OA’ have all been used over 
time, since the 1920s whilst studies continued to try and explain the stiffness, 
inflammation, pain and the presence of Heberden’s nodes in the joints of those that were 
typically middle aged, obese and female (Spector and Campion 1989). One of the earlier 
studies in 1938 noted that some of these joint symptoms occurred post menopause or 
after having a hysterectomy (Hall 1938). Later in the 1980s, a case control study found that 
women with OA had twice the number of hysterectomies in comparison with the age 
matched controls (Spector, Brown et al. 1988). A more recent study found that joint 
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symptoms are twice as likely to be seen in post-menopausal women as in those 
experiencing menopause as shown by findings from the Melbourne Women’s Mid-life 
Health Project. Hand OA, when experienced post menopause, also frequently occurs 
without OA occurring at other sites (Szoeke, Cicuttini et al. 2008).  
Previous observational studies of HRT and hand OA have shown mixed results. A study in 
1997 found that current MHT use showed a protective effect for distal interphalangeal 
(DIP) joint OA (Spector, Nandra et al. 1997), however a study in 2003 then reported that 
use of HRT was associated with more severe and a higher prevalence of distal 
interphalangeal (DIP) disease (Cooley, Stankovich et al. 2003). There have been no 
differences found in MHT use or non-use and hand OA (Maheu, Dreiser et al. 2000), 
however, there has been a positive association found between hand OA and MHT when 
taken for less than 5 years and those using MHT for more than 1 year were also found to be 
at an increased risk of hand OA (Von Mühlen, Morton et al. 2002).  
Studies investigating associations between reproductive factors and cartilage have found 
no association with HRT (Wei, Venn et al. 2011). Obesity in females is a cause of 
hyperoestrogenism due to the formation of oestrogen from androstenedione in adipose 
tissue suggesting the endocrine system plays a key role in OA development. However, it 
was once thought that a lack of oestrogens could be a cause of OA but after years of 
studies showing that oestrogens do not improve clinical OA it has since been suggested 
that the ratio of high concentrations of oestrogen, found both before and after 
menopause, in relation to the decreasing levels of progesterone is of more importance with 
regard to the development of OA (Spector and Campion 1989).  
1.8 The Role of Genetics in the development of OA 
 
In addition to biomechanical and inflammatory mechanisms, genetics are also suggested to 
play a role in the development of OA/pain. Dietary modification to reduce occurrence of 
disease is now being investigated widely but this can be difficult due to the complex genetic 
factors that influence food choice. The role of nutritional factors in OA needs to be 
interpreted against the knowledge that there is a genetic contribution to OA. With around 
half of the risk of developing clinical OA accounted for by heritability (Zengini, Finan et al. 
2016), this chapter explores the strong genetic component in OA. 
The finding of genes that influence OA have come to light through genome wide 
association studies (GWAS). GWAS has widely recognised many SNPs which means studies 
can now investigate those genetic factors most important in the risk of OA (Hochberg, 
Yerges-Armstrong et al. 2013). Due to SNPs occurring randomly every 100 to 300 
nucleotides throughout the genome and the discovery that SNP sequences at specific loci 
are shared by the population, SNPs have been used as a genetic testing marker (Klug, 
Cummings et al. 2009). Studies are now identifying genes involved in the development of 
OA which could provide clues as to the pathological progression (Hochberg, Yerges-
Armstrong et al. 2013).  
There have been various candidate genes, found to be implicated in OA. The arcOGEN 
GWAS, which was a large powered GWAS, found that the genes type II procollagen 
(COL2A1), oestrogen receptor-α (ERS-α), growth differentiation factor 5 (GDF5), double von 
Willebrand factor A domains (DVWA), fizzled-related protein (FRZB), Asporin and IL-6 all 
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conferred susceptibility to OA (Consortium 2012). Due to few genetic variants having been 
identified for OA, a more recent GWAS investigating a structural component of OA to try 
and reduce heterogeneity identified four novel loci phosphatidylinositol 3-kinase receptor 1 
(PIK3R1), fibroblast growth factor receptor 3 (FGFR3), trehalase (TREH) and transforming 
growth factor α (TGFA) to be associated with cartilage thickness (Castaño-Betancourt, 
Evans et al. 2016).  
Of particular interest are those genetic factors that have a shared aetiology with obesity 
and lipid metabolism. By gaining access to genes of interest, investigations into the 
mechanisms of cause and effect, by Mendelian Randomisation, will allow us to see whether 
a particular risk factor that contributes to OA and pain is indeed causal. This will contribute 
to the current knowledge of genetic factors and their influence on OA and will also help us 
to understand the relationship that exists between diet and OA. 
Variants of the fat mass and obesity associated gene FTO, are of particular interest as it is 
known to be associated with increased risk of obesity. Variants of FTO are suggested to 
affect the functioning of adipocytes by disrupting repression of Iroquois 3 (IRX3) and 
Iroquois 5 (IRX5) causing a shift from energy dispelling brown adipose tissue to energy 
storing white adipose tissue (Claussnitzer, Dankel et al. 2015). The SNP rs1421085, found 
within the fat mass and obesity associated gene, is known to be associated with increased 
risk of obesity due to a T to C change. Those with the genotype that is homozygous for the 
risk allele are, on average, 3 kg heavier than those with the genotype that is homozygous 
for the protective allele (Frayling, Timpson et al. 2007). Both rs1421085 and rs17817449, 
found within FTO, have been found to be associated with adiposity, waist circumference, 
hip girth, body fat and weight (Do, Bailey et al. 2008) The SNP rs8044769 was also found 
among hundreds of others to be associated with obesity and has been reported to affect 
other SNPs from FTO (Frayling, Timpson et al. 2007).  
The Apolipoprotein A5 (APOA5) gene is linked to lipid metabolism (Chen, Ding et al. 2018). 
The ApoA1/C3/A4/A5 gene cluster is a widely investigated and well characterised region of 
the genome found to be associated with lipid levels (Gombojav, Lee et al. 2015). It has also 
been suggested that differences seen in serum lipid levels could be due to interactions 
between APOA1/C3/A5 haplotypes and alcohol consumption (Yin, Li et al. 2013). With 
triglycerides, total cholesterol, LDL-C and HDL-C not only being heritable risk factors but 
also being targets for intervention of disease (Teslovich, Musunuru et al. 2010) genetics 
studies investigating genes associated with lipids and obesity are becoming increasingly 
popular and important.  
Studies investigating the genetics of lipid levels have been focused mostly within European 
cohorts but there is potential to identify novel genes if studies could investigate lipid levels 
in other cohorts. For instance, using the EpiDREAM and INTERHEART cohorts. A study using 
these cohorts scanned 31, 739 common SNPs from candidate genes to try and identify 
novel genetic modifiers of plasma ApoB levels and found a significant association between 
SNP rs4664443, within dipeptidyl peptidase-4 (DPP4), and cholesterol, LDL-C and also ApoB 
but only in those with a BMI <25 kg/m². Another study identified just under 100 loci in 
GWAS data that showed significant genome wide associations with circulating lipids. 
(Teslovich, Musunuru et al. 2010). Looking at lipids specifically between genders, due to the 
suggested differences that exist in heritability between males and females (Weiss, Pan et 
al. 2006), four of the ninety-five loci found showed significant differences between men 
and women and five additional loci showed significant associations in females. SNP 
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rs1562398, from Krüppel-like factor 14 (KLF14), for instance was found to be associated 
with HDL-C in both genders but was significantly associated with triglycerides just in 
females. ATP-binding cassette subfamily A 8 (ABCA8) was also found to be associated with 
HDL-C in both genders and was associated with triglycerides and LDL-C but again just in 
females.  
DNA variants have also been found to regulate expression levels of nearby genes in liver 
and fat tissues. For example SNP rs9987289 (associated with both LDL-C and HDL-C) was 
found to be associated with changes in liver expression of protein phosphatase 1, 
regulatory (inhibitor) subunit 3B (PPP1R3B) (despite being 174kb away from the gene). 
SNP rs2972146 (associated with HDL-C and triglycerides) is correlated with gene 
expression of insulin receptor substrate protein 1 (IRS1) in omental fat, but is found 495kb 
away from the gene (Teslovich, Musunuru et al. 2010).  
Whilst GWAS studies revealed 18 loci associated with OA, this only accounts for a very 
small proportion of the genetic contribution in OA. Therefore, more research is needed to 
investigate interactions and contribute to current knowledge, in the hope that underlying 
mechanisms between genotype and phenotype can be better understood and potentially 
lead to other approaches to treating OA (Zengini, Finan et al. 2016). SNPs are, therefore, of 
great importance and can be used as instrumental variables in Mendelian Randomisation 
studies to investigate reverse causality.  
It is also worth noting here that epigenetic alterations may be playing a role in the genetic 
component of OA. Instead of a genetic mutation and therefore a specific allele directly 
affecting the risk of OA it could be that heritable modifications in gene function (which 
occur quickly and in response to environmental changes without altering the underlying 
DNA sequence) could be contributing towards the development of OA (Barter, Bui et al. 
2012). 
1.9 Summary of the Contribution of Nutrition and Rationale for the 
Present Study 
 
Despite the various biomechanical, genetic, endocrine and inflammatory factors that 
influence osteoarthritis and pain, the eitopathogenesis of OA still needs clarification 
(Pavelka 2017). Although there are many of studies contributing to the knowledge of diet 
and nutrition with a focus specifically on OA and associated symptoms, further 
investigation is needed and replication and validation of results in other datasets should 
also be conducted to confirm findings (Deutsch 2007). More research into this area could 
result in lifestyle improvements and better health and wellbeing opposed to a lifestyle of 
surgery, drugs, interventions and side effects. Studies are needed to investigate those who 
respond to nutrition and those who do not. Future studies also need to assess the risk 
factors, at the rates at which they are reduced, in those whose primary treatment is dietary 
intervention (Dean and Gormsen Hansen 2012). By promoting healthy nutrition, less 
saturated and trans-fat content would exist in the diet, which is the suggested mechanism 
by which inflammation is caused through being overweight (Liu, Wei et al. 2013). By 
changing lifestyle factors, such as nutrition, as a way of treating inflammation and 
alleviating symptoms there is potential for reducing the rate of the development and 
progression of OA. 
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Many types of studies exist, from cell culture to identify compounds of interest and 
laboratory studies to improve our understanding of the mechanisms of action to metabolic 
studies which look into the physiologic effects. However epidemiologic studies are needed 
to look at the relationship between diet and disease directly (Willett 2012). Further 
research into diet and nutrition and the finding of potential associations could lead to the 
identification of certain aspects of diet that may be able to alleviate symptoms or slow the 
progression of OA. It may also provide information before onset and therefore reveal a 
dietary prevention strategy easily implemented on a population scale. New evidence 
(although limited) is emerging through the literature regarding nutrition and OA but these 
effects and the relationship between nutrition and OA/pain need clarifying. Further 
research is needed before there is certainty about specific associations seen between diet 
and OA and the direction of causality between these associations. 
Research investigating lifestyle factors has improved over recent decades as large 
population based data resources have become available. These include cohorts such as the 
European Prospective Investigation into Cancer (EPIC), TWINS-UK, the Rotterdam Study, 
the Chingford Study and the Osteoarthritis Initiative (OAI). Detailed phenotypic information 
on the clinical features of OA and OA pain such as radiographic data and clinical symptoms 
together with extensive data on dietary exposures, relevant lifestyle factors such as 
smoking and physical activity and genetic data from GWAS exist. These large population 
data sets act as very useful resources for investigating OA. They are sufficiently powered 
due to their large numbers and are prospective cohort studies which identify exposure at 
present and determine future disease onset as opposed to being retrospective which 
arguably are quicker and more cost efficient but relies on sufficient information being 
available on past exposure, current exposure and risk factors. Therefore prospective cohort 
studies are considered the most powerful methodology as limitations such as recall bias 
etc. do not affect the cohort and can also account for changes to exposure status (Silman 
and Macfarlane 2002). These studies are also of longitudinal design with follow-up of 
participants and collection of additional data allowing further study of disease over 
multiple time points. This produces more reliable results than cross-sectional analyses 
where data is investigated at a single point in time.  
With these cohorts, research into diet and its effects on OA and pain can take place, 
increasing our knowledge of the contribution of various risk factors towards OA. In 
particular through investigating SNPs of interest, helping to identify those more at risk and 
leading to new ideas for treatment (preventative or otherwise). With OA causing dramatic 
changes to lifestyle, leading to other health problems and with numbers in the population 
showing it to be on the increase there is a need to investigate potential ways in which 
patients may be able to change aspects of their lifestyle in order to alleviate their 
symptoms successfully. 
In summary diet and nutrition is able to influence the underlying mechanisms such as 
inflammation involved in OA and research is ongoing into finding those dietary components 
that could have pro or anti-inflammatory effects. However more research is needed 
specifically into the associations that exist between nutrition and OA/pain for which 
sufficient dietary data is needed. Two of the large cohorts above, TWINS-UK and a subset of 
the EPIC cohort (EPIC-Norfolk cohort) are used in this research to provide additional insight 
into those lifestyle and dietary factors that play a role in OA and the onset of pain.  
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There are numerous studies on the Mediterranean diet and it’s suggested protective 
association with chronic diseases that are underlined by inflammaging. However, as 
discussed in Chapter 1, there are a very limited number of studies looking at associations 
between Mediterranean diet and OA specifically. Most of these studies have focused on 
knee OA and have also been of cross-sectional design so further studies are needed to 
investigate associations between dietary factors and OA particularly of other joints, 
especially non weight bearing joints such as the hand. The effects of dietary factors on pain 
have also been investigated previously but there is limited research looking at the effects of 
diet on pain specifically associated with OA. The TWINS-UK cohort is a great resource and 
provides a large volume of dietary data, from which a Mediterranean dietary pattern can 
be created, as well as radiographic OA and musculoskeletal pain data. This will allow an 
analysis of the analysis of dietary and OA/pain variables in order to further the knowledge 
of how diet as a modifiable factor may influence the onset or progression of OA and 
associated pain. In addition this research provides an opportunity for associations to be 
looked at in greater detail through analysis of genetic data from EPIC which allows for 
causal mechanisms to be investigated holding the potential to confirm the direction of 
causality between associations observed.  
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2 Study Design and Aims. 
 
This chapter discusses the collection and use of the data, why these two cohorts are suited 
to this research and the study design and statistical methods used to investigate the effects 
of lifestyle and dietary factors on OA/pain. 
2.1 Cohorts 
 
 TWINS-UK Data 
 
With continuing genetic studies, the demand for twin cohorts has increased and resulted in 
twin registries forming around the world. Cohorts such as the Danish Registry, the Finish 
Twin Cohort Study and the UK Adult Twin Registry (TWINS-UK) all contain thousands of 
phenotyped twins and hold this data for a number of different traits (Moayyeri, Hammond 
et al. 2013). The present study uses data collected by the UK Adult Twin registry which was 
started in 1993. The cohort of approximately 10,000 twins, aged 16 to 85, were recruited 
through media campaigns with an overall aim of recruiting healthy volunteers and not 
selecting individuals for specific studies. Most twins are subjected to clinical assessment 
and given detailed questionnaires regarding aspects of lifestyle at many different time 
points (Spector and Williams 2006). All data was collected at St. Thomas’s Hospital, Kings 
College London, and passed onto researchers at the Norwich Medical School, University of 
East Anglia in a collaborative effort to investigate the associations between nutrition, 
genetics and disease. Data was cleaned eliminating those individuals that have missing data 
for the variables of interest. Datasets were then merged, using Stata, in order for the 
variables for each individual of interest to be contained within the same dataset allowing 
statistical analysis to take place. 
The dietary data, used in this study, consists of dietary food patterns. Dietary data was 
collected through food frequency questionnaires (FFQs) and principle component analysis 
(PCA) created five dietary derived patterns (discussed further in Chapter 6). This type of 
data collection enables the capturing of data over a long period of time in order to 
investigate associations between dietary intake and disease (Willett 2012). FFQs are known 
to be sufficient at measuring dietary intake, however, due to inaccuracies in estimating 
food consumption frequency, questionnaires are still not as reliable or accurate as weighed 
food diaries (Bingham, Gill et al. 1994). One of the main reasons for the inaccuracy of FFQs 
is due to the nature of under-reporting by participants. The FFQ used in the Twins was the 
same one that had been previously used in EPIC (discussed further in Chapter 6) which was 
validated against urinary biomarkers and plasma ascorbic acid levels (Bingham, Gill et al. 
1997). 
 EPIC and EPIC-Norfolk Data 
 
The European Prospective Investigation into Cancer (EPIC) study contains half a million 
adult volunteers recruited between 1992 and 2000 and is a multicentre prospective study 
with participants from 23 centres across 10 western European countries. The study was 
designed primarily to follow participants for cancer incidence and cause-specific mortality 
42 
 
but has been used to study other diseases as well. The ages ranged between 35 and 70 
years and the study populations are samples of volunteers agreeing to participate.  
The data used in this study, from the EPIC-Norfolk cohort, is an example of a prospective 
cohort study whereby exposure in the past is taken into account and disease status 
currently is investigated. It contains clinical OA data from the Hospital Episode Statistics 
(HES) Database, joint pain data and dietary data (outlined further in Chapter 3). 
Questionnaires used included questions on education, socio-economic status, current job, 
current and past occupation which might have led to exposure to carcinogens, history of 
previous illness, disorders or surgical operations, lifetime history of tobacco smoking, 
lifetime history of consumption of alcoholic beverages, physical activity (occupational, 
walking, cycling, gardening, housework, physical exercise, climbing stairs), menstrual and 
reproductive history and use of exogenous hormones for contraception and 
postmenopausal replacement therapy.  
Those adult volunteers who gave informed consent were invited to participate either in 
person or by post. Firstly individuals were sent a questionnaire on diet and a questionnaire 
on lifestyle which, for most, were completed at home and a visit to the study centre for an 
examination followed. Lifestyle variables were collected through non dietary 
questionnaires and separate dietary questionnaires addressed usual diet. Blood samples 
were taken from so called healthy populations from which fractions were separated and 
stored long-term. Nutritional methods in EPIC-Norfolk included FFQs, 7 day food diaries 
and standardised computer-assisted 24-hour dietary recall which took place at each centre 
on stratified random samples to calibrate dietary measurements, making the sub-cohorts 
comparable on an absolute scale, correcting for over and underestimations in baseline 
dietary assessments between centres. The study follows the participants in order to pick up 
on the occurrence of cancer, disease and to observe overall mortality. This allows for 
incidence and mortality to be compared by exposure variables. For any changes to aspects 
of lifestyle that are strongly suspected or well known to be related to disease risk, follow-
up questionnaires are used at regular intervals to keep information up to date (Arriola, 
Martinez-Camblor et al. 2010).  
2.2 Study Design and Statistical Analyses 
 
Epidemiological studies are needed to investigate factors which affect the existence of a 
health problem in the hope of gaining control over disease (Domínguez-Almendros, 
Benítez-Parejo et al. 2011) and, in the case of the present study, help to establish potential 
causes of clinical and radiographic OA. The aim of this epidemiological study is to use 
previously validated statistical methods to predict and assess the onset and development 
of OA and pain in OA in relation to dietary intake.  
Cohort studies, when conducting longitudinal analysis, allow for the control of confounding 
effects and participants are followed to investigate disease rates whilst analysing dietary 
data collected from participants who do not have the disease. Cohort studies are also less 
susceptible to bias as disease cannot affect diet due to dietary data being collected before 
onset. With larger numbers in these cohorts the relationships between diet and disease are 
not affected by low rates of participation. These studies also allow for repeated assessment 
over time which has been made possible by use of self-administered questionnaires. 
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However the disadvantages are that this is quite costly and there can be losses in follow up 
data. Some cohorts do not have a sufficient number of cases, therefore, case-control 
studies are a useful study design used in nutritional epidemiology (Willett 2012). 
Using the cohorts described previously containing information about current exposure and 
disease state, there is the chance to determine the association of potential risk factors with 
the disease. The EPIC-Norfolk cohort is utilised in this research but using a case-control 
study design specifically for Chapters 3, 4 and 9 as this study design allows results to be 
produced more quickly due to participants not being followed, however, the validity of 
results must be considered in relation to potential methodological bias. This study design is 
also inexpensive, in comparison to other study designs, whilst identifying those with 
chronic cases whether symptoms are short lived or long term.  
EPIC-Norfolk analysis in this thesis is of both a cross-sectional and longitudinal design 
whereas TWINS-UK analysese are cross-sectional only. A longitudinal study design can be 
used in this cohort study to follow subjects over time. These studies aim to determine 
whether the status of initial exposure might subsequently influence the risk of disease. 
Within the cross-sectional design of this research is also a type of association study. These 
are used when there are many measures of association needed to quantify the level of 
increased risk of exposure to predictor/explanatory variables which could be responsible 
for the onset of disease (Silman and Macfarlane 2002). In this study odd ratios are the 
effect measure used to quantify the strength of associations in both the cross-sectional and 
longitudinal study design used within this research. 
EPIC-Norfolk is used in this research to identify factors that best predict OA and pain, a 
case-control analysis using a logistic regression method, with a backwards stepwise 
algorithm, removed each variable that is non-significant to leave those variables most 
significantly predicting the outcome (Hip OA, Knee OA, Hip pain and Knee pain) as those 
that best explain the variation in the data. This method was chosen due to the modest 
number of selected potential explanatory variables in EPIC-Norfolk. In case-control studies, 
data relating to potential risk factors is collected from patients already with the disease and 
compared to those in which the disease is absent.  
Within the TWINS-UK cross-sectional analysis a multi-level mixed effects logistic regression 
with adjustment for confounders of the diet-OA/pain relationship is used. This method was 
chosen as it takes into account the hierarchical structure within the data (that participants 
exist as individuals but within twin pairs). A logistic regression analysis is able to measure 
the strength of a relationship between two variables of interest; the dependent variable 
being radiographic OA and musculoskeletal pain which is assessed in relation to the 
independent variables (dietary pattern scores) whilst allowing for control over confounding 
factors. This is one of the most widely used methods in epidemiological research 
(Domínguez-Almendros, Benítez-Parejo et al. 2011). 
Table 1 describes the data, study design and statistical analysis for each of the following 
analysis chapters.  
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TABLE 1. OVERVIEW OF THESIS ANALYSIS CHAPTERS. 
 
 
 
  
Analysis Chapters  
(Chapters 3-10) Cohort Data Study Design Statistical Analysis 
Chapter 3. An Investigation 
into associations between 
Dietary and Lifestyle Factors 
and Osteoarthritis/Pain of 
the Hip and Knee. EPIC-Norfolk Cross-sectional 
Case-control 
Study 
Regression analysis 
with Stepwise 
Algorithm and 
Randomisation 
Function. 
Chapter 4. A Gender-Specific 
Investigation into Dietary 
and Lifestyle Factors and 
Osteoarthritis/Pain of the 
Hip and Knee. EPIC-Norfolk Cross-sectional 
Case-control 
Study 
Regression analysis 
with Stepwise 
Algorithm and 
Randomisation 
Function. 
Chapter 5. Exploring Dietary 
Patterns and Radiographic 
OA of the Hip, Knee and 
Hand. TWINS-UK Cross-sectional Cohort Study 
Multi-level Mixed 
Effects Logistic 
Regression 
Chapter 6. Exploring Dietary 
Patterns and 
Musculoskeletal 
Pain/Chronic Widespread 
Pain. TWINS-UK Cross-sectional Cohort Study 
Multi-level Mixed 
Effects Logistic 
Regression 
Chapter 7. Exploring the 
Mediterranean Dietary 
Pattern and Radiographic 
OA, Musculoskeletal Pain 
and CWP. TWINS-UK Cross-sectional Cohort Study 
Multi-level Mixed 
Effects Logistic 
Regression 
Chapter 8. An Investigation 
into Serum Blood Lipids and 
Radiographic OA, 
Musculoskeletal Pain and 
Chronic Widespread Pain. TWINS-UK Cross-sectional Cohort Study 
Multi-level Mixed 
Effects Logistic 
Regression 
Chapter 9. An Investigation 
into Dietary and Lifestyle 
Factors and Change and 
Incidence of Hip and Knee 
Pain. EPIC-Norfolk Longitudinal 
Case-control 
Study 
Regression analysis 
with Stepwise 
Algorithm and 
Randomisation 
Function. 
Chapter 10. Investigating 
Cause and Effect. An Analysis 
of Single Nucleotide 
Polymorphism Data from the 
EPIC-Norfolk Cohort. EPIC-Norfolk Cross sectional 
Mendelian 
Randomisation 
Study 
Two-stage least 
squares regression 
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2.3 Aims and Objectives 
 
This project aims to contribute to the existing literature and give further valuable insight 
into the effects of diet on OA and pain by analysing data within the two cohorts described 
previously, EPIC-Norfolk and TWINS-UK. 
 
This thesis aims to: 
1. Further our understanding of the relationship between lifestyle and dietary factors 
and osteoarthritis of weight bearing joints such as the hip and knee and of non-
weight bearing joints such as the hand. 
2. Further our understanding of the relationship between lifestyle and dietary factors 
and joint pain associated with OA, again in both weight bearing joints (such as the 
knee, hip and foot) and non-weight bearing joints (such as the hand, elbow and 
shoulder). 
3. Further understand the direction of causality between explanatory factors of 
interest and OA/pain. 
The objectives of this research are to: 
1. Investigate the relationship between lifestyle and dietary factors and clinical OA of 
the hip and knee in the EPIC-Norfolk cohort.  
2. Using joint pain as a proxy for OA, investigate associations between lifestyle and 
dietary factors and joint pain of the hip and knee in EPIC-Norfolk.    
3. Further investigate the relationship between diet and radiographic OA of the hip, 
knee and hand by analysing PCA derived dietary patterns created from FFQ data in 
TWINS-UK. 
4. Using joint pain as a proxy for OA and chronic widespread pain as a proxy for joint 
pain, investigate associations between diet and musculoskeletal pain variables in 
TWINS-UK. 
 
5. Investigate further any initial exploratory cross-sectional associations found in EPIC 
using available data from TWINS-UK. 
6. Using EPIC-Norfolk Longitudinal joint pain data, further investigate any dietary 
associations found from the cross-sectional analysis of OA/pain in order to 
replicate and validate findings. 
7. Request genetic data from EPIC-Norfolk and use a Mendelian Randomisation 
approach to better understand in which direction relationships may occur to 
produce findings on selected SNPs of interest and their association with OA.  
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Figure 9 shows the flow of the following chapters, starting with cross-sectional analysis 
investigating EPIC variables to explore those factors that best predict OA and 
musculoskeletal pain. Due to female gender influencing the onset and progression of 
OA/pain, further analysis took place to investigate these same factors in separate analysis 
for males and females and with females stratified by age. TWINS-UK provides extensive 
dietary data so analysis took place to investigate associations between dietary patterns and 
OA/musculoskeletal pain and the dietary data provided the chance to create a 
Mediterranean dietary pattern to investigate OA and pain. Due to the results from the EPIC 
and TWINS-UK analysis the effects of blood lipids were also investigated. However whether 
an association is in fact casual is difficult to determine throughout cross-sectional analysis 
so further analysis of a longitudinal design took place in EPIC with the final chapter using 
single nucleotide polymorphisms to investigate reverse causality.  
 
 
  
Investigating factors that 
best predict 
OA/musculoskeletal pain in 
both males and females in 
EPIC-Norfolk (Chapter 3). 
FIGURE 9. FLOWCHART SHOWING HOW THE CHAPTERS CONTAINING ANALYSIS IN THIS THESIS ARE LINKED. 
Investigating factors that 
best predict 
OA/musculoskeletal pain in 
males and females 
separately and in females 
when stratified by age in 
EPIC-Norfolk (Chapter 4). 
Investigating 
associations between 
dietary patterns and OA 
in females in TWINS-UK 
(Chapter 5).  
Investigating 
associations between 
dietary patterns and 
Musculoskeletal Pain in 
females in TWINS-UK 
(Chapter 6).  
Investigating 
associations between 
Mediterranean Diet and 
OA/Musculoskeletal 
Pain in TWINS-UK 
(Chapter 7). 
Investigating 
associations 
between 
blood lipids 
and 
OA/musculosk
eletal pain in 
TWINS-UK 
(Chapter 8). 
Investigating factors that 
best predict 
musculoskeletal pain in 
both males and females in 
EPIC-Norfolk (Chapter 9). 
Investigating 
cause and 
effect using 
SNPs and OA 
data in both 
males and 
females in EPIC-
Norfolk       
(Chapter 10). 
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3 An Investigation into associations between Dietary and Lifestyle 
Factors and Osteoarthritis/Pain of the Hip and Knee. A Case-
Control Analysis using Data from EPIC-Norfolk. 
 
3.1 Chapter Overview 
 
OA and musculoskeletal pain are subject to influence from multiple lifestyle and dietary 
factors as discussed in Chapter 1. Previous research has suggested that both dietary 
manipulation and modification of lifestyle factors are ways in which patients can help 
themselves to alleviate symptoms. This chapter investigates associations within the EPIC-
Norfolk cohort, using a case-control analysis of cross-sectional design to explore those 
factors that best predict clinical OA and pain of the hip and knee. The main findings from 
this analysis is that age and BMI are consistently associated with OA and pain. Consumption 
of fatty foods is also positively associated with hip and knee OA and Triglycerides are 
positively associated with knee OA and knee pain. 
3.2 Introduction 
 
EPIC-Norfolk is one of two UK centres within EPIC. The EPIC-Norfolk cohort contains dietary 
and lifestyle data alongside clinical OA and pain data of the hip and knee. This allows the 
opportunity to investigate the aims of this project using a large cohort, containing both 
male and female participants.  
EPIC-Norfolk included a baseline health examination (1st health check) of 25,639 men and 
women, aged 40–79 years of age. These volunteers were recruited between 1993 and 
1997, from East Anglia, via general practice registers. At baseline, there exists nutritional 
data and clinical OA data for diagnosis of hip and knee OA. Participants were invited to a 
follow-up assessment (2nd health check), between 1998 and 2000, which included the same 
tests as undertaken at baseline in addition to further variables. Between 2006 and 2011, 
the 3rd health check occurred with 8623 participants (aged 48–92 years), to investigate 
conditions relevant to ageing (Day, Oakes et al. 1999) (see Figure 10). Lifestyle and pain 
data were therefore collected at three different time points post-baseline but there is no 
pain data available at baseline so this cross-sectional analysis uses the pain data collected 
at the first health check (the first time point at which pain data became available). 
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FIGURE 10. EPIC-NORFOLK TIMELINE OF DATA COLLECTION (WWW.MRC-
EPID.CAM.AC.UK/RESEARCH/STUDIES/EPIC-NORFOLK). 
 
Figure 10 outlines when the EPIC-Norfolk data, for each of the variables of interest, was 
collected and the method by which this was done. 
Data collected from FFQs and lifestyle questionnaires was requested from EPIC-Norfolk to 
investigate the effects of lifestyle and dietary factors on OA and pain. This aimed to 
determine, to what extent, diet plays a role in predicting the onset of disease and also 
explore those lifestyle factors that best predict the onset of OA/pain. This subset of the 
EPIC-Norfolk cohort differs from TWINS-UK (investigated in the following chapters) in that 
it has a larger number of participants, contains both male and female participants and 
contains data on hip pain but not hand pain. EPIC-Norfolk also contains pain data at 
multiple time points, enabling a longitudinal approach (please see Chapter 9).  
The EPIC-Norfolk cohort, therefore, provides a good opportunity to conduct an exploratory 
analysis to investigate which dietary factors alongside lifestyle factors best predict clinical 
OA and musculoskeletal pain. 
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3.3 Methods 
 
 Clinical OA Data 
 
Hip OA and Knee OA variables were gained by linking existing EPIC-Norfolk data from 
participants to the Hospital Episode Statistics (HES) Database which holds information on 
20, 517 patients, some of whom have been diagnosed with OA and some of whom have 
undergone surgery for end stage OA. The HES OA data for EPIC-Norfolk analysis was coded 
0 for no diagnosed OA and 1 for any degree of OA severity. Table 2 below shows the 
numbers for the presence and absence of knee and hip OA within the EPIC-Norfolk cohort. 
TABLE 2. CHARACTERISTICS OF EPIC-NORFOLK HES OA DATA. 
OA variable Present Absent 
Knee OA 789 19728 
Hip OA 680 19837 
 
 Pain Data 
Pain data within EPIC-Norfolk was collected at multiple time points: 18 months post 
baseline (first health check), 3 years post baseline (second health check) and 10 years post 
baseline (third health check). The pain data used for the cross-sectional analysis (Table 3 
below) was that of the first health check post baseline. 
TABLE 3. CHARACTERISTICS OF PAIN DATA AT FIRST HEALTH CHECK. 
  
 Pain 
 
No 
Pain Missing 
Hip 
Pain 2467 17199 850 
Knee 
Pain 3886 15897 733 
 
Knee, hip and back pain in EPIC-Norfolk is defined as ‘Have you had hip/knee pain on most 
days of the last month?’ 
 Dietary Data 
 
Using previously developed and validated methods (Willett 2012), dietary intake was 
assessed in EPIC-Norfolk. The method which represents the dietary data used in this study 
was collected via a semi-quantitative food-frequency questionnaire. A 130-item, semi-
quantitative FFQ, based on the FFQ used in the Nurses’ Health Study, was designed and 
used at the 1st health check to evaluate the habitual diet of participants over the past year.  
Participants were asked how often they consumed each food, on average, within the last 
year of which the options were:  
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 Never or less than once per month 
 1-3 times per month 
 Once a week 
 2-4 times per week 
 5-6 times per week 
 Once a day 
 2-3 times per day 
 4-5 times per day 
 6 or more times per day 
Further questions on type and brand of foods and method of cooking followed and 
participants were instructed not to leave any questions within the FFQ blank but to 
estimate as best they could. Food intake values were then calculated from the FFQ data 
through the use of Compositional Analyses from Frequency Estimates (CAFE) program and 
extreme outliers of nutrient intake were flagged when identifying the top and bottom 0.5% 
of the ratio of energy intake to estimated basal metabolic rate.  
The range of EPIC FFQ data available to use for this thesis was limited and dietary intakes 
were recorded as a combination of both weight of food (g/day) and portions of food (per 
day/week) where food groups were classified as the following: 1= Never, 2= Seldom, 3= 
Once a week, 4= 2-4 times a week, 5= 5-6 times a week, 6= once or more daily (see tables 
below).  
To gain blood lipid data, non-fasting blood samples were taken by venepuncture. Serum 
concentrations of total cholesterol and HDL were measured with RA 1000 Technicon 
analyser and when triglycerides did not exceed 4mmol/l LDL was calculated using the 
Friedewald formula. 
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 Characteristics of EPIC-Norfolk Data 
 
TABLE 4. CHARACTERISTICS OF CONFOUNDERS IN EPIC-NORFOLK DATA. 
  Missing data 
Total 20517  
Gender  3 
Females 11594  
Males 8920  
Mean Age (years) 60 7 
Mean BMI (kg/m²) 26.2 2204 
Physical Activity  3 
Active 8243  
Inactive 12269  
Alcohol Consumption  640 
Use 18582  
Never use 1295  
Smoking  179 
Current-use 2074  
Former-use 8498  
Never-use 9765  
HRT  8931 
Current-use 2223  
Former-use 1268  
Never-use 8031  
 
The EPIC-Norfolk cohort is useful for Investigating Osteoarthritis/Pain as the mean age of 
60 (as above) is when onset and progression is typically seen and, as can be seen from 
Tables 5-8, the mean age of those with OA/Pain cases is higher than the average for non-
cases for all outcome variables. With mean BMI at 26 (as in Table 4 above) this cohort is 
also representative of an overweight population which, again, is useful for the investigation 
of Osteoarthritis and associated pain as onset and progression are seen with increasing 
BMI. As can be seen from Tables 5-8 below the average BMI for OA/Pain cases is higher 
than non-cases. Within the EPIC-Norfolk cohort there are also more females than males 
and 18582 participants (out of a total 20517) reported consuming alcohol on a regular 
basis. The number who reported smoking currently or being a former smoker was also 
higher than those who had never smoked in both cases and non-cases and numbers of 
those who reported being active or moderately active were lower in both cases and non-
cases than those who were inactive. The average levels of blood lipids were also elevated 
for all outcome variables with the exception of HDL which was shown to be lower in knee 
OA and knee pain cases than non-cases (see Tables 5-8).  
TABLE 5. CHARACTERISTICS OF EPIC-NORFOLK DATA BY OA SITE. 
Knee OA OA 
Cases 
      Non cases       
  mean  min max SD mean min max SD 
Age (years) 64 41 79 8 60 40 80 9 
BMI (kg/m²) 28.7 19.6 52.7 4.5 26.1 15.5 49.7 3.8 
Energy Intake (kj) 8578.03 3632.77 17726.41 2422.74 8616.52 3075.29 21409.25 2462.87 
                  
Cholesterol (mmol/l) 6.37 2.70 12.00 1.24 6.19 2.10 18.00 1.17 
Triglycerides (mmol/l) 1.99 0.50 10.60 1.15 1.79 0.20 26.00 1.10 
HDL (mmol/l) 1.40 0.50 5.90 0.43 1.43 0.20 4.40 0.42 
LDL (mmol/l) 4.10 0.99 9.52 1.09 3.97 0.45 10.30 1.04 
                  
Energy Adjusted Dietary Data                 
Allium Vegetables 0.003 0.000 0.022 0.003 0.003 0.000 0.031 0.002 
Cruciferous Vegetables 0.011 0.000 0.074 0.008 0.010 0.000 0.143 0.007 
Green Vegetables 0.002 0.000 0.016 0.002 0.002 0.000 0.043 0.002 
Yellow Vegetables 0.007 0.000 0.054 0.004 0.007 0.000 0.078 0.004 
Other Vegetables 0.005 0.000 0.028 0.004 0.005 0.000 0.052 0.004 
Citrus Fruits 0.007 0.000 0.077 0.008 0.006 0.000 0.125 0.008 
Non Citrus Fruits 0.024 0.000 0.135 0.018 0.023 0.000 0.176 0.017 
Chips 0.004 0.000 0.022 0.003 0.004 0.000 0.039 0.003 
Dietary Data (portions/week)                 
Fruits 5.11 1 6 1.18 4.97 1 6 1.27 
Leafy Vegetables 4.60 1 6 1.03 4.46 1 6 1.05 
Fatty Fish 2.57 1 6 0.92 2.46 1 6 0.85 
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Other Fish 3.06 1 6 0.70 3.02 1 6 0.70 
Chicken 3.33 1 6 0.75 3.27 1 6 0.79 
Meat 3.58 1 6 0.87 3.47 1 6 0.95 
Meat Products 2.80 1 6 0.88 2.83 1 6 0.90 
Eggs 3.23 1 6 0.88 3.21 1 6 0.91 
Cheese 3.77 1 6 1.11 3.84 1 6 1.10 
Brown Bread 4.33 1 6 1.77 4.32 1 6 1.76 
Milk (1(None), 2(<=1/2 pints/week), 3(>1/2 
pints/week & <1/2pint/day), 4(1/2 to 1 pint/day), 
5(more than 1 pint daily). 
3.65 1 5 0.89 3.67 1 5 0.86 
Snacks (No. of times a day you eat including meals, 
snacks, coffee breaks etc.) 
3.90 0 8 1.10 3.97 0 15 1.20 
                  
  Active Inactive     Active Inactive     
Physical Activity 298 490     7947 11778     
  Current Never     Current Never     
Alcohol 713 58     17869 1237     
  Current Former Never   Current Former Never   
Smoking 61 354 362   2013 8144 9403   
HRT 78 69 326   2145 1199 7765   
                  
Hip OA                 
  mean  min max SD mean min max SD 
Age (years) 64 40 78 8 60 40 80 9 
BMI (kg/m²) 27.7 18.1 52.7 4.6 26.1 15.5 49.7 3.8 
Energy Intake (kj) 8410.40 3807.97 16482.69 2325.43 8622.01 3075.29 21409.25 2465.55 
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Cholesterol (mmol/l) 6.34 3.60 10.20 1.13 6.19 2.10 18.00 1.18 
Triglycerides (mmol/l) 1.86 0.40 9.30 1.04 1.80 0.20 26.00 1.10 
HDL (mmol/l) 1.46 0.50 3.00 0.44 1.43 0.20 5.90 0.42 
LDL (mmol/l) 4.05 1.83 7.15 1.00 3.97 0.45 10.30 1.04 
                  
Energy Adjusted Dietary Data                 
Allium Vegetables 0.003 0.000 0.022 0.003 0.003 0.000 0.031 0.002 
Cruciferous Vegetables 0.012 0.000 0.143 0.010 0.010 0.000 0.108 0.007 
Green Vegetables 0.002 0.000 0.043 0.003 0.002 0.000 0.035 0.002 
Yellow Vegetables 0.007 0.000 0.078 0.006 0.007 0.000 0.069 0.004 
Other Vegetables 0.005 0.000 0.037 0.004 0.005 0.000 0.052 0.004 
Citrus Fruits 0.006 0.000 0.062 0.008 0.006 0.000 0.125 0.008 
Non Citrus Fruits 0.026 0.000 0.157 0.019 0.023 0.000 0.176 0.017 
Chips 0.003 0.000 0.026 0.003 0.004 0.000 0.039 0.003 
Dietary Data (portions/week)                 
Fruits 5.13 1 6 1.21 4.97 1 6 1.27 
Leafy Vegetables 4.63 1 6 1.01 4.45 1 6 1.05 
Fatty Fish 2.58 1 6 0.91 2.46 1 6 0.85 
Other Fish 3.10 1 6 0.73 3.02 1 6 0.70 
Chicken 3.33 1 6 0.81 3.27 1 6 0.78 
Meat 3.55 1 6 0.92 3.47 1 6 0.95 
Meat Products 2.81 1 6 0.90 2.83 1 6 0.90 
Eggs 3.25 1 6 0.88 3.21 1 6 0.91 
Cheese 3.78 1 6 1.08 3.83 1 6 1.10 
Brown Bread 4.37 1 6 1.77 4.31 1 6 1.76 
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Milk (1(None), 2(<=1/2 pints/week), 3(>1/2 
pints/week & <1/2pint/day), 4(1/2 to 1 pint/day), 
5(more than 1 pint daily). 
3.70 1 5 0.89 3.66 1 5 0.86 
Snacks (No. of times a day you eat including meals, 
snacks, coffee breaks etc.) 
3.88 0 9 1.18 3.98 0 15 1.26 
                  
  Active Inactive     Active Inactive     
Physical Activity 240 439     8004 11830     
  Current Never     Current Never     
Alcohol 602 54     17980 1241     
  Current Former Never   Current Former Never   
Smoking 47 324 301   2027 8175 9462   
HRT 64 45 320   2159 1223 7770   
 
TABLE 6. CHARACTERISTICS OF EPIC-NORFOLK DATA BY PAIN SITE. 
Knee Pain Pain Cases       Non cases       
  mean  min max SD mean min max SD 
Age (years) 61 40 79 9 59 40 80 9 
BMI (kg/m²) 27.3 15.5 50.0 4.3 25.8 16.1 49.6 3.6 
Energy Intake (kj) 8678.40 3119.89 19812.46 2567.17 8619.72 3075.29 21409.25 2439.71 
                  
Cholesterol (mmol/l) 6.26 2.10 11.40 1.18 6.17 2.60 18.00 1.17 
Triglycerides (mmol/l) 1.89 0.30 13.10 1.08 1.77 0.20 26.00 1.10 
HDL (mmol/l) 1.41 0.60 4.00 0.42 1.43 0.20 4.40 0.42 
LDL (mmol/l) 4.01 0.91 8.83 1.04 3.96 0.45 10.30 1.04 
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Energy Adjusted Dietary Data                 
Allium Vegetables 0.002 0.000 0.025 0.002 0.003 0.000 0.031 0.002 
Cruciferous Vegetables 0.011 0.000 0.108 0.008 0.010 0.000 0.074 0.007 
Green Vegetables 0.002 0.000 0.035 0.002 0.002 0.000 0.035 0.002 
Yellow Vegetables 0.007 0.000 0.063 0.004 0.007 0.000 0.069 0.004 
Other Vegetables 0.005 0.000 0.045 0.004 0.005 0.000 0.052 0.004 
Citrus Fruits 0.006 0.000 0.125 0.008 0.006 0.000 0.096 0.008 
Non Citrus Fruits 0.023 0.000 0.141 0.018 0.023 0.000 0.176 0.017 
Chips 0.004 0.000 0.024 0.003 0.004 0.000 0.035 0.003 
Dietary Data (portions/week)                 
Fruits 4.90 1 6 1.31 4.99 1 6 1.26 
Leafy Vegetables 4.46 1 6 1.07 4.45 1 6 1.05 
Fatty Fish 2.50 1 6 0.87 2.45 1 6 0.84 
Other Fish 3.03 1 6 0.73 3.01 1 6 0.69 
Chicken 3.28 1 6 0.79 3.26 1 6 0.78 
Meat 3.47 1 6 0.94 3.46 1 6 0.96 
Meat Products 2.83 1 6 0.90 2.83 1 6 0.90 
Eggs 3.23 1 6 0.92 3.21 1 6 0.91 
Cheese 3.82 1 6 1.08 3.84 1 6 1.10 
Brown Bread 4.25 1 6 1.79 4.33 1 6 1.75 
Milk (1(None), 2(<=1/2 pints/week), 3(>1/2 
pints/week & <1/2pint/day), 4(1/2 to 1 pint/day), 
5(more than 1 pint daily). 
3.67 1 5 0.84 3.67 1 5 0.84 
Snacks (No. of times a day you eat including meals, 
snacks, coffee breaks etc.) 
1.03 0 3 0.96 1.03 0 3 0.96 
                  
  Active Inactive     Active Inactive     
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Physical Activity 1200 2008     6328 8931     
  Current Never     Current Never     
Alcohol 2877 235     13891 898     
  Current Former Never   Current Former Never   
Smoking 372 1418 1387   1519 6174 7450   
HRT 385 263 1247   1618 859 5924   
                  
Hip Pain                 
  mean  min max SD mean min max SD 
Age (years) 61 41 78 9 59 40 80 9 
BMI (kg/m²) 27.0 16.1 49.1 4.1 25.9 15.5 50.0 3.7 
Energy Intake (kj) 8504.59 3119.89 19481.25 2524.93 8650.55 3075.29 21409.25 2454.52 
                  
Cholesterol (mmol/l) 6.34 2.60 11.40 1.20 6.16 2.10 18.00 1.17 
Triglycerides (mmol/l) 1.90 0.30 13.10 1.18 1.77 0.20 26.00 1.09 
HDL (mmol/l) 1.44 0.60 4.00 0.42 1.42 0.20 4.40 0.42 
LDL (mmol/l) 4.07 1.10 8.91 1.07 3.95 0.50 10.30 1.04 
                  
Dietary Data (g/day)                 
Allium Vegetables 0.003 0.000 0.025 0.003 0.002 0.000 0.031 0.002 
Cruciferous Vegetables 0.011 0.000 0.108 0.008 0.010 0.000 0.081 0.007 
Green Vegetables 0.002 0.000 0.022 0.002 0.002 0.000 0.035 0.002 
Yellow Vegetables 0.007 0.000 0.057 0.005 0.006 0.000 0.069 0.004 
Other Vegetables 0.005 0.000 0.040 0.004 0.005 0.000 0.052 0.004 
Citrus Fruits 0.006 0.000 0.061 0.008 0.006 0.000 0.125 0.008 
Non Citrus Fruits 0.024 0.000 0.157 0.018 0.023 0.000 0.176 0.017 
58 
 
Chips 0.004 0.000 0.039 0.003 0.004 0.000 0.035 0.003 
Dietary Data (portions/week)                 
Fruits 4.92 1 6 1.31 4.98 1 6 1.26 
Leafy Vegetables 4.49 1 6 1.10 4.45 1 6 1.05 
Fatty Fish 2.48 1 6 0.87 2.46 1 6 0.84 
Other Fish 3.03 1 6 0.70 3.02 1 6 0.70 
Chicken 3.29 1 6 0.79 3.27 1 6 0.78 
Meat 3.45 1 6 0.98 3.46 1 6 0.96 
Meat Products 2.79 1 6 0.89 2.84 1 6 0.90 
Eggs 3.20 1 6 0.93 3.22 1 6 0.91 
Cheese 3.76 1 6 1.11 3.85 1 6 1.09 
Brown Bread 4.24 1 6 1.80 4.33 1 6 1.75 
Milk (1(None), 2(<=1/2 pints/week), 3(>1/2 
pints/week & <1/2pint/day), 4(1/2 to 1 pint/day), 
5(more than 1 pint daily). 
3.67 1 6 0.96 3.70 1 6 0.87 
Snacks (No. of times a day you eat including meals, 
snacks, coffee breaks etc.) 
1.03 0 3 0.98 1.03 0 3 0.96 
                  
  Active Inactive     Active Inactive     
Physical Activity 711 1334     6791 9531     
  Current Never     Current Never     
Alcohol 1819 171     14858 958     
  Current Former Never   Current Former Never   
Smoking 249 898 880   1635 6649 7910   
HRT 315 204 850   1687 920 6275   
 Energy Intake 
 
It is important in nutritional epidemiology to adjust for total energy intake. This factor, also 
known as caloric intake, needed to be adjusted for as it is used to take into account the 
individual differences in energy intake (of which the many associated variables can be body 
size, metabolic efficiency and net energy balance) which is extremely important in all 
nutritional epidemiological research (Willett and Stampfer 1986). The EPIC-Norfolk FFQ 
dietary variables were, therefore, adjusted for total energy intake by dividing the FFQ 
nutritional variable (mass per day) by the FFQ energy intake (kj/day) to create a new 
adjusted variable for each FFQ dietary component. 
 Statistical Analysis 
 
Using a case-control design, the independent variables, outlined below, were investigated 
against the dependent variables; hip and knee OA and hip and knee pain. After defining the 
group for each of these outcome variables, random selection of participants for the control 
group took place to ensure a fair predictive value using a simple randomisation function in 
R. This selected the appropriate number of controls to cases (1:1 ratio) by separating all 
potential controls into one group and then randomly selecting the number required using 
the ‘sample’ function in the base package of R. This function uses a random number 
generator (RNG) to select data from a list providing data for a case-control analysis.   
Nutritional and lifestyle variables were selected due to them having been found to 
influence OA and pain, as discussed in Chapter 1. These were modelled using a logistic 
regression analysis with a stepwise algorithm, as discussed in Chapter 2. This analysis 
investigates the relationship between the dependent variables (clinical hip and knee OA 
and joint pain of the hip and knee) and independent variables of interest. Lifestyle variables 
include age, BMI, gender, waist circumference, hip circumference, height, smoking status, 
teetotal, alcohol intake, ethnic group, physical activity, cholesterol, triglycerides, HDL and 
LDL. Dietary variables of interest include citrus fruits, non-citrus fruits, leafy vegetables, 
other vegetables, allium vegetables, cruciferous vegetables, green vegetables, yellow 
vegetables, fatty fish, other fish, chicken, meat, meat products, eggs, cheese, brown bread, 
milk, snacks, chips and energy intake. The analysis was then repeated but using only the 
nutrition related variables. 
Due to the limited availability of dietary variables in this subset of EPIC-Norfolk data, 
dietary patterns were not investigated.  
3.4 EPIC-Norfolk Predictors of OA and Musculoskeletal Pain Results 
 
 Predictors of Hip OA 
 
This analysis randomly selected those who did not have hip OA (n=666) as control against 
those who have hip OA (n=680) (see methods). Table 7 shows the results for the significant 
explanatory factors of hip OA. 
60 
 
TABLE 7. SIGNIFICANT EXPLANATORY VARIABLES FOR HIP OA IN EPIC-NORFOLK. 
Significant predictors OR 95% CI 
Age 1.07 (1.05, 1.09) 
BMI 1.18 (1.13, 1.24) 
   
Chips 0.80 (0.72, 0.89) 
 
Analysis of independent variables of interest showed that increased age leads to an 
increased risk of hip OA (p<0.0001). BMI shows that an increased BMI leads to an increased 
risk of hip OA (p<0.0001). Consumption of chips is also significantly negatively associated 
with hip OA (p<0.0001). 
 Predictors of Knee OA 
 
Consistent with the analysis for hip OA (Table 7), random selection of participants who did 
not have knee OA (n=765) were selected as controls against those who have knee OA 
(n=789) (see methods). Table 8 (below) shows the results of those risk factors found to be 
significantly associated with knee OA. 
TABLE 8. SIGNIFICANT EXPLANATORY VARIABLES FOR KNEE OA IN EPIC-NORFOLK. 
Significant predictors OR 95% CI 
Age 1.06 (1.05, 1.08) 
BMI 1.21 (1.17, 1.25) 
   
Leafy Vegetables 1.27 (1.11, 1.46) 
Other vegetables 0.83 (0.71, 0.97) 
Fatty Fish 1.20 (1.05, 1.38) 
Triglycerides 1.13 (1.02, 1.25) 
 
Age is a significant predictor of knee OA and shows that increased age leads to an increased 
risk of knee OA (p<0.0001). BMI is a significant predictor of knee OA and shows that 
increased BMI leads to an increased risk of knee OA (p<0.0001)). 
Consumption of leafy Vegetables is significantly positively associated with knee OA 
(p<0.001). The food group ‘other vegetables’ is significantly negatively associated with knee 
OA. (p=0.023). Fatty Fish is significantly positively associated with knee OA (p=0.008) and 
triglycerides is also significantly positively associated with knee OA (p=0.023). 
 Predictors of Hip Pain 
There are approximately 2000 cases of hip pain so 2000 non-cases were randomly selected 
to form the combined dataset (see methods). Table 9 shows the results of those factors 
found to be most significantly associated with hip pain. 
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TABLE 9. SIGNIFICANT EXPLANATORY VARIABLES FOR HIP PAIN IN EPIC-NORFOLK. 
Significant explanatory variables OR 95% CI 
Age 1.03 (1.02, 1.03) 
BMI 1.06 (1.04, 1.08) 
Gender 1.95 (1.71, 2.22) 
Smoking status 0.58 (0.46, 0.72) 
Teetotal 0.79 (0.67, 0.94)). 
   
Energy intake 1.00 (1.00, 1.00) 
Cruciferous vegetables 1.11 (1.05, 1.18) 
These findings suggest that increased age increases the risk of hip pain (p<0.0001). Having 
female gender also increases the risk of hip pain (p<0.0001). Being a non-smoker is 
associated with hip pain and suggests a decrease in the risk of hip pain (p<0.001). Not being 
teetotal is also significantly associated with hip pain and suggests a decrease in the risk of 
hip pain (p=0.01). Increased BMI was found to increase the risk of hip pain (p<0.001). 
Repeating the analysis using only the nutrition related variables, increased intake of 
calories was found to be positively associated with the risk of hip pain (p=0.040). Increased 
intake of cruciferous vegetables was also found to be positively associated with the risk of 
hip pain (p<0.001). 
 Predictors of Knee Pain 
There are about 3000 cases of knee pain so 3000 non-cases were randomly selected to 
form the combined dataset (see methods). Table 10 shows those variables that are 
significant predictors of knee pain. 
TABLE 10. SIGNIFICANT EXPLANATORY VARIABLES FOR KNEE PAIN IN EPIC-NORFOLK. 
Significant explanatory variables OR 95% CI 
Age 1.30 (1.02, 1.03) 
BMI 1.11 (1.10, 1.13) 
Gender 1.30 (1.17, 1.44) 
Smoking status 0.62 (0.52, 0.74) 
   
Triglycerides 1.15 (1.10, 1.21) 
These findings suggest that increased age increases the risk of knee pain (p<0.0001). Having 
female gender increases the risk of knee pain (p<0.0001). Being a non-smoker is 
significantly negatively associated with the risk of knee pain (p<0.0001). Increased BMI also 
suggests an increase in the risk of knee pain (p<0.0001). Repeating the analysis using only 
the nutrition related variables, the results showed that higher triglycerides is positively 
associated with the risk of knee pain (p<0.0001). 
3.5 Discussion 
 
The result that age and BMI are significantly associated with hip OA is the result of a 
statistical model which, based on the pseudo r² value, explains approximately 9% of the 
variation in the data. This result supports previous findings that show that obesity is 
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positively associated with hip OA (Lievense, Bierma‐Zeinstra et al. 2002). The results from 
the case-control analysis of knee OA showed that increased age and BMI are significantly 
associated with knee OA and this model explains approximately 13% of the variation in the 
data. This finding also supports those found in previous studies. BMI is considered to be an 
important contributing factor to the development of knee OA (Blumenfeld, Williams et al. 
2013) and BMI has been found to be the strongest risk factor for incidence and progression 
of knee OA (Jonsson, Helgadottir et al. 2011).  
Alongside age, gender, smoking status and being teetotal, BMI was also found to be 
significantly associated with hip pain with all five of these predictors of hip pain explaining 
approximately 5% of the variation. The result that age, gender, smoking status and BMI are 
associated with knee pain also explains approximately 5% of the variation in knee pain. 
The results from the dietary analysis for knee OA highlighted some key results, however, 
this explains less than 2% of the variation and further to this less than 0.5% of the variation 
in knee pain is explained by the result that increased triglycerides and increased 
consumption of cruciferous vegetables is positively associated with knee pain.  
An increase in triglycerides was found to be positively associated with risk of knee OA 
(p=0.023) (Table 8) and risk of knee pain (p<0.0001) (Table 10). Triglycerides are lipid 
components of chylomicrons which are synthesised and secreted by intestinal enterocytes. 
They are also found within very low density lipoprotein which is synthesised and secreted 
by the liver (Khetarpal and Rader 2015). Lipoprotein lipase (LPL), produced by multiple 
tissues including adipose tissue, is required for the hydrolysis of these triglyceride rich 
lipoproteins. The reaction products, monoacylglycerol and fatty acids are then taken up 
and stored by adipose tissue, muscle and macrophages. It is important to consider the 
actions of LPL (due to diet and hormonal status being able to affect LPL and its associated 
proteins) as the function of this enzyme regulates the supply of fatty acids to its target 
tissues (Wang and Eckel 2009). 
The finding that not being teetotal is suggested to decrease the risk of hip pain (Table 9) is 
an interesting result and there have been many studies investigating the effects of alcohol 
consumption on health. There exists much speculation as to the reasons why excessive 
alcohol consumption increases risk of disease but moderate consumption has been found 
to have beneficial effects compared to no alcohol consumption which results in a J shaped 
curve (Plunk, Syed‐Mohammed et al. 2014). The finding that not being teetotal decreases 
risk of pain can therefore be explained by the idea that complete abstinence from alcohol 
consumption is not as beneficial as a small amount of exposure to the substance.  
A study that investigated lipid accumulation in patients with hypertension, found that both 
U and J shaped relationships existed between intake of alcohol and lipid accumulation 
products, suggesting that a light to moderate amount of exposure is more beneficial than 
no exposure (Wakabayashi 2015). A moderate consumption of alcohol has been found to 
inhibit lipopolysaccharide activation of NF-κB regulating expression of TNF-α and IL-1β 
(Mandrekar, Catalano et al. 2006). The cytokine IL-10 (which has been found to have anti-
inflammatory effects due to its ability to inhibit TNF-α (Wang, Wu et al. 1994)), was also 
heightened by moderate intake of alcohol (Mandrekar, Catalano et al. 2006). This suggests 
that moderate amounts of alcohol could be protective of inflammation and there are, 
therefore, multiple mechanisms by which the association found in this research could be 
explained.   
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The cross-sectional analysis in this chapter also found that smoking status is associated 
with hip pain (Table 9). This finding suggests that being a non-smoker decreases the risk of 
hip pain (p<0.001). CRP levels are elevated in OA and could be related to OA symptoms, 
such as loss of function and onset of pain, in those suffering from OA (Jin, Beguerie et al. 
2015). Cigarette smoking has also been found to be positively associated with serum high 
sensitivity CRP levels in men and women suffering from the early stages of radiographic 
knee OA (Zhang, Zeng et al. 2016).  
Cigarette smoke is known to interfere with mechanisms involved in the inflammatory 
response, for instance the SIRT1 and Rel protein interaction which causes activation of NF-
κB in macrophages (Yang, Wright et al. 2007). However, there is conflicting evidence as to 
the effect smoking has on OA. Smokers have been found to have more severe and 
persistent musculoskeletal pain than non-smokers (Felson and Zhang 2015) as nicotine has 
pro-nociceptive effects through the CNS. The dorsal route ganglion contains many nicotine 
sensitive acetylcholine receptors and increased pain sensitivity occurs from downregulation 
of the hypothalamic pituitary axis, all as a result of smoking (Miao, Green et al. 2004).  
The 1958 British Birth Cohort Study found that both past and current smoking history (as 
well as elevated BMI) and a more physically demanding job, were all associated with CWP 
in both men and women. Addiction to tobacco is a risk factor for chronic pain, however, 
those who live with conditions where the main symptom is pain are more likely to become 
dependent on nicotine questioning the direction of causality (Bakhshaie, Ditre et al. 2016). 
Some studies have found that being a current smoker is associated with OA (Haugen, 
Magnusson et al. 2017) but other studies have found inverse associations between 
smoking and OA. A mechanism behind this is that smoking prevents weight gain (Felson 
and Zhang 2015) and may, therefore, have a protective effect on osteoarthritis. However 
many of the studies that show such associations are unlikely to represent true associations 
due to bias (Hui, Doherty et al. 2011). Even if a true association existed, smoking tobacco 
products would not be recommended due to the number of negative health effects but, 
similarly to looking at diet, research is ongoing to understand the effects of components, if 
indeed there does exist a protective effect (Felson and Zhang 2015).  
Fried foods are found in high volumes in a westernised world of fast food culture and a 
substantial part of the diet is consumption of chips. The process of frying foods causes 
them to become crunchy and aromatic improving palatability which can lead to over 
consumption (Drewnowski and Almiron-Roig 2009).  
The process of frying foods also modifies fatty acid composition. The oils used deteriorate 
and the degradation products are absorbed into the fried food, leading to the ingestion of 
higher amounts of oxidised fatty acids (Casal, Malheiro et al. 2010). This is due to the 
process of oxidation and hydrogenation, causing a loss of unsaturated fats and an increase 
in trans-fats (Fillion and Henry 1998). This causes the fried food to increase in energy 
density whilst reducing in water content (Guallar-Castillón, Rodríguez-Artalejo et al. 2012).  
The health risks of consuming trans-fats are due to the changes they induce and 
incorporation into the phospholipid membranes of cells, altering transport and cellular 
signalling. In addition COX and lipoxygenase enzymes cannot metabolise trans-fatty acids 
as they do not recognise the unusual shape (Ginter and Simko 2016).  
The observed association with chips is unexpected due to the negative effects of trans- fats 
on cellular and inflammatory processes, however, the formation of resistant starch 
64 
 
(through frying potato) also alters the dietary fibre content of this food (Fillion and Henry 
1998).  
Dietary fibre intake has been found to be closely related to body composition/BMI and 
inflammation. A recent study found inverse associations between dietary fibre and body 
composition in multiple food sources, with the exception of potato fibre intake (Gibson, 
Eriksen et al. 2019). The changes that take place in starch-rich foods through heating and 
cooling are known as retrogradation (Fredriksson, Björck et al. 2000). For example, 
retrograded amylase and starch known as resistant starch III (RSIII) can form when starchy 
foods are processed, but more studies are needed to investigate the effects of this 
digestion resistant carbohydrate (Gibson, Eriksen et al. 2019).  
Fried foods and their effects on health have been investigated widely. A longitudinal study 
(over an eight year period) investigating the effects of fried potato and their effect on 
mortality found that consumption of fried potato, twice a week or more, was associated 
with an increased risk of mortality. In contrast, the consumption of potato that had not 
been fried was not associated with increased mortality (Veronese, Stubbs et al. 2017). The 
inverse association of consumption of chips with hip OA observed could, therefore, be 
explained by the fact that diet may have been altered in those suffering from hip OA.  
Analysis of EPIC-Norfolk dietary variables showed a positive association between 
consumption of fatty fish and knee OA. Deep fried fish related foods can be separated into 
those with a battered coating and those without (He, Franco et al. 2015). The fat uptake of 
deep fried raw fish increases from 1.4% to 18%, however, this is not as much of an increase 
as that seen in other fried foods, such as potato chips (Makinson, Greenfield et al. 1987). 
Studies completed over the last few years have been investigating how changing the 
ingredients in batter (to those with a low oil binding capacity) could reduce the uptake of 
fat (He, Franco et al. 2015). 
Oils have also been investigated for their frying abilities and shelf life by looking specifically 
at their stability under frying conditions. Olive oil (the oil of choice within the 
Mediterranean dietary pattern) has been found to be highly resistant to oxidation which 
could be due in part to the phenolic compounds found within it (Casal, Malheiro et al. 
2010). An EPIC study that investigated fried food consumption when the oils used were 
those within a Mediterranean diet (such as olive oil), found that consumption of fried foods 
was not found to be associated with coronary heart disease or mortality (Guallar-Castillón, 
Rodríguez-Artalejo et al. 2012). However, other studies have found fried food consumption 
to be associated with a higher risk of hypertension despite investigating effects within a 
Mediterranean cohort (Sayon-Orea, Bes-Rastrollo et al. 2014). An increased or more 
frequent consumption of fried foods has been found to be significantly associated with 
increased risk of type-2 diabetes (Cahill, Pan et al. 2014) and obesity (Sayon-Orea, Bes-
Rastrollo et al. 2013); a mechanism through which associations with OA may be influenced.  
With increased consumption of fried foods having been found to be associated with 
inflammatory disease, the intake of fats and the negative effect on inflammation is still a 
mechanism through which the association seen in this research could be occurring. There 
has been no previous research investigating the direct effect of fried food consumption on 
OA, so further studies are needed.  
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The results from the initial dietary analyses also showed some unexpected results. Leafy 
vegetables showed a positive association with knee OA (p<0.001) (Table 8) closely followed 
by the finding that cruciferous vegetables is positively associated with risk of hip pain 
(p<0.001) (Table 9) and knee pain (p<0.001) (Table 10). However, the consumption of the 
food group other vegetables is suggested to decrease the risk of knee OA (p=0.023) (Table 
8).  
An explanation as to the associations seen with the vegetable food groups could be that 
those with pain and suffering from OA (who were aware of their symptoms, and who 
attempted to alleviate these through self-help) began eating more vegetables due to the 
health messages through the media. As a result, when reporting dietary intake these 
participants would have reported high consumption of vegetables but would have also 
been diagnosed with clinical OA and or reported feeling pain, causing an association where 
there likely is not. These associations may also have been seen due to the inaccuracy of 
FFQ data, discussed further in Chapter 11. The finding that energy intake and the food 
group cruciferous vegetables are positively associated with hip pain explains less than 0.5% 
of the variation in hip pain.  
In summary for non-dietary variables in both the case-control OA and musculoskeletal pain 
analysis, BMI was found to increase the risk of all OA and pain variables which explained a 
much higher percentage of the variation of the data. 
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4 A Gender-Specific Investigation into Dietary and Lifestyle 
Factors and Osteoarthritis/Pain of the Hip and Knee. A Case-
Control Analysis using Data from EPIC-Norfolk. 
 
4.1 Chapter Overview 
 
The previous chapter investigated those factors that best predict clinical OA and joint pain. 
Due to EPIC-Norfolk containing both male and female participants, and with OA and joint 
pain being more prevalent in females, this analysis uses hip and knee pain data at the first 
health check (post baseline data) to investigate explanatory variables separately for males 
and females. With the female data, menopause, oral contraceptive and hormone 
replacement therapy status were all included. As menopause status and HRT use are age 
dependent, stratification by age quartiles took place for just the female data. The main 
finding from this chapter is that BMI is significantly associated with females in all age 
quartiles. 
4.2 Introduction 
Studies have shown that prevalence in chronic musculoskeletal pain can be explained by 
differences in gender, with females being at a greater risk (Wijnhoven, de Vet et al. 2006). 
It has been suggested that the onset of OA/pain could be related to an incidence of 
hormone imbalance (Spector and Campion 1989). Musculoskeletal pain is prevalent in 
females and onset is typically seen around the time of menopause (Prieto-Alhambra, Judge 
et al. 2014). Studies have found that postmenopausal women have significantly higher 
prevalence of musculoskeletal symptoms compared with premenopausal women. It is, 
therefore, important to investigate age related differences in musculoskeletal symptoms in 
females (Gao, Lin et al. 2013).  
The EPIC-Norfolk cohort provides dietary, lifestyle and OA/pain data, for both males and 
females. This analysis will investigate those factors which are implicated in the 
development of joint pain, in males and females separately. With age being key to the 
development of joint pain particularly in females, the analysis in this chapter is stratified by 
age to investigate differences in those factors that best predict the onset of joint pain in 
females of different age groups. 
4.3 Methods 
 
 Lifestyle and Dietary Variables 
 
This chapter uses the independent variables and covariates which are described in Tables 
4-6 in Chapter 3.3.4. Please see Chapter 3.3.3 for the methods used for the collection of 
dietary data and blood lipid data. 
Lifestyle variables include age, BMI, gender, waist circumference, hip circumference, 
height, smoking status, teetotal, alcohol intake, ethnic group, physical activity, cholesterol, 
triglycerides, HDL and LDL. For females, menopause status, oral contraceptive use and 
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hormone replacement therapy use were all included also. Dietary variables of interest 
include citrus fruits, non-citrus fruits, leafy vegetables, other vegetables, allium vegetables, 
cruciferous vegetables, green vegetables, yellow vegetables, fatty fish, other fish, chicken, 
meat, meat products, eggs, cheese, brown bread, milk, snacks, chips and energy intake.  
 Musculoskeletal Pain Data 
Pain data within EPIC-Norfolk was collected at multiple time points: 18 months post 
baseline (first health check), 3 years post baseline (second health check) and 10 years post 
baseline (third health check). Please see Figure 10, Chapter 3.2). The pain data used for the 
cross-sectional analysis was that of the first health check post baseline (please see Table 3, 
Chapter 3.3). 
 Statistical Analysis 
 
The relationship between hip and knee pain and the independent variables (outlined 
previously) was investigated in EPIC-Norfolk by putting all variables into a logistic 
regression model. A stepwise algorithm was used to remove each that was non-significant 
so that only those independent variables that were significantly associated with hip and 
knee pain remained. 
Data was used to generate four age quartiles for analysis. These were as follows:  
 Lower quartile (39.6 to 51.6 years) 
 Lower-middle quartile (51.6 to 59.6 years) 
 Upper-middle quartile (59.6 to 67.5 years) 
 Upper quartile (67.5 to 79.8 years). 
4.4 EPIC-Norfolk Gender Analysis Results 
 
 Gender Analysis of Hip Pain in EPIC-Norfolk 
 
Table 11 shows those explanatory factors that best predict hip pain, in males and females 
separately. 
TABLE 11. SIGNIFICANT PREDICTORS OF HIP PAIN, IN MALES AND FEMALES, IN EPIC-NORFOLK. 
Significant predictors of hip pain in males OR 95% CI 
Age 1.03 (1.02, 1.04) 
BMI 1.08 (1.05, 1.10) 
Brown bread 0.95 (0.91, 0.99) 
Significant predictors of hip pain in females   
Age 1.03 (1.02, 1.04) 
BMI 1.07 (1.05, 1.08) 
Physical Activity 0.73 (0.60, 0.88) 
HRT use 0.60 (0.52, 0.70) 
Teetotal status 0.78 (0.68, 0.90) 
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The results from the analysis investigating hip pain in males found that increased age is 
suggested to increase the risk of hip pain (p<0.0001). Increased BMI is also suggested to 
increase the risk of hip pain (p<0.0001). Brown bread consumption was significantly 
negatively associated with hip pain (p=0.022). All other variables were taken out of the 
analysis by the stepwise algorithm as they were not significant. 
The results from the analysis of independent variables and hip pain in females found that 
increased age is significantly positively associated with increased risk of hip pain 
(p<0.0001). Not being teetotal is significantly associated with risk of hip pain (p<0.001). 
Physical activity is significantly associated with hip pain in females suggesting that an 
increase in physical activity decreases the risk of hip pain (p=0.0026). Never having used 
HRT is significantly associated and is suggested to decrease the risk of hip pain in 
comparison to being a current user of HRT (p<0.0001). Increased BMI is significantly 
associated with hip pain and is suggested to increase the risk of hip pain (p<0.0001). All 
other variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
 Hip pain in females in EPIC-Norfolk 
 
A logistic regression analysis investigated associations between explanatory variables and 
females stratified into quartiles based on age. Table 12 shows those variables that best 
predict hip pain, in females, in each quartile. 
TABLE 12. SIGNIFICANT PREDICTORS OF HIP PAIN, IN FEMALES, STRATIFIED BY AGE IN EPIC-NORFOLK. 
Significant predictors of hip pain in females OR 95% CI 
Lower Quartile   
HRT use 0.55 (0.41, 0.74) 
BMI 1.05 (1.02, 1.08) 
Lower-middle Quartile   
HRT use 0.52 (0.40, 0.67) 
BMI 1.09 (1.07, 1.12) 
Upper-middle Quartile   
BMI 1.08 1.06, 1.11) 
Upper Quartile   
Physical Activity 0.43 (0.25, 0.69) 
BMI 1.05 (1.02, 1.08) 
 
4.4.2.1 Lower Quartile 
Analysis that took place with females, aged 39.6 to 51.6 years, showed that never having 
used HRT is significantly associated with hip pain in comparison to being a current user of 
HRT (p<0.0001). Increased BMI is suggested to increase the risk of hip pain (p<0.001). All 
other variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
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4.4.2.2 Lower-middle Quartile 
Analysis that took place with females, aged 51.6 to 59.6 years, showed that never having 
used HRT is negatively associated with hip pain in comparison to being a current user of 
HRT (p<0.0001). Increased BMI is suggested to increase the risk of hip pain (p<0.0001). All 
other variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
4.4.2.3 Upper-middle Quartile  
Analysis that took place with females, aged 59.5 to 67.5 years, showed that BMI is 
significantly associated with hip pain and suggests an increased risk of hip pain (p<0.0001). 
All other variables were taken out of the analysis by the stepwise algorithm as they were 
not significant. 
4.4.2.4 Upper Quartile 
Analysis that took place with females, aged 67.5 to 79.8 years, showed that physical activity 
is significantly negatively associated with hip pain (p<0.001). BMI is significantly positively 
associated with hip pain (p<0.001). All other variables were taken out of the analysis by the 
stepwise algorithm as they were not significant. 
 Gender Analysis of Knee Pain in EPIC-Norfolk. 
 
Table 13 shows those explanatory factors that best predict knee pain in males and females 
separately. 
 
TABLE 13. SIGNIFICANT PREDICTORS OF KNEE PAIN, IN MALES AND FEMALES, IN EPIC-NORFOLK. 
Significant predictors of knee pain in males OR 95% CI 
Age 1.02 (1.02, 1.03) 
BMI 1.10 (1.08, 1.12) 
Significant predictors of knee pain in females   
Age 1.04 (1.03, 1.04) 
BMI 1.11 (1.10, 1.12) 
HRT use 0.71 (0.62, 0.81) 
 
The results from the analysis investigating knee pain in males showed that increased age is 
suggested to increase the risk of knee pain (p<0.0001). BMI is a significant explanatory 
suggesting that increased BMI also increases the risk of knee pain (p<0.0001). All other 
variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
The results from the analysis investigating knee pain in females showed that increased age 
is suggested to increase the risk of knee pain (p<0.0001). HRT is a significant explanatory 
factor. Never having used HRT is negatively associated with knee pain (p<0.0001) in 
comparison to being a current user of HRT. Increased BMI is suggested to lead to increased 
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risk of knee pain (p<0.0001). All other variables were taken out of the analysis by the 
stepwise algorithm as they were not significant. 
 Knee Pain in females in EPIC-Norfolk. 
 
As with hip pain, analysis took place with females stratified into quartiles based on age. 
Table 14 shows those explanatory factors that best predict knee pain, in females, in each 
quartile.  
TABLE 14. SIGNIFICANT PREDICTORS OF KNEE PAIN, IN FEMALES, STRATIFIED BY AGE IN EPIC-
NORFOLK. 
Significant predictors of knee pain in females OR 95% CI 
Lower Quartile   
HRT use 0.59 (0.45, 0.79) 
BMI 1.07 (1.04, 1.10) 
Triglycerides 1.30 (1.11, 1.52) 
Lower-middle Quartile   
HRT use 0.69 (0.54, 0.87) 
BMI 1.11 (1.09, 1.14) 
Non-citrus fruits 1.55 (1.12, 2.18) 
Upper-middle Quartile   
BMI 1.11 (1.09, 1.13) 
Upper Quartile   
BMI 1.12 (1.10, 1.15) 
 
4.4.4.1  Lower Quartile  
Analysis that took place with females, aged 39.6 to 51.6 years, found that never having 
used HRT is negatively associated with the risk of knee pain (p<0.0001) in comparison to 
being a current user of HRT. Increased triglycerides is significantly positively associated with 
knee pain (p=0.001) and BMI is also significantly positively associated with knee pain 
(p<0.0001). All other variables were taken out of the analysis by the stepwise algorithm as 
they were not significant. 
4.4.4.2  Lower-middle Quartile 
Analysis that took place with females, aged 51.6 to 59.6 years, found that never having 
used HRT is negatively associated with knee pain (p=0.003) in comparison to being a 
current user of HRT. Non-citrus fruit consumption is significantly positively associated with 
knee pain (p=0.002) and BMI is significantly associated with knee pain suggesting that 
increased BMI increases the risk of knee pain (p<0.0001). All other variables were taken out 
of the analysis by the stepwise algorithm as they were not significant. 
4.4.4.3  Upper-middle Quartile 
Analysis that took place with females, aged 59.6 to 67.5 years, found that BMI is 
significantly associated with knee pain and suggests that increased BMI leads to an 
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increased risk of knee pain (p<0.0001). All other variables were taken out of the analysis by 
the stepwise algorithm as they were not significant. 
4.4.4.4  Upper Quartile  
Analysis that took place with females, aged 67.5 to 79.8 years, found that BMI is 
significantly positively associated with knee pain (p<0.001). All other variables were taken 
out of the analysis by the stepwise algorithm as they were not significant. 
4.5 Discussion 
 
The consistent factors across the gender analyses were the associations with age and BMI. 
BMI appeared consistently throughout the analysis and is a strong predictor of hip and 
knee pain in both males and females. It is not unexpected that BMI shows an increase in 
the risk of hip and knee pain as the joint is under pressure and could either be experiencing 
pain as a result of the excess weight or undergoing changes due to OA resulting in the pain 
experience. BMI was found to be positively associated with hip and knee pain in females in 
every quartile. This finding supports that of previous studies that found higher BMI to be 
associated with increased prevalence of knee pain in a cohort of women aged 35-64 years 
(Gao, Lin et al. 2013). 
Physical activity was found to be inversely associated with hip pain in females (p=0.003). 
For management of OA, clinical guidelines recommend exercise which can be combined 
with pain relief and physiotherapy for treatment purposes (Bennell and Hinman 2011). A 
more recent study showed that higher levels of leisurely physical activity is associated with 
increased levels of tibiofemoral cartilage glycosaminoglycan in women who were 
postmenopausal and suffering from less severe knee OA (Munukka, Waller et al. 2017). 
Those studies investing physical activity as a preventative measure are inconclusive. No 
associations were found in the Framingham cohort when investigating the effects of 
exercise on older adults (Felson, Niu et al. 2007). Meta analyses have explored studies that 
have investigated the role of specific activities, such as running, on OA and have not been 
able to draw any conclusions (Timmins, Leech et al. 2017). The 1958 British birth cohort 
study also reported that higher levels of CWP remained when participants reported high or 
low levels of physical activity (VanDenKerkhof, Macdonald et al. 2011). Therefore inactivity 
and physical activity could both act as risk factors for pain. Those with low levels of physical 
activity become at high risk of developing chronic widespread pain. Those with higher 
levels of physical activity could be affected directly (where high levels of physical activity 
could lead to injury to the joints and muscles resulting in pain), or indirectly (where 
inactivity is the result of injury therefore putting them at risk) (VanDenKerkhof, Macdonald 
et al. 2011).  
HRT use was suggested to be positively associated with hip and knee pain in females 
throughout the age dependent analysis. The results found that never having used HRT 
suggest a decrease in the risk of pain (Table 12 & 14). Hormone Replacement Therapy is a 
form of relief from menopausal symptoms and is found in this analysis to be positively 
associated with both hip and knee pain particularly in the lower to lower-middle quartiles 
(those aged 40-60 years). A large study, in the Framingham cohort, found the opposite 
effect of estrogen use when investigating radiographic OA in a cohort of 831 females 
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(Hannan, Felson et al. 1990). Aromatases synthesise oestrogen in connective tissue and 
oestrogen receptors are found in cartilage, subchondral bone and synovium. In vitro pro-
chondrogenic effects have been seen from hormones such as oestrogen and progesterone 
which have been shown to inhibit IL-1 catabolic effects in cartilage. However, an increase in 
OA (and in the degradation of the matrix) is seen when pharmacological doses of oestrogen 
are administered. HRT (also known as MHT) alongside selective estrogen receptor 
modulators (SERMs) (such as levormeloxifene and raloxifene) have been shown to reduce 
levels of the two OA matrix degradation biomarkers COMP and CTXII. It is suggested that 
HRT could play a role in OA via its protective effects on bone changes (seen in the 
progression of OA) and also by inhibiting pain pathways as oestrogen is anti-nociceptive 
and a deficiency has been shown to be associated with increased pain (Watt 2016). This 
association could be one seen due to cross-sectional design. HRT is sought after because of 
musculoskeletal symptoms, so many of the epidemiological studies investigating this area 
are conflicted (Watt 2016) and poses the question of which direction the association 
occurs. 
There were differences in the significant results for hip and knee pain between males and 
females. As well as age and BMI, an inverse association was seen between brown bread 
consumption and hip pain in males. Brown bread is considered a source of dietary fibre due 
to the presence of whole grains (Jones, Mann et al. 2017). As pain is known to be 
associated with OA (due to excess weight), this finding is of particular interest when taking 
into account previous research, which has found whole grain sources of fibre to be 
inversely associated with body composition (Gibson, Eriksen et al. 2019). A lower intake of 
bread and particularly whole grain bread has been reported in those who had central 
obesity in a study, involving both males and females. Another study also supports the 
association seen in this analysis in males, which found dietary fibre to be inversely 
associated with BMI only in males (Van de Vijver, Van den Bosch et al. 2009). A way in 
which pain in OA is influenced by diet could, therefore, be through the molecular 
mechanism that links diet, the gut microbiome and fat storage within adipose tissue.  
The gut microbiota have been found to influence a number of metabolic processes 
including energy absorption, appetite and glucose and lipid metabolism (Chassaing and 
Gewirtz 2014). Short chain fatty acids (SCFAs) due to the fermentation of dietary fibre from 
bacteria in the gut microbiome have been shown to have an impact on metabolic 
pathways. The production of these SCFAs leads to the release of the appetite regulating 
hormones, peptide YY (PYY) and glucagon like peptide-1 (GLP-1). These are able to activate 
the G protein coupled free fatty acid receptor 2 (FFAR 2) found on colonic L cells (Tolhurst, 
Heffron et al. 2012) for which the SCFA with the highest affinity has been found to be 
propionate (Le Poul, Loison et al. 2003).  
Propionate has been a focus of recent research and has been found to stimulate the 
release of hormones in vivo, reduce food intake and prevent weight gain in adults 
(Chambers, Viardot et al. 2015). The gut microbiota is closely linked to Metabolic syndrome 
of which obesity is one of the main features (Festi, Schiumerini et al. 2014). In smaller 
cohort studies component of metabolic syndrome have been found to be positively 
associated with OA (Askari, Ehrampoush et al. 2017) however in larger more sufficiently 
powered studies metabolic syndrome has not shown an association with OA (Niu, Clancy et 
al. 2017). Despite conflicting epidemiological evidence there is likely a very close link 
between diet, the gut microbiome, metabolic processes and OA/pain.  
73 
 
Non-citrus fruits were found to be positively associated with knee pain (p=0.002) in those 
aged 51.6 to 59.6 years. This is unexpected as were the vegetable food groups also showing 
positive associations with knee OA and hip and knee pain in Chapter 3. Again this could be 
due to the reliability of FFQ data or to the fact that participants were trying to self-help and 
had already modified their diet due to general health messages about fruit and vegetables 
being beneficial for health. This, as mentioned with the associations seen with the 
vegetable food groups in the last chapter, would result in the reporting of a high intake of 
fruit and vegetables as well having clinical OA diagnosis and pain symptoms which would 
explain the positive associations seen. 
Alongside age and BMI, not being teetotal was found to be significantly associated with hip 
pain (p<0.001) suggesting, as seen previously, that being teetotal is not as beneficial as 
moderate alcohol intake, as discussed in Chapter 3. With the J and U shaped curves in 
mind, mechanisms by which excess alcohol consumption could be impacting pain is 
through direct interaction with cellular components and the effect of alcohol metabolism 
on the build-up of oxidative stress and inflammatory state.  
Alcohol metabolism produces acetaldehyde and ROS resulting in oxidative stress and 
damage, with secondary stress resulting from a release of pro-inflammatory cytokines due 
to the cellular response to alcohol. Ethanol is able to interact with the cell membrane, 
modifying receptors alongside signalling proteins resulting in altered function and damage 
to healthy tissues (Jung, Callaci et al. 2011). Excessive alcohol consumption leads to 
increased ethanol metabolism and has been found to be associated with high levels of 
circulatory pro-inflammatory mediators (McClain, Barve et al. 1999).  
Alcohol consumption has been found to be associated with severe OA of the DIP and PIP 
joints of the hand and although this study found no statistical significance in the results 
between gender, this has previously appeared to more robust in females than males 
(Haugen, Magnusson et al. 2017). The effects of alcohol consumption may also depend on 
the type of alcoholic drink consumed. Consumption of beer has been found to be positively 
associated with hip and knee OA. However, wine has been found to be inversely associated 
with knee OA and spirits have been found to be inversely associated with hip OA in a dose 
dependent manner (Muthuri, Zhang et al. 2015). Not only can excess alcohol consumption 
be a factor that increases risk of OA/pain, it is also a way of self-medicating in those 
suffering with arthritic symptoms. This has been noted as so excessive that clinical studies 
have found, that for 28% of patients with chronic pain, alcohol becomes an abusive 
substance (Riley III and King 2009) leading to uncertainty about causality.   
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5 Exploring Dietary Patterns and Radiographic OA of the Hip, Knee 
and Hand. A Cross-Sectional Analysis using Data from TWINS-
UK.  
 
5.1 Chapter Overview 
 
Having discussed the current evidence for the role of nutrition in OA and with the nutrition 
related variables showing food groups high in fats to be positively associated with hip and 
knee OA in EPIC-Norfolk, it is important to further investigate and add to these findings. 
This chapter investigates cross-sectional associations between PCA derived dietary 
patterns, collected from FFQs, and Radiographic OA variables, to assess the risk that 
different dietary patterns may have on hip, knee and hand OA in TWINS-UK. The main 
finding from this cross-sectional analysis is that the ‘Traditional English’ dietary pattern is 
significantly positively associated hand OA. 
5.2 Introduction 
 
The previous two chapters have investigated lifestyle and dietary factors in relation to hip 
and knee OA and hip and knee pain. The nutritional analysis has found that food high in 
fats are positively associated with hip and knee OA but there have also been some 
unexpected results.  
TWINS-UK, although smaller in size when compared to the EPIC-Norfolk cohort, has a 
wealth of nutritional data available. In addition to hip and knee OA, there also exists hand 
OA. Despite the prevalence of hand OA being higher than that of other joint sites, knee OA 
has been the focus of research, with very little if any nutritional research investigating the 
effects of diet on hip and hand OA. Previous studies have investigated dietary modification 
to reduce occurrence of disease. This is due to pharmacologic treatment of arthritic 
symptoms leading to other chronic health issues. Research has indicated that diet can 
improve inflammation and symptoms of OA, without negative side effects, and there are 
many inflammatory pathways and biological mechanisms by which diet may be having an 
effect on OA, as discussed in Chapter 1. 
Although there are previous studies that have investigated the associations between diet 
and OA, most seems to have focused on how diet affects inflammation as opposed to 
associations with OA and joint pain. The purpose of this research, therefore, is to 
investigate the effects of different dietary patterns on radiographic hip, knee and hand OA 
in an all-female cohort, which was obtained from the TWINS-UK Registry.  
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5.3 Methods 
 
 Food Frequency Questionnaires and Principal Component Analysis 
 
From the TWINS-UK FFQs, the recorded data initially consisted of information reported on 
the 131 food items. Participants were asked how often they consumed each food, on 
average, within the last year of which the options were:  
 Never or less than once per month 
 1-3 times per month 
 Once a week 
 2-4 times per week 
 5-6 times per week 
 Once a day 
 2-3 times per day 
 4-5 times per day 
 6 or more times per day 
Participants were also asked not to leave any questions within the FFQ blank and to 
estimate as best they could if they were not sure. The food items data recorded was 
then gathered into 54 food groups based on similarities in nutrient content and use 
when cooking. Food items were also combined, for heritability analysis (Teucher, 
Skinner et al. 2007), to create 24 custom food types based on nutrient content and 
common tastes: Fruit and Vegetable Sources, Garlic, Alcohol, Fruit, Coffee, Red Meat, 
Fish (other than fried), Tea, Root vegetables, Allium, Brassica, Low fat dairy/dieting, 
Wholemeal grains, Salad, Nuts, Sweet tastes, Legumes-earthy, Eggs, Savoury tastes, 
Poultry, Refined grains, Fast food, Fresh Juice and High-fat dairy.  
Also, from the FFQ data, there were derived five diverse patterns of dietary 
consumption which were identified through principal component analysis (PCA) 
(Teucher, Skinner et al. 2007), using the energy adjusted frequency of intake (number 
of servings per week), and named according to what was typically seen within each 
pattern:  
 Fruit and Vegetable (“Frequent intakes of fruit, allium and cruciferous 
vegetables; low intakes of fried potatoes”) 
 High Alcohol (“Frequent intakes of beer, wine and allium vegetables; low 
intakes of high fibre breakfast cereals and fruit”) 
 Traditional English (“Frequent intakes of fried fish and potatoes, meats, 
savoury pies and cruciferous vegetables”) 
 Dieting (“Frequent intakes of low fat dairy products, low-sugar soda; low intake 
of butter and sweet baked products”) 
 Low Meat (“Frequent intakes of baked beans, pizza and soy foods; low intakes 
of meat, other fish and seafood and poultry”).  
The five distinct dietary patterns used in this analysis are therefore Fruit and Vegetable, 
High Alcohol, Traditional English, Dieting and Low Meat (Teucher, Skinner et al. 2007). 
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Please see Appendix 2 for the distribution of food groups and FFQ items from which 
these five dietary patterns were derived. 
 Radiographic OA Data 
 
Within TWINS-UK there is a large volume of radiographic OA data from those participants 
that suffered from OA. The severity of OA was assessed using the Kellgren Lawrence 
grading system. This grading system assesses the severity of OA based on specific changes 
that occur within the joint. These radiological features include the following:  
 Osteophyte formation on the joint margins or tibial spines 
 Periarticular ossification 
 Narrowing of joint space and therefore loss of cartilage which is connected with 
sclerosis of the layer of subchondral bone beneath the cartilage 
 Within the layer of subchondral bone there can be seen small areas that contain 
pseudocysts with sclerotic walls surrounding these areas 
 Changes in the shape of the ends of the bone especially within the head of the 
femur 
Based on the above OA, when assessed through looking at x-rays, could then be given a 
grade: 0 (none), 1 (doubtful), 2 (minimal), 3 (moderate) and 4 (severe) where grade 0 
represents the definite absence of changes, grade 2 represents a definite presence but with 
a low level of severity and grade 4 represents chronic OA (Kellgren and Lawrence 1957). 
Table 15, below, shows the numbers of those within the TWINS-UK cohort that have 
presence or absence of knee, hip and hand OA, based on the above Kellgren Lawrence 
grading system, and also shows the number of those without X-ray data.  
TABLE 15. CHARACTERISTICS OF DEPENDENT VARIABLES OF INTEREST WITHIN TWINS-UK. 
 
 
 
 
 Energy Intake and Confounding Factors 
 
Analysis of the nutritional data, from the TWINS UK FFQs, adjusted for total energy intake 
and other common confounders.  
The models used firstly, adjust for total energy intake and secondly, for energy intake as 
well as other confounders; age, BMI, physical activity, smoking history, alcohol 
consumption and the use of Hormone Replacement Therapy which have all been suggested 
to have relevance in the development of chronic OA. The models of adjustment within this 
cross-sectional analysis are therefore: 
 Model 1. Adjustment for energy intake. 
 Model 2. Adjustment for energy intake, age, BMI, smoking, alcohol consumption, 
physical activity and HRT. 
  Present Absent No. without X-ray data 
Knee OA 355 1297 6699 
Hip OA 102 1198 7051 
Hand OA 291 1560 6500 
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Gender was not adjusted for in the TWINS-UK analysis, due to it being an all-female subset 
of data from the cohort. 
TABLE 16. CHARACTERISTICS OF CONFOUNDERS WITHIN TWINS-UK DATA. 
Total 8351   No. without X-ray data  
Mean age (years) 52.19 (SD 14.25)   6466 
Mean BMI (kg/m²) 25.18 (SD 4.63)   6490 
  Active Inactive   
Physical Activity 179 1659  6513 
  Current Social Never  
Alcohol 521 539 200 6604 
  Current use Former-use Never use  
Smoking 345 534 939 6533 
HRT 416 248 1155 6527 
 
As can be seen from Table 16, above, the total number of participants is lower in TWINS-UK 
than in EPIC-Norfolk and comprises an all-female cohort. The mean age of this cohort is less 
than in EPIC-Norfolk but is still the age at which onset and progression of OA and 
associated pain is typically seen. The mean BMI in TWINS-UK is also similar to that of EPIC-
Norfolk. 
In TWINS-UK, age, BMI and energy intake are all higher in OA cases than non-cases as 
overall the TWINS-UK cohort is characterised by higher levels of inactivity, more alcohol 
consumption and less smoking and HRT use which is reflected across the OA variables for 
both cases and non-cases (see Table 17). However the exception, when investigating the 
data specifically for knee, hip and hand OA, is that participants have higher levels of activity 
across cases and non-cases. 
 
   
 
TABLE 17. CHARACTERISTICS OF TWINS-UK DATA BY OA SITE. 
  OA Cases       Non cases       
Knee OA mean  min max SD mean min max SD 
Age (years) 59 39 79 8 53 24 76 7 
BMI (kg/m²) 26.5 16.2 44.0 4.6 24.4 16.2 51.4 4.0 
Energy Intake (kcal) 2004.83 730.39 3700.19 505.94 1981.47 794.07 3885.62 476.79 
Fruit and Vegetable 0.43 -3.70 14.51 2.11 0.23 -5.64 13.28 1.89 
High Alcohol -0.45 -4.36 3.81 1.35 -0.20 -4.38 4.99 1.37 
Traditional English 0.38 -4.33 9.24 1.44 0.11 -4.17 6.36 1.33 
Dieting 0.37 -3.77 4.49 1.23 0.27 -4.00 7.50 1.15 
Low Meat -0.31 -3.17 4.45 1.08 -0.21 -3.82 6.97 1.07 
  Active Inactive     Active Inactive     
Physical Activity 188 125     748 375     
  Current Social Never   Current Social Never   
Alcohol 176 99 43   708 353 128   
  Current Former Never   Current Former Never   
Smoking 53 97 188   244 376 626   
HRT 70 56 217   306 148 786   
         
Hip OA mean  min max SD mean min max SD 
Age (years) 58 42 73 8 53 24 73 8 
BMI (kg/m²) 25.8 16.2 40.4 4.5 24.8 16.2 48.2 4.3 
Energy Intake (kcal) 2040.79 1070.50 3276.11 476.84 1986.89 737.44 3885.62 490.24 
Fruit and Vegetable -0.02 -5.64 6.71 2.05 0.33 -4.57 14.51 1.97 
High Alcohol -0.55 -4.36 4.60 1.44 -0.13 -3.96 4.70 1.36 
Traditional English 0.31 -3.14 3.76 1.27 0.13 -4.33 9.24 1.37 
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Dieting 0.34 -2.79 3.42 1.11 0.24 -4.00 7.50 1.21 
Low Meat -0.14 -2.94 2.89 1.10 -0.23 -3.82 6.97 1.09 
  Active Inactive     Active Inactive     
Physical Activity 47 40     662 367     
  Current Social Never   Current Social Never   
Alcohol 47 30 19   682 328 104   
  Current Former Never   Current Former Never   
Smoking 21 26 53   231 357 590   
HRT 18 15 66   310 139 717   
                  
Hand OA mean  min max SD mean min max SD 
Age (years) 62 45 79 6 53 24 76 7 
BMI (kg/m²) 25.0 16.2 44.0 3.9 24.8 15.0 51.4 4.3 
Energy Intake (kcal) 2027.63 737.44 3226.89 457.85 1972.68 730.39 3885.62 487.94 
Fruit and Vegetable 0.23 -3.70 7.98 1.89 0.30 -5.64 14.51 1.96 
High Alcohol -0.55 -4.42 4.99 1.33 -0.19 -4.38 4.70 1.35 
Traditional English 0.40 -2.93 4.19 1.26 0.15 -4.33 9.24 1.37 
Dieting 0.51 -2.88 4.42 1.18 0.25 -4.00 7.50 1.17 
Low Meat -0.33 -3.38 4.19 1.07 -0.22 -3.82 6.97 1.07 
  Active Inactive     Active Inactive     
Physical Activity 159 86     891 478     
  Current Social Never   Current Social Never   
Alcohol 125 97 25   852 423 166   
  Current Former Never   Current Former Never   
Smoking 39 89 147   289 433 760   
HRT 52 39 185   358 197 927   
 Statistical Analyses 
 
The TWINS-UK data was analysed using a multi-level model in order to take into account 
the twin pairs. A mixed effects logistic regression was used, with the models of adjustment 
outlined, to investigate cross-sectional associations between dietary pattern scores and the 
presence of radiographic OA in the hip, knee and hand. The statistical software programme 
Stata, version 12, was used for analysis and p<0.05 indicated statistically significant 
findings.  
5.4 TWINS-UK Dietary Pattern and OA Results 
 
A logistic regression analysis of the five derived dietary patterns and radiographic OA 
variables of interest (knee, hip and hand OA) took place, using the two models of 
adjustment outlined previously. 
TABLE 18. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND RADIOGRAPHIC HIP 
OA IN TWINS-UK. 
Hip OA Model 1 (n=1102)   Model 2 (n=626)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 0.88 (0.75, 1.02) 0.84 (0.68, 1.03) 
High Alcohol 0.76 (0.61, 0.94)* 0.94 (0.69, 1.30) 
Traditional English 1.12 (0.92, 1.37) 1.06 (0.82, 1.37) 
Dieting 1.11 (0.88, 1.40) 1.09 (0.80, 1.49) 
Low Meat 1.15 (0.89, 1.50) 1.11 (0.77, 1.60) 
*p<0.05 
**p<0.01 
 
TABLE 19. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND RADIOGRAPHIC 
KNEE OA IN TWINS-UK. 
Knee OA Model 1 (n=1417)   Model 2 (=800)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 1.07 (0.98, 1.17) 1.19 (1.06, 1.34)** 
High Alcohol 0.84 (0.73, 0.96) 0.99 (0.81, 1.20) 
Traditional English 1.21 (1.06, 1.38) 1.15 (0.97, 1.36) 
Dieting 1.09 (0.94, 1.26) 1.11 (0.90, 1.36) 
Low Meat 0.93 (0.79, 1.10) 0.84 (0.67, 1.07) 
*p<0.05 
**p<0.01 
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TABLE 20. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND RADIOGRAPHIC 
HAND OA IN TWINS-UK. 
Hand OA Model 1 (n=1592)   Model 2 (n=901)    
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 1.00 (0.90, 1.13) 0.92 (0.79, 1.07) 
High Alcohol 0.78 (0.66, 0.92)** 1.00 (0.78, 1.29) 
Traditional English 1.22 (1.04, 1.42)* 1.28 (1.03, 1.58)* 
Dieting 1.24 (1.04, 1.49)* 1.09 (0.85, 1.40) 
Low Meat 0.84 (0.68, 1.03) 0.95 (0.70, 1.27) 
*p<0.05 
**p<0.01 
 
The ‘Fruit and Vegetable’ dietary pattern shows a significant positive association (p=0.004) 
with knee OA (Table 19) when adjusted for confounding factors. An initial association 
(p=0.012) was observed between the ‘High Alcohol’ dietary pattern and hip OA (Table 18), 
which disappeared after adjusting for confounding factors. The ‘Traditional English’ dietary 
pattern shows a consistent statistically significant positive association (p=0.015) with hand 
OA (Table 20), which was still seen after adjustment of confounding factors (p=0.025). The 
‘Dieting’ pattern shows a significant positive association (p=0.018) with hand OA initially, 
and the ‘High Alcohol’ dietary pattern shows an association with hand OA (p=0.004) (Table 
20) but both of these associations disappeared when adjusting for confounding factors. 
5.5 Discussion 
 
A westernized dietary pattern such as the typical English diet, represented by the 
‘Traditional English’ dietary pattern, contains elevated amounts of highly processed meals 
and unhealthy snacks alongside a lack of fresh foods. This so called ‘fatty’ diet (due to the 
saturated fat content of the foods consumed e.g. meats, processed meat products and 
animal fats (Landaeta-Diaz, Fernandez et al. 2013)) results in a higher dietary intake of fatty 
acids. The effects of these nutrients in high volumes are widely known to have negative 
effects on health.  
When investigating OA it is important to consider the whole diet effect on the disease 
process, however, consideration must also be given to nutrients and compounds found 
within this dietary pattern, in order to further investigate the biological mechanisms that 
may be playing a role in the development of the disease. Reviewing the key results it can be 
seen that a higher intake of the ‘Traditional English’ dietary pattern is suggested to increase 
the risk of hand OA by 28% (p=0.025). The concept in epidemiological research of 
association versus causation is discussed further in Chapter 10. The discussion below 
outlines how a diet high in fats could be negatively impacting OA, in terms of the 
mechanisms of action. 
Whilst dietary fats and lipids, are incredibly important, due to their nature as an efficient 
energy source and also the role that they play in cell structure and cellular signalling, they 
can also be a contributing factor to detrimental metabolic outcomes. With an increased 
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intake of lipids, the lipid influx into the adipose tissue is exceeded, resulting in harmful 
lipids species accumulating in cells and in the circulation. Lipotoxicity can influence lipid 
metabolism, which is closely linked to immune response through the activation of signalling 
intermediates, and can induce chronic low grade inflammation (Ertunc and Hotamisligil 
2016). Previous studies, investigating the role of fatty acids in OA, have indicated the 
detrimental effect of saturated fatty acids and ω-6 PUFA on chondrocytes. This occurs via 
induction of prostaglandins and upregulation of gene expression related to apoptosis and 
cartilage degradation (Ertunc and Hotamisligil 2016). 
Exogenous saturated fatty acids, such as palmitate, have been investigated for their pro-
inflammatory effects. The mechanisms of excess lipids are related to the properties of 
cellular organelles such as the endoplasmic reticulum (ER) (Pineau, Colas et al. 2009). 
Palmitate is taken up by cells, which upregulates cytosolic small nucleolar RNAs (snoRNAs) 
involved in ER stress (Michel, Holley et al. 2011). Protein Kinase R (PKR), involved in 
palmitate-mediated snoRNA upregulation, can also activate protein complexes (known as 
inflammasomes which initiate inflammatory responses), JNK and AP-1 mediated 
inflammatory gene expression (Nakamura, Furuhashi et al. 2010).  
Palmitate supports the synthesis of diacylglycerols which, in turn, activate stress kinases 
(JNK and p38) and NF-κB (Glass and Olefsky 2012). Palmitate supports synthesis of 
ceramides which activates JNK signalling and can also activate toll-like receptor 4 (TLR4) 
signalling (Lee, Sohn et al. 2001). This leads to activation of inflammasomes and stimulation 
of transcription factors such as NF-κB and AP-1 (Kang and Tang 2012). Figure 11 shows the 
signalling pathways influenced by intake of this saturated fatty acid. This figure also shows 
how cholesterol is taken up by cells (through scavenger receptors) and accumulation, as 
both oxidized cholesterol and cholesterol crystals, is able to activate TLR4 and stress 
kinases in addition to inflammasome activation and pro-inflammatory gene expression. 
Another negative effect of lipotoxicity is the production of ROS from the mitochondria 
which can also result in inflammasome activation (Ertunc and Hotamisligil 2016).  
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FIGURE 11. THE MECHANISMS OF ACTION OF LIPIDS INVOLVING THE ENDOPLASMIC RETICULUM 
(PINEAU, COLAS ET AL. 2009). 
 
ω-6 PUFAs exist excessively within the western diet at a much higher ratio to ω-3 PUFAs 
(15:1) than the recommended range (from 2:1 to 5:1) (Simopoulos 2006). High levels of ω-6 
PUFAs are known to be associated with inflammation (Tokuyama and Nakamoto 2011). A 
mechanism of action by which ω-6 PUFAs have an effect on inflammation is the generation 
of prostaglandins, derived from the ω-6 PUFA arachidonic acid which is metabolised by 
COX-1 and COX-2 after AA is released from the plasma membrane by phospholipases. 
There are four prostaglandins which are vital to the inflammatory process due to their 
ability to behave as inflammatory mediators and play a crucial role in a number of signalling 
pathways (Ricciotti and FitzGerald 2011). Other derivatives from ω-6 PUFAs are 
inflammatory eicosanoids and inflammatory cytokines, such as IL-1 and IL-6 (Tokuyama and 
Nakamoto 2011), known to play a role in the development of inflammatory joint disease. 
The effects of fatty acids have been investigated extensively. Bone has an important role to 
play in the progression of Osteoarthritis (Lajeunesse and Reboul 2007). BMLs specifically 
have been associated with higher intakes of monounsaturated fatty acids and ω-6 PUFAs 
(Wang, Wluka et al. 2008). BML size has been found to be associated with HDL cholesterol 
(Doré, de Hoog et al. 2012).  
Obesity is a known risk factor, not only for OA of weight baring joints but also for hand OA, 
(Yusuf, Nelissen et al. 2010) and it is clear that metabolic factors are involved in the 
progression of hand OA (Visser, De Mutsert et al. 2015). With a mean cohort BMI of 
25.18kg/m² (and therefore the average BMI of the cohort being just within the overweight 
category) it is possible that excess adipose tissue (accumulated as a result of a ‘Traditional 
English’ dietary pattern) could be an underlying mechanism for increased risk of hand OA 
and could be influencing hand OA in different ways.  
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An increase in ingested fats, as part of the diet, are absorbed in the form of triglycerides 
and are transported and stored in adipose tissue. Adipose tissue then releases adipokines 
known to play a role in inflammation and there are many factors released as a result of 
excessive adipose tissue. Leptin, visfatin, adiponectin and resistin, are all involved in 
cartilage damage during the development of OA (Gabay and Gabay 2013) but further 
research is needed to understand the exact role as there is an abundance of conflicting 
evidence (Hu, Bao et al. 2011).  
Leptin has been shown to increase risk of OA, by being associated with metabolic 
abnormalities, and shows a correlation with BMI. Despite an increase in leptin levels seen 
in OA, and correlations with cartilage destruction and osteophytes, its role is still uncertain. 
High leptin levels may be protective against cartilage degradation due to it stimulating 
chondrocyte’s anabolic properties. Exogenous leptin also increases IGF-1 and TGFβ 
production. However, both leptin and its receptor (Ob-R) have been found to share 
common structural and functional properties with IL-6 and has, as a result, been classified 
as a cytokine. Upon binding to Ob-R, leptin has been found to trigger JAK/STAT as well 
as/PI3K/Akt/NF-κB and p300 signalling cascades (Tang, Lu et al. 2007).  
Serum resistin levels have been found to be associated with radiographic changes, 
particularly subchondral bone, in hand OA. The pro-inflammatory nature of resistin appears 
to have been stopped by an NF-κB inhibitor suggesting a role of the NF-κB pathway in 
inflammation. Increased serum adiponectin has been found to be associated (in females) 
with erosive hand OA. A study that looked into the serum levels of adipokines and 
radiographic progression of hand OA, over 6 years, found that higher levels of adiponectin 
were associated with lower risk of the progression of hand OA. This particular adipokine 
has been shown to protect against cartilage damage (Yusuf, Ioan-Facsinay et al. 2011). A 
potential mechanism, by which this is thought to be possible, is adiponectin inducing tissue 
inhibitor of metalloproteinase-2 which reduces the defects in cartilage caused by MMPs 
(Chen, Chen et al. 2006).  
Visfatin is also known to stimulate inflammatory mediators. Visfatin synthesis has been 
shown to be increased by IL-1β treatment in chondrocytes, in vitro. It has also shown a pro-
degradative effect by increased synthesis and release of key matrix degrading enzymes 
MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5 and has also been found to decrease 
aggrecan production in chondrocytes (Gosset, Berenbaum et al. 2008). Whilst many of 
these adipocytokines have shown catabolic functions in cartilage, there are still many 
conflicting studies. What is clear however, is the important role that adipose tissue plays, 
with respect to the pathophysiology of OA, through the release of these factors. 
The finding that consumption of the ‘Low Meat’ dietary pattern is inversely associated with 
the risk of knee OA (Table 19) is intriguing. This is an aspect of the Mediterranean style diet 
and would be of interest in further analysis investigating the effects of a Med diet on OA. 
Another aspect of the Med diet is high fruit and vegetable content which, in this TWINS-UK 
analysis, shows unexpected associations. Findings indicate that at a higher intake of the 
‘Fruit and Vegetable’ dietary pattern was suggested to increase the risk of knee OA by 19% 
(p=0.004). As discussed in Chapters 3 and 4, a reason for this unexpected result in the 
analysis could be that participants, who had severe OA and pain, had received advice and 
had an awareness of health messages about consumption of fruit and vegetables. They 
could, therefore, have already been self-treating through the modification of diet and this 
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would have, therefore, resulted in the reporting of eating lots of fruit and vegetables with 
high scores of OA/pain revealing the associations observed. 
Whilst a diet high in fatty acids, as discussed, is a possible mechanism of action for 
influencing OA, another explanation could be due to a lack of nutrients, such as ω-3 fatty 
acids. These are known to be characteristic of a Mediterranean style dietary pattern and 
which have been widely investigated for their beneficial effects on health. Whilst there are 
mixed results for the ‘low meat’ and ‘fruit and vegetable’ dietary patterns, worth noting is 
the suggested protective effects of both of these dietary patterns with hand OA (Table 20). 
Although these associations are not statistically significant, they are observations 
consistent with the consumption of a Mediterranean dietary pattern. More research is, 
therefore, needed into the effects of a Mediterranean style diet on OA, specifically hand 
OA.   
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6 Exploring Dietary Patterns and Musculoskeletal Pain/Chronic 
Widespread Pain. A Cross-Sectional Analysis using Data from 
TWINS-UK.  
 
6.1 Chapter Overview 
 
Having investigated the associations between dietary patterns and radiographic OA, this 
chapter investigates the cross-sectional associations between dietary patterns and 
musculoskeletal pain in the TWINS-UK cohort. In this analysis musculoskeletal pain is used 
as a proxy for OA, due to it being one of the main symptoms of the disease. A logistic 
regression, with two models of adjustment, was used in order to assess the effect that 
dietary patterns have on both site specific pain and CWP, to see if there were any similar 
results to those dietary associations seen with radiographic OA. The main finding from 
analysis is that the ‘Traditional English’ dietary pattern was positively associated with pain 
variables but only reached statistical significance when investigating CWP. 
6.2 Introduction 
 
As discussed the relationship between OA and pain is key when defining OA. With the 
symptom of pain in the joint being a critical factor in determining clinical OA, the 
relationship between dietary factors and joint pain is of interest when considering the 
effect dietary factors may be having on OA. 
Musculoskeletal pain affects over 50% of adult populations, is most prevalent in females 
and most commonly occurs at the knee, hand, hip, spine and shoulder (Watt 2018). 
Available in the TWINS-UK data set are four out of these five with more pain data in 
addition. Spine is represented by back pain and shoulder pain is combined with neck pain. 
TWINS-UK also provide foot pain and CWP for this analysis investigating the effects of 
dietary factors on pain. Joint pain acts as a proxy for OA, being one of the main symptoms 
of the disease, and due to the nature of pain being very complex and the theory of 
convergence pain, CWP acts as a proxy for joint pain. 
The previous chapter suggested that a ‘Traditional English’ dietary pattern is positively 
associated with radiographic hand OA. This analysis will investigate associations between 
the PCA derived dietary patterns and the joint specific pain outcome variables (knee, hand, 
back, neck and shoulder, elbow and forearm, foot pain and CWP).  
6.3 Methods 
 
 Principal Component Analysis 
 
The PCA derived dietary patterns, discussed in Chapter 5, were again used in this analysis. 
Please refer to Chapter 5.3.2. 
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 Pain Data 
 
The site-specific pain data was collected through questionnaires which was sent to study 
participants asking subjects ‘if they had experienced pain for the most part of the last 
month in the neck and back, or at the elbow, knee, thigh, hand or foot’. 57% of the 9036 
twins responded to the questionnaire. The sample with musculoskeletal pain data 
contained 991 complete monozygotic twins (age range 18-82 years) with a mean age of 
50.4 years and 1074 dizygotic twins (age range 19-82 years) with a mean age of 50.7 years. 
18% of these respondents had radiographic OA data recorded and had been included in 
previous OA studies. The chronic widespread pain data was collected through two 
questionnaires completed in 2002 and 2008. Chronic widespread pain was defined in both 
the 2002 and 2008 questionnaires as having had pain in muscles, bones or joints lasting at 
least one week within the past three months. 
TABLE 21. CHARACTERISTICS OF DEPENDENT VARIABLES OF INTEREST WITHIN TWINS-UK. 
 Present Absent No. without pain data 
Knee Pain 1876 3136 3339 
Hand Pain 1369 3621 3361 
Neck and Shoulder Pain 2370 2714 3267 
Elbow and Forearm Pain 938 4020 3393 
Foot Pain 1162 3660 3529 
Back pain 372 1910 6069 
CWP 1230 4347 2774 
 
Across the musculoskeletal pain variables used in this chapter, age BMI and energy intake 
are all higher in cases than in non-cases with the exception of energy intake which was 
higher in non-cases for hand pain and CWP and age which was higher for non-cases of 
elbow and forearm pain (see Table 22). 
Levels of physical activity but also alcohol consumption were reported to be higher across 
both cases and non-cases for all pain variables. Across all pain variables there were more 
participants that recorded never smoking compared to those that were current or former 
smokers and this was also the case with HTR use. Figures for those that had never used HRT 
were higher than those who were using or who had previously used HRT across cases and 
non-cases for all pain variables (see Table 22).  
 
 
TABLE 22. CHARACTERISTICS OF TWINS-UK DATA BY MUSCULOSKELETAL SITE PAIN. 
  Pain Cases       Non cases       
Knee Pain mean  min max SD mean min max SD 
Age (years) 55 32 79 7 53 32 76 8 
BMI (kg/m²) 25.4 15.0 48.2 4.5 24.2 16.4 38.5 3.8 
Energy Intake (kcal) 1955.86 626.32 3752.07 508.23 1931.94 676.18 3933.62 496.91 
                  
Fruit and Vegetable 0.48 -5.64 17.64 2.08 0.35 -7.45 14.51 2.04 
High Alcohol -0.13 -4.82 6.56 1.33 0.19 -6.86 7.40 1.43 
Traditional English 0.28 -5.18 10.02 1.38 0.05 -4.66 9.24 1.34 
Dieting 0.21 -4.66 5.23 1.24 0.18 -6.35 5.44 1.20 
Low Meat -0.18 -3.54 5.96 1.12 -0.09 -7.68 9.45 1.19 
  Active Inactive     Active Inactive     
Physical Activity 953 472     1456 815     
  Current Social Never   Current Social Never   
Alcohol 270 163 69   371 183 59   
  Current Former Never   Current Former Never   
Smoking 84 156 271   95 177 352   
HRT 128 90 300   138 68 415   
                  
Hand Pain mean  min max SD mean min max SD 
Age (years) 54 32 72 7 54 32 79 8 
BMI (kg/m²) 25.1 15.0 45.4 4.4 24.6 16.2 48.2 4.0 
Energy Intake (kcal) 1938.00 697.93 3752.07 499.67 1943.75 626.32 3933.62 501.34 
                  
Fruit and Vegetable 0.56 -7.45 11.18 2.00 0.34 -6.90 17.64 2.08 
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High Alcohol -0.07 -4.36 7.40 1.36 0.11 -4.82 7.06 1.42 
Traditional English 0.27 -4.33 6.33 1.36 0.09 -5.18 10.02 1.36 
Dieting 0.19 -6.35 4.93 1.22 0.19 -5.93 5.44 1.21 
Low Meat -0.20 -7.68 5.17 1.13 -0.10 -5.65 9.45 1.17 
  Active Inactive     Active Inactive     
Physical Activity 706 374     1695 906     
  Current Social Never   Current Social Never   
Alcohol 211 130 58   425 214 69   
  Current Former Never   Current Former Never   
Smoking 63 126 221   114 210 402   
HRT 124 68 222   140 91 497   
                  
Neck and Shoulder Pain mean  min max SD mean min max SD 
Age (years) 54 32 79 8 54 32 76 7 
BMI (kg/m²) 24.9 15.0 48.2 4.4 24.7 16.4 46.0 3.9 
Energy Intake (kcal) 1942.24 626.32 3933.62 501.19 1939.49 697.93 3885.62 500.40 
                  
Fruit and Vegetable 0.43 -7.45 17.64 2.06 0.37 -6.90 11.18 2.05 
High Alcohol 0.04 -6.86 6.13 1.37 0.08 -4.38 7.40 1.43 
Traditional English 0.22 -4.33 10.02 1.42 0.08 -4.66 7.98 1.30 
Dieting 0.22 -6.35 5.44 1.25 0.17 -4.59 5.23 1.17 
Low Meat -0.12 -3.55 9.45 1.17 -0.13 -7.68 9.45 1.17 
  Active Inactive     Active Inactive     
Physical Activity 1143 619     1303 685     
  Current Social Never   Current Social Never   
Alcohol 313 162 78   356 186 51   
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  Current Former Never   Current Former Never   
Smoking 95 174 292   89 170 346   
HRT 156 89 317   114 74 421   
                  
Elbow and Forearm Pain mean  min max SD mean min max SD 
Age (years) 53 34 79 7 54 32 79 8 
BMI (kg/m²) 25.0 17.5 45.4 4.3 24.7 15.0 48.2 4.2 
Energy Intake (kcal) 1946.83 626.32 3675.75 504.22 1935.40 676.18 3933.62 496.93 
                  
Fruit and Vegetable 0.41 -7.45 9.14 2.02 0.40 -6.90 17.64 2.06 
High Alcohol -0.04 -6.86 7.40 1.46 0.09 -4.82 7.25 1.39 
Traditional English 0.28 -3.39 5.14 1.38 0.11 -5.18 10.02 1.36 
Dieting 0.25 -5.93 5.23 1.28 0.18 -6.35 5.44 1.19 
Low Meat -0.17 -4.78 9.45 1.21 -0.12 -7.68 9.45 1.16 
  Active Inactive     Active Inactive     
Physical Activity 481 254     1905 1019     
  Current Social Never   Current Social Never   
Alcohol 128 73 35   507 261 89   
  Current Former Never   Current Former Never   
Smoking 51 73 113   127 252 495   
HRT 72 35 132   187 117 574   
                  
Foot Pain mean  min max SD mean min max SD 
Age (years) 54 32 72 7 54 32 79 8 
BMI (kg/m²) 25.6 17.5 48.2 4.5 24.4 15.0 46.0 4.1 
Energy Intake (kcal) 1962.21 697.93 3662.71 501.95 1932.84 626.32 3933.62 495.95 
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Fruit and Vegetable 0.48 -7.45 11.18 2.03 0.40 -6.73 17.64 2.07 
High Alcohol -0.09 -6.86 6.56 1.37 0.11 -4.82 7.40 1.41 
Traditional English 0.29 -4.17 6.36 1.42 0.09 -5.18 10.02 1.34 
Dieting 0.30 -6.35 5.44 1.27 0.16 -5.93 5.23 1.18 
Low Meat -0.19 -5.65 5.00 1.15 -0.11 -7.68 9.45 1.16 
  Active Inactive     Active Inactive     
Physical Activity 1069 578     1752 927     
  Current Social Never   Current Social Never   
Alcohol 345 175 75   431 236 82   
  Current Former Never   Current Former Never   
Smoking 107 183 315   109 225 426   
HRT 169 105 337   162 92 509   
                  
Back Pain mean  min max SD mean min max SD 
Age (years) 52 20 74 10 50 19 85 12 
BMI (kg/m²) 26.0 16.2 52.4 5.0 24.7 13.9 51.7 4.3 
Energy Intake (kcal) 1992.85 751.46 3752.07 516.36 1968.32 716.68 3885.62 488.64 
                  
Fruit and Vegetable 0.47 -5.64 8.91 1.95 0.19 -5.21 17.64 1.94 
High Alcohol -0.06 -4.08 6.12 1.36 0.01 -4.42 6.13 1.35 
Traditional English 0.02 -5.70 4.16 1.27 0.07 -4.33 10.02 1.27 
Dieting 0.17 -4.66 4.42 1.31 0.19 -6.35 5.23 1.19 
Low Meat -0.17 -3.31 4.74 1.14 -0.18 -5.65 5.96 1.10 
  Active Inactive     Active Inactive     
Physical Activity 304 170     988 543     
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  Current Social Never   Current Social Never   
Alcohol 126 58 21   475 251 90   
  Current Former Never   Current Former Never   
Smoking 49 65 95   142 237 443   
HRT 52 40 116   167 112 547   
                  
CWP mean  min max SD mean min max SD 
Age (years) 56 19 84 12 54 34 76 7 
BMI (kg/m²) 26.7 15.1 51.4 5.2 24.1 17.1 46.0 3.8 
Energy Intake (kcal) 1918.15 783.21 3488.61 493.55 1925.84 676.18 3933.62 499.34 
                  
Fruit and Vegetable 0.52 -7.45 11.18 2.07 0.40 -6.90 17.64 2.05 
High Alcohol -0.08 -6.86 5.01 1.34 0.12 -4.82 6.13 1.38 
Traditional English 0.35 -5.18 6.33 1.41 0.05 -4.66 10.02 1.35 
Dieting 0.23 -6.35 7.03 1.31 0.18 -5.93 5.23 1.19 
Low Meat -0.14 -3.96 10.01 1.29 -0.13 -7.68 6.15 1.16 
  Active Inactive     Active Inactive     
Physical Activity 527 319     1789 978     
  Current Social Never   Current Social Never   
Alcohol 141 90 38   452 219 75   
  Current Former Never   Current Former Never   
Smoking 64 70 143   107 226 422   
HRT 79 49 151   133 87 532   
 
 Confounding Factors 
 
As with the analysis in Chapter 5, the models of adjustment within this cross-sectional 
analysis are: 
 Model 1. Adjustment for energy intake. 
 Model 2. Adjustment for energy intake, age, BMI, smoking, alcohol consumption, 
physical activity and HRT. 
Gender was not adjusted for in the TWINS due to it being an all-female subset of data from 
the cohort. 
 Statistical Analyses 
 
The TWINS-UK data was analysed, as in Chapter 5, using a multi-level model in order to 
take into account the twin pairs. A mixed effects logistic regression was used, with the 
models of adjustment outlined, to investigate cross-sectional associations between the 
independent variables (dietary exposures) and the dependent variable (joint pain and 
CWP). The statistical software programme Stata, version 12, was used for analysis and 
p<0.05 indicated statistically significant findings. 
6.4 TWINS-UK Dietary Pattern and Musculoskeletal Pain Results 
 
TABLE 23. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND KNEE PAIN IN 
TWINS-UK. 
Knee Pain Model 1 (n=1133)   Model 2 (n=778)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 1.00 (0.93, 1.07) 1.02 (0.93, 1.11) 
High Alcohol 0.88 (0.80, 0.98)* 0.89 (0.76, 1.04) 
Traditional English 1.09 (0.99, 1.20) 1.08 (0.95, 1.22) 
Dieting 0.97 (0.86, 1.09) 0.94 (0.81, 1.10) 
Low Meat 0.95 (0.83, 1.08) 0.92 (0.77, 1.11) 
*p<0.05 
**p<0.01 
 
TABLE 24. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND HAND PAIN IN 
TWINS-UK. 
Hand Pain Model 1 (n=1135)   Model 2 (n=779)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 1.04 (0.95, 1.13) 0.99 (0.89, 1.12) 
High Alcohol 1.00 (0.89, 1.13) 1.09 (0.90, 1.32) 
Traditional English 1.11 (0.98, 1.24) 1.17 (1.00,1.37) 
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Dieting 0.96 (0.84, 1.11) 1.00 (0.82, 1.21) 
Low Meat 1.04 (0.89, 1.22) 0.99 (0.79, 1.24) 
*p<0.05 
**p<0.01 
 
TABLE 25. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND CWP IN TWINS-
UK. 
Chronic Widespread Pain Model 1 (n=1019)   Model 2 (n=941)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 0.97 (0.85, 1.10) 1.00 (0.88, 1.14) 
High Alcohol 0.95 (0.79, 1.14) 1.03 (0.83, 1.28) 
Traditional English 1.26 (1.06, 1.49)** 1.18 (0.99, 1.41) 
Dieting 0.99 (0.80, 1.22) 1.13 (0.91, 1.41) 
Low Meat 1.21 (0.96, 1.53) 1.21 (0.94, 1.56) 
*p<0.05 
**p<0.01 
 
Please see the appendix for the results from the analysis between dietary patterns and 
back, neck and shoulder, elbow and forearm and foot pain analysis. 
Analysis of dietary patterns revealed a significant association (p=0.017) between the ‘High 
Alcohol’ dietary pattern and knee pain (Table 23), which disappears after adjustment of 
confounding factors. 
Although no statistically significant associations were found between hand pain and the 
five PCA derived dietary patterns (Table 24), worth noting is the association seen with the 
‘Traditional English’ dietary pattern. This shows a positive association with hand pain which 
only just lost statistical significance (p=0.051), after adjustment of confounding factors. The 
dietary pattern ‘Traditional English’ also shows a significant (p=0.009) positive association 
with CWP, in model one, but does not remain statistically significant when adjusted for 
confounding factors (Table 25). 
6.5 Discussion 
 
The results from this chapter showed that the ‘Traditional English’ dietary pattern (or so 
called ‘fatty’ diet) increases the risk of hand pain by 17%, which was on the edge of 
statistical significance (p=0.051), after adjustment for all confounders. However, 
significance could have been lost due to other factors which are discussed further in 
Chapter 11. Hand pain, which is closely linked to radiographic changes in the hand, shows 
the same positive association (when investigating this particular dietary pattern) as the 
results investigating hand OA in the previous chapter. This dietary pattern also increased 
the risk of CWP by 26% (p=0.009) (Table 25) and of neck and shoulder pain by 16% 
(p=0.010) when unadjusted for confounders (see Table 48 in Appendix). It also suggested 
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an increase in the risk of knee pain (Table 23), elbow and forearm pain and foot pain (see 
Tables 49 and 50 in Appendix), although these were not statistically significant. 
A westernised diet such as the ‘Traditional English’ (as discussed in Chapter 5) contains high 
amounts of processed foods and unhealthy snacks, which results in a higher intake of 
nutrients found to have negative effects on health.  The finding that a ‘Traditional English’ 
dietary pattern increases the risk of CWP is consistent with results from the 1958 British 
Birth Cohort Study, which demonstrated that women (aged 45 years) with CWP reported a 
diet of high fats and low fruit and vegetable consumption twelve years previously, 
compared to women of the same age who were free of pain (VanDenKerkhof, Macdonald 
et al. 2011).  
The effects and mechanisms of the saturated fat palmitate and ω-6 poly-unsaturated fatty 
acids have already been discussed in the previous chapter, overviewing the effects on 
inflammatory mechanisms of action which have been found to play a role in the 
development of OA. High levels of ω-6 PUFAs are known to be associated not only with 
inflammation but with chronic pain also (Tokuyama and Nakamoto 2011). Mechanisms by 
which this may occur are through dihomo-γ-linolenic and docosatetraenoic acid (which, as 
can be seen in Figure 12, are part of the metabolism of ω-6 PUFAs). Levels of these two 
fatty acids along with elevated levels of trans-fatty acids have been found to be significantly 
increased in patients with complex regional pain syndrome (Ramsden, Gagnon et al. 2010). 
 
FIGURE 12. COMPLEX METABOLISM OF PUFAS INVOLVING ENZYMES OF DESATURATION, 
ELONGATION AND Β-OXIDATION (PATTERSON, WALL ET AL. 2012). 
 
Another mechanism in which pain may be induced through consuming ω-6 PUFAs (as part 
of a western diet), is through oxidised linoleic acid metabolites, which can form and 
activate signalling through transient receptor potential vanilloid (TRPV) (Patwardhan, 
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Akopian et al. 2010). TRVP1 was the first member of a subgroup of TRP family of ligand-
gated ion channels to be discovered and is expressed in a substantial proportion of 
nociceptors. Activation of TRPV1 occurs through endogenous lipids (e.g. lipoxygenase and 
phospholipase D metabolites of arachidonic acid) (Cortright and Szallasi 2004). Linoleic acid 
metabolites are synthesized following stimuli such as peripheral inflammation and have 
been investigated as a family of endogenous TRPV1 ligands that are able to regulate central 
sensitization (Patwardhan, Scotland et al. 2009). 
Not only are there mechanisms through which ω-6 PUFAs (in high amounts in a western 
diet) could be having a negative effect on pain there is also a lack of ω-3 PUFAs in a western 
diet which could also be having a negative effect. ω-3 PUFAs are known to be anti-
inflammatory and suppress pain through inhibition of the MAP-Kinase signalling cascade 
which is involved in the regulation of central sensitization (Woolf and Salter 2000). 
Alongside inhibition of MAP-K, cytokine activation occurs due to the activation of satellite 
glial cells (now thought to be a key mechanism of inflammatory pain) (Zhang, Song et al. 
2019). Intake of the ω-3 PUFA (α-linoleic acid) has been found to inhibit the production of 
lysophosphatidic acid, which is strongly related to the development of neuropathic pain 
(Miyazawa, Ikemoto et al. 2003). DHA also has a calming effect on neuropathic pain and 
has been reported to have anti-nociceptive effects in a dose dependent manner 
(Nakamoto, Nishinaka et al. 2010). This effect could be occurring through different 
mechanisms. Firstly DHA can inhibit the arachidonic acid cascade (Gaudette and Holub 
1990). Secondly it can inhibit both calcium channels and voltage gated sodium channels 
(Xiao, Kang et al. 1995) and influences TRPV1 (Grant, Cottrell et al. 2007). 
With the dietary pattern analysis another interesting observation is that consumption of 
the ‘Low Meat’ dietary pattern was suggested to decrease the risk of knee pain (Table 23). 
Although this was not statistically significant, this result, just like those seen in the previous 
chapter suggest that a diet low in meat, such as the Mediterranean diet, could be beneficial 
and supports the need for further research as there is limited research investigating the 
effects of a Mediterranean dietary pattern specifically on OA.  
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7 Exploring the Mediterranean Dietary Pattern and Radiographic 
OA, Musculoskeletal Pain and CWP. A Cross-Sectional Analysis 
using Data from TWINS-UK. 
 
7.1 Chapter Overview 
 
The literature surrounding chronic disease suggests that a Mediterranean style dietary 
pattern is protective of inflammation, but further investigation is needed into the effects of 
this dietary pattern on OA. Within TWINS-UK there is a substantial volume of dietary data 
available for analysis. This allowed for the creation of a Mediterranean style dietary 
pattern, providing the data for a cross-sectional analysis, investigating associations 
between radiographic OA variables and pain. The main finding from this study showed that 
with increased consumption of a Mediterranean dietary pattern, there is a decreased risk 
in OA of the hand suggesting that consumption of a Med diet could be protective of hand 
OA. 
7.2 Introduction 
 
The Mediterranean diet, as discussed in Chapter 1, emphasizes eating a variety of fruits, 
vegetables, legumes, nuts, fish, healthy fats (such as olive oil) and limiting the consumption 
of processed meats whilst consuming alcohol (usually red wine), in moderation and at meal 
times. This dietary pattern, high in anti-inflammatory compounds and with antioxidant 
properties, has been the focus of research. This is due to its ability to confer health benefits 
and has been shown to be protective of a number of chronic diseases. There are a vast 
number of studies focusing their research efforts on investigating a Mediterranean style 
dietary pattern, however, research into OA is in single figures and has focused primarily on 
knee OA. The current evidence for Med diet and OA is not only limited to only a few studies 
but these are also of cross-sectional design. At present only one study has investigated 
Med diet and OA longitudinally. Despite hand OA being most prevalent, studies have 
investigated the effects of Med diet on knee OA, leaving other joint sites unexplored. There 
is therefore very little evidence for the effects of Med diet on other joints, that are also at 
risk of OA. This research is the first to address this and investigate the associations that 
exist between a Med diet and both weight bearing and non-weight bearing joints, along 
with joint pain and CWP, in an all-female cohort.    
7.3 Methods 
 
 Mediterranean Dietary Pattern Score 
 
A Mediterranean diet score was created, within TWINS-UK, from the following dietary food 
groups. Some of the food groups had to be amalgamated to reflect the food groups used in 
previous publications that best described the Mediterranean diet. Scores were assigned 
based on the median of the variable of interest as this is a commonly used method 
throughout the literature (Tong, Wareham et al. 2016). The food groups generated or used 
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in the creation of the Mediterranean diet pattern score (which was constructed using 
Microsoft Excel) were: legumes, nuts, eggs, poultry, vegetable (made up of allium, 
cruciferous, green leafy, other and yellow vegetables), fruit (made up of berries, citrus fruit 
and other fruit), dairy (made up of both high fat dairy products and low fat dairy products), 
fish (made up of oily fish, other fish and seafood), cereals (made up of crispbread, high 
fibre cereals, low fibre cereals, porridge, white and brown bread refined grains and 
wholemeal bread and grains) and alcohol (made up of wine, beer and spirits and liquor). 
These food groups are all either high consumption or moderate consumption and were all 
found to be high within a Mediterranean diet. They were, therefore, assigned a 1 if 
consumption was high (above the median) and were assigned a 0 if consumption was low 
(below the median). In contrast, processed meats, meats, cooked potatoes, sweets (made 
up of high sugar soda, low sugar soda, sweet baked and sweets and condiments) and fats 
(made up of butter, low fat spread, margarine, poly-unsaturated margarine, high fat 
dressing and low fat dressing) were all considered food groups found in a non-
Mediterranean diet. These were assigned a 1 if consumption was low (below the median) 
and were assigned a 0 if consumption was high (above the median) providing a 
Mediterranean dietary pattern score based on the traditional Mediterranean diet 
constructed by Trichopoulou et. al., 1995 for further analysis.  
The following tables show the energy adjusted intakes for those food groups used in the 
creation of the Mediterranean dietary pattern for cases and non-cases. Across outcome 
variables the highest intakes are seen for fruits, vegetables, cereals, sweets and fats. For 
many of the outcome variables intakes for fruit and vegetable consumption are higher in 
cases compared to non-cases (discussed further in Chapter 11). Please see Tables 26-28 for 
all TWINS-UK OA variables and Tables 29-35 for all TWINS-UK musculoskeletal pain 
variables. 
TABLE 26. ENERGY ADJUSTED INTAKES OF FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR KNEE OA. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.31 -1.50 25.27 3.17 4.05 -1.52 25.52 2.58 
Nuts 0.76 -1.15 15.90 1.97 1.16 -1.18 38.49 2.28 
Eggs 1.49 -0.95 7.67 1.36 1.55 -0.84 12.19 1.36 
Poultry 1.73 -0.35 6.77 1.17 1.77 -0.42 5.59 1.10 
Vegetables 28.55 0.54 219.32 20.68 27.01 -1.42 113.06 12.50 
Fruit 18.14 -1.91 68.65 11.45 17.33 -5.47 92.14 11.11 
Dairy 12.61 0.62 42.37 5.96 12.33 -1.73 55.34 6.16 
Fish 2.17 -0.45 9.26 1.74 2.13 -0.70 15.31 1.66 
Cereals 21.89 -10.14 65.10 10.57 21.60 -1.11 63.85 9.42 
Alcohol 4.11 -2.11 25.41 5.69 5.08 -2.80 63.89 6.99 
Processed Meats 2.75 -1.02 10.28 1.86 2.63 -1.31 21.03 2.06 
Meats 2.49 -1.50 9.87 1.85 2.47 -1.32 10.77 1.73 
Cooked Potatoes 4.41 -0.54 40.03 4.06 3.73 -1.00 40.83 2.28 
Sweets 23.13 -7.35 85.51 16.70 23.86 -8.16 114.65 16.91 
Fats 15.14 -4.69 197.05 18.92 14.18 -8.15 89.08 9.50 
 
TABLE 27. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR HIP OA. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.04 -0.49 13.68 2.67 4.07 -0.85 25.52 2.65 
Nuts 1.07 -0.73 21.97 2.72 1.19 -1.18 38.49 2.27 
Eggs 1.62 -0.33 7.12 1.45 1.50 -0.84 10.20 1.32 
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Poultry 1.46 -0.26 4.62 1.04 1.81 -0.37 11.51 1.17 
Vegetables 25.30 7.05 67.64 11.45 27.70 -1.42 219.32 14.27 
Fruit 16.87 -0.81 49.68 10.43 17.51 -5.47 92.14 11.43 
Dairy 12.60 3.65 32.80 5.85 12.28 -1.73 50.01 5.93 
Fish 1.95 -0.26 6.32 1.52 2.18 -0.70 15.31 1.68 
Cereals 19.66 -0.67 40.45 9.95 21.56 -10.14 65.10 9.57 
Alcohol 3.84 -1.34 50.92 7.25 5.11 -2.80 63.89 6.45 
Processed Meats 2.71 -0.74 18.85 2.60 2.66 -1.31 15.12 1.96 
Meats 2.35 -0.69 8.88 1.87 2.45 -1.32 10.77 1.74 
Cooked Potatoes 4.37 -0.43 31.70 3.60 3.74 -0.88 17.85 2.19 
Sweets 23.26 -10.13 68.11 16.16 23.31 -7.54 98.88 16.51 
Fats 13.34 -1.91 68.79 11.67 14.53 -8.15 197.05 11.64 
 
TABLE 28. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR HAND OA. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.11 -0.14 16.10 2.69 4.15 -1.52 25.52 2.66 
Nuts 0.77 -0.96 17.50 1.73 1.15 -1.18 38.49 2.23 
Eggs 1.48 -0.53 6.28 1.20 1.55 -0.95 12.19 1.36 
Poultry 1.67 -0.28 5.69 1.09 1.78 -0.42 11.51 1.15 
Vegetables 27.48 4.55 98.14 13.15 23.86 -1.42 219.32 15.81 
Fruit 18.42 -0.73 88.91 12.65 15.03 -5.47 92.14 11.64 
Dairy 12.65 1.84 53.18 6.42 10.78 -1.73 55.34 7.05 
Fish 2.06 -0.37 8.79 1.55 1.87 -0.70 18.87 1.77 
Cereals 21.33 -1.59 71.90 10.25 18.66 -10.14 63.85 11.42 
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Alcohol 4.19 -1.85 60.04 6.54 4.35 -2.80 63.89 6.47 
Processed Meats 2.65 -0.63 9.80 1.79 2.65 -1.31 18.85 2.00 
Meats 2.72 -0.56 10.45 1.85 2.47 -1.50 10.77 1.74 
Cooked Potatoes 4.45 -0.73 31.70 2.98 3.76 -1.00 40.83 2.46 
Sweets 24.08 -7.33 114.65 16.61 20.28 -10.13 105.67 17.31 
Fats 14.89 -5.74 153.13 13.45 12.23 -8.15 197.05 10.68 
 
TABLE 29. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR KNEE PAIN. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.36 -1.56 31.77 2.91 4.03 -1.60 18.02 2.65 
Nuts 1.20 -1.12 38.49 2.26 1.43 -1.33 40.71 2.45 
Eggs 1.48 -1.00 17.53 1.37 1.44 -0.64 18.15 1.43 
Poultry 1.94 -0.51 7.26 1.21 1.90 -0.54 11.51 1.21 
Vegetables 28.69 -2.58 233.92 14.77 28.07 -3.89 219.32 14.43 
Fruit 18.09 -7.63 92.14 11.45 17.17 -8.78 92.61 11.33 
Dairy 12.21 -1.81 53.18 6.32 11.67 -4.86 57.48 5.87 
Fish 2.29 -0.84 18.87 1.88 2.15 -0.92 13.43 1.68 
Cereals 21.18 -6.40 96.64 9.73 21.03 -9.09 82.40 9.28 
Alcohol 4.97 -2.61 52.05 6.67 5.94 -2.87 84.46 7.69 
Processed Meats 2.72 -1.31 18.85 2.07 2.67 -1.58 15.12 1.97 
Meats 2.49 -1.32 10.67 1.78 2.26 -1.46 9.87 1.68 
Cooked Potatoes 3.66 -0.95 24.00 2.11 3.48 -1.69 18.30 2.00 
Sweets 22.94 -18.81 107.43 16.46 22.81 -16.12 123.53 16.64 
Fats 12.76 -6.66 99.87 8.83 13.33 -7.56 114.16 8.79 
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TABLE 30. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR HAND PAIN. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.33 -1.60 20.36 2.66 4.08 -1.56 31.77 2.78 
Nuts 1.31 -1.10 24.68 2.19 1.38 -1.33 40.71 2.48 
Eggs 1.49 -1.00 17.54 1.48 1.44 -0.69 18.15 1.38 
Poultry 1.93 -0.51 6.99 1.20 1.92 -0.54 11.51 1.22 
Vegetables 29.26 -3.07 113.57 14.13 27.95 -3.89 233.92 14.80 
Fruit 18.24 -7.63 92.14 11.50 17.23 -8.78 92.61 11.48 
Dairy 12.03 -4.86 51.34 5.90 11.77 -3.51 57.48 6.14 
Fish 2.31 -0.84 18.87 1.85 2.16 -0.92 18.33 1.75 
Cereals 20.83 -6.40 76.01 9.05 21.05 -9.09 96.64 9.66 
Alcohol 5.17 -2.61 84.46 7.11 5.73 -2.87 81.56 7.41 
Processed Meats 2.73 -1.31 15.12 2.01 2.68 -1.58 18.85 2.00 
Meats 2.52 -1.32 10.67 1.81 2.28 -1.46 10.45 1.68 
Cooked Potatoes 3.67 -1.07 24.00 2.07 3.50 -1.69 18.30 2.04 
Sweets 22.84 -16.12 123.53 16.49 22.78 -18.81 118.50 16.66 
Fats 12.73 -6.66 72.44 8.45 13.14 -7.56 114.16 9.02 
 
TABLE 31. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR NECK AND SHOULDER PAIN. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.27 -1.03 31.77 2.82 4.04 -1.60 20.36 2.68 
Nuts 1.40 -1.33 40.71 2.50 1.31 -1.16 38.49 2.30 
Eggs 1.49 -1.00 17.94 1.45 1.43 -0.64 18.15 1.36 
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Poultry 1.93 -0.53 11.51 1.25 1.89 -0.54 7.15 1.17 
Vegetables 28.81 -3.89 233.92 15.41 27.78 -2.59 113.57 13.76 
Fruit 17.58 -7.63 92.14 11.41 17.56 -8.78 92.61 11.52 
Dairy 11.88 -1.81 57.48 6.28 11.87 -4.86 47.74 5.74 
Fish 2.17 -0.92 18.33 1.71 2.23 -0.76 18.87 1.83 
Cereals 20.95 -6.40 76.01 9.64 21.15 -9.09 96.64 9.30 
Alcohol 5.40 -2.87 81.56 7.06 5.67 -2.80 84.46 7.45 
Processed Meats 2.77 -1.31 15.12 2.07 2.64 -1.58 21.03 2.00 
Meats 2.44 -1.32 10.67 1.81 2.27 -1.46 10.45 1.65 
Cooked Potatoes 3.64 -1.34 24.00 2.09 3.45 -1.69 17.76 2.00 
Sweets 23.16 -18.81 123.53 16.66 22.53 -11.19 118.50 16.33 
Fats 13.04 -7.56 99.87 8.82 13.12 -6.79 114.16 8.86 
 
TABLE 32. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR ELBOW AND FOREARM PAIN. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.35 -0.87 14.52 2.68 4.12 -1.60 31.77 2.77 
Nuts 1.32 -1.10 40.71 2.86 1.37 -1.33 24.68 2.29 
Eggs 1.51 -1.00 17.53 1.51 1.45 -0.69 18.15 1.38 
Poultry 2.01 -0.44 7.20 1.25 1.89 -0.54 11.51 1.19 
Vegetables 28.21 -2.59 98.07 13.54 28.33 -3.89 233.92 14.84 
Fruit 18.06 -4.24 81.14 11.65 17.47 -8.78 92.61 11.36 
Dairy 11.93 -4.86 50.01 5.96 11.94 -3.51 57.48 6.11 
Fish 2.26 -0.84 11.37 1.73 2.20 -0.92 18.87 1.79 
Cereals 20.75 -4.29 59.21 9.01 21.15 -9.09 96.64 9.51 
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Alcohol 5.43 -2.09 84.46 7.75 5.58 -2.87 81.56 7.18 
Processed Meats 2.81 -1.31 12.48 2.07 2.67 -1.58 18.85 1.99 
Meats 2.48 -1.22 10.67 1.85 2.32 -1.46 10.45 1.68 
Cooked Potatoes 3.59 -0.95 18.30 2.06 3.54 -1.69 24.00 2.04 
Sweets 23.80 -16.12 123.53 17.87 22.58 -11.19 118.50 16.16 
Fats 12.95 -7.56 63.48 8.56 13.06 -6.79 114.16 8.82 
 
TABLE 33. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR FOOT PAIN. 
 OA Cases       Non cases       
Food Groups  mean  min max SD mean min max SD 
Legumes 4.10 -1.60 42.03 2.83 4.07 -1.60 31.77 2.75 
Nuts 1.34 -1.33 38.49 2.43 1.37 -1.33 40.71 2.45 
Eggs 1.46 -1.11 17.94 1.40 1.42 -0.84 18.15 1.38 
Poultry 1.92 -0.62 11.51 1.24 1.90 -0.54 11.51 1.20 
Vegetables 25.99 -10.42 233.92 15.76 28.26 -3.89 233.92 14.88 
Fruit 16.08 -8.78 92.61 12.06 17.37 -7.63 92.61 11.51 
Dairy 10.96 -5.79 57.48 6.75 11.90 -3.51 52.79 6.08 
Fish 2.01 -0.93 21.64 1.83 2.18 -0.92 18.33 1.75 
Cereals 19.37 -9.09 96.64 10.82 20.95 -3.64 96.64 9.44 
Alcohol 5.13 -2.87 84.46 7.27 5.67 -2.87 84.46 7.31 
Processed Meats 2.74 -1.82 22.10 2.07 2.68 -1.58 18.85 2.01 
Meats 2.35 -1.69 10.77 1.74 2.30 -1.46 10.45 1.67 
Cooked Potatoes 3.58 -1.69 40.86 2.37 3.49 -1.34 24.00 2.02 
Sweets 21.43 -18.81 130.61 17.44 22.63 -18.81 118.50 16.40 
Fats 12.21 -9.99 153.13 9.48 12.73 -7.56 99.87 8.35 
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TABLE 34. ENERGY ADJUSTED INTAKES OF FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR BACK PAIN. 
 OA Cases       Non cases       
Food Groups  mean  min max SD mean min max SD 
Legumes 4.00 -0.64 14.13 2.45 3.96 -0.68 25.27 2.59 
Nuts 1.38 -1.12 36.58 2.64 1.08 -1.33 38.49 2.04 
Eggs 1.44 -1.05 6.07 1.18 1.44 -0.84 12.02 1.27 
Poultry 1.95 -0.44 7.15 1.19 1.86 -0.51 5.87 1.14 
Vegetables 28.46 1.15 104.25 13.55 27.04 -3.07 233.92 13.47 
Fruit 17.74 -7.63 63.74 10.35 16.77 -5.39 92.61 11.08 
Dairy 12.24 -5.79 42.76 6.00 12.02 -4.86 55.34 5.68 
Fish 2.14 -0.64 11.34 1.63 2.06 -0.92 18.87 1.61 
Cereals 22.20 -1.11 83.05 10.39 21.43 -10.14 71.90 9.30 
Alcohol 5.33 -2.61 59.97 7.42 5.49 -2.80 81.56 7.12 
Processed Meats 2.55 -1.29 10.19 1.78 2.62 -1.31 18.35 1.93 
Meats 2.23 -1.20 9.86 1.66 2.35 -1.32 10.77 1.69 
Cooked Potatoes 3.65 -0.62 40.86 2.69 3.58 -0.88 40.83 2.19 
Sweets 24.96 -14.41 114.65 18.07 23.61 -9.91 118.05 16.29 
Fats 13.49 -9.99 99.87 9.89 13.81 -8.15 197.05 10.25 
 
TABLE 35. ENERGY ADJUSTED INTAKES FOR FOOD GROUPS USED IN MEDITERRANEAN DIETARY PATTERN FOR CWP. 
 OA Cases       Non cases       
Food Groups mean  min max SD mean min max SD 
Legumes 4.44 -1.52 19.65 2.79 4.00 -1.60 31.77 2.69 
Nuts 1.28 -1.12 36.12 2.68 1.50 -1.33 40.71 2.57 
Eggs 1.49 -1.00 9.51 1.36 1.43 -0.95 18.21 1.48 
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Poultry 1.99 -0.42 7.26 1.31 1.89 -0.62 11.51 1.20 
Vegetables 29.43 -3.07 111.77 14.18 28.08 -3.89 233.92 14.62 
Fruit 18.28 -4.24 92.14 11.57 17.56 -8.78 92.61 11.59 
Dairy 12.07 -1.81 51.34 6.33 11.84 -4.86 47.74 5.97 
Fish 2.31 -0.84 18.33 1.94 2.18 -0.92 18.87 1.72 
Cereals 20.53 -6.40 64.28 9.27 20.86 -9.09 96.64 9.19 
Alcohol 4.99 -1.88 52.05 6.98 5.84 -2.87 81.56 7.34 
Processed Meats 2.84 -1.23 18.85 2.19 2.69 -1.82 22.10 2.05 
Meats 2.50 -1.32 10.67 1.91 2.28 -1.69 10.77 1.66 
Cooked Potatoes 3.71 -1.00 16.96 1.95 3.49 -1.69 40.03 2.29 
Sweets 23.53 -18.81 123.53 16.76 22.54 -16.12 118.50 16.19 
Fats 12.81 -6.66 72.13 8.55 12.85 -7.56 114.16 8.46 
 Dependent Variables 
 
The same radiographic OA variables (hip, knee and hand OA) and the pain variables (knee, 
hand, back, neck and shoulder, elbow and forearm, foot pain and CWP), analysed in 
Chapters 5 and 6, are the dependent variables of interest for this analysis. Please see 
Chapters 5.3.and 6.3 for outcome assessment criteria and characteristics tables. 
 Confounding Factors 
 
As with the analysis in Chapters 5 and 6, the models used adjust for total energy intake and 
for the most commonly known confounders; age, BMI, physical activity, smoking history, 
alcohol consumption and the use of Hormone Replacement Therapy which have all been 
suggested to have relevance in the development of chronic OA. The models of adjustment 
are: 
 Model 1. Adjustment for energy intake. 
 Model 2. Adjustment for energy intake, age, BMI, smoking, alcohol consumption, 
physical activity and HRT. 
Gender was not adjusted for in the TWINS-UK analysis, due to it being an all-female subset 
of data from the cohort. 
 Statistical Analysis 
 
The TWINS-UK data was analysed, as in Chapters 5 and 6, using a multi-level model in order 
to take into account the twin pairs. A mixed effects logistic regression was used, with the 
models of adjustment above, to investigate cross-sectional associations between the 
independent variable (Mediterranean dietary pattern) and the dependent variables 
(Radiographic OA, joint pain and CWP). The statistical software programme Stata, version 
12, was used for analysis and p<0.05 indicated statistically significant findings.  
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7.4 TWINS-UK Mediterranean Diet Results 
 
Table 36 shows associations between the Mediterranean dietary pattern and the 
dependent variables of interest. 
TABLE 36. OR AND 95% CI FOR ASSOCIATIONS BETWEEN THE MEDITERRANEAN DIETARY PATTERN 
AND THE OA/PAIN VARIABLES OF INTEREST IN TWINS-UK. 
Mediterranean Dietary Pattern Model 1   Model 2   
Variable OR 95% CI OR 95% CI 
Knee OA  
(model 1 n=1417, model 2 n=800) 0.96 (0.90, 1.03) 1.03 (0.94, 1.12) 
Hip OA  
(model 1 n=1102, model 2 n=626) 0.89 (0.80, 1.00)* 0.95 (0.82, 1.10) 
Hand OA  
(model 1 n=1592, model 2 n=901) 0.90 (0.83, 0.98)* 0.88 (0.79, 0.99)* 
Knee Pain  
(model 1 n=1133, model 2 n=778) 1.00 (0.95, 1.06) 1.01 (0.94, 1.08) 
Hand Pain  
(model 1 n=1135, model 2 n=779) 1.01 (0.95, 1.08) 1.01 (0.92, 1.10) 
Foot Pain  
(model 1 n=1090, model 2 n=746) 1.01 (0.95, 1.08) 1.02 (0.93, 1.12) 
Neck and Shoulder Pain  
(model 1 n=1166, model 2 n=806) 0.99 (0.93, 1.05) 1.06 (0.98, 1.14) 
Elbow and Forearm Pain  
(model 1 n=1113, model 2 n=770) 0.98 (0.91, 1.05) 0.94 (0.85, 1.03) 
Back pain  
(model 1 n=1012, model 2 n=597) 0.93 (0.83, 1.04) 0.88 (0.76, 1.02) 
CWP  
(model 1 n=1019, model 2 n=941) 0.97 (0.88, 1.06) 1.01 (0.91, 1.11) 
*p<0.05 
**p<0.01 
 
Table 36 shows an inverse association between the Mediterranean dietary pattern and hip 
OA (p=0.049) although this does not remain statistically significant with adjustment of 
confounding factors. However, there is a consistent statistically significant inverse 
association (model 1 p=0.015 and model 2 p=0.027) seen between the Mediterranean 
dietary pattern and hand OA. 
7.5 Discussion 
 
The Mediterranean diet (a dietary pattern which is rich in complex carbohydrates and 
fibres and low in animal proteins and fats) is shown in this research to decrease the risk of 
hip OA (p=0.049) although this lost statistical significance after further adjustment of 
confounding factors). However, the consumption of a Mediterranean style diet showed an 
inverse association with hand OA (p=0.027) in both model one and model two and there 
are multiple ways in which the mediterranean diet could be demonstrating this protective 
effect on Osteoarthritis.  
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A way in which the Med diet may be having a protective effect on hand OA, therefore, is 
through the effect of the fatty acid content of foods, found within a Mediterranean style 
diet, on inflammation. 
When ω-3 PUFAs are metabolised, there is a shift towards an anti-inflammatory profile (as 
discussed in Chapter 1). ω-3 fatty acids play an important role in chondrocytes, inhibiting 
mTOR and activating autophagy as a protective mechanism for cartilage maintenance. 
Fatty acids are essential and the effects that they have on chondrocyte metabolism support 
potential benefits of having ω-3 PUFA content within the diet (Villalvilla, Gómez et al. 
2013).  
Previous research has found that ω-3 PUFAs can significantly enhance wound repair 
(Villalvilla, Gómez et al. 2013). Krill oil supplements have become popular as an additional 
source of ω-3 FAs (Tou, Jaczynski et al. 2007). A randomised double blind trial found 
significant reductions in pain, stiffness and CRP, when 300mg of krill oil was consumed in 
those with OA confirmed at the hip and knee (Deutsch 2007). The MOST study looked at 
individuals either suffering from or at high risk of knee OA and the relationship with dietary 
fatty acids to help establish dietary recommendations for fatty acid intake in order to 
reduce inflammation in OA. High levels of total ω-3 PUFAs had lower patellofemoral 
cartilage loss. Higher synovitis severity was seen with high levels of ω-6 PUFAs concluding 
that diet is, therefore, a focus to influence and help maintain the structural integrity of the 
knee (Baker, Matthan et al. 2012).  
There have been many more studies looking into the different characteristics of OA in 
relation to dietary fatty acids (Lajeunesse and Reboul 2007), which support the findings 
found by the MOST study. In osteoarthritic bone, for example, levels of ω-6 PUFAs were 
found to be higher (Plumb and Aspden 2004), whereas the regulation of catabolic factors 
by ω-3 PUFAs in turn regulates cartilage destruction (Curtis, Rees et al. 2002). Arachidonic 
acid, as mentioned in Chapter 1, is an omega-6 PUFA, which can modulate inflammation. It 
is metabolised by phospholipase C into eicosanoids, of which 2-series prostaglandins and 4-
series leukotrienes have pro-inflammatory effects when in excess (Ferretti, Nelson et al. 
1997). However, omega-3 PUFAs can reduce the effect of arachidonic acid and the 
formation of eicosanoids by impacting on the composition of plasma phospholipid fatty 
acids and alternatively producing 3-series and 5- series prostaglandins and leukotrienes (Li, 
Birdwell et al. 1994). 
With the results from TWINS-UK analysis in this chapter being focused around a very 
different dietary pattern to the one studied in the previous two chapters, it is important to 
think about the differences between a ’Traditional English’ dietary pattern and a 
Mediterranean dietary pattern and in which foods the nutrients are found. Figure 13 shows 
the foods in which ω-3 and ω-6 PUFAs are found and their abundance within these foods. 
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FIGURE 13. FATTY ACID CONTENT OF FOOD SOURCES OF DIETARY FATS IN MG/100G EDIBLE FOOD 
(PATTERSON, WALL ET AL. 2012). 
Unlike the western diet which is also rich in fats, the majority of the fat content in the Med 
diet (approximately 85%) is due to the single component olive oil, making it high in MUFAs 
and low in saturated fats and cholesterol (Serra-Majem, De La Cruz et al. 2003). The 
presence of olive oil also facilitates the consumption of other food components, such as 
vegetables and legumes that promote health (Oliviero, Spinella et al. 2015). One of the 
ways in which olive oil exerts its beneficial effects is due to the component oleic acid 
interfering with signal transduction pathways and cytokine production. Due to its ability to 
modulate expression of pleitrophic genes, oleic acid has been shown, using rat models, to 
regulate genes within signal transduction pathways. It also decreases the production of 
pro-inflammatory cytokines IL-1β and IL-6 (Magdalon, Vinolo et al. 2012). Lubricin 
expression in cartilage has also been restored after supplementation with extra virgin olive 
oil (containing high amounts of the ω-9 FA oleic acid) (Magdalon, Vinolo et al. 2012). Diets 
rich in monounsaturated fats have been shown to be effective at lowering cholesterol 
levels due to the 17.9% reduction in serum LDL cholesterol level. This was noted in those 
participants who were given a mixed diet rich in MUFAs and a 12.9% reduction was noted 
in those on the same mixed diet but rich in PUFAs (Mensink and Katan 1989). 
The second way in which the Mediterranean diet could be having a beneficial effect, is 
through the action of polyphenol compounds on inflammation. Oleuropein found in olives, 
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hydroxytyrosol found in extra virgin olive oil and resveratrol found in red grapes (and red 
wine) are suggested to be able to block inflammatory pathways. They have been shown to 
inhibit the activation of the NF-κB and AP-1 transcription factors (Carluccio, Siculella et al. 
2003) and influence COX-2, prostanoid and MMP activity (Scoditti, Calabriso et al. 2012). 
Compounds found within olive oil specifically, are noted to have anti-inflammatory effects 
concerning joint inflammation. The first being hydroxytyrosol, which has shown significant 
improvement in disease activity (in rat models) by down-regulating COX-2 and iNOS 
expression (Silva, Sepodes et al. 2015). The second is secoiridoid oleocanthal, which has 
been shown to downregulate pro-inflammatory cytokines such as IL-6, IL-1 and TNFα in 
chondrocytes (Scotece, Gómez et al. 2012). The third is oleuropein aglycone, which has also 
been shown to regulate the inflammatory response, improve tissue damage and reduce the 
plasma levels of pro-inflammatory cytokines (Impellizzeri, Esposito et al. 2011).  
Polyphenol extract from olive oil has also been shown to reduce joint oedema, bone 
erosion and cartilage degradation by influencing the JNK, p38, STAT3 and NF-κB signalling 
pathways (Rosillo, Alcaraz et al. 2014). A more recent study found that polyphenol extract 
was able to reduce the production of pro-inflammatory mediators in human synovial 
fibroblasts. As with the animal models mentioned above, this study also suggested that 
protective effects could be linked to the inhibition of the MAPK and NF-κB signalling 
pathways (Rosillo, Alarcón-de-la-Lastra et al. 2019). 
A recent study investigated the antioxidant hydroxytyrosol, which has been found to 
protect chondrocytes from DNA damage and even cell death caused by oxidative stress. 
Findings indicated that chondrocyte autophagy markers were elevated and the 
accumulation of the deacetylase Sirtuin-1 (SIRT-1), in the nucleus, was needed for 
hydroxytyrosol to perform this protective effect (Cetrullo, D'Adamo et al. 2016). The Sirtuin 
(SIRT) family of genes are activated by the consumption of foods that contain the highest 
levels of polyphenols and have shown hugely beneficial effects in health and disease. 
Therefore the finding that SIRT-1 is required for protective effects to take place is not 
surprising as olive oil is considered a SIRT food. One biological mechanism, discussed in the 
literature, through which the Mediterranean diet may have a protective effect is the Nrf2 
signalling pathway (a known antioxidant response mechanism) (Jain, Lamark et al. 2010). It 
has been noted that hydroxytyrosol increases p62 transcription (Cetrullo, D'Adamo et al. 
2016) which is an activator of Nrf2 (Jain, Lamark et al. 2010). The way in which the 
Mediterranean diet has a protective effect could also be through the inflammatory 
mediator hs-CRP, which plays a key role in the inflammatory response. 
Clinical studies that have taken place in order to investigate the efficacy of a Med diet on 
joint disease activity have focused their attention on rheumatoid arthritis. These studies 
have assessed the effects of consumption of a Med diet by comparing health assessment 
questionnaires and visual analogue scale pain scores as primary variables but with mixed 
results (Oliviero, Spinella et al. 2015). Skoldstam et al., also measured CRP and cholesterol 
levels and found significant improvement in these. Also noted was improvement in 
questionnaires used as primary efficacy variables (in respect to baseline values) in 
comparison to the control group where no change was found (Sköldstam, Hagfors et al. 
2003). There is a need, therefore, to investigate other cohorts to confirm the associations 
between a Med diet and hand OA, found in this research. Clinical studies should also be 
conducted in order to see whether there is a true and direct protective effect of consuming 
a Mediterranean style diet on hand OA. 
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8 An Investigation into Serum Blood Lipids and Radiographic OA, 
Musculoskeletal Pain and Chronic Widespread Pain. A Cross-
Sectional Analysis using Data from TWINS-UK. 
 
8.1 Chapter Overview 
 
The analysis within the TWINS-UK cohort shows that an increase in the consumption of a 
‘Traditional English’ dietary pattern increases the risk of OA/pain. The cross-sectional case-
control analysis within EPIC-Norfolk found that triglycerides are positively associated with 
pain. With excessive exposure to dietary lipids being one of the causes of inflammatory 
responses (Pfluger, Herranz et al. 2008) and with dietary fats affecting circulating lipid 
levels, there is, therefore, a need to further investigate the effect of diet on OA/pain by 
analysing serum blood lipid data. The main finding is that triglycerides significantly 
increased the risk of hip OA (p=0.009), hand OA (p=0.003), elbow and forearm pain 
(p=0.005) and CWP (p=0.020).  
8.2 Introduction 
 
Nutrient excess and obesity can lead to a complete lipid overload, alongside increased 
levels of circulating fatty acids and lipotoxicity. Dietary fatty acids, consumed as part of the 
diet, (depending on the type and quantity) have an effect on plasma cholesterol which 
circulates in the blood as part of lipoprotein complexes, such as LDL and HDL (Ertunc and 
Hotamisligil 2016). It is known that lipids play a role and are important in metabolic and 
homeostatic processes, such as immune function, energy metabolism, organelle 
homeostasis, communication between organs and cell survival. Despite their necessity and 
their playing a key role within the joint, when in excess or when their composition or 
balance in metabolism is altered, they can lead to metabolic disturbance, organelle 
dysfunction, cell death and chronic inflammation. This occurs through lipids becoming 
incorporated in signalling cascades which are damaging to cell and tissue function (Ertunc 
and Hotamisligil 2016).  
The previous chapters have investigated associations, between diet and OA/pain, many of 
which support the theory that a Western diet is pro-inflammatory and the Mediterranean 
diet is anti-inflammatory (Landaeta-Diaz, Fernandez et al. 2013). The findings from EPIC-
Norfolk showed that nutritional food groups high in fats are positively associated with hip 
and knee OA. The EPIC-Norfolk analysis also showed that triglycerides are positively 
associated with knee OA and knee pain. The findings from the TWINS-UK dietary analysis 
showed that a ‘Traditional English’ dietary pattern (defined as a dietary pattern high in 
fats/fatty foods) is positively associated with hand OA and is also positively associated with 
knee and hand pain (although not significant). With this in mind, this next chapter 
investigates biological mechanisms by which diet could be having an effect on OA/pain. 
Serum blood lipid data from TWINS-UK was, therefore, analysed to explore associations 
between lipids and OA/pain in an attempt to replicate findings seen in EPIC-Norfolk. 
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8.3 Methods 
 
 Serum Blood Lipid Data 
 
Blood lipid concentrations were determined by taking venous blood samples from 
participants in the morning after an overnight fast. Blood was extracted from twins within 
each pair less than 5 minutes apart and lipid levels were measured using a Cobas Fara 
machine. The serum blood lipid data, from TWINS-UK, consists of triglycerides, cholesterol, 
HDL, LDL, apoA1 and apoB1. Triglycerides, cholesterol and HDL were determined by the 
colorimetric enzymatic method, Apolipoprotein A1 and B1 by immunoturbidometric 
method and LDL levels were estimated using the Friedewald equation. These lipids are 
investigated in this chapter to improve our understanding of how dietary factors can 
influenc OA/pain. 
The following tables show the levels of blood lipids across cases and non-cases for all knee, 
hip and hand OA variables (Table 37) and for all musculoskeletal pain variables (Table 38). 
As can be seen from these tables, the mean levels of triglycerides, LDL, Cholesterol and 
ApoB1 are elevated in OA and pain cases compared to non-cases. Levels of HDL are lower 
across pain cases compared to non-cases and levels of APOA1 vary across outcome 
variables when comparing cases and non-cases.
TABLE 37. CHARACTERISTICS OF BLOOD LIPID DATA BY OA SITE (MMOL/L). 
  OA Cases       Non cases       
Knee OA mean  min max SD mean min max SD 
Apolipoprotein A1 1.70 0.89 2.65 0.31 1.71 0.83 2.85 0.32 
Apolipoprotein B1 1.31 0.37 2.34 0.37 1.23 0.43 2.33 0.35 
Cholesterol 6.19 3.00 9.16 1.28 5.87 2.82 9.28 1.12 
High Density Lipoprotein 1.49 0.67 2.51 0.37 1.54 0.60 2.67 0.38 
Low Density Lipoprotein 3.97 1.32 6.99 1.14 3.71 0.91 7.32 1.03 
Triglycerides  1.42 0.07 3.71 0.68 1.28 0.27 3.62 0.64 
Hip OA                 
Apolipoprotein A1 1.71 1.16 2.40 0.30 1.72 0.83 2.85 0.32 
Apolipoprotein B1 1.39 0.68 2.34 0.38 1.24 0.37 2.33 0.35 
Cholesterol 6.14 3.92 8.68 1.20 5.87 2.82 9.28 1.17 
High Density Lipoprotein 1.53 0.89 2.60 0.38 1.53 0.60 2.67 0.39 
Low Density Lipoprotein 3.81 2.17 6.15 1.05 3.72 0.91 7.32 1.07 
Triglycerides  1.57 0.43 3.60 0.82 1.27 0.27 3.62 0.62 
Hand OA                 
Apolipoprotein A1 1.72 0.83 2.84 0.33 1.71 0.85 2.85 0.32 
Apolipoprotein B1 1.39 0.45 2.30 0.35 1.24 0.37 2.34 0.35 
Cholesterol 6.41 3.47 9.10 1.11 5.87 2.82 9.28 1.13 
High Density Lipoprotein 1.53 0.60 2.58 0.38 1.53 0.60 2.67 0.38 
Low Density Lipoprotein 4.12 1.11 6.97 0.99 3.72 0.91 7.32 1.05 
Triglycerides  1.51 0.39 3.71 0.71 1.28 0.07 3.60 0.62 
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TABLE 38. CHARACTERISTICS OF BLOOD LIPID DATA BY MUSCULOSKELETAL PAIN SITE (MMOL/L). 
  Pain Cases       Non cases       
Knee Pain mean  min max SD mean min max SD 
Apolipoprotein A1 1.70 0.73 2.84 0.32 1.68 0.82 2.85 0.33 
Apolipoprotein B1 1.20 0.32 2.34 0.36 1.11 0.36 2.22 0.34 
Cholesterol 5.77 2.50 9.30 1.19 5.53 2.45 9.28 1.19 
High Density Lipoprotein 1.53 0.60 2.67 0.37 1.56 0.56 2.72 0.38 
Low Density Lipoprotein 3.64 1.11 7.18 1.11 3.44 0.56 7.32 1.06 
Triglycerides  1.28 0.07 3.71 0.63 1.14 0.30 3.60 0.57 
Hand Pain                 
Apolipoprotein A1 1.70 0.73 2.84 0.33 1.68 0.82 2.85 0.32 
Apolipoprotein B1 1.19 0.32 2.34 0.37 1.12 0.36 2.26 0.35 
Cholesterol 5.81 2.45 9.30 1.24 5.53 2.77 9.28 1.16 
High Density Lipoprotein 1.54 0.56 2.63 0.38 1.55 0.60 2.72 0.38 
Low Density Lipoprotein 3.66 1.01 6.97 1.12 3.45 0.56 7.32 1.06 
Triglycerides  1.28 0.07 3.71 0.64 1.15 0.30 3.60 0.56 
Neck and Shoulder Pain                 
Apolipoprotein A1 1.68 0.73 2.84 0.33 1.69 0.83 2.85 0.31 
Apolipoprotein B1 1.16 0.32 2.34 0.36 1.15 0.37 2.33 0.35 
Cholesterol 5.65 2.45 9.30 1.20 5.63 2.50 9.32 1.20 
High Density Lipoprotein 1.53 0.56 2.72 0.38 1.57 0.60 2.70 0.37 
Low Density Lipoprotein 3.54 0.88 6.99 1.10 3.52 0.56 7.32 1.08 
Triglycerides  1.22 0.07 3.62 0.60 1.18 0.30 3.71 0.60 
Elbow and Forearm Pain                 
Apolipoprotein A1 1.68 0.91 2.84 0.32 1.69 0.73 2.85 0.32 
Apolipoprotein B1 1.18 0.49 2.34 0.37 1.14 0.32 2.33 0.35 
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Cholesterol 5.72 3.09 9.30 1.24 5.59 2.45 9.23 1.18 
High Density Lipoprotein 1.50 0.61 2.67 0.37 1.57 0.56 2.72 0.38 
Low Density Lipoprotein 3.61 0.88 6.88 1.12 3.49 0.56 7.18 1.07 
Triglycerides  1.30 0.30 3.62 0.64 1.16 0.07 3.71 0.58 
Foot Pain                 
Apolipoprotein A1 1.69 0.72 2.85 0.32 1.69 0.73 2.85 0.33 
Apolipoprotein B1 1.16 0.30 2.34 0.35 1.12 0.32 2.33 0.34 
Cholesterol 5.66 2.45 9.30 1.18 5.53 2.45 9.30 1.16 
High Density Lipoprotein 1.54 0.56 2.72 0.38 1.56 0.56 2.72 0.38 
Low Density Lipoprotein 3.55 0.56 7.32 1.08 3.44 0.56 6.97 1.05 
Triglycerides  1.20 0.07 3.71 0.60 1.15 0.07 3.71 0.57 
Back Pain                 
Apolipoprotein A1 1.71 0.98 2.82 0.31 1.69 0.73 2.85 0.35 
Apolipoprotein B1 1.17 0.41 2.20 0.34 1.18 0.30 2.33 0.36 
Cholesterol 5.74 2.82 9.22 1.23 5.74 2.47 9.28 1.16 
High Density Lipoprotein 1.48 0.81 2.70 0.37 1.53 0.60 2.70 0.38 
Low Density Lipoprotein 3.65 0.91 6.69 1.10 3.64 0.56 7.32 1.05 
Triglycerides  1.28 0.40 3.71 0.65 1.20 0.27 3.60 0.57 
CWP                 
Apolipoprotein A1 1.70 0.73 2.76 0.33 1.69 0.82 2.85 0.32 
Apolipoprotein B1 1.22 0.32 2.34 0.36 1.12 0.33 2.33 0.34 
Cholesterol 5.92 2.82 9.30 1.24 5.52 2.45 9.32 1.12 
High Density Lipoprotein 1.50 0.66 2.72 0.38 1.57 0.56 2.71 0.38 
Low Density Lipoprotein 3.80 0.88 7.18 1.16 3.43 0.56 7.32 1.02 
Triglycerides  1.35 0.07 3.62 0.65 1.13 0.30 3.60 0.56 
Please see Chapters 5.3.and 6.3 for outcome assessment criteria and characteristics tables 
for OA and musculoskeletal pain sites. 
 Statistical Analysis 
 
A mixed effects logistic regression analysis was used to investigate cross-sectional 
associations between serum blood lipids and the radiographic OA and musculoskeletal pain 
variables. 
 Confounding Factors 
 
As seen with the analysis in Chapters 5-7, this analysis into TWINS-UK data used models of 
adjustment. The models of adjustment remain the same as with the previous analysis: 
 Model 1. No adjustment. 
 Model 2. Adjustment for age, BMI, smoking, alcohol consumption, physical activity 
and HRT. 
Gender was not adjusted for in the TWINS-UK analysis, due to it being an all-female subset 
of data from the cohort. 
8.4 TWINS-UK Blood Lipid Results 
 
 Analysis investigating Serum Blood Lipids and Radiographic OA 
 
Tables 39-41 show the findings from the analysis of blood lipids and hip, knee and hand OA. 
TABLE 39. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND RADIOGRAPHIC HIP OA 
IN TWINS-UK. 
Hip OA Model 1 (n=839)   Model 2 (n=434)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.98 (0.34, 2.81) 0.84 (0.21, 3.33) 
Apolipoprotein B1 3.15 (1.34, 7.40)** 2.73 0.87, 8.61) 
Cholesterol 1.18 (0.89, 1.56) 0.78 (0.53, 1.17) 
High Density Lipoprotein 1.04 (0.45, 2.38) 0.51 (0.17, 1.55) 
Low Density Lipoprotein 1.07 (0.80, 1.42) 0.73 (0.49, 1.10) 
Triglycerides  1.96 (1.28, 3.02)** 2.05 (1.20, 3.51)** 
*p<0.05 
**p<0.01 
 
 
118 
 
TABLE 40. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND RADIOGRAPHIC KNEE 
OA IN TWINS-UK. 
Knee OA Model 1 (n=1065)   Model 2 (n=600)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.82 (0.43, 1.57) 0.56 (0.22, 1.40) 
Apolipoprotein B1 1.95 (1.11, 3.44)* 0.86 (0.39, 1.88) 
Cholesterol 1.25 (1.05, 1.48)* 0.93 (0.73, 1.19) 
High Density Lipoprotein 0.63 (0.36, 1.10) 0.71 (0.35, 1.45) 
Low Density Lipoprotein 1.26 (1.04, 1.52)* 0.97 (0.75, 1.27) 
Triglycerides  1.36 (1.00,1.84)* 0.85 (0.54, 1.32) 
*p<0.05 
**p<0.01 
 
TABLE 41. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND RADIOGRAPHIC HAND 
OA IN TWINS-UK. 
Hand OA Model 1 (n=1218)   Model 2 (n=690)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 1.19 (0.53, 2.67) 0.78 (0.30, 2.04) 
Apolipoprotein B1 4.67 (2.15, 10.16)** 2.67 (1.10, 6.53)* 
Cholesterol 1.64 (1.31, 2.05)** 1.31 (0.99, 1.73) 
High Density Lipoprotein 0.95 (0.48, 1.89) 0.63 (0.29, 1.38) 
Low Density Lipoprotein 1.54 (1.19, 2.00)** 1.15 (0.84, 1.56) 
Triglycerides  2.05 (1.37, 3.08)** 1.94 (1.22, 3.08)** 
*p<0.05 
**p<0.01 
 
Table 39 shows that triglycerides are significantly positively associated with hip OA, across 
model one (p=0.002) and model two (p=0.009). ApoB1 also shows an initial significant 
association (p=0.008) with hip OA, although this was lost with adjustment for confounders. 
There are no statistically significant associations between blood lipids and knee OA (Table 
40) when adjusting for confounding factors, although apoB1 (p=0.020), cholesterol 
(p=0.012), LDL (p=0.017) and triglycerides (p=0.047) are all positively associated with knee 
OA initially. 
Table 41 shows that triglycerides are consistently significantly positively associated with 
hand OA, across model one (p=0.001) and model two (p=0.005). It also shows apoB1 to 
have a statistically significant positive association with hand OA across both model one 
(p=0.000) and model two (p=0.031). Cholesterol (p<0.001) and LDL (p=0.001) also show an 
initial statistically significant positive association with hand OA, but these lose statistical 
significance with adjustment of confounders.  
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 Analysis investigating Serum Blood Lipids and Joint Pain 
 
Tables 42-44 show the findings from the analysis between blood lipids and musculoskeletal 
pain variables (see Tables 51-54 in Appendix 1 for analysis with additional musculoskeletal 
pain variables).  
TABLE 42. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND KNEE PAIN IN TWINS-
UK. 
Knee Pain Model 1 (n=1791)   Model 2 (n=593)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.99 (0.61, 1.62) 0.99 (0.53, 1.86) 
Apolipoprotein B1 1.08 (0.69, 1.70) 0.73 (0.39, 1.36) 
Cholesterol 0.99 (0.87, 1.13) 0.85 (0.71, 1.02) 
High Density Lipoprotein 0.90 (0.60, 1.35) 1.15 (0.68, 1.94) 
Low Density Lipoprotein 0.98 (0.84, 1.13) 0.81 (0.66, 1.00)* 
Triglycerides  1.16 (0.91, 1.49) 1.08 0.77, 1.52) 
*p<0.05 
**p<0.01 
 
TABLE 43. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND HAND PAIN IN TWINS-
UK. 
Hand Pain Model 1 (n=1782)   Model 2 (n=596)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 1.03 (0.59, 1.78) 0.65 (0.28, 1.49) 
Apolipoprotein B1 0.97 (0.60, 1.57) 0.75 (0.35, 1.60) 
Cholesterol 1.03 (0.89, 1.19) 0.95 (0.76, 1.20) 
High Density Lipoprotein 0.96 (0.60, 1.51) 0.56 (0.28, 1.11) 
Low Density Lipoprotein 0.98 (0.83, 1.17) 0.94 (0.73, 1.21) 
Triglycerides  1.39 (1.04, 1.86)* 1.51 (0.97, 2.36) 
*p<0.05 
**p<0.01 
 
 
 
 
 
 
120 
 
TABLE 44. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND CWP IN TWINS-UK. 
CWP Model 1 (n=1583)   Model 2 (n=775)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 1.02 (0.45, 2.29) 1.60 (0.68, 3.78) 
Apolipoprotein B1 1.61 (0.74, 3.51) 1.13 (0.50, 2.56) 
Cholesterol 1.17 (0.93, 1.48) 1.10 (0.86, 1.40) 
High Density Lipoprotein 0.54 (0.27, 1.08) 0.81 (0.40, 1.66) 
Low Density Lipoprotein 1.16 (0.90, 1.50) 1.06 (0.81, 1.39) 
Triglycerides  2.10 (1.34, 3.31)** 1.62 (1.01, 2.60)* 
*p<0.05 
**p<0.01 
 
Table 42 shows the findings from analysis investigating blood lipids and knee pain, which 
revealed one statistically significant association between LDL and knee pain (p=0.047). The 
blood lipid and hand pain analysis (Table 43) did not reveal any consistent statistically 
significant associations, however, triglycerides shows a positive statistically significant 
association, in model one (p=0.026), but this is lost with adjustment for confounding 
factors. Analysis investigating CWP and lipids (Table 44), however, revealed a significant 
positive association (p=0.001) with triglycerides which remains statistically significant when 
adjusted for confounding factors (p=0.046). 
When investigating additional musculoskeletal pain variables no statistically significant 
associations were found with back pain. Analysis for neck and shoulder pain revealed one 
statistically significant (p=0.039) association; apoB1 which remained significant (p=0.033) in 
model two (Table 52, see Appendix 1). Analysis for elbow and forearm pain (Table 53, see 
Appendix 1) revealed a statistically significant positive association (p=0.027) with 
triglycerides when adjusted for confounding factors. Initial significant associations were 
also found with foot pain. Cholesterol (p=0.025) and triglycerides (p=0.024) were 
significantly associated with foot pain although this was lost with adjustment for further 
confounders (Table 54, see Appendix 1). 
8.5 Discussion 
 
The investigation into the effects of lipids and the lipid-OA relationship was an approach 
used in this research, to try and define what is being seen within the dietary data. This 
analysis found triglycerides to be significantly positively associated with hip OA (p=0.009), 
hand OA (p=0.005), elbow and forearm (p=0.027) pain (see appendix) and CWP (p=0.046). 
Associations were also seen with knee OA (p=0.047), hand pain (p=0.026) and foot pain 
(p=0.024) (see Appendix 1) although these lost statistical significance with adjustment for 
confounding factors. Cholesterol was also positively associated with hand OA, although did 
not remain significant in model two (Table 41). HDL was found to be inversely associated 
with neck and shoulder pain (Table 52, see Appendix 1) and LDL, which was found to be 
positively associated with knee pain (Table 42). 
Triglycerides in particular showed a consistent statistically significant association with hip 
and hand OA across both models. It is also positively associated with all other pain variables 
with the exception of knee OA. Despite not replicating the previous findings in EPIC-Norfolk 
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for knee OA, this analysis has replicated the finding that triglycerides are positively 
associated with knee pain in females, however this result is not statistically significant. This 
study replicates findings from a study using the Chingford cohort (that investigated the 
effects of lipids on hand OA) and found that triglycerides showed an increased risk of hand 
OA although the findings from this particular study were not significant (Garcia-Gil, Reyes 
et al. 2017). Triglycerides have been found, through previous Mendelian randomisation 
studies, to be causal for atherosclerotic cardiovascular disease (Budoff 2016). The 
Rotterdam study also showed that measures of atherosclerosis are associated with the 
prevalence of knee and hand osteoarthritis (in women) and the progression of hand OA 
(Hoeven, Kavousi et al. 2013). Having seen associations between triglycerides and knee OA 
and knee pain in the EPIC-Norfolk analysis, and with very strong statistically significant 
positive associations in this chapter also, SNPs that influence triglyceride levels could be a 
good choice for a Mendelian randomisation approach investigating OA.    
With the development of OA, there is greater inflammation and the synovium and cartilage 
becomes more permeable, allowing lipids in the form of lipoproteins the chance to diffuse 
through the tissues. Studies have suggested that some lipoproteins have a damaging 
nature. For example LDL, very low density lipoprotein (VLDL) and its remnants, all of which 
contain the major protein apoB, which reflects the concentration of lipoproteins likely to 
contribute towards the formation of fatty deposits within blood vessels (Pischon, Girman et 
al. 2005).  
HDL, which inhibits pro-inflammatory cytokine production (therefore having an anti-
inflammatory effect) (Oliviero, Nigro et al. 2012), is of great importance for the transport of 
lipoproteins and is associated with tissue lipid metabolism and homeostasis. HDL is 
produced by the combined efforts of apoA1, lipid transporter ABCA1 and plasma enzyme 
lecithin cholesterol acyltransferase (LCAT) which is produced by the liver and activated, in 
plasma, by apoA-1. LCAT is necessary for the esterification of free cholesterol, by 
transferring a fatty-acyl group from lecithin to cholesterol. LCAT acts to convert apoA1 
particles into active HDL, after lipidation of apoA-1 by ABCA1. Deficiencies in apoA-1 or 
LCAT can cause deposits of triglycerides in the liver which can lead to fatty liver disease, 
suggesting that liver damage could lead to the destruction of cartilage.  
Evidence suggests that dysfunctional HDL and LCAT deficiency (resulting in no production 
of mature HDL) is associated with the development of OA and studies have shown that, in 
OA patients, serum HDL-C levels are lower than in non-OA cases. Research has also found 
that APOA1 negative mice, when fed a western diet, immediately developed OA due to 
alterations in HDL metabolism (Triantaphyllidou, Kalyvioti et al. 2013). Oxidised LDL has 
been detected in OA, in human cartilage, and stimulates senescence in chondrocytes by 
decreasing cell viability. It is known to induce ROS in bovine chondrocytes and reduce 
proteoglycan synthesis, as well as increasing MMP-3 production in human cartilage. 
Products from the breakdown of lipids (as a result of ROS), found in the joints of OA 
patients, have been suggested to contribute towards cartilage degradation and the 
pathogenesis of OA, by inducing collagen oxidation and cleavage and MMP13 activity.  
It is, therefore, not unexpected that HDL shows inverse associations with pain, throughout 
this analysis, although LDL was found to be inversely associated with knee pain (p=0.047) 
also. ApoB1 is significantly positively associated with OA/pain (with the exception of neck 
and shoulder pain) especially with hand OA (p=0.031) and hip OA (p=0.008). The TWINS-UK 
lipid analysis also shows cholesterol to be positively associated with hand OA (p=0.000) 
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(Table 41) and foot pain (p=0.025) (Table 54, see Appendix 1), although these did not 
remain statistically significant after adjustment for confounding factors.  
Many studies have found that dietary fats influence total cholesterol levels in the blood 
serum. Saturated fatty acids have been found to increase cholesterol concentration 
whereas unsaturated fatty acids have been found to decrease cholesterol concentration. 
That most affected is the level of cholesterol transported by LDL-C and HDL-C for which the 
levels found in the bloodstream is based on the metabolic events within the liver (Dietschy 
1998). Cholesterol fluxes lead to elevated levels of harmful lipids in the circulation, 
particularly oxidised cholesterol, which leads to ER stress and the resulting response 
intersects with inflammatory pathways (Chapter 5, Figure 11) (Ertunc and Hotamisligil 
2016). Cholesterol is found in this chapter to be positively associated with CWP and 
(although not significant) is consistent with previous findings. CWP has been found in 
previous research to be associated with a lack of anti-inflammatory cytokines and these 
patients within this particular study had high blood cholesterol levels. (Üçeyler, Valenza et 
al. 2006).   
Diets high in ω-3 FAs, such as the Mediterranean style diet, appear to decrease levels of AA 
and LA and increase levels of EPA in cartilage (Lippiello, Fienhold et al. 1990). While AA has 
been found to activate mTOR signalling in chondrocytes, DHA appears to be able to reverse 
this effect (Huang, Wang et al. 2014). Unlike AA, LA, oleic and palmitic acids, ω-3 FAs have 
an effect on proteinases involved in cartilage matrix degradation. Levels of COX-2, IL-1α, IL-
1β and TNFα expression in chondrocytes have been found to decrease (Zainal, Longman et 
al. 2009).  
Changes in the levels of fatty acids in cartilage are also suggested to occur with age in that 
there are less MUFAs and ω-3 PUFAs and increased saturated fatty acids found in the more 
mature cartilage (Cleland, James et al. 1995). It has been shown that saturated fatty acids 
and ω-6 PUFAs independently increased OA severity, scar tissue formation and ossification 
(Wu et.al., 2014). Figure 14 gives a visual summary of the effects of lipids and fatty acids on 
the various processes in OA which support the findings presented in this research. 
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FIGURE 14. SUMMARY OF ACTIONS OF LIPIDS IN CARTILAGE METABOLISM. PROCESSES THAT ARE 
ACTIVATED ARE REPRESENTED BY GREEN LINES AND PROCESSES THAT ARE INHIBITED ARE REPRESENTED 
BY RED LINES (VILLALVILLA, GÓMEZ ET AL. 2013). 
 
This cross-sectional analysis of blood lipids in TWINS-UK data, supports previous research 
and replicates the findings in the initial EPIC-Norfolk cross-sectional analysis. However, 
more research is still needed to confirm the findings and assess prevalence between 
populations. The next chapter, therefore, returns to the EPIC-Norfolk cohort to investigate 
longitudinal pain data, in an attempt to validate the cross-sectional findings throughout this 
research so far.  
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9 An Investigation into Dietary and Lifestyle Factors and Change 
and Incidence of Hip and Knee Pain. A Case-Control Longitudinal 
Analysis using Data from EPIC-Norfolk. 
 
9.1 Chapter Overview 
 
Having explored the cross-sectional associations between those factors that best predict 
hip and knee OA and hip and knee pain, in the EPIC-Norfolk cohort in Chapter 3 (and then 
further exploring the differences in these results based on gender by conducting more 
specific analyses in Chapter 4), it can be seen that increased age and BMI, having female 
gender, HRT use and being physically inactive are all positively associated with OA and pain. 
Dietary components that are particularly high in fats also showed positive associations with 
hip and knee OA. The TWINS-UK cross-sectional analyses investigated these associations 
further confirming that a dietary pattern high in fats and lipids, such as cholesterol, LDL and 
especially triglycerides, are positively associated with OA/pain. Using longitudinal EPIC-
Norfolk data from the post-baseline health checks, this chapter will investigate if these 
factors replicate as being predictive of change and onset of hip pain and knee pain over 
time. This chapter is a case-control analysis investigating change (both improvement and 
worsening) of hip and knee pain over time and incidence of hip and knee pain over time. 
The main findings from this analysis are that BMI is significantly positively associated with 
incident hip and knee pain, female gender is significantly positively associated with incident 
hip pain but not knee pain, cholesterol is significantly positively associated with knee pain 
and increased vegetable consumption is inversely associated with hip pain. 
9.2 Introduction 
EPIC-Norfolk, as previously discussed, is a large prospective cohort which holds nutritional 
and lifestyle data alongside clinical OA and pain data of the hip and knee for both males 
and females, aged 40-79 years of age. Cross-sectional analysis of EPIC-Norfolk data 
(Chapters 3 and 4) revealed those dietary and lifestyle factors that best predict clinical OA 
and pain of the hip and knee. The TWINS-UK analysis (Chapters 5-8) investigated the effects 
of dietary patterns and blood lipids on radiographic OA and musculoskeletal pain, in an all-
female cohort. The findings from the cross-sectional analysis in EPIC-Norfolk and TWINS-UK 
analysis suggest that a diet high in saturated fats, trans-fats and ω-6 PUFAs increases the 
risk of OA/pain whilst a Mediterranean diet appears protective. Triglycerides are positively 
associated with knee OA and knee pain in EPIC-Norfolk and this was replicated in TWINS-UK 
where triglycerides were found to be positively associated with hip, knee and hand OA, 
joint pain and CWP (although the association with knee OA lost significance after adjusting 
for confounders). BMI has been found to be consistently associated with OA/pain in the 
EPIC-Norfolk cross-sectional analysis, however, lifestyle factors such as alcohol 
consumption and smoking show mixed results. Longitudinal analysis into those lifestyle and 
dietary factors that best predict OA/pain is needed in an attempt to replicate and validate 
the findings from the previous chapters. EPIC-Norfolk is a large and sufficiently powered 
data set and due to the nature of the collection of pain data, pain can be investigated over 
multiple time points. Previously, the associations between dietary and lifestyle factors and 
hip and knee pain were investigated at a fixed point in time using baseline nutrition and 
lifestyle data and pain data from the first health check. However, further analysis is needed 
to see if these associations remain when the analysis is of a longitudinal design.  
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This analysis will firstly investigate longitudinal associations between lifestyle and dietary 
factors and change in hip and knee pain over time. This will, therefore, look specifically at 
those who experienced pain improvement and pain worsening between the first health 
check (post-baseline) and second health check and then between the second and third 
health check. Secondly this chapter will continue to investigate longitudinal associations by 
looking specifically at those participants that experienced the onset of hip and knee pain 
between the initial collection of joint pain data at the first health check (post baseline) and 
the second and third follow-up health checks.  
The EPIC-Norfolk cohort, used in such a way as described above, provides the opportunity 
to investigate which dietary factors alongside lifestyle factors best predict the course of 
occurrence and recurrence of pain over time. This chapter identifies those explanatory 
variables that best predict changes in hip and knee pain, however, as this analysis uses 
baseline dietary data, the assumption when investigating joint pain data from multiple time 
points is that the diet of the participants in this cohort did not change significantly post-
baseline. 
9.3 Methods 
 
 Statistical Analysis 
 
A logistic regression with a stepwise algorithm to remove non-significant explanatory 
variables was used to investigate the relationship between independent variables and, 
firstly, change in hip and knee pain and, secondly, incidence of hip and knee pain. 
 Independent Variables 
 
This chapter uses EPIC-Norfolk dietary, lipid and lifestyle data outlined previously (please 
see Chapter 3.3.4, Tables 4-6).Potential explanatory variables included in this analysis are 
those used previously as in Chapter 3: age, gender, hip circumference, waist circumference, 
smoking status, teetotal, alcohol intake, ethnic group, physical activity, fruit, leafy 
vegetables, other vegetables, fatty fish, other fish, chicken, meat, meat products, eggs, 
cheese, brown bread, milk, snacks, allium vegetables, cruciferous vegetables, green 
vegetables, yellow vegetables, other vegetables, citrus fruits, non-citrus fruits, chips, 
energy intake, cholesterol, triglycerides, HDL, LDL and BMI.  
 Longitudinal Pain Data 
 
The variables relating to pain in the EPIC-Norfolk cohort are knee pain and hip pain and 
whilst the TWINS-UK subset of data contains much more site specific pain data, it does not 
include hip pain. This data is therefore very valuable for this research, not only does EPIC-
Norfolk include this additional pain variable but it holds this data at multiple time points 
enabling us to investigate the main predictors and their effects over time. 
There is no pain data at baseline in the EPIC- Norfolk cohort. The data used in this analysis 
was collected at multiple time points: 18 months post baseline (first health check), 3 years 
post baseline (second health check) and 10 years post baseline (third health check). The 
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first health check is approximately 18 months after baseline, the second health check is 1.5 
years after and the third health check is approximately 3.5 years further after that. The 
average time elapsed from baseline to the second health check is therefore approximately 
3 years and the time from baseline to the third health check is approximately 6.5 years. 
Table 45 shows the characteristics of EPIC-Norfolk pain data. 
TABLE 45. CHARACTERISTICS OF EPIC-NORFOLK PAIN VARIABLES OF INTEREST, AT MULTIPLE TIME 
POINTS. 
  
1st 
Health 
Check     
2nd 
Health 
Check     
3rd 
Health 
Check     
  Pain 
No 
Pain Missing Pain 
No 
Pain Missing Pain 
No 
Pain Missing 
Hip 
Pain 2467 17199 850 1644 13849 5023 1582 12116 6818 
Knee 
Pain 3886 15897 733 2642 12996 4878 2790 11125 6601 
 
Hip and knee pain variables were generated so that they included those who suffered 
onset of hip and knee pain during the specified time periods (first-second health check and 
first-third health check). The joint pain variables were coded as binary variables (1= have 
pain, 2=do not have pain which was recoded 1= have pain, 0=does not have pain for use in 
statistical software packages). The variable to represent change was also generated as a 
binary variable (coded: 0=’got better having had pain at baseline’, 1=’got worse (now have 
pain) compared to baseline’). 
Those that reported having pain and still had pain at the later time points and those who 
did not report having pain and responded at the later time points as still not having pain 
were defined as ‘stayed the same’. The analysis selected these randomly by splitting the 
numbers of those that ‘stayed the same’ proportionally between these two groups. 
 Inclusion Criteria 
 
For the analysis investigating the factors that most influence change in pain over time, only 
those who saw an improvement in joint pain having suffered at baseline and those whose 
joint pain had worsened since baseline were included. Those who saw no change were 
excluded from the analysis. 
For the analysis investigating the factors that most influence incidence of hip and knee pain 
over time, only those who experienced the onset of hip and knee pain between time points 
were included. Those who already had hip and knee pain were excluded.  
9.4 EPIC-Norfolk Longitudinal Results 
 
Table 46 shows those explanatory factors that best predict change and onset of hip and 
knee pain over time. 
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TABLE 46. SIGNIFICANT PREDICTORS OF CHANGE AND INCIDENCE OF HIP AND KNEE PAIN IN EPIC-
NORFOLK OVER TWO TIME PERIODS. 
Significant Predictors 1st-2nd Health Check 1st-3rd Health Check 
 OR (95% CI) OR (95% CI) 
Change in hip pain No significant results  
Other vegetables  0.61 (0.46, 0.81) 
   
Change in knee pain  No significant results 
Gender 0.76 (0.63, 0.92)  
Cholesterol 1.10 (1.02, 1.20)  
   
Onset of hip pain   
Gender 1.61 (1.28, 2.03) 1.38 (1.13, 1.69) 
BMI 1.07 (1.04, 1.10) 1.06 (1.03, 1.08) 
Age  1.02 (1.01, 1.03) 
   
Onset of knee pain   
Age  1.01 (1.00, 1.02) 
BMI 1.09 (1.06, 1.12) 1.03 (1.01, 1.05) 
Energy Intake 1.00 (1.00, 1.00)  
 
 Change in Hip Pain between Health Checks 
 
Analysis took place to investigate change in hip pain between the health checks, outlined 
previously. When investigating change in hip pain the number of those who suffered onset 
of hip pain between the 1st and 2nd health checks was n=670. For those who ‘stayed the 
same’ n=13393 and for those who ‘got better’ n=904, so the total number of observations 
for absolute change in hip pain was n=1574. A stepwise algorithm was used to remove each 
variable that was non-significant of which the results were that nothing was significant in 
the model.  
When investigating change in hip pain between the 1st and 3rd health checks, the number of 
those who suffered onset of hip pain was n=867. For those who ‘stayed the same’ n=11411 
and for those who ‘got better’ n=958, so the total number of observations for absolute 
change is n=1825. The results showed that the food group ‘other vegetables’ is the only 
significant explanatory factor of hip pain (p=0.0045). All other variables were taken out of 
the analysis by the stepwise algorithm as they were not significant. 
 Change in Knee Pain between Health Checks 
Analysis also took place to investigate change in knee pain between the health checks 
outlined previously. When investigating change in knee pain between the 1st and 2nd health 
checks, the number of those who suffered onset of knee pain was n=914. For those who 
‘stayed the same’ n=12975 and for those who ‘got better’ n=1288, so the total number of 
observations for absolute change is n=2202. The results showed that female gender is 
significantly inversely associated with knee pain. Being female suggests a decreased risk of 
knee pain (p=0.0048). Cholesterol is significantly positively associated with change in knee 
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pain (p=0.016). All other variables were taken out of the analysis by the stepwise algorithm 
as they were not significant. 
When investigating change in knee pain between the 1st and 3rd health checks, the number 
of those who suffered the onset of knee pain was n=1379. For those who ‘stayed the same’ 
n=10908 and for those who ‘got better’ n=1229, so the total number of observations is 
n=2608. A stepwise algorithm was used to remove each variable that was non-significant of 
which the results were that nothing was significant in the model.  
 Incidence of Hip Pain between Health Checks 
 
Table 46 shows the results from the investigation of the onset of hip pain, between the 
health checks (outlined previously). When investigating incidence of hip pain the number 
for those who suffered onset of hip pain between the 1st and 2nd health checks was n=670. 
With there being 670 cases of those who suffered onset of hip pain over approximately 
three years, 670 of the 13393 who ‘stayed the same’ were randomly selected as controls 
and those who had previously suffered but no longer had hip pain were excluded. The 
results showed that strong predictors of onset of hip pain in EPIC-Norfolk are female 
gender (p<0.0001) which significantly increases the risk of experiencing hip pain compared 
to being male. BMI (p<0.0001) also increases the risk of experiencing more hip pain. All 
other variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
Investigating the onset of hip pain (within the time period of approximately six years), using 
the same method as above, 867 cases experienced onset of knee pain so 867 non-cases 
were randomly selected from the 11411 who ‘stayed the same’. Those who had previously 
suffered but no longer had hip pain were excluded. The results showed that strong 
predictors of hip pain over this time period are female gender (p=0.0016) which 
significantly increases the risk of hip pain, age (p=0.0028) which significantly increases the 
risk of hip pain and BMI (p<0.0001), which significantly increases the risk of hip pain. All 
other variables were taken out of the analysis by the stepwise algorithm as they were not 
significant. 
 Incidence of Knee Pain between Health Checks 
 
Analysis took place to investigate the onset of knee pain between the health checks 
outlined previously. When investigating incidence of knee pain those who suffered onset of 
hip pain between the 1st and 2nd health check was n=914. With there being 914 cases of 
knee pain, 914 controls were randomly selected from the 12975 who ‘stayed the same’. 
Those who had previously suffered but no longer had knee pain were excluded, creating a 
total of 1828 participants. The strongest predictors of the onset of knee pain during this 
period of time are BMI (p<0.001) which significantly increases the risk of onset of knee pain 
and energy intake (kj) which is significantly associated with the onset of knee pain 
(p=0.022). All other variables were taken out of the analysis by the stepwise algorithm as 
they were not significant. 
Investigating the onset of knee pain within the time period of approximately six years 
(between 1st and 3rd health check), using the same method, there were 1379 cases so 1379 
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controls were randomly selected from those who ‘stayed the same’. Those who had 
previously suffered but no longer had knee pain were excluded, creating a total number of 
2758. The strongest predictors of the onset of knee pain, during this period of time, were 
age (p=0.020) which significantly predicts the onset of knee pain and BMI (p=0.002) which 
also increases the risk of onset of knee pain. All other variables were taken out of the 
analysis by the stepwise algorithm as they were not significant.   
9.5 Discussion 
 
This longitudinal analysis investigating change in pain over time addressed, in part, the 
previous findings that showed an unexpected positive association between vegetable 
consumption and risk of OA and pain. This analysis found that increased vegetable 
consumption is inversely associated with risk of hip pain (over a period of approximately six 
and a half years) which confirms findings from previous research. A study in TWINS UK 
investigated the effects of dietary components in OA and identified diallyl disulphide 
(DADs), found in allium vegetables such as garlic, to be associated with reduced hip OA 
occurrence. DADs have been found to block expression of key matrix-degrading proteases 
(Williams, Skinner et al. 2010). This longitudinal analysis, therefore, supports findings from 
previous research. 
The results looking at the longitudinal analysis of onset of hip and knee pain over time 
confirms that the cases (those that experienced the onset of knee pain) in this study were 
of older age, higher BMI and female gender suggesting that these all play a key role in the 
development of pain. These known risk factors for OA confirm the associations seen in the 
cross-sectional analysis in Chapters 3 and 4, where each of these factors was found to be 
strongly associated with the risk of both OA and pain.  
Female gender was found to be inversely associated with change in knee pain over a three 
year period however was consistently found to be positively associated with incident hip 
pain (61% increased risk) over three years and this association remained in the analysis 
investigating incident hip pain over six and a half years (38% increased risk). The finding 
that gender plays a significant role in the onset of hip pain supports the previous findings 
that show that HRT use is positively associated with increased hip/knee pain in middle aged 
females. Energy intake was found to be associated with incident knee pain, over a three 
year period. This finding is as expected if it is assumed that the excess calories contribute to 
weight gain. Therefore, caloric restriction (reducing weight gain) could prevent OA/pain 
despite caloric restriction in mouse models having not found any protective effects on age 
related OA (McNeill, Wu et al. 2014).      
BMI particularly is consistently positively associated with incident hip and knee pain (in all 
analysis), however, no association was found between BMI and change in hip and knee 
pain. There is a lot of research investigating the effects of BMI and weight gain and studies 
have found body fat distribution to be a strong determinant of insulin resistance and 
inflammation (Jennings, MacGregor et al. 2017). It is now recognised that adipose tissue 
plays a role in inflammatory processes and not necessarily just by exerting negative effects 
by putting additional pressure on the joints, through increased load. 
Adipocytes (the main component of adipose tissue) are mainly for storing and releasing 
lipids but adipose tissue is also now well regarded as an endocrine organ (Scherer 2006). It 
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is involved in regulating metabolic homeostasis and balancing energy. This leads to the 
polypeptides secreted by adipocytes, known as adipokines, and fatty acids being regulated.  
The signalling effects from adipose tissue also include regulation of satiety and interference 
of glucose related hormones from the pancreas. There is now also more recognition of 
communication from other tissues that can change the regulation of adipokines (Stern, 
Rutkowski et al. 2016). Pro-inflammatory and anti-inflammatory factors are both released 
from adipose tissue for example leptin, adiponectin, resistin and visfatin. Alongside these, 
cytokines and chemokines such as TNF-α, IL-6 and monocyte chemoattractant protein 1 are 
also released (Fantuzzi 2005).  
Adipocytokines have been explored specifically in relation to osteoarthritis of the hand 
which is a more suitable option to investigate how metabolic factors might influence OA 
due to there being no explanation of mechanical force (Yusuf, Ioan-Facsinay et al. 2011).  
The most secreted protein is the adiponectin hormone which is believed to play a role in 
the pathology of OA and has been heavily investigated in relation to many other diseases 
and biological pathways. Studies have found plasma adiponectin to be associated with OA 
severity specifically in knee OA (Cuzdan Coskun, Ay et al. 2015). However, adiponectin has 
also been found to potentially protect against inflammation, by influencing NF-κB 
components and downstream transcription factors. Increased serum adiponectin levels 
have been found to reduce levels of MMP-9 and exogenous adiponectin has been found to 
increase gene expression of eNOS and IL-10 known to be anti-inflammatory mediators. 
Exogenous adiponectin has also been found to reduce gene expression of pro-inflammatory 
factors such as TNF-α and IL-6 (Wang, Chen et al. 2016).  
There have been many conflicting studies and the role of adiponectin is still not well 
understood (Zembala-Szczerba, Jaworowski et al. 2017) but adiponectin’s potential uses as 
a biomarker have been suggested (Cuzdan Coskun, Ay et al. 2015). Adiponectin levels in 
synovial fluid have been investigated alongside the adipocytokine leptin, also secreted by 
adipose tissue (Simopoulou, Malizos et al. 2007). It had been suggested that in 
malnourished individuals reduced leptin levels may increase vulnerability to infection due 
to the reduced immune response (Fantuzzi 2005).  
With regard to OA, it has been shown that a greater adiponectin/leptin ratio is associated 
with lower levels of pain in patients with severe knee OA (Gandhi, Takahashi et al. 2010). 
Leptin has also been shown to directly affect chondrocytes (Simopoulou, Malizos et al. 
2007) which is unsurprising. Leptin expression is upregulated in tissues surrounding the 
joint such as cartilage and subchondral bone (which, as already discussed, experience vast 
structural and biochemical changes as a result of OA) compared with tissues that remain 
unaffected. Larger amounts of ‘free leptin’  have been found in the synovial fluid of female 
OA patients than in males (Pottie, Presle et al. 2006).  
Another adipocytokine detected in both the synovial fluid and the plasma within OA 
patients is resistin (Presle, Pottie et al. 2006). Recent studies have found levels of resistin to 
be positively associated with damage to the cartilage and with BMLs (Wang, Xu et al. 2015). 
With adipose tissue being an important regulator of metabolic processes and lipid 
metabolism it is important to consider the link with and the potential adverse effects of 
obesity. As a result of over-nutrition there exists stimulation of the release of non-esterified 
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fatty acids (NEFAs) whereas under-nutrition decreases circulating leptin and increases 
adiponectin (Stern, Rutkowski et al. 2016).  
The other way in which excess adipose tissue may play a key role in the development of OA 
is through its role in regulating hormones. As discussed in Chapter 1, hand OA may be 
influenced by hormones and the mechanisms through which adipose tissue may be 
affecting hormone imbalance.  
Hand OA, when experienced post menopause, frequently occurs without other joints being 
affected (Szoeke, Cicuttini et al. 2008) so hormones could be playing a role in the 
development of OA. Therefore, another way in which excess adipose tissue could be 
affecting the progression of OA is through hyperoestrogenism, which relies on the stores of 
androstenedione in adipose tissue for the formation of oestrogen. Oestrogen is known to 
play a role in the degradation of the ECM when pharmacological doses of oestrogen are 
administered. With the evidence throughout the literature it has been suggested that the 
onset of OA could be related to an incidence of hormone imbalance (Spector and Campion 
1989) and from the evidence above it appears, with regard to hand OA specifically, that 
obesity is a risk factor because of its pro-inflammatory nature rather than the potential 
mechanical effect. Since many experience menopause with no appearance of joint 
symptoms it could be that onset of disease is more likely in those who experience 
fluctuations in hormone levels, alongside other existing risk factors or that these changes 
could influence the progression and/or symptoms of the disease (Watt 2016).  
Reviewing the literature on adipocytokines and discussing how each can affect OA of the 
hand has shown how metabolic factors produced by the fat tissue are potentially having a 
direct effect and it is, therefore, suggested that factors associated with obesity are involved 
in the onset and development of OA (Yusuf, Ioan-Facsinay et al. 2011). Since obesity and 
female gender are both heavily associated with OA, it is also suggested that females could 
be predisposed to higher adipokine levels. This could, therefore, explain the increased 
prevalence of hand OA (Gabay and Gabay 2013) and is consistent with the hand OA and 
lipid results seen in this thesis within the all-female TWINS-UK cohort. 
Cholesterol showed a positive association with change in knee pain (p=0.016) over a three 
year period. Cholesterol and fatty acids are lipids frequently linked to cartilage 
physiopathology. High cholesterol content is found in chondrocyte cell membranes and is 
therefore important for structural maintenance. Cholesterol biosynthesis has been found 
to be essential for chondrogenesis in rats. Liver X Receptor (LXR) is a sensor of oxygenated 
cholesterol derivatives, which can protect cells from an overload of cholesterol and 
regulate cholesterol during chondrocyte differentiation.  
Another critical regulator of cholesterol metabolism is the mammalian or mechanistic 
target of rapamycin (mTOR), which regulates the expression of genes such as ABCA1, LXR 
the LDL scavenger receptor LOX-1. If cholesterol distribution in plasma membranes is 
altered the mTOR pathway is affected. Inhibition of mTOR by rapamycin has been found to 
prevent chondrocyte differentiation and has shown decreased severity of OA and less 
cartilage degradation (Villalvilla, Gómez et al. 2013). Previous studies have shown that high 
serum cholesterol or hypercholesterolemia is positively associated with knee OA (Stürmer, 
Sun et al. 1998). Positive associations have also been seen between high serum cholesterol 
and generalized OA, in knee OA participants. It is believed that serum cholesterol has a role 
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as a systemic risk factor for OA and that differences seen in OA patterns are likely to be due 
to adjusting for other risk factors (Stürmer, Sun et al. 1998).  
The results from the longitudinal analysis although supporting many of the findings from 
the cross-sectional analyses do also show some differences from the cross-sectional 
analysis which calls into question the reliability of cross-sectional observations, discussed 
further in Chapter 11. Having found consistent associations particularly with BMI the next 
chapter, therefore, investigates how OA is influenced and addresses the issue of reverse 
causality. 
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10 Investigating Cause and Effect. An Analysis of Single Nucleotide 
Polymorphism Data from the EPIC-Norfolk Cohort. 
 
10.1 Chapter Overview 
 
BMI has been shown throughout cross-sectional and longitudinal analyses to be a strong 
predictor of OA/pain in the EPIC-Norfolk cohort. Triglycerides were also found to increase 
the risk of knee pain in EPIC-Norfolk, especially in females, aged 40 to 52 years. 
Triglycerides then showed consistent associations across models with hip and hand OA a 
pain variables in the TWINS-UK cross sectional analysis in Chapter 8. Two SNPs that 
influenced both BMI and triglycerides were therefore requested, from EPIC-Norfolk, to 
explore reverse causality. A logistic regression analysis was first performed to ensure there 
was a positive association of each explanatory variable (BMI and triglycerides) with each 
outcome variable (knee OA and hip OA). A Mendelian Randomisation approach then used 
SNP rs1421085 from FTO and SNP rs662799 from APOA5 to investigate whether BMI and 
triglycerides were causal of OA. With the exception of triglycerides and hip OA the 
explanatory variables showed positive associations with knee and hip OA and analysis 
between the SNPs and explanatory variables confirmed them as being good instrumental 
variables. However the analysis with the fitted values from the regression analysis did not 
show any statistically significant associations. The analysis for this chapter did not, 
therefore, lead to any ‘causal’ conclusions for hip or knee OA for either BMI or triglyceride 
levels. 
10.2 Introduction 
 
In epidemiological studies when an association is observed it is then a question of whether 
that association is one that represents a true cause and effect relationship so if the 
exposure were to be altered would the frequency of the disease be influenced also? 
(Willett 2012). Mendelian randomization refers to the event whereby an individual’s 
genotype is randomly assigned from the parental genotypes before conception. The aim of 
Mendelian Randomisation studies is to build knowledge with regard to gene function, using 
genotype as a tool for understanding more about the modifiable exposure of interest 
(Lawlor, Harbord et al. 2008). Single Nucleotide Polymorphisms (SNPs) are the variations in 
single nucleotides within DNA sequences across the genome resulting in genetic 
differences between individuals (Klug, Cummings et al. 2009). This variation at a single 
position in a DNA sequence must occur in at least 1% of individuals to be classed as a SNP. 
If a SNP occurs within a gene, then the gene is described as having more than one allele 
which may lead to variations in the amino acid sequence and therefore contribute to a 
change in the phenotype of individuals. SNPs can therefore be used as Instrumental 
variables (IVs) in aetiological epidemiology, to investigate associations between genotype 
and the effects of a modifiable non-genetic exposure on disease outcome. Applying the 
theory of IV analysis to investigate associations between genotype and the effects of 
modifiable non genetic exposures on OA deals with endogeneity i.e. confounding, reverse 
causality and regression dilution bias. In this method the IV variable is associated with the 
outcome through a strong association with an intermediary variable, a risk factor or 
exposure, such as BMI. Mendelian Randomization studies therefore use genetic variation as 
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a proxy for ‘environmentally modifiable exposures of interest’ or an ‘intermediate 
phenotype’ in order to investigate causation (Lawlor, Harbord et al. 2008). 
In studies that are seeking to explain the ‘causes’ of diseases, the method of Mendelian 
Randomisation uses a SNP or combination of SNPs in a gene (or multiple genes) that are 
known to be significantly associated with the explanatory variable that appears to be 
‘causing’ the disease of interest. The data used in this thesis are SNPs, identified through 
GWAS, which act as an IV because they meet the prerequisite for a valid Instrumental 
variable: the IV induces changes in the explanatory variable (BMI or Triglycerides) and has 
no significant effect on the dependent variable (OA).  
The results, using data from the TWINS-UK cohort, showed associations between a 
‘Traditional English’ diet (a diet high in saturated fats) and OA/pain. In Chapter 8, again 
using data from the TWINS-UK cohort, results revealed associations between elevated lipid 
levels (particularly triglycerides) and OA/pain. Both the initial cross-sectional and the 
longitudinal analyses, in the EPIC-Norfolk cohort, consistently show BMI as a strong 
predictor of OA and pain. The main finding from the longitudinal analysis found that BMI is 
consistently associated with incidence of hip and knee pain and is the main predictor of 
onset of both hip and knee pain over both over the three year time period and the six year 
time period. 
This poses an important research question when considering cause and effect especially 
when interpreting cross-sectional associations. Is it that people experience weight gain, due 
to dietary intake, and the onset of OA/pain then occurs or does the onset of OA and 
subsequent pain cause a shift in dietary eating habits to more palatable foods in order to 
make themselves feel better? A study that took place in the US, investigated student’s 
eating habits and revealed how eating tasty foods in order to cope is linked to increases in 
BMI (Boggiano, Wenger et al. 2015). The same question of reverse causality can be applied 
to increases in circulating lipids. Is it that people eat a particularly fatty diet and experience 
a rise in lipid levels that causes the onset of OA/pain or is it that people experience pain 
symptoms and then tend to eat a diet higher in fats as a way of comforting themselves 
which then results in these negative effects on health? VanDenKerkhof et al., discusses the 
relationship between pain, diet and lifestyle being confused with regard to those feeling 
pain having had specific past dietary patterns or whether diet and lifestyle changes were 
perhaps altered after the onset of pain. Results from this study showed that deterioration 
of diet was found to be likely in those with CWP, aged 33-42, compared to those of the 
same age without CWP where diet was found to be stable (VanDenKerkhof, Macdonald et 
al. 2011).  
The main question therefore is could it be that these associations are appearing because 
people are eating highly palatable foods simply to comfort themselves in order to try and 
cope with joint pain resulting in increased BMI and elevated lipid levels. Or are these two 
explanatory variables indeed causing OA? Although OA has been shown to have strong 
associations with BMI and triglyceride concentrations in the previous chapters, it is as 
discussed above, still unclear which ‘direction’ the association is in (i.e. which is ‘causal’).  
It is possible to introduce an Instrumental Variable (IV) in the statistical analysis to assist in 
defining causal relationships. Therefore, the two SNPs within EPIC-Norfolk chosen to be 
investigated in this thesis are FTO SNP rs1421085 and APOA5 SNP rs662799. The SNP 
rs1421085, found within the fat mass and obesity associated gene, is known to be 
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associated with increased risk of obesity and is just one of the many co-inherited SNPs 
within the FTO gene, as discussed in Chapter 1. The SNP rs662799, found within APOA5, 
has been found to be associated with triglyceride metabolism (M Forte and O Ryan 2015). 
These are both the subject of this analysis and by gaining access to additional data through 
EPIC-Norfolk, there was an opportunity to investigate further what genetic influence exists, 
how this may contribute towards OA/pain and in which direction associations found 
throughout this project may occur (Figure 15). 
 
FIGURE 15. THE POTENTIAL DIRECTION OF CAUSALITY BETWEEN BMI AND OA USING FTO GENOTYPE 
AS AN IV. 
10.3 Methods 
 
Chapter 3.3.1 and Table 5 (Chapter 3.3.4) describes the HES OA data using for this 
Mendelian Randomisation analysis. 
For an individual in EPIC-Norfolk that has been genotyped for the gene of interest, each 
SNP will be comprised of two letters (e.g. CC, CT or TT) that are the two possible 
nucleotides that can occur at that position within the gene. Each of these combination of 
letters is a genotype and there are therefore three possible genotypes for each SNP. For 
analysis into the effect of the SNP on the explanatory variable, the three genotypes are 
labelled either 0, 1 or 2 which reflects their ‘effect’ on the variable (a ‘per allele’ effect). As 
an example, if it is known that the ‘C’ nucleotide has a greater effect on BMI than the ‘T’ 
nucleotide in a particular SNP, the ‘CC’ genotype would be labelled as ‘2’, the ‘CT’ as ‘1’ and 
the ‘TT’ as ‘0’. This is done so that the resultant, recoded, ordered SNP data can be used as 
an explanatory variable in a regression analysis. 
The modelling process follows what is known as two-stage least squares regression: stage 1 
is fitting the SNP data (as an explanatory variable) to the BMI (the variable that appears to 
be ‘causing’ disease) and then using the predicted values from this in stage 2, as the 
explanatory variable in a logistic regression model with the disease (OA) as the outcome. 
The significance of the resulting regression coefficient will be taken as evidence for (or 
against) BMI ‘causing’ OA. 
By using statistical models to help us determine causality, firstly a regression model of the 
ordered SNP data and BMI was generated. The resulting linear model calculated the values 
of BMI that minimised the (squared) differences between the actual data and the predicted 
values. The range (or variance) of these predicted values are the values of BMI that the 
SNPs can explain. The predicted values were then used as the explanatory variable with OA 
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as the outcome. If the predicted values are significantly associated with the disease then 
this provides good evidence that changes in BMI is casual of OA. 
10.4 Mendelian Randomisation Results 
 
For the SNP rs1421085 the group with the lowest risk (TT) comprised 5275 participants, 
7235 participants are CT and those within the high risk group (CC) comprised 2514. Of the 
initial 20,517 analysis took place with 15,024 due to 5493 having missing data. 
The number of participants with the lowest risk (AA), when investigating SNP rs662799, are 
much higher and comprised 13,207. 1512 participants had an increased risk (AG) leaving 55 
participants in the group with the highest risk (GG). Of the initial 20,267, analysis took place 
with 14,774 due to 5493 having missing data. 
 Hip OA 
 
SNPs of interest, were used as IVs, in a Mendelian Randomisation approach to looking at 
causality of BMI (through the FTO gene) and causality of triglycerides (through the APOA5 
gene) with hip OA. 
10.4.1.1  FTO SNP rs1421085 
 
A logistic regression of hip OA against BMI revealed a very strong positive statistically 
significant association (OR 1.09, CI (1.08, 1.11), p<2x10-16). To determine whether BMI is 
‘causal’ the IV in this analysis is SNP rs1421085 from the FTO gene. In this SNP, the ‘C’ 
nucleotide leads to a higher risk of obesity so the SNP was therefore coded TT=0, CT=1, 
CC=2. 
In order to check that the SNP is not a ‘weak instrument’ a regression analysis for this SNP 
and BMI took place in which the regression coefficient=0.340 (se=0.044) is highly 
significant (p=8.85x10-13) so the SNP is therefore a good instrument. The fitted values from 
the regression of BMI against the SNP were then used as the explanatory variable in a 
logistic regression with hip OA (OR 0.91, CI (0.62, 1.34), p=0.65). 
The conclusion is that the evidence (from SNP rs1421085) leads us to believe that BMI is 
not causing hip OA. 
10.4.1.2   APOA5 SNP rs662799 
 
A logistic regression of hip OA against triglyceride levels revealed an association that was 
not statistically significant (OR 1.05, CI (0.97, 1.12), p=0.19). Due to there being no 
significant association triglycerides are therefore not suggested to be ‘causal’ for hip OA 
and no further analysis took place. 
 Knee OA 
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SNPs of interest, were used as IVs, in a Mendelian Randomisation approach to looking at 
causality of BMI (through the FTO gene) and causality of triglycerides (through the APOA5 
gene) with knee OA. 
10.4.2.1   FTO SNP rs1421085 
 
A logistic regression of knee OA against BMI revealed a very strong positive statistically 
significant association (OR 1.14, CI (1.13, 1.16), p<2x10-16). To determine whether BMI is 
‘causal’ the IV in this analysis is SNP rs1421085 from the FTO gene. In this SNP, the ‘C’ 
nucleotide leads to a higher risk of obesity so the SNP was therefore coded TT=0, CT=1, 
CC=2. 
In order to check that the SNP is not a ‘weak instrument’ a regression analysis for this SNP 
and BMI took place in which the regression coefficient=0.340 (se=0.044) is highly 
significant (p=8.85x10-13) so the SNP is therefore a good instrument. The fitted values from 
the regression of BMI against the SNP were then used as the explanatory variable in a 
logistic regression with knee OA (OR 1.10, CI (0.77, 1.54), p=0.62). 
The conclusion is that the evidence (from SNP rs1421085) leads us to believe that BMI is 
not causing knee OA. 
10.4.2.2   APOA5 SNP rs662799 
 
A logistic regression of knee OA against triglyceride levels revealed a very strong positive 
statistically significant association (OR 1.14, CI (1.07, 1.21), p=6.55x10-5). To determine 
whether triglyceride levels are ‘causal’, the IV in this analysis is SNP rs662799 from the 
APOA5 gene. In this SNP, the ‘G’ nucleotide leads to a higher risk of obesity so the SNP was 
therefore coded AA=0, GA=1, GG=2. 
In order to check that the SNP is not a ‘weak instrument’ a regression analysis for this SNP 
and triglyceride levels took place in which the regression coefficient=0.265 (se=0.028) is 
highly significant (p<2x10-16) so the SNP is therefore a good instrument. The fitted values 
from the regression of triglyceride levels against the SNP were then used as the 
explanatory variable in a logistic regression with knee OA (OR 1.21, CI (0.45, 3.08), p=0.70). 
The conclusion is that the evidence (from SNP rs662799) leads us to believe that BMI is not 
causing knee OA. 
10.5 Discussion 
 
Mendelian Randomisation does bring with it statistical challenges and although studies can 
take place without exclusion criteria or participants consenting to being randomly allocated 
treatment, studies occur within representative samples within the general population so 
they are susceptible to the alteration of factors. When investigating the association 
between genetic variants and disease outcome, alleles are not considered related to 
confounding factors such as socioeconomic position and other lifestyle factors and so are 
not included. In addition, genotypes are not affected by the disease process and 
associations between genotype and disease outcomes are therefore not affected by 
reverse causality (Lawlor, Harbord et al. 2008).  
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Within this analysis, the data showed that statistically significant associations existed 
between BMI and triglycerides and OA proving them to be good instrumental variables to 
use. Both SNPs satisfied the IV criteria in that the genetic variant is reliably associated with 
the exposure, in this case overweight status and elevated triglycerides, the exposures are 
positively associated with disease outcome, there is no direct effect of genotype on disease 
and that any mediated effect exists through the exposure of interest. Both SNPs, therefore, 
appeared to be good instrumental variables to use for a mendelian randomisation analysis.  
All logistic regression analysese within this data were found to be positive and significant 
with the exception of SNP rs662799 from the APOA5 gene which did not show a statistically 
significant association with hip OA and did not therefore lead to further analysis. The 
analysis of APOA5 SNP rs662799 that did take place, however, showed that triglycerides (as 
explained by this SNP of APOA5) are not ‘causal’ of knee OA. The analysis of the FTO SNP 
rs1421085 in this chapter did not lead to any ‘causal’ conclusions for BMI (as explained by 
this SNP of FTO) for hip or knee OA. 
Published results show that a variant within FTO contributes to risk of OA and the 
association was mediated solely by BMI suggesting that FTO plays a role in the casual 
association found between BMI and OA. The SNP rs8044769 was found in a GWAS to be 
strongly associated with the risk of developing OA (Consortium 2012). It was recently found 
to support BMI as having a causal effect on OA using a Mendelian Randomisation approach 
(Panoutsopoulou, Metrustry et al. 2013), however, a study investigating this same SNP in a 
Chinese population found that FTO was not associated with susceptibility to OA or BMI of 
which one of the reasons could be due to differences in heterogeneity between ethnicities 
(Wang, Chu et al. 2016).  
A reason for there not being an association in this study could be due to gender differences 
in the EPIC-Norfolk cohort.A study published in 2009 concluded that a variant of FTO was 
associated only with males and postmenopausal females (Hubacek, Pitha et al. 2009). With 
not all females being affected and there being more females than males in the EPIC-Norfolk 
cohort this could have affected the strength of these findings. As just one of the many co-
inherited SNPs within the FTO gene (Frayling, Timpson et al. 2007) and perhaps not the SNP 
that has the strongest association with BMI (as it is suggested that there are other SNPs 
within FTO that show a stronger association with obesity), it is not unexpected that no 
causal associations have been found. There is therefore a need to investigate the causal 
relationship that BMI may have with OA further through looking at other SNPs within the 
FTO gene as it contains many polymorphisms that have shown associations in previous 
studies.  
APOA5 specifically has been found to be associated with triglyceride metabolism (M Forte 
and O Ryan 2015). The SNP rs662799, found within APOA5, has been found to be 
associated with higher levels of total cholesterol, LDL-C and lower levels of HDL-C (Wang, 
Lu et al. 2016). No causal conclusions were found in this research for the APOA5 variant 
and OA. Not only could this also be due to selection of this single SNP, associations seen 
here could be that, due to the low numbers in the EPIC-Norfolk cohort with the high risk 
genotype, this study is therefore lacking sufficient power. This could therefore be the main 
reason that in this particular study the selected SNPs from the FTO and APOA5 gene did not 
lead to any causal conclusions. 
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11 Conclusions. 
 
11.1 Summary 
 
Obesity/BMI is associated with the development of OA and musculoskeletal pain. 
Throughout this thesis there is a consistent pattern emerging which shows that a fatty diet, 
lipids and increasing BMI appear to be strong predictors of OA and musculoskeletal pain. 
There is also evidence emerging from this project that a Mediterranean dietary pattern is 
protective of radiographic hand OA and joint pain. To investigate the role of obesity and 
lipids further in OA, two SNPs from two genes that influence BMI and triglyceride levels 
were analysed but no causal associations were found. This chapter discusses the main 
findings, the strengths and the limitations of this research and discusses the future 
direction of this research. 
11.2 Main Findings 
 
The main findings from the cross-sectional analysis using the TWINS-UK cohort were that 
the dietary pattern that contained the most food items of a fatty nature was positively 
associated with radiographic hand OA, hand pain, neck and shoulder pain, knee pain and 
CWP. This finding confirmed what has been reported throughout the literature with regard 
to health and chronic disease, that a diet higher in fats but lower in omega-3 fats is one of a 
pro-inflammatory nature.  
The most interesting of these results from the TWINS-UK analysis is that with a higher 
intake the ‘Traditional English’ dietary pattern there is a 28% increased risk of hand OA 
(p=0.025). This association was seen consistently across both models of adjustment 
suggesting a dietary pattern consisting largely of fatty foods could be influencing the 
development of radiographic hand OA and the same positive association was seen with 
hand pain. One crucial point, throughout the literature, is whether the associations seen 
between a western diet and OA exists because of the foods consumed resulting in an 
increase in weight resulting in an increased load on the joint. However there is an 
argument for foods consumed causing a shift in the inflammatory profile through a 
biological mechanism of action. With the finding that a ‘Traditional English’ dietary pattern 
increases the risk of hand OA, this research helps to confirm the theory that the level of 
inflammation is affected by a diet high in fats without weight loading on the joint. As 
discussed the ‘Traditional English’ dietary pattern is characteristic of the dietary pattern 
found today in industrialized society. Increased intake of pro-inflammatory saturated fat, 
ω-6 PUFAs and trans-fatty acids combined with a lack of the anti-inflammatory ω-3 PUFAs 
are mechanisms through which the associations found may be occurring. In addition 
elevated levels of these fats in the diet can result in an increase in white adipose tissue and 
the negative effects due to the release of pro-inflammatory factors are also plausible in 
explaining this association. 
A Mediterranean dietary pattern was created to further investigate the role of dietary 
patterns on the development of OA/pain. Although this is an area that has been paid 
attention to within the literature, research to date has focused primarily on knee OA and 
most of these studies have been of a cross-sectional nature. From observing the studies in 
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the current literature, this is the first study to investigate the relationship between a 
Mediterranean dietary pattern and hand OA. The result showed that with a higher intake of 
the Mediterranean dietary pattern there is a significant decrease in the risk of radiographic 
hand OA (p=0.027) suggesting a protective effect. This result is in line with the findings 
from Chapters 5 and 6 and the suggestions of the roles that dietary fatty acids play in the 
development of hand OA/pain. Protective mechanisms, as discussed, may include the anti-
inflammatory effects of ω-3 fatty acids or the contribution of polyphenol compounds which 
have also been found to have anti-inflammatory effects.  
The exploratory analysis in EPIC-Norfolk into the predictors of hip and knee OA and hip and 
knee pain in, Chapters 3 and 4, found unexpected associations with vegetable food groups 
and there was also the finding that increased non-citrus fruit consumption is positively 
associated with knee pain in females when stratified by age. A similar association was then 
seen in the TWINS-UK dietary analysis, in Chapter 5, with the fruit and vegetable dietary 
pattern showing a positive association with knee OA (p=0.004).  
The significance of increased cruciferous vegetable consumption being associated with 
increased risk of knee and hip pain contradicts the foundation of healthy eating and the 
longitudinal data showed that increased ‘other’ vegetable consumption decreased the risk 
of hip pain when looking at change in hip pain over time. The reliability of cross-sectional 
results are therefore called into question and this must be considered when looking at all 
cross-sectional results.  
A possible explanation for these unexpected observations, could be that at the point at 
which the FFQ was completed, those participants who suffer with severe symptoms were 
aware of the health message that consumption of cruciferous vegetables could lead to 
reduced inflammation. Those suffering from OA/pain have most likely tried to find ways of 
alleviating their symptoms or stop them from getting worse which could have perhaps 
drawn their attention to fruit and vegetable intake as one of many potential remedies. This 
could have increased their intake of fruit and vegetable consumption which therefore led 
to the reporting of higher fruit and vegetable consumption on the FFQs but with OA/pain 
symptoms also developing over time the results therefore show this as a positive 
association between fruit and vegetables and OA/pain.  
A study in the US investigated the consumption of fruit and vegetable intake and found 
that a community based fruit and vegetable intervention improved knowledge of intake 
recommendations and found a decrease in the perception of cost of fruit and vegetables as 
a barrier (Hendrix, Fischer et al. 2008). There is also therefore the chance that participants 
in TWINS-UK and EPIC-Norfolk were likely to have agreed to take part in other studies and 
had therefore gained prior knowledge of the beneficial effects of having a health balanced 
diet rich in fruit and vegetables. This would also have resulted in an increased intake in fruit 
and vegetable consumption and could explain the positive associations seen. The 
differences seen, therefore, between the cross sectional and longitudinal data in this thesis 
question the reliability of observations seen in cross sectional analysis. 
Obesity is an emergent property of a complex system of social psychological physical and 
biological factors. As a result of lifestyle choices, combined with genetics, obesity is an issue 
in westernised society. Epidemiological studies consider BMI to be one of the most 
important risk factors for OA (Simopoulou, Malizos et al. 2007) and the findings from the 
EPIC-Norfolk analysis in this research support that of previous studies. In the EPIC-Norfolk 
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analysis BMI appeared consistently throughout all analysese (with the exception of the 
longitudinal analysis investigating change in pain) as a strong predictor of hip and knee OA 
and hip and knee pain in both males and females and remained consistent in the 
longitudinal analysis investigating incident hip and knee pain. It is not unexpected that BMI 
should be positively associated with hip and knee OA/pain as the joint is under more 
pressure with increased weight. The pain experience could be as a result of the excess 
weight or due to the joint undergoing physiological changes as a result of onset of OA 
which then leads to the pain. As discussed, excess adipose tissue could also be having a 
negative effect on OA/pain directly through the ability to mediate a number of metabolic 
processes. It was, therefore, important to investigate further the role of lipids in the 
development of OA/pain. The initial case-control analysis in EPIC-Norfolk showed a positive 
association between triglycerides and knee OA and knee pain especially knee pain in 
females, aged 39.6 to 51.6. Replication of these findings took place in TWINS-UK with the 
result that Triglycerides were significantly associated with OA/pain particularly hip OA 
(p=0.009), hand OA (p=0.005) and CWP (p=0.046). Longitudinal analysis in EPIC-Norfolk 
then showed a positive association between cholesterol and change in knee pain over a 
three year period (p=0.016).  
This exploratory analysis in EPIC-Norfolk, in Chapters 3 and 4, also found that being teetotal 
was positively associated with hip pain which is consistent with the observations in other 
studies where no alcohol consumption and excessive alcohol consumption tend to be 
worse than moderate alcohol consumption. However when investigating hip pain in 
females being teetotal was inversely associated with hip pain so more research is needed in 
this area to confirm associations. Age, BMI, female gender and energy intake were the 
biggest predictors of incident knee and hip pain in the longitudinal analysis. When 
investigating pain data in females based on age BMI and HRT use were found to be 
associated with increased risk of hip pain whilst increased physical activity was found to be 
inversely associated with hip pain in females, aged 67.5 to 79.8, which is in line with studies 
that have suggested there may be benefits of physical activity in later life. The EPIC-Norfolk 
longitudinal analysese investigating the onset of hip and knee pain over time found that 
female gender, age and BMI are recurring predictors that significantly increase the risk of 
knee and hip pain suggesting that these three risk factors have the biggest contribution to 
the onset and experience of joint pain. 
The main message from this research is therefore that a diet high in fats, BMI and lipids are 
all positively associated with OA/pain. The question as to whether these are causal of 
OA/pain, however, was also investigated using a Mendelian Randomisation approach. This 
analysis investigated one SNP from FTO and one SNP from APOA5 two SNPs that have been 
found to influence BMI and triglyceride metabolism. The SNP from the FTO gene, 
associated with obesity, found that BMI, as explained by this SNP, not to be causal of knee 
or hip OA. The SNP, associated with triglycerides, from APOA5 also found triglycerides, as 
explained by this SNP, not to be causal of knee OA. Further analysis investigating cause and 
effect is needed to confirm the role of these SNPs in influencing OA through the 
explanatory factors found in this research. 
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11.3 Strength, Limitations and Bias 
 
The cross sectional analysis from the TWINS-UK provided many inconsistent results and the 
cross-sectional analysis from EPIC-Norfolk provided a different message to the TWINS-UK 
and to the current evidence with regard to lipids for instance HDL is suggested to decrease 
risk of pain in the TWINS-UK but is suggested to increase risk of hip OA in EPIC-Norfolk. 
Triglycerides were also found to increase risk of hip and hand OA in the TWINS-UK but the 
cross sectional analysis in EPIC-Norfolk suggested a decrease in the risk of hip OA, although 
this did not stay statistically significant across all models. So there remains the question of 
the reliability of using cross sectional data particularly if there is a low number of 
observations and therefore a lack of power. This is why discussing dietary results from the 
cross sectional analysis in this project reviews the overall signals of the data. The main 
reason for this analysis was to look at the key findings that had strength. Although both the 
cross-sectional analysis from TWINS-UK and EPIC-Norfolk were inconsistent, looking at both 
of these analysis combined with the observations seen in the longitudinal study there is an 
emerging story of a link between obesity/BMI/lipids and OA/pain that suggests there may 
be many metabolic pathways involved in the onset and development of OA/pain 
particularly with regard to hand OA. The Mediterranean dietary pattern was also found to 
be protective of Hand OA and associations between polyphenols and OA/pain were also 
observed. 
Methods for measuring dietary intake have been criticised for being responsible for the 
correlations and associations seen in cross sectional studies especially when metabolic 
studies have shown opposing results (Willett 2012). The use of FFQs in both cohorts is a 
form of information and measurement bias and is a limitation of this research. The use of 
FFQs as a means of collecting data could also have been improved by the use of food 
diaries which is more accurate for recording dietary data. Reference measures and 
biomarkers of dietary intake such as whole body calorimetry, urinary nitrogen excretion 
and doubly labelled water have confirmed that misreporting not only occurs but is quite 
commonly seen as under-reporting (Mullaney, O'Higgins et al. 2014).  
With the extent of under-reporting increasing with intake it has been suggested that the 
intakes reported are closer to what are perceived to be the norm than the actual intake 
(Schoeller 1990). It has also since been suggested, therefore, that every study should 
include a measure of validity (Black, Prentice et al. 1993). Due to cost and suitability of 
some of these measures a method based on the ratio of energy intake to basal metabolic 
rate has been used for some time now to detect mis-reporting of dietary intakes (Goldberg, 
Black et al. 1991). FFQ data is therefore known to be less accurate than other methods of 
measuring dietary intake and there appears to be under-reporting of energy intake for 
those with BMI>30 kg/m² within the EPIC-Norfolk data used in this research. This would 
result from under-reporting of portion sizes in the FFQ which is a well-known phenomenon 
affecting the reliability of results. The use of FFQs, therefore, is a limitation due to the mis-
reporting typically seen when reporting on energy intake.  
A study in the US, published in 2015, found that specific groups were more or less likely to 
misreport on their diet. Under-reporting for example was associated with female gender, 
older age, those falling into the overweight or obese categories and those who had been 
less well-educated. Over-reporting, in complete contrast, was associated with male gender, 
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younger age, those falling into the underweight category and smokers (compared to those 
who had never smoked) (Murakami and Livingstone 2015). Another study investigated 
whether the degree of misreporting of nutrients differed between under-, acceptable and 
over-reporters and found that in comparison to acceptable reporters absolute intake of 
protein, potassium and sodium was under-reported in those who under-reported energy 
intake and over-reported in those who over-report energy intake (Murakami, Sasaki et al. 
2012). In the EPIC-Norfolk analysis there is a negative correlation with BMI for energy 
intake which suggests that as more calories are consumed, there is a decrease in BMI. This 
could be explained by the under-reporting of food consumption as people put on weight or 
that they could be dieting. Although using FFQ dietary data in cross sectional analysis may 
not address the direct relationship between diet, lipids and OA/pain, it does have a 
substantial contribution. 
A major advantage of using the TWINS-UK cohort was the high number of females 
especially as higher levels of pain have been reported in women (VanDenKerkhof, 
Macdonald et al. 2011). With regard to selections bias females within the TWINS-UK 
registry have been proven to be representative of the rest of the UK population with a few 
differences seen in the weight in monozygotic twins, the prevalence of HRT and current 
smoking (Andrew, Hart et al. 2001). However, whilst measuring the occurrence of pain in a 
sample representative of the female population, this analysis gives no information about 
recurrence or continuing pain in order for a longitudinal approach to be taken.  
The EPIC-Norfolk cohort is representative of the rural population in the UK but is not 
ethnically diverse enough to be representative of the general population, however the fact 
that it is concentrated within one area means follow up is more easily achieved. Also upon 
looking closely at the dietary data the majority consume healthy diets which is not truly 
representative of the general population but those who participate in studies tend to be 
those naturally take more of an interest and are potentially more knowledgeable about 
general health. With regard to the EPIC-Norfolk pain data collected over the three time 
points another factor to consider is the way in which the questions were asked and 
interpreted e.g. the question ’Have you had hip/knee pain on most days of the last 
month?’. Ideally this needed to be asked in the same way at each of the health checks so 
preferably questionnaire based and phrased exactly the same way. This is very important 
with regard to the reliability of results when comparing across time. 
A limitation of this research is the inconsistency of definitions of OA and pain. In the 
TWINS-UK cohort radiographic OA is recorded by KL score based on x-rays whereas data 
from HES is clinical OA data diagnosed by GPs and Hospitals based on symptoms. EPIC-
Norfolk and most TWINS-UK musculoskeletal pain variables asked about pain within the 
last month whereas back pain in the TWINS-UK, for example, asked about pain in the last 
12 months so the definition of pain differed. Due to the multiple risk factors held 
responsible for the occurrence and severity of pain, in addition to its highly subjective 
nature, pain is therefore a very challenging research area. In this research pain is used as an 
outcome variable because it defines OA but because it is subjective and because of the way 
in which the pain questions were asked the data available for analysis is limited. 
Also worth noting for both cohorts, due to TWINS-UK being all female and EPIC-Norfolk 
having more females than male participants in this research, is that the age at which OA is 
most commonly seen is also the age at which menopause occurs. Although pain is being 
investigated in this project as a proxy for OA it is also very important to keep in mind, 
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specifically with regard to CWP, the potential confounder that menopause can be 
associated with fatigue, reduced quality of sleep/sleep deprivation and fluctuations in 
mood which are all known to enhance feelings of pain (Watt 2016). The relationship 
between CWP and fatigue, which has also been investigated, has been found to be linked 
to limited social interactions (Ericsson, Palstam et al. 2016). Studies have taken place based 
on the theory that those who live in socially isolated areas, as opposed to having busy 
urban lifestyles with constant distractions, experience the feelings of pain more. This was 
found to be true of CWP in that those more at risk were those in rural areas with poor 
health, low mood and who rarely had social interactions (Docking, Beasley et al. 2015). 
With chronic pain and musculoskeletal pain being influenced by many factors and due to 
OA pain originating from many of the different changes within the joint, it is very difficult to 
measure pain assessment and find direct associations with specific mechanisms (Cuzdan 
Coskun, Ay et al. 2015). 
With regard to the analysis it is important that all explanatory variables e.g. all of the 
dietary data, and the outcome variables e.g. all OA data, was analysed together within the 
same model to avoid the issues of multiple testing which is where statistical significance is 
seen due to chance when analysing each variable separately. The stepwise logistic 
regression, although a model with selected variables input into it and analysed as one test, 
does involve multiple computer based tests within so it is important to consider that there 
may be type I error here. In avoiding multiple testing issues there is always a risk of 
multiple collinearity whereby the effects of one dietary variable mask another (for instance 
a food group and nutrient within the same analysis) and although this is important to 
consider when assessing the reliability of results a factor to keep in mind with regard to 
dietary intake is that a meal contains many different foods and therefore dietary 
components are not consumed one by one. One way of conducting analysis and correcting 
for multiple testing could have been to use the Bonferroni correction where the p value is 
divided by the number of tests in the analysis which adjusts the p value (Armstrong 2014). 
The issue with this, however, would have been that with such a large number of nutritional 
variables of interest within the TWINS combined with a very low cut off point for statistical 
significance there would have been very few if any statistically significant associations to 
discuss.  
A limitation within TWINS-UK is the low number of observations seen with some of the 
analysis due to missing data. The lower number of participants in the TWINS-UK compared 
to EPIC-Norfolk and the even lower number of observations for the associations between 
diet and OA/pain means there is less confidence in the conclusions. For the TWINS-UK 
analysis (Chapters 5-8) the initial number of observations for the analysis in model one was 
consistently higher than the number of observations in model two due to participants not 
having data recorded for confounding factors. All OA and musculoskeletal pain variables 
suffered a drop in numbers for the dietary pattern analysis in model two. This left a lower 
number for analysis, however, hand OA (901 observations) CWP (941 observations) and 
back pain (931 observations) had the highest numbers. The pain variables all experienced a 
much higher drop in numbers from being over 3000 participants in model one to less than 
1000 participants in model two. The same occurred for the numbers of observations for the 
analysis of a Mediterranean dietary pattern. Hand OA (901 observations) and CWP (941 
observations) were left with the highest numbers. The lipid results had the lowest numbers 
out of all the TWINS cross-sectional analysis (yet all still remained above 450 observations). 
This drop in numbers seen throughout the TWINS-UK analysis in this thesis means there is a 
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loss of power for model two however studies have investigated associations with far fewer 
so there is still strength in these the results.  
The benefits of using the EPIC-Norfolk cohort means that there is a much larger sample of 
approximately 20,000 and despite there being missing data particularly with HRT the 
numbers remain high and have more statistical power. The incident knee pain analysis 
between the first and second health check contained 1596, losing only around 200 
participants, but this number increased substantially when investigating the time period 
between the first and third health checks with the total number of participants ending up 
as 2533, again losing just over 200 participants. There were also a greater number of 
participants investigating incidence of hip pain between the first and third health checks 
than there were between the first and second health checks. As this looked at participants 
over a longer time period (approximately six years as opposed to three years) these are not 
only  better at predicting lifestyle and dietary factors involved in the development of pain 
(especially when compared to cross-sectional analysese but this study is also sufficiently 
powered by the increase in numbers which means there is a good chance of avoiding type 
II error.  
11.4 Future Research 
 
Twins are able to provide a natural and unique case control study. In the case of 
monozygotic twin pairs the corresponding genes, gender, age and upbringing makes using 
twins advantageous over other epidemiological approaches (Pallister, Spector et al. 2014). 
Twin registers are valuable as they provide information on the genetics of complex traits 
and an insight into the genetic epidemiology of disease which allows investigation into the 
interaction of genotype with gender, age and lifestyle factors and also allows for the study 
of causes of co-morbidity between traits and disease. Twins are therefore a unique 
opportunity (Boomsma, Busjahn et al. 2002) especially as there exists problems defining 
what is normal, due to the high variability between individuals with regard to metabolism, 
genetic epidemiological studies that are undertaken in the future could benefit greatly 
from the twin approach (Pallister, Spector et al. 2014). In terms of next steps and future 
direction it would be good to look at diet and nutrition in the TWINS but instead of using 
the twins cohort as individuals analysis could be completed using the twins as controls 
against each other. 
A greater focus on symptoms as well as aetiology is needed to reveal clinically relevant 
therapies for OA and some studies have incorporated a large number of patients who have 
had a joint replacement in acknowledgement of this. It is clear that genes contribute to the 
risk of developing OA but studies into the genetics of OA pain are also important. A 
Genome Wide Association Study that is unbiased would be the best study to investigate 
causation especially if it takes into account those who have had a joint replacement, like 
that of the arcOGEN study. Using subjects that have undergone joint replacement, who 
would have been referred due to the pain and disability OA caused them, acts as a valid 
measure for joint pain. Joint pain is one of the driving factors behind prescribing joint 
replacement and there have been few studies examining genomics associated with OA 
pain, instead much of the focus has been on genomics of OA risk and cartilage loss (Thakur, 
Dawes et al. 2013) which shows a gap in the research and a need for more research. 
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With regard to the genetics chapter and use of SNPs, an improvement on the current work 
would be to include more SNPs from more genes to have ‘composite’, weighted 
Instrumental Variables for BMI and triglyceride levels. Due to investigating only two genetic 
variants the Mendelian Randomisation analysese were not as strong as if there had been 
multiple variants so future work would therefore be to use multiple genetic variants as IVs 
to improve strength and statistical power.  
Within EPIC-Norfolk, there have been some interesting results with hip and knee pain 
especially when stratified for age in females. These variables could be investigated further 
by stratifying for both age and BMI in males and females separately. Further analysis that 
could take place within EPIC-Norfolk could be to define the different dietary groups (for 
example healthy vs unhealthy) and then analyse these as potential explanatory variables 
for hip and knee pain. Future research within EPIC-Norfolk data could also think about how 
to deal with those participants who had operations for knee/hip pain. They have been 
included in the EPIC-Norfolk analysis in this project as the majority had operations more 
than 6.5 years post baseline which is after the third health check. There are also other 
response variables that would be interesting to look at for knee and hip pain, specifically at 
the second and third health checks in order to investigate the change in knee and hip pain 
over time. 
Having seen the interesting results emerging between hand OA and BMI/lipids, future work 
might involve a meta-analysis for hand OA in other data. Due to the protective effect seen 
between hand OA and a Mediterranean diet and flavonoids it could also be that a 
randomised controlled trial looking at antioxidants in the role of hand OA would be a 
meaningful way to investigate these associations further.  
With the quantity of TWINS-UK data that has been collected, merged and created e.g. the 
mediterranean dietary pattern, there is sufficient data for more research to take place. This 
research provides a starting point for further analysis into OA and pain, particularly of the 
hand, and contributes to the current knowledge and understanding in the areas of 
nutrition, OA, pain and causality. Future research would be to gain access to metabolite 
data from the TWINS Registry which could be investigated to see whether a specific 
metabolite in a certain pathway may be involved in causing OA/pain. Mendelian 
Randomisation could then be used to determine the direction of causality between 
metabolites and OA/pain by selecting SNPs of interest. 
With the results from Chapter 7 showing that a Mediterranean diet is protective of hand 
OA further research is needed in order to replicate and validate this association in other 
cohorts. The limited dietary data available in EPIC-Norfolk meant that there wasn’t enough 
data to be able to create a Mediterranean dietary pattern and an investigation looking into 
associations between Mediterranean diet and OA/pain in EPIC-Norfolk could not take 
place. Dietary data does exist at the time points post baseline but is not available for 
research purposes. If and when it does become available, it would be useful to request and 
analyse this data using longitudinal hip and knee pain data over time. In this analysis it is 
assumed that the diets of participants do not change over time and while it is unlikely that 
dietary habits would change drastically, this is only an assumption and if the data becomes 
available in future it would be able to confirm the findings throughout this thesis.   
The Norfolk Osteoarthritis Registry (NOAR) contains a sufficient amount of data on the 
joints of the hand to be able to investigate diet and hand OA more closely. Some of the 
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participants for NOAR are also within EPIC-Norfolk so where data could be merged 
together there could then be a new data set available to investigate associations between 
dietary variables and the joints of the hand. This would be helped if the EPIC-Norfolk 
nutritional data that was collected at those later time points post-baseline could also be 
made available as it would become a great source of dietary data for analysis where 
participants of EPIC-Norfolk overlap with NOAR. Analysis of a Mediterranean dietary 
pattern could then investigated looking specifically at DIP and PIP joints of the hand which 
would be a novel and exciting research proposal.     
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List of Abbreviations 
 
A Disintegrin-like And Metalloprotease with Thrombospondin  ADAMTS 
Adenosine Di-phosphate       ADP 
American College of Rheumatology       ACR 
Apolipoprotein A1        ApoA1 
Apolipoprotein B1        ApoB1 
Arachidonic Acid         AA 
Arthritis Research UK Osteoarthritis Genetics Consortium   arcOGEN 
Body Mass Index        BMI 
Bone Marrow Lesions        BMLs 
Chronic Widespread Pain       CWP 
c-Jun N-terminal kinase       JNK 
Confidence Interval         CI 
C-reactive protein        CRP 
Cyclooxygenases        COX 
Distal Interphalangeal        DIP 
Deoxyribonucleic Acid       DNA 
Docosahexaenoic Acid        DHA 
Eicosapentaenoic Acid        EPA 
Extracellular signal-regulated kinase      ERK 
Erucin          ERN 
European Prospective Investigation into Cancer    EPIC 
Extra Cellular Matrix        ECM 
Fatty Acids         FAs 
Fat mass and Obesity associated      FTO  
Food Frequency Questionnaire       FFQ 
Genome-Wide Association Studies      GWAS 
Global Burden of Disease       GBD 
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High Density Lipoprotein        HDL 
Hospital Episode Statistics       HES 
Hormone Replacement Therapy      HRT 
Insulin-like Growth Factor       IGF 
Interleukin-1         IL-1 
Isothiocyanate        ITC 
Janus Kinase Signal Transducers and Activators of Transcription  JAK-STAT 
Lecithin Cholesterol Acyltransferase       LCAT 
Linolenic Acid          LA 
Lipoprotein Lipase         LPL 
Low Density Lipoprotein       LDL 
Matrix Metalloproteinase       MMP 
Manchester definition of CWP      CWP-M 
Macrophage-colony stimulating factors     M-CSF 
Menopausal Hormonal Therapy      MHT 
Messenger Ribonucleic Acid       mRNA 
Mitogen-activated protein kinase      MAPK 
Monounsaturated Fatty Acids      MUFA 
Natural Health Products        NHPs 
Nicotinamide Adenine Dinucleotide      NAD  
N-methyl-D-aspartate        NMDA 
Nuclear Factor-Kappa B       NF-κB 
Nuclear factor of activated T cells      NFATc1 
Osteoarthritis Research Society International    OARSI 
Odds Ratio          OR 
Osteoarthritis          OA 
Peroxisome Proliferators-Activated Receptor    PPAR 
Principle Component Analysis      PCA 
Polyunsaturated Fatty Acids       PUFA 
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Psoriatic Arthritis        PsA 
Randomised Controlled Trial       RCT 
Receptor Activated NF-κB Ligand       RANKL 
Recombinant DNA        rDNA 
Research on Osteoarthritis against Disability     ROAD 
Reactive Oxygen Species        ROS 
Short Chain Fatty Acids       SCFAs 
Single Nucleotide Polymorphism      SNP 
Silent Information Regulator       SIR 
Sirtuin          SIRT 
Sulforaphane         SFN 
Transforming Growth Factor       TGF 
Transient Receptor Potential Vanilloid      TRPV 
Tumor Necrosis Factor       TNF 
Vitamin D Receptor         VDR 
World Health Organisation       WHO 
Years Lived with Disability       YLD 
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Glossary 
 
Case–control Studies 
A case-control study is designed to help determine if an exposure is associated with an 
outcome firstly by identifying the cases (a group known to have the outcome) and the 
controls (a group known to be free of the outcome). This type of study traces back to 
investigate exposures to learn which subjects in each group had the exposure(s) and 
compares the frequency of the exposure in the case group to the control group. 
Confidence Interval 
A confidence interval refers to the amount of uncertainty associated with a sample 
population estimate of a true population. A 95% confidence interval is a range of values 
that you can be 95% certain contains the true population value. 
Confounding 
In epidemiological analysis, confounding is a form of bias. It is a variable that is associated 
with the exposure of interest and the outcome. The effect should be taken into account to 
avoid a false relationship being thought to exist between exposure and outcome.   
Cross-sectional studies 
Cross-sectional studies sample distributions of healthy and diseased subjects in the 
population at one point in time. 
Incidence and Incidence Rate 
Incidence is the number of new events (for example, number of new cases of a disease) 
that occur during a specified period in a population at risk. Incidence rate is incidence 
divided by the sum of the length of time each individual was exposed to the risk.  
Logistic Regression 
Logistic regression is the appropriate regression analysis to conduct when the dependent 
variable is dichotomous (binary). Like all regression analyses, the logistic regression is a 
predictive analysis.  Logistic regression is used to describe data and to explain the 
relationship between one dependent binary variable and one or more nominal, ordinal, 
interval or ratio-level independent variables. 
Mendelian Randomisation 
Mendelian randomisation is a study design that uses genetic variants as instrumental 
variables (a variable that is associated with the explanatory variable but not with the 
outcome variable and is independent of the confounding factors of the association 
between explanatory and outcome variable) to test the causal effect of a risk factor on a 
disease or health related outcome.  
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Odds Ratio 
The odds ratio is a ratio of two odds where the individual odds that appear in the ratio are 
usually for an experimental group and a control group, or two different demographic 
groups. 
Prevalence  
Prevalence is the fraction of a population that has the disease and is the total number 
suffering from a disease at a given time.  
Principle Component Analysis 
A dimension-reduction tool that can be used to reduce a large set of variables to a small set 
that still contains most of the information in the large set. It involves a mathematical 
procedure that transforms a number of (potentially) correlated variables into a smaller 
number of uncorrelated variables called principal components.  
Prospective longitudinal study 
A study based on observations over the same subjects for a given period. Incidence is 
investigated via prospective studies/longitudinal studies/follow-up studies. Whichever 
word is used, these studies monitor a population for a time to track the transition of non-
cases into cases. 
 
 
 
  
153 
 
12   References. 
 
Website reference - http://oarsi.org/research/standardization-osteoarthritis-definitions 
Ackerman, I. N., et al. (2017). "Hip and Knee Osteoarthritis Affects Younger People, Too." 
journal of orthopaedic & sports physical therapy 47(2): 67-79. 
  
Adcocks, C., et al. (2002). "Catechins from green tea (Camellia sinensis) inhibit bovine and 
human cartilage proteoglycan and type II collagen degradation in vitro." The Journal of 
nutrition 132(3): 341-346. 
  
Adelantado‐Renau, M., et al. (2019). "The influence of adherence to the Mediterranean 
diet on academic performance is mediated by sleep quality in adolescents." Acta 
Paediatrica 108(2): 339-346. 
  
Ageberg, E. and E. M. Roos (2015). "Neuromuscular exercise as treatment of degenerative 
knee disease." Exercise and sport sciences reviews 43(1): 14-22. 
  
Albaladejo-Blázquez, N., et al. (2018). "Poor dietary habits in bullied adolescents: The 
moderating effects of diet on depression." International journal of environmental research 
and public health 15(8): 1569. 
  
Allen, K. (2011). "Central pain contributions in osteoarthritis: next steps for improving 
recognition and treatment." Arthritis Res Ther 13(6): 133. 
  
Ameye, L. G. and W. S. Chee (2006). "Osteoarthritis and nutrition. From nutraceuticals to 
functional foods: a systematic review of the scientific evidence." Arthritis Research & 
Therapy 8(4): R127. 
  
Amin, S., et al. (2007). "Cigarette smoking and the risk for cartilage loss and knee pain in 
men with knee osteoarthritis." Annals of the rheumatic diseases 66(1): 18-22. 
  
Andersson, H. I. (2004). "The course of non‐malignant chronic pain: A 12‐year follow‐
up of a cohort from the general population." European journal of pain 8(1): 47-53. 
  
Andrew, T., et al. (2001). "Are twins and singletons comparable? A study of disease-related 
and lifestyle characteristics in adult women." Twin research 4(06): 464-477. 
  
Arden, N. and C. Cooper (2005). Osteoarthritis handbook, CRC Press. 
  
Arkill, K. P. and C. P. Winlove (2006). "Fatty acid transport in articular cartilage." Archives of 
biochemistry and biophysics 456(1): 71-78. 
  
154 
 
Armstrong, R. A. (2014). "When to use the Bonferroni correction." Ophthalmic and 
Physiological Optics 34(5): 502-508. 
  
Arriola, L., et al. (2010). "Alcohol intake and the risk of coronary heart disease in the 
Spanish EPIC cohort study." Heart 96(2): 124-130. 
  
Askari, A., et al. (2017). "Relationship between metabolic syndrome and osteoarthritis: The 
Fasa Osteoarthritis Study." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 
11: S827-S832. 
  
Assmann, K. E., et al. (2017). "Association between adherence to the mediterranean diet at 
midlife and healthy aging in a cohort of french adults." The Journals of Gerontology: Series 
A 73(3): 347-354. 
  
Baker, K. R., et al. (2012). "Association of plasma n-6 and n-3 polyunsaturated fatty acids 
with synovitis in the knee: the MOST study." Osteoarthritis and Cartilage 20(5): 382-387. 
  
Bakhshaie, J., et al. (2016). "Pain intensity and smoking behavior among treatment seeking 
smokers." Psychiatry research 237: 67-71. 
  
Barak, Y. and D. Fridman (2017). "Impact of mediterranean diet on cancer: Focused 
literature review." Cancer Genomics-Proteomics 14(6): 403-408. 
  
Barter, M., et al. (2012). "Epigenetic mechanisms in cartilage and osteoarthritis: DNA 
methylation, histone modifications and microRNAs." Osteoarthritis and Cartilage 20(5): 
339-349. 
  
Baur, J. A., et al. (2006). "Resveratrol improves health and survival of mice on a high-calorie 
diet." Nature 444(7117): 337-342. 
  
Bennell, K. L., et al. "Osteoarthritis year in review 2015: rehabilitation and outcomes." 
Osteoarthritis and Cartilage 24(1): 58-70. 
  
Bennell, K. L. and R. S. Hinman (2011). "A review of the clinical evidence for exercise in 
osteoarthritis of the hip and knee." Journal of Science and Medicine in Sport 14(1): 4-9. 
  
Berendsen, A., et al. (2018). "Changes in Dietary Intake and Adherence to the NU-AGE Diet 
Following a One-Year Dietary Intervention among European Older Adults—Results of the 
NU-AGE Randomized Trial." Nutrients 10(12): 1905. 
  
Bergman, S. (2005). "Psychosocial aspects of chronic widespread pain and fibromyalgia." 
Disability & Rehabilitation 27(12): 675-683. 
  
155 
 
Bergman, S. (2007). "Management of musculoskeletal pain." Best practice & research 
Clinical rheumatology 21(1): 153-166. 
  
Bergman, S., et al. (2002). "Chronic widespread pain: a three year followup of pain 
distribution and risk factors." The Journal of rheumatology 29(4): 818-825. 
  
Bergman, S., et al. (2004). "Health status as measured by SF-36 reflects changes and 
predicts outcome in chronic musculoskeletal pain: a 3-year follow up study in the general 
population." Pain 108(1): 115-123. 
  
Bingham, S., et al. (1994). "Comparison of dietary assessment methods in nutritional 
epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and 
estimated-diet records." British Journal of Nutrition 72(04): 619-643. 
  
Bingham, S. A., et al. (1997). "Validation of dietary assessment methods in the UK arm of 
EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum 
vitamin C and carotenoids as biomarkers." International journal of epidemiology 26(suppl 
1): S137. 
  
Black, A. E., et al. (1993). "Measurements of total energy expenditure provide insights into 
the validity of dietary measurements of energy intake." Journal of the American Dietetic 
Association 93(5): 572-579. 
  
Blumenfeld, O., et al. (2013). "Lower limbs composition and radiographic knee 
osteoarthritis (RKOA) in Chingford sample—A longitudinal study." Archives of gerontology 
and geriatrics 56(1): 148-154. 
  
Boggiano, M., et al. (2015). "Eating tasty food to cope. Longitudinal association with BMI." 
Appetite 87: 365-370. 
  
Boomsma, D., et al. (2002). "Classical twin studies and beyond." Nat Rev Genet 3(11): 872-
882. 
  
Bortoluzzi, A., et al. (2018). "Osteoarthritis and its management-epidemiology, nutritional 
aspects and environmental factors." Autoimmunity reviews. 
  
Brenna, J. T., et al. (2009). "α-Linolenic acid supplementation and conversion to n-3 long-
chain polyunsaturated fatty acids in humans." Prostaglandins, leukotrienes and essential 
fatty acids 80(2): 85-91. 
  
Bucourt, E., et al. (2016). "Comparison of the Big Five personality traits in fibromyalgia and 
other rheumatic diseases." Joint Bone Spine. 
  
156 
 
Budoff, M. (2016). "Triglycerides and triglyceride-rich lipoproteins in the causal pathway of 
cardiovascular disease." The American journal of cardiology 118(1): 138-145. 
  
Cahill, L. E., et al. (2014). "Fried-food consumption and risk of type 2 diabetes and coronary 
artery disease: a prospective study in 2 cohorts of US women and men." The American 
journal of clinical nutrition 100(2): 667-675. 
  
Carluccio, M. A., et al. (2003). "Olive oil and red wine antioxidant polyphenols inhibit 
endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals." 
Arteriosclerosis, thrombosis, and vascular biology 23(4): 622-629. 
  
Casal, S., et al. (2010). "Olive oil stability under deep-frying conditions." Food and chemical 
toxicology 48(10): 2972-2979. 
  
Castaño-Betancourt, M. C., et al. (2016). "Novel genetic variants for cartilage thickness and 
hip osteoarthritis." PLoS genetics 12(10): e1006260. 
  
Cetrullo, S., et al. (2016). "Hydroxytyrosol prevents chondrocyte death under oxidative 
stress by inducing autophagy through sirtuin 1-dependent and-independent mechanisms." 
Biochimica et Biophysica Acta (BBA)-General Subjects 1860(6): 1181-1191. 
  
Cevenini, E., et al. (2013). "Inflamm-ageing." Current Opinion in Clinical Nutrition & 
Metabolic Care 16(1): 14-20. 
  
Chaaban, H., et al. (2017). "The photostability of flavanones, flavonols and flavones and 
evolution of their antioxidant activity." Journal of Photochemistry and Photobiology A: 
Chemistry 336: 131-139. 
  
Chambers, E. S., et al. (2015). "Effects of targeted delivery of propionate to the human 
colon on appetite regulation, body weight maintenance and adiposity in overweight 
adults." Gut 64(11): 1744-1754. 
  
Chassaing, B. and A. T. Gewirtz (2014). "Gut microbiota, low-grade inflammation, and 
metabolic syndrome." Toxicologic pathology 42(1): 49-53. 
  
Chen, H., et al. (2018). "Association of rs662799 in APOA5 with CAD in Chinese Han 
population." BMC cardiovascular disorders 18(1): 2. 
  
Chen, T.-H., et al. (2006). "Evidence for a protective role for adiponectin in osteoarthritis." 
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762(8): 711-718. 
  
Chen, W.-P., et al. (2012). "Stigmasterol blocks cartilage degradation in rabbit model of 
osteoarthritis." Acta Biochimica Polonica 59(4). 
  
157 
 
Cheung, C., et al. (2016). "Managing knee osteoarthritis with yoga or aerobic/strengthening 
exercise programs in older adults: a pilot randomized controlled trial." Rheumatology 
International: 1-10. 
  
Chiu, P.-R., et al. (2016). "Vitamin C protects chondrocytes against monosodium 
iodoacetate-induced osteoarthritis by multiple pathways." International journal of 
molecular sciences 18(1): 38. 
  
Clarke, J. D., et al. (2011). "Bioavailability and inter-conversion of sulforaphane and erucin 
in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study 
design." Pharmacological Research 64(5): 456-463. 
  
Claussnitzer, M., et al. (2015). "FTO obesity variant circuitry and adipocyte browning in 
humans." New England Journal of Medicine 373(10): 895-907. 
  
Cleland, K. A., et al. (1995). "Differences in fatty acid composition of immature and mature 
articular cartilage in humans and sheep." Lipids 30(10): 949-953. 
  
Consortium, a. (2012). "Identification of new susceptibility loci for osteoarthritis (arcOGEN): 
a genome-wide association study." The Lancet 380(9844): 815-823. 
  
Control, C. f. D. and Prevention (2013). "Prevalence of doctor-diagnosed arthritis and 
arthritis-attributable activity limitation--United States, 2010-2012." MMWR. Morbidity and 
mortality weekly report 62(44): 869. 
  
Cooley, H. M., et al. (2003). "The association between hormonal and reproductive factors 
and hand osteoarthritis." Maturitas 45(4): 257-265. 
  
Cortright, D. N. and A. Szallasi (2004). "Biochemical pharmacology of the vanilloid receptor 
TRPV1." European journal of biochemistry 271(10): 1814-1819. 
  
Corvol, M., et al. (1981). Cartilage and vitamin D in vitro (author's transl). Annales 
d'endocrinologie. 
  
Crofford, L. (1997). "COX-1 and COX-2 tissue expression: implications and predictions." The 
Journal of Rheumatology. Supplement 49: 15-19. 
  
Cross, M., et al. (2014). "The global burden of hip and knee osteoarthritis: estimates from 
the global burden of disease 2010 study." Annals of the rheumatic diseases 73(7): 1323-
1330. 
  
Curtis, C. L., et al. (2002). "Pathologic indicators of degradation and inflammation in human 
osteoarthritic cartilage are abrogated by exposure to n‐3 fatty acids." Arthritis & 
Rheumatism 46(6): 1544-1553. 
158 
 
  
Cuzdan Coskun, N., et al. (2015). "Adiponectin: is it a biomarker for assessing the disease 
severity in knee osteoarthritis patients?" International journal of rheumatic diseases. 
  
Davidson, R., et al. (2017). "Isothiocyanates are detected in human synovial fluid following 
broccoli consumption and can affect the tissues of the knee joint." Scientific reports 7(1): 
3398. 
  
Day, N., et al. (1999). "EPIC-Norfolk: study design and characteristics of the cohort. 
European Prospective Investigation of Cancer." British journal of cancer 80: 95. 
  
De Luis, D., et al. (2012). "Effect of a hypocaloric diet with a commercial formula in weight 
loss and quality of life in obese patients with chronic osteoarthritis." Nutr Hosp 27(5): 1648-
1654. 
  
De Roos, A. J., et al. (2001). "Serum carotenoids and radiographic knee osteoarthritis: the 
Johnston County Osteoarthritis Project." Public health nutrition 4(05): 935-942. 
  
Dean, E. and R. Gormsen Hansen (2012). "Prescribing optimal nutrition and physical activity 
as “first-line” interventions for best practice management of chronic low-grade 
inflammation associated with osteoarthritis: evidence synthesis." Arthritis 2012. 
  
Deutsch, L. (2007). "Evaluation of the effect of Neptune Krill Oil on chronic inflammation 
and arthritic symptoms." Journal of the American college of nutrition 26(1): 39-48. 
  
Dietschy, J. M. (1998). "Dietary fatty acids and the regulation of plasma low density 
lipoprotein cholesterol concentrations." The Journal of nutrition 128(2): 444S-448S. 
  
Do, R., et al. (2008). "Genetic variants of FTO influence adiposity, insulin sensitivity, leptin 
levels, and resting metabolic rate in the Quebec Family Study." Diabetes 57(4): 1147-1150. 
  
Docking, R. E., et al. (2015). "The epidemiology of regional and widespread musculoskeletal 
pain in rural versus urban settings in those≥ 55 years." British journal of pain 9(2): 86-95. 
  
Docking, R. E., et al. (2011). "Epidemiology of back pain in older adults: prevalence and risk 
factors for back pain onset." Rheumatology 50(9): 1645-1653. 
  
Doherty, M., et al. (2000). "Session 1: Epidemiology and genetics of hand osteoarthritis." 
Osteoarthritis and Cartilage 8: S14-S15. 
  
Domínguez-Almendros, S., et al. (2011). "Logistic regression models." Allergologia et 
immunopathologia 39(5): 295-305. 
  
159 
 
Doré, D., et al. (2012). "A longitudinal study of the association between dietary factors, 
serum lipids, and bone marrow lesions of the knee." Arthritis Res Ther 14(1): R13. 
  
Drewnowski, A. and E. Almiron-Roig (2009). "11 Human Perceptions and Preferences for 
Fat-Rich Foods." Fat detection: Taste, texture, and post ingestive effects 23: 265. 
  
Elliott, K. S., et al. (2013). "Evaluation of the genetic overlap between osteoarthritis with 
body mass index and height using genome-wide association scan data." Annals of the 
rheumatic diseases 72(6): 935-941. 
  
Ericsson, A., et al. (2016). "Resistance exercise improves physical fatigue in women with 
fibromyalgia: a randomized controlled trial." Arthritis Research & Therapy 18(1): 1. 
  
Ertunc, M. E. and G. S. Hotamisligil (2016). "Lipid signaling and lipotoxicity in 
metaflammation: indications for metabolic disease pathogenesis and treatment." Journal 
of lipid research 57(12): 2099-2114. 
  
Esteve, E., et al. (2005). "Dyslipidemia and inflammation: an evolutionary conserved 
mechanism." Clinical nutrition 24(1): 16-31. 
  
Estruch, R. and A. Bach-Faig (2018). Mediterranean diet as a lifestyle and dynamic food 
pattern, Nature Publishing Group. 
  
Estruch, R., et al. (2013). "Primary prevention of cardiovascular disease with a 
Mediterranean diet." New England Journal of Medicine 368(14): 1279-1290. 
  
Falcone Ferreyra, M. L., et al. (2012). "Flavonoids: biosynthesis, biological functions, and 
biotechnological applications." Frontiers in plant science 3: 222. 
  
Fantuzzi, G. (2005). "Adipose tissue, adipokines, and inflammation." Journal of Allergy and 
Clinical Immunology 115(5): 911-919. 
  
Felson, D. and Y. Zhang (2015). Smoking and osteoarthritis: a review of the evidence and its 
implications, Elsevier. 
  
Felson, D. T. (2005). "The sources of pain in knee osteoarthritis." Current opinion in 
rheumatology 17(5): 624-628. 
  
Felson, D. T., et al. (2001). "The association of bone marrow lesions with pain in knee 
osteoarthritis." Annals of internal medicine 134(7): 541-549. 
  
Felson, D. T., et al. (2000). "Osteoarthritis: new insights. Part 1: the disease and its risk 
factors." Annals of internal medicine 133(8): 635-646. 
160 
 
  
Felson, D. T., et al. (2003). "Bone marrow edema and its relation to progression of knee 
osteoarthritis." Annals of internal medicine 139(5_Part_1): 330-336. 
  
Felson, D. T., et al. (2007). "Effect of recreational physical activities on the development of 
knee osteoarthritis in older adults of different weights: the Framingham Study." Arthritis 
Care & Research: Official Journal of the American College of Rheumatology 57(1): 6-12. 
  
Ferrer-Cascales, R., et al. (2018). "Low Adherence to the Mediterranean Diet in Isolated 
Adolescents: The Mediation Effects of Stress." Nutrients 10(12): 1894. 
  
Ferretti, A., et al. (1997). "Increased dietary arachidonic acid enhances the synthesis of 
vasoactive eicosanoids in humans." Lipids 32(4): 435-439. 
  
Festi, D., et al. (2014). "Gut microbiota and metabolic syndrome." World journal of 
gastroenterology: WJG 20(43): 16079. 
  
Fillingim, R. B., et al. (2009). "Sex, gender, and pain: a review of recent clinical and 
experimental findings." The Journal of Pain 10(5): 447-485. 
  
Fillion, L. and C. Henry (1998). "Nutrient losses and gains during frying: a review." 
International journal of food sciences and nutrition 49(2): 157-168. 
  
Frayling, T. M., et al. (2007). "A common variant in the FTO gene is associated with body 
mass index and predisposes to childhood and adult obesity." Science 316(5826): 889-894. 
  
Fredriksson, H., et al. (2000). "Studies on α-amylase degradation of retrograded starch gels 
from waxy maize and high-amylopectin potato." Carbohydrate Polymers 43(1): 81-87. 
  
Frye, R. A. (2000). "Phylogenetic classification of prokaryotic and eukaryotic Sir2-like 
proteins." Biochemical and biophysical research communications 273(2): 793-798. 
  
Gabay, O. and C. Gabay (2013). "Hand osteoarthritis: New insights." Joint Bone Spine 80(2): 
130-134. 
  
Gandhi, R., et al. (2010). "The synovial fluid adiponectin-leptin ratio predicts pain with knee 
osteoarthritis." Clinical rheumatology 29(11): 1223-1228. 
  
Gao, H., et al. (2013). "The effect of age and menopausal status on musculoskeletal 
symptoms in Chinese women aged 35–64 years." Climacteric 16(6): 639-645. 
  
Garcia-Gil, M., et al. (2017). "Serum lipid levels and risk of hand osteoarthritis: the 
Chingford Prospective Cohort Study." Scientific reports 7(1): 1-7. 
161 
 
  
Gasper, A. V., et al. (2005). "Glutathione S-transferase M1 polymorphism and metabolism 
of sulforaphane from standard and high-glucosinolate broccoli." The American journal of 
clinical nutrition 82(6): 1283-1291. 
  
Gaudette, D. C. and B. J. Holub (1990). "Albumin‐bound docosahexaenoic acid and 
collagen‐induced human platelet reactivity." Lipids 25(3): 166-169. 
  
Ghosh, S., et al. (2010). "NAD: a master regulator of transcription." Biochimica et 
Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799(10): 681-693. 
  
Gibson, R., et al. (2019). "Intakes and Food Sources of Dietary Fibre and Their Associations 
with Measures of Body Composition and Inflammation in UK Adults: Cross-Sectional 
Analysis of the Airwave Health Monitoring Study." Nutrients 11(8): 1839. 
  
Ginter, E. and V. Simko (2016). "New data on harmful effects of trans-fatty acids." 
Bratislavske lekarske listy 117(5): 251-253. 
  
Glass, C. K. and J. M. Olefsky (2012). "Inflammation and lipid signaling in the etiology of 
insulin resistance." Cell metabolism 15(5): 635-645. 
  
Goldberg, G., et al. (1991). "Critical evaluation of energy intake data using fundamental 
principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording." 
European journal of clinical nutrition 45(12): 569-581. 
  
Goljanek-Whysall, K., et al. (2016). "Ageing in relation to skeletal muscle dysfunction: redox 
homoeostasis to regulation of gene expression." Mammalian Genome: 1-17. 
  
Gombojav, B., et al. (2015). "Multiple susceptibility loci at chromosome 11q23. 3 are 
associated with plasma triglyceride in East Asians." Journal of lipid research: jlr. P063461. 
  
Gosset, M., et al. (2008). "Crucial role of visfatin/pre–B cell colony‐enhancing factor in 
matrix degradation and prostaglandin E2 synthesis in chondrocytes: Possible influence on 
osteoarthritis." Arthritis & Rheumatism 58(5): 1399-1409. 
  
Gran, J. T. (2003). "The epidemiology of chronic generalized musculoskeletal pain." Best 
practice & research Clinical rheumatology 17(4): 547-561. 
  
Grant, A. D., et al. (2007). "Protease‐activated receptor 2 sensitizes the transient receptor 
potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice." The Journal of 
physiology 578(3): 715-733. 
  
162 
 
Guallar-Castillón, P., et al. (2012). "Consumption of fried foods and risk of coronary heart 
disease: Spanish cohort of the European Prospective Investigation into Cancer and 
Nutrition study." Bmj 344: e363. 
  
Gupta, A., et al. (2007). "The role of psychosocial factors in predicting the onset of chronic 
widespread pain: results from a prospective population-based study." Rheumatology 46(4): 
666-671. 
  
Haigis, M. C. and L. P. Guarente (2006). "Mammalian sirtuins—emerging roles in 
physiology, aging, and calorie restriction." Genes & development 20(21): 2913-2921. 
  
Haigis, M. C., et al. (2006). "SIRT4 inhibits glutamate dehydrogenase and opposes the 
effects of calorie restriction in pancreatic β cells." Cell 126(5): 941-954. 
  
Haigis, M. C. and D. A. Sinclair (2010). "Mammalian sirtuins: biological insights and disease 
relevance." Annual Review of Pathological Mechanical Disease 5: 253-295. 
  
Hall , F. C. (1938). "Menopause Arthralgia." New England Journal of Medicine 219(26): 
1015-1026. 
  
Hannan, M. T., et al. (1990). "Estrogen use and radiographic osteoarthritis of the knee in 
women." Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 
33(4): 525-532. 
  
Haugen, I. K., et al. (2017). "The prevalence, incidence, and progression of hand 
osteoarthritis in relation to body mass index, smoking, and alcohol consumption." The 
Journal of rheumatology 44(9): 1402-1409. 
  
Haviv, B., et al. (2013). "The complexity of pain around the knee in patients with 
osteoarthritis." The Israel Medical Association journal: IMAJ 15(4): 178-181. 
  
He, S., et al. (2015). "Fish Protein Hydrolysates: Application in Deep‐Fried Food and Food 
Safety Analysis." Journal of food science 80(1): E108-E115. 
  
Hedbom, E. and H. Häuselmann (2002). "Molecular aspects of pathogenesis in 
osteoarthritis: the role of inflammation." Cellular and Molecular Life Sciences CMLS 59(1): 
45-53. 
  
Hendrix, S. J., et al. (2008). "Fruit and vegetable intake and knowledge increased following 
a community-based intervention in older adults in Georgia senior centers." Journal of 
Nutrition for the Elderly 27(1-2): 155-178. 
  
Hochberg, M. C., et al. (2013). "Genetic epidemiology of osteoarthritis: recent 
developments and future directions." Current opinion in rheumatology 25(2): 192. 
163 
 
  
Hoeven, T. A., et al. (2013). "Association of atherosclerosis with presence and progression 
of osteoarthritis: the Rotterdam Study." Annals of the rheumatic diseases 72(5): 646-651. 
  
Holliday, K., et al. (2011). "Lifetime body mass index, other anthropometric measures of 
obesity and risk of knee or hip osteoarthritis in the GOAL case-control study." Osteoarthritis 
and Cartilage 19(1): 37-43. 
  
Hooper, P. L., et al. (2010). "Xenohormesis: health benefits from an eon of plant stress 
response evolution." Cell Stress and Chaperones 15(6): 761-770. 
  
Hosnijeh, F. S., et al. (2016). "Association between biomarkers of tissue inflammation and 
progression of osteoarthritis: evidence from the Rotterdam study cohort." Arthritis 
Research & Therapy 18(1): 81. 
  
Hu, P.-f., et al. (2011). "The emerging role of adipokines in osteoarthritis: a narrative 
review." Molecular biology reports 38(2): 873-878. 
  
Huang, M.-j., et al. (2014). "Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic 
mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison 
with wild-type mice." Annals of the rheumatic diseases 73(9): 1719-1727. 
  
Hubacek, J. A., et al. (2009). "A common variant in the FTO gene is associated with body 
mass index in males and postmenopausal females but not in premenopausal females. 
Czech post-MONICA and 3PMFs studies." Clinical chemistry and laboratory medicine 47(4): 
387-390. 
  
Hui, M., et al. (2011). "Does smoking protect against osteoarthritis? Meta-analysis of 
observational studies." Annals of the rheumatic diseases 70(7): 1231-1237. 
  
Hunt, I., et al. (1999). "The prevalence and associated features of chronic widespread pain 
in the community using the'Manchester'definition of chronic widespread pain." 
Rheumatology 38(3): 275-279. 
  
Hunter, D. J., et al. (2013). "Structural correlates of pain in joints with osteoarthritis." 
Osteoarthritis and Cartilage 21(9): 1170-1178. 
  
Imai, S.-I., et al. (2000). "Transcriptional silencing and longevity protein Sir2 is an NAD-
dependent histone deacetylase." Nature 403(6771): 795-800. 
  
Impellizzeri, D., et al. (2011). "Oleuropein aglycone, an olive oil compound, ameliorates 
development of arthritis caused by injection of collagen type II in mice." Journal of 
Pharmacology and Experimental Therapeutics 339(3): 859-869. 
  
164 
 
Innes, J., et al. (2003). "Randomised, double-blind, placebo-controlled parallel group study 
of P54FP for the treatment of dogs with osteoarthritis." The Veterinary Record 152(15): 
457-460. 
  
Jain, A., et al. (2010). "p62/SQSTM1 is a target gene for transcription factor NRF2 and 
creates a positive feedback loop by inducing antioxidant response element-driven gene 
transcription." Journal of Biological Chemistry 285(29): 22576-22591. 
  
Jennings, A., et al. (2017). "Higher dietary flavonoid intakes are associated with lower 
objectively measured body composition in women: evidence from discordant monozygotic 
twins." The American journal of clinical nutrition 105(3): 626-634. 
  
Jin, X., et al. (2015). "Circulating C reactive protein in osteoarthritis: a systematic review 
and meta-analysis." Annals of the rheumatic diseases 74(4): 703-710. 
  
Jones, A. R., et al. (2017). "The whole grain content of foods consumed in the UK." Food 
chemistry 214: 453-459. 
  
Jonsson, H., et al. (2011). "Hand osteoarthritis severity is associated with total knee joint 
replacements independently of BMI. The Ages-Reykjavik Study." The open rheumatology 
journal 5: 7. 
  
Jung, M. K., et al. (2011). "Alcohol exposure and mechanisms of tissue injury and repair." 
Alcoholism: Clinical and Experimental Research 35(3): 392-399. 
  
Kaeberlein, M., et al. (1999). "The SIR2/3/4 complex and SIR2 alone promote longevity in 
Saccharomyces cerevisiae by two different mechanisms." Genes & development 13(19): 
2570-2580. 
  
Kang, R. and D. Tang (2012). "PKR-dependent inflammatory signals." Sci. signal. 5(247): 
pe47-pe47. 
  
Kawahara, T. L., et al. (2009). "SIRT6 links histone H3 lysine 9 deacetylation to NF-κB-
dependent gene expression and organismal life span." Cell 136(1): 62-74. 
  
Kellgren, J. and J. Lawrence (1957). "Radiological assessment of osteo-arthrosis." Annals of 
the rheumatic diseases 16(4): 494. 
  
Kerkhof, H., et al. (2014). "Prediction model for knee osteoarthritis incidence, including 
clinical, genetic and biochemical risk factors." Annals of the rheumatic diseases 73(12): 
2116-2121. 
  
Khalifé, S. and M. Zafarullah (2011). "Molecular targets of natural health products in 
arthritis." Arthritis Res Ther 13(1): 102. 
165 
 
  
Khanna, D., et al. (2007). "Natural products as a gold mine for arthritis treatment." Current 
Opinion in Pharmacology 7(3): 344-351. 
  
Khetarpal, S. A. and D. J. Rader (2015). "Triglyceride-rich lipoproteins and coronary artery 
disease risk: new insights from human genetics." Arteriosclerosis, thrombosis, and vascular 
biology 35(2): e3-e9. 
  
Kim, H. A., et al. (2009). "Phase 2 enzyme inducer sulphoraphane blocks matrix 
metalloproteinase production in articular chondrocytes." Rheumatology 48(8): 932-938. 
  
Kim, J.-H., et al. (2014). "Regulation of the catabolic cascade in osteoarthritis by the zinc-
ZIP8-MTF1 axis." Cell 156(4): 730-743. 
  
Kinoshita, T., et al. (2006). "An integrated database of flavonoids." Biofactors 26(3): 179-
188. 
  
Kivimaki, M., et al. (2004). "Work stress and incidence of newly diagnosed fibromyalgia: 
prospective cohort study." Journal of Psychosomatic Research 57(5): 417-422. 
  
Klug, W. S., et al. (2009). Concepts of genetics, Pearson. 
  
Kosek, E. and G. Ordeberg (2000). "Abnormalities of somatosensory perception in patients 
with painful osteoarthritis normalize following successful treatment." European journal of 
pain 4(3): 229-238. 
  
Krüger, T., et al. (2009). "Coagulation meets calcification: the vitamin K system." The 
International journal of artificial organs 32(2): 67-74. 
  
Lajeunesse, D. and P. Reboul (2007). The role of bone in the development of osteoarthritis. 
Bone and Osteoarthritis, Springer: 19-39. 
  
Lam, Y. Y., et al. (2013). "Resveratrol vs. calorie restriction: data from rodents to humans." 
Experimental gerontology 48(10): 1018-1024. 
  
Landaeta-Diaz, L., et al. (2013). "Mediterranean diet, moderate-to-high intensity training, 
and health-related quality of life in adults with metabolic syndrome." European journal of 
preventive cardiology 20(4): 555-564. 
  
Lawlor, D. A., et al. (2008). "Mendelian randomization: using genes as instruments for 
making causal inferences in epidemiology." Statistics in medicine 27(8): 1133-1163. 
  
166 
 
Le Poul, E., et al. (2003). "Functional characterization of human receptors for short chain 
fatty acids and their role in polymorphonuclear cell activation." Journal of Biological 
Chemistry 278(28): 25481-25489. 
  
Lee, J. Y., et al. (2001). "Saturated fatty acids, but not unsaturated fatty acids, induce the 
expression of cyclooxygenase-2 mediated through Toll-like receptor 4." Journal of 
Biological Chemistry 276(20): 16683-16689. 
  
Lei, M., et al. (2012). "Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide 
synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing 
nuclear factor-κB activity." European journal of pharmacology 674(2): 73-79. 
  
Leveille, S. G., et al. (2005). "Sex differences in musculoskeletal pain in older adults." Pain 
116(3): 332-338. 
  
Li, B., et al. (1994). "Antithetic relationship of dietary arachidonic acid and 
eicosapentaenoic acid on eicosanoid production in vivo." Journal of lipid research 35(10): 
1869-1877. 
  
Li, H., et al. (2016). "Associations between dietary antioxidants intake and radiographic 
knee osteoarthritis." Clinical rheumatology 35(6): 1585-1592. 
  
Li, X. (2013). "SIRT1 and energy metabolism." Acta biochimica et biophysica Sinica 45(1): 
51-60. 
  
Lichtenstein, A. H., et al. (2006). "Diet and lifestyle recommendations revision 2006: a 
scientific statement from the American Heart Association Nutrition Committee." Circulation 
114(1): 82-96. 
  
Lievense, A., et al. (2002). "Influence of obesity on the development of osteoarthritis of the 
hip: a systematic review." Rheumatology 41(10): 1155-1162. 
  
Lippiello, L., et al. (1990). "Metabolic and ultrastructural changes in articular cartilage of 
rats fed dietary supplements of omega‐3 fatty acids." Arthritis & Rheumatology 33(7): 
1029-1036. 
  
Liu, R., et al. (2013). "Octreotide alleviates obesity by reducing intestinal glucose absorption 
and inhibiting low-grade inflammation." European journal of nutrition 52(3): 1067-1075. 
  
Liu, Y.-H., et al. (2019). Dietary Pattern Score, Diet Quality, and Major Neurodegenerative 
Diseases: A Meta-analysis of Observational Cohort Studies (OR33-07-19), Oxford University 
Press. 
  
167 
 
Loef, M., et al. (2019). "The association of plasma fatty acids levels with hand and knee 
osteoarthritis." Osteoarthritis and Cartilage 27: S263-S264. 
  
López-Otín, C., et al. (2013). "The hallmarks of aging." Cell 153(6): 1194-1217. 
  
Lopez, H. L. (2012). "Nutritional interventions to prevent and treat osteoarthritis. Part I: 
focus on fatty acids and macronutrients." PM&R 4(5): S145-S154. 
  
LOTKE, P. and J. GRANDA (1971). ALTERATION IN PERMEABILITY OF ARTICULAR CARTILAGE 
BY PROTEOLYTIC ENZYMES. ARTHRITIS AND RHEUMATISM, LIPPINCOTT WILLIAMS & 
WILKINS 227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106. 
  
Loveless, M. S. and A. L. Fry (2016). "Pharmacologic Therapies in Musculoskeletal 
Conditions." Medical Clinics of North America 100(4): 869-890. 
  
Lu, M.-F., et al. (2013). "Where do health benefits of flavonoids come from? Insights from 
flavonoid targets and their evolutionary history." Biochemical and biophysical research 
communications 434(4): 701-704. 
  
Lyons, T. J., et al. (2006). "The normal human chondro-osseous junctional region: evidence 
for contact of uncalcified cartilage with subchondral bone and marrow spaces." BMC 
musculoskeletal disorders 7(1): 1. 
  
M Forte, T. and R. O Ryan (2015). "Apolipoprotein A5: extracellular and intracellular roles in 
triglyceride metabolism." Current drug targets 16(12): 1274-1280. 
  
Magdalon, J., et al. (2012). "Oral administration of oleic or linoleic acids modulates the 
production of inflammatory mediators by rat macrophages." Lipids 47(8): 803-812. 
  
Maheu, E., et al. (2000). "Hand osteoarthritis patients characteristics according to the 
existence of a hormone replacement therapy." Osteoarthritis and Cartilage 8: S33-S37. 
  
Maiani, G., et al. (2009). "Carotenoids: actual knowledge on food sources, intakes, stability 
and bioavailability and their protective role in humans." Molecular nutrition & food 
research 53(S2). 
  
Makinson, J., et al. (1987). "Fat uptake during deep-fat frying of coated and uncoated 
foods." Journal of Food Composition and Analysis 1(1): 93-101. 
  
Malfait, A. (2016). "Osteoarthritis year in review 2015: biology." Osteoarthritis and 
Cartilage 24(1): 21-26. 
  
Manach, C., et al. (2004). "Polyphenols: food sources and bioavailability." The American 
journal of clinical nutrition 79(5): 727-747. 
168 
 
  
Mandrekar, P., et al. (2006). "Moderate alcohol intake in humans attenuates monocyte 
inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of 
interleukin 10." Alcoholism: Clinical and Experimental Research 30(1): 135-139. 
  
March, L. M. and H. Bagga (2004). "Epidemiology of osteoarthritis in Australia." The 
Medical Journal of Australia 180(5 Suppl): S6-10. 
  
Maroudas, A. (1976). "Transport of solutes through cartilage: permeability to large 
molecules." Journal of anatomy 122(Pt 2): 335. 
  
Martucci, M., et al. (2017). "Mediterranean diet and inflammaging within the hormesis 
paradigm." Nutrition reviews 75(6): 442-455. 
  
Matsuzaki, T., et al. (2013). "Disruption of Sirt1 in chondrocytes causes accelerated 
progression of osteoarthritis under mechanical stress and during ageing in mice." Annals of 
the rheumatic diseases: annrheumdis-2012-202620. 
  
McAlindon, T. E., et al. (1996). "Relation of dietary intake and serum levels of vitamin D to 
progression of osteoarthritis of the knee among participants in the Framingham Study." 
Annals of internal medicine 125(5): 353-359. 
  
McAlindon, T. E., et al. (1996). "Do antioxidant micronutrients protect against the 
development and progression of knee osteoarthritis?" Arthritis & Rheumatism 39(4): 648-
656. 
  
McBeth, J., et al. (2001). "Risk factors for persistent chronic widespread pain: a 
community‐based study." Rheumatology 40(1): 95-101. 
  
McClain, C. J., et al. (1999). Cytokines in alcoholic liver disease. Seminars in liver disease, © 
1999 by Thieme Medical Publishers, Inc. 
  
McNeill, J. N., et al. (2014). "Life-long caloric restriction does not alter the severity of age-
related osteoarthritis." Age 36(4): 9669. 
  
Meeus, M. and J. Nijs (2007). "Central sensitization: a biopsychosocial explanation for 
chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome." 
Clinical rheumatology 26(4): 465-473. 
  
Mehmood, A., et al. (2013). "Vitamin E protects chondrocytes against hydrogen peroxide-
induced oxidative stress in vitro." Inflammation Research 62(8): 781-789. 
  
Mensink, R. P. and M. B. Katan (1989). "Effect of a diet enriched with monounsaturated or 
polyunsaturated fatty acids on levels of low-density and high-density lipoprotein 
169 
 
cholesterol in healthy women and men." New England Journal of Medicine 321(7): 436-
441. 
  
Miao, F.-P., et al. (2004). "Central terminals of nociceptors are targets for nicotine 
suppression of inflammation." Neuroscience 123(3): 777-784. 
  
Michel, C. I., et al. (2011). "Small nucleolar RNAs U32a, U33, and U35a are critical 
mediators of metabolic stress." Cell metabolism 14(1): 33-44. 
  
Miyazawa, D., et al. (2003). "Dietary alpha-linolenic acid suppresses the formation of 
lysophosphatidic acid, a lipid mediator, in rat platelets compared with linoleic acid." Life 
sciences 73(16): 2083-2090. 
  
Moayyeri, A., et al. (2013). "The UK adult twin registry (TwinsUK resource)." Twin Research 
and Human Genetics 16(01): 144-149. 
  
Molina-Montes, E., et al. (2017). "Mediterranean diet and risk of pancreatic cancer in the 
European Prospective Investigation into Cancer and Nutrition cohort." British journal of 
cancer 116(6): 811. 
  
Morales-Ivorra, I., et al. (2018). "Osteoarthritis and the Mediterranean diet: a systematic 
review." Nutrients 10(8): 1030. 
  
Mostoslavsky, R., et al. (2006). "Genomic instability and aging-like phenotype in the 
absence of mammalian SIRT6." Cell 124(2): 315-329. 
  
Mullaney, L., et al. (2014). "An estimation of periconceptional under-reporting of dietary 
energy intake." Journal of Public Health: fdu086. 
  
Munukka, M., et al. (2017). "Physical Activity Is Related with Cartilage Quality in Women 
with Knee Osteoarthritis." Medicine and science in sports and exercise 49(7): 1323-1330. 
  
Murakami, K. and M. B. E. Livingstone (2015). "Prevalence and characteristics of 
misreporting of energy intake in US adults: NHANES 2003–2012." British Journal of 
Nutrition 114(08): 1294-1303. 
  
Murakami, K., et al. (2012). "The degree of misreporting of the energy-adjusted intake of 
protein, potassium, and sodium does not differ among under-, acceptable, and over-
reporters of energy intake." Nutrition Research 32(10): 741-750. 
  
Muraki, S., et al. (2014). "Association of dietary intake with joint space narrowing and 
osteophytosis at the knee in Japanese men and women: the ROAD study." Modern 
rheumatology 24(2): 236-242. 
  
170 
 
Muraki, S., et al. (2011). "Association of vitamin D status with knee pain and radiographic 
knee osteoarthritis." Osteoarthritis and Cartilage 19(11): 1301-1306. 
  
Muthuri, S. G., et al. (2015). "Beer and wine consumption and risk of knee or hip 
osteoarthritis: a case control study." Arthritis Research & Therapy 17(1): 23. 
  
Nájera, D. D. R., et al. (2016). "Rheumatic Diseases in Chihuahua, México: A COPCORD 
Survey." JCR: Journal of Clinical Rheumatology 22(4): 188-193. 
  
Nakamoto, K., et al. (2010). "Antinociceptive effects of docosahexaenoic acid against 
various pain stimuli in mice." Biological and Pharmaceutical Bulletin 33(6): 1070-1072. 
  
Nakamura, T., et al. (2010). "Double-stranded RNA-dependent protein kinase links 
pathogen sensing with stress and metabolic homeostasis." Cell 140(3): 338-348. 
  
Nelson, A. E. (2018). "Osteoarthritis year in review 2017: clinical." Osteoarthritis and 
Cartilage 26(3): 319-325. 
  
Niu, J., et al. (2017). "Metabolic syndrome, its components, and knee osteoarthritis: the 
framingham osteoarthritis study." Arthritis & Rheumatology 69(6): 1194-1203. 
  
Oka, H., et al. (2009). "Association of low dietary vitamin K intake with radiographic knee 
osteoarthritis in the Japanese elderly population: dietary survey in a population-based 
cohort of the ROAD study." Journal of Orthopaedic Science 14(6): 687-692. 
  
Oliviero, F., et al. (2012). "A comparative study of serum and synovial fluid lipoprotein 
levels in patients with various arthritides." Clinica Chimica Acta 413(1): 303-307. 
  
Oliviero, F., et al. (2015). "How the Mediterranean diet and some of its components 
modulate inflammatory pathways in arthritis." Swiss medical weekly 145(4546). 
  
Pallister, T., et al. (2014). "Twin studies advance the understanding of gene–environment 
interplay in human nutrigenomics." Nutrition research reviews 27(02): 242-251. 
  
Pan, J., et al. (2009). "In situ measurement of transport between subchondral bone and 
articular cartilage." Journal of Orthopaedic Research 27(10): 1347-1352. 
  
Panoutsopoulou, K., et al. (2013). "The effect of FTO variation on increased osteoarthritis 
risk is mediated through body mass index: a mendelian randomisation study." Annals of the 
rheumatic diseases: annrheumdis-2013-203772. 
  
Patterson, E., et al. (2012). "Health implications of high dietary omega-6 polyunsaturated 
fatty acids." Journal of nutrition and metabolism 2012. 
171 
 
  
Patwardhan, A. M., et al. (2010). "Heat generates oxidized linoleic acid metabolites that 
activate TRPV1 and produce pain in rodents." The Journal of clinical investigation 120(5): 
1617-1626. 
  
Patwardhan, A. M., et al. (2009). "Activation of TRPV1 in the spinal cord by oxidized linoleic 
acid metabolites contributes to inflammatory hyperalgesia." Proceedings of the National 
Academy of Sciences 106(44): 18820-18824. 
  
Pavelka, K. (2017). "Osteoarthritis as part of metabolic syndrome?" Vnitrni lekarstvi 63(10): 
707-711. 
  
Pelletier, J. P., et al. (2001). "Osteoarthritis, an inflammatory disease: potential implication 
for the selection of new therapeutic targets." Arthritis & Rheumatism 44(6): 1237-1247. 
  
Peng, S. L. (2007). "Immune regulation by Foxo transcription factors." Autoimmunity 40(6): 
462-469. 
  
Peregoy, J. and F. V. Wilder (2011). "The effects of vitamin C supplementation on incident 
and progressive knee osteoarthritis: a longitudinal study." Public health nutrition 14(4): 
709-715. 
  
Pereira, D., et al. (2011). "The effect of osteoarthritis definition on prevalence and 
incidence estimates: a systematic review." Osteoarthritis and Cartilage 19(11): 1270-1285. 
  
Pineau, L., et al. (2009). "Lipid‐induced ER stress: synergistic effects of sterols and 
saturated fatty acids." Traffic 10(6): 673-690. 
  
Pischon, T., et al. (2005). "Non–high-density lipoprotein cholesterol and apolipoprotein B in 
the prediction of coronary heart disease in men." Circulation 112(22): 3375-3383. 
  
Plumb, M. S. and R. M. Aspden (2004). "High levels of fat and (n-6) fatty acids in cancellous 
bone in osteoarthritis." Lipids in health and disease 3(1): 12. 
  
Plunk, A. D., et al. (2014). "Alcohol consumption, heavy drinking, and mortality: Rethinking 
the J‐shaped curve." Alcoholism: Clinical and Experimental Research 38(2): 471-478. 
  
Pottie, P., et al. (2006). "Obesity and osteoarthritis: more complex than predicted!" Annals 
of the rheumatic diseases 65(11): 1403-1405. 
  
Presle, N., et al. (2006). "Differential distribution of adipokines between serum and synovial 
fluid in patients with osteoarthritis. Contribution of joint tissues to their articular 
production." Osteoarthritis and Cartilage 14(7): 690-695. 
  
172 
 
Prieto-Alhambra, D., et al. (2014). "Incidence and risk factors for clinically diagnosed knee, 
hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other 
joints." Annals of the rheumatic diseases 73(9): 1659-1664. 
  
Purushotham, A., et al. (2009). "Hepatocyte-specific deletion of SIRT1 alters fatty acid 
metabolism and results in hepatic steatosis and inflammation." Cell metabolism 9(4): 327-
338. 
  
Qin, B., et al. (2012). "Association of dietary magnesium intake with radiographic knee 
osteoarthritis: Results from a population‐based study." Arthritis care & research 64(9): 
1306-1311. 
  
Qin, J., et al. (2017). "Lifetime risk of symptomatic hand osteoarthritis: the Johnston County 
Osteoarthritis Project." Arthritis & Rheumatology 69(6): 1204-1212. 
  
Ramsden, C., et al. (2010). "Do omega-6 and trans fatty acids play a role in complex 
regional pain syndrome? A pilot study." Pain Medicine 11(7): 1115-1125. 
  
Rattan, S. I. (2008). "Hormesis in aging." Ageing research reviews 7(1): 63-78. 
  
Rayman, M. P. and D. J. Pattison (2008). "Dietary manipulation in musculoskeletal 
conditions." Best practice & research Clinical rheumatology 22(3): 535-561. 
  
Ricciotti, E. and G. A. FitzGerald (2011). "Prostaglandins and inflammation." 
Arteriosclerosis, thrombosis, and vascular biology 31(5): 986-1000. 
  
Riley III, J. L. and C. King (2009). "Self-report of alcohol use for pain in a multi-ethnic 
community sample." The Journal of Pain 10(9): 944-952. 
  
Rizza, W., et al. (2016). "Prototypical versus contemporary Mediterranean Diet." Clinical 
nutrition ESPEN 15: 44-48. 
  
Rosa, F. T., et al. (2012). "Bioactive compounds with effects on inflammation markers in 
humans." International journal of food sciences and nutrition 63(6): 749-765. 
  
Rosillo, M. Á., et al. (2019). "Polyphenolic extract from extra virgin olive oil inhibits the 
inflammatory response in IL-1β-activated synovial fibroblasts." British Journal of Nutrition 
121(1): 55-62. 
  
Rosillo, M. Á., et al. (2014). "Anti-inflammatory and joint protective effects of extra-virgin 
olive-oil polyphenol extract in experimental arthritis." The Journal of nutritional 
biochemistry 25(12): 1275-1281. 
  
173 
 
Sadeghi, O., et al. (2019). "Adherence to Mediterranean dietary pattern is inversely 
associated with depression, anxiety and psychological distress." Nutritional neuroscience: 
1-12. 
  
Sánchez, P. H., et al. (2012). "Adherence to the Mediterranean diet and quality of life in the 
SUN Project." European journal of clinical nutrition 66(3): 360. 
  
Sayon-Orea, C., et al. (2013). "Consumption of fried foods and weight gain in a 
Mediterranean cohort: the SUN project." Nutrition, Metabolism and Cardiovascular 
Diseases 23(2): 144-150. 
  
Sayon-Orea, C., et al. (2014). "Reported fried food consumption and the incidence of 
hypertension in a Mediterranean cohort: the SUN (Seguimiento Universidad de Navarra) 
project." British Journal of Nutrition 112(6): 984-991. 
  
Schäfers, M., et al. (2003). "Tumor necrosis factor-α induces mechanical allodynia after 
spinal nerve ligation by activation of p38 MAPK in primary sensory neurons." The Journal of 
neuroscience 23(7): 2517-2521. 
  
Schell, J., et al. (2017). "Strawberries Improve Pain and Inflammation in Obese Adults with 
Radiographic Evidence of Knee Osteoarthritis." Nutrients 9(9): 949. 
  
Scherer, P. E. (2006). "Adipose tissue from lipid storage compartment to endocrine organ." 
Diabetes 55(6): 1537-1545. 
  
Schoeller, D. A. (1990). "How accurate is self-reported dietary energy intake?" Nutrition 
reviews 48(10): 373-379. 
  
Scoditti, E., et al. (2012). "Mediterranean diet polyphenols reduce inflammatory 
angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a 
potentially protective mechanism in atherosclerotic vascular disease and cancer." Archives 
of biochemistry and biophysics 527(2): 81-89. 
  
Scotece, M., et al. (2012). "Further evidence for the anti-inflammatory activity of 
oleocanthal: inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 
chondrocytes." Life sciences 91(23-24): 1229-1235. 
  
Serra-Majem, L., et al. (2003). "Olive oil and the Mediterranean diet: beyond the rhetoric." 
European journal of clinical nutrition 57(S1): S2. 
  
Settembre, C., et al. (2008). "Proteoglycan desulfation determines the efficiency of 
chondrocyte autophagy and the extent of FGF signaling during endochondral ossification." 
Genes & development 22(19): 2645-2650. 
  
174 
 
Shakibaei, M., et al. (2007). "Suppression of NF-κB activation by curcumin leads to 
inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human 
articular chondrocytes: implications for the treatment of osteoarthritis." Biochemical 
pharmacology 73(9): 1434-1445. 
  
Shakibaei, M., et al. (2011). "Curcumin synergizes with resveratrol to stimulate the MAPK 
signaling pathway in human articular chondrocytes in vitro." Genes & nutrition 6(2): 171. 
  
Silman, A. J. and G. J. Macfarlane (2002). Epidemiological studies: a practical guide, 
Cambridge University Press. 
  
Silva, S., et al. (2015). "Protective effects of hydroxytyrosol-supplemented refined olive oil 
in animal models of acute inflammation and rheumatoid arthritis." The Journal of 
nutritional biochemistry 26(4): 360-368. 
  
Simopoulos, A. P. (2006). "Evolutionary aspects of diet, the omega-6/omega-3 ratio and 
genetic variation: nutritional implications for chronic diseases." Biomedicine & 
pharmacotherapy 60(9): 502-507. 
  
Simopoulou, T., et al. (2007). "Differential expression of leptin and leptin's receptor isoform 
(Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on 
cartilage metabolism." Osteoarthritis and Cartilage 15(8): 872-883. 
  
Sköldstam, L., et al. (2003). "An experimental study of a Mediterranean diet intervention 
for patients with rheumatoid arthritis." Annals of the rheumatic diseases 62(3): 208-214. 
  
Smita, S., et al. (2016). "Deciphering hallmark processes of aging from interaction 
networks." Biochimica et Biophysica Acta (BBA)-General Subjects 1860(11): 2706-2715. 
  
Smith, B. H., et al. (2007). "Epidemiology of chronic pain, from the laboratory to the bus 
stop: time to add understanding of biological mechanisms to the study of risk factors in 
population-based research?" Pain 127(1-2): 5-10. 
  
Smith, J. S. and J. D. Boeke (1997). "An unusual form of transcriptional silencing in yeast 
ribosomal DNA." Genes & development 11(2): 241-254. 
  
Smith, M. V., et al. (2016). "Knee Osteoarthritis Is Associated With Previous Meniscus and 
Anterior Cruciate Ligament Surgery Among Elite College American Football Athletes." 
Sports Health: A Multidisciplinary Approach: 1941738116683146. 
  
Sohn, D. H., et al. (2012). "Plasma proteins present in osteoarthritic synovial fluid can 
stimulate cytokine production via Toll-like receptor 4." Arthritis Research & Therapy 14(1): 
1. 
  
175 
 
Solfrizzi, V., et al. (2011). "Mediterranean diet in predementia and dementia syndromes." 
Current Alzheimer Research 8(5): 520-542. 
  
Sommer, C. and M. Kress (2004). "Recent findings on how proinflammatory cytokines cause 
pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia." Neuroscience 
letters 361(1): 184-187. 
  
Spector, T., et al. (1991). "Frequency of osteoarthritis in hysterectomized women." The 
Journal of rheumatology 18(12): 1877-1883. 
  
Spector, T., et al. (1993). "Definition of osteoarthritis of the knee for epidemiological 
studies." Annals of the rheumatic diseases 52(11): 790-794. 
  
Spector, T. D., et al. (1988). "Increased rates of previous hysterectomy and gynaecological 
operations in women with osteoarthritis." BMJ : British Medical Journal 297(6653): 899-
900. 
  
Spector, T. D. and G. D. Campion (1989). "Generalised osteoarthritis: a hormonally 
mediated disease." Annals of the rheumatic diseases 48(6): 523-527. 
  
Spector, T. D., et al. (1997). "Is hormone replacement therapy protective for hand and knee 
osteoarthritis in women?: The Chingford study." Annals of the rheumatic diseases 56(7): 
432. 
  
Spector, T. D. and F. M. Williams (2006). "The UK adult twin registry (TwinsUK)." Twin 
Research and Human Genetics 9(06): 899-906. 
  
Stannus, O. P., et al. (2013). "Associations between serum levels of inflammatory markers 
and change in knee pain over 5 years in older adults: a prospective cohort study." Annals of 
the rheumatic diseases 72(4): 535-540. 
  
Steck, S. E., et al. (2007). "GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary 
isothiocyanate metabolites following broccoli consumption in humans." The Journal of 
nutrition 137(4): 904-909. 
  
Stern, J. H., et al. (2016). "Adiponectin, Leptin, and Fatty Acids in the Maintenance of 
Metabolic Homeostasis through Adipose Tissue Crosstalk." Cell metabolism 23(5): 770-784. 
  
Stockwell, R. (1967). "Lipid content of human costal and articular cartilage." Annals of the 
rheumatic diseases 26(6): 481. 
  
Stürmer, T., et al. (1998). "Serum cholesterol and osteoarthritis. The baseline examination 
of the Ulm Osteoarthritis Study." The Journal of rheumatology 25(9): 1827-1832. 
  
176 
 
Sucuoğlu, H., et al. (2016). "Short-term efficacy of joint and soft tissue injections for 
musculoskeletal pain: An interventional cohort study." 
  
Sun, J., et al. (2007). "Estimating osteoarthritis incidence from population-based 
administrative health care databases." Annals of epidemiology 17(1): 51-56. 
  
Szoeke, C., et al. (2008). "The relationship of reports of aches and joint pains to the 
menopausal transition: a longitudinal study." Climacteric 11(1): 55-62. 
  
Tang, C.-H., et al. (2007). "Leptin-induced IL-6 production is mediated by leptin receptor, 
insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-κB, and p300 pathway 
in microglia." The Journal of Immunology 179(2): 1292-1302. 
  
Tang, L., et al. (2006). "The principal urinary metabolites of dietary isothiocyanates, N-
acetylcysteine conjugates, elicit the same anti-proliferative response as their parent 
compounds in human bladder cancer cells." Anti-cancer drugs 17(3): 297-305. 
  
Tanigawa, S., et al. (2011). "Interleukin-17F affects cartilage matrix turnover by increasing 
the expression of collagenases and stromelysin-1 and by decreasing the expression of their 
inhibitors and extracellular matrix components in chondrocytes." Cytokine 56(2): 376-386. 
  
Tanna, S. (2004). "Osteoarthritis “Opportunities to address pharmaceutical gaps”." Priority 
Medicines for Europe and World: a public health approach to innovation: 3-23. 
  
Teslovich, T. M., et al. (2010). "Biological, clinical and population relevance of 95 loci for 
blood lipids." Nature 466(7307): 707-713. 
  
Teucher, B., et al. (2007). "Dietary patterns and heritability of food choice in a UK female 
twin cohort." Twin Research and Human Genetics 10(05): 734-748. 
  
Thakur, M., et al. (2013). "Genomics of pain in osteoarthritis." Osteoarthritis and Cartilage 
21(9): 1374-1382. 
  
Timmins, K. A., et al. (2017). "Running and knee osteoarthritis: a systematic review and 
meta-analysis." The American journal of sports medicine 45(6): 1447-1457. 
  
Tokuyama, S. and K. Nakamoto (2011). "Unsaturated fatty acids and pain." Biological and 
Pharmaceutical Bulletin 34(8): 1174-1178. 
  
Tolhurst, G., et al. (2012). "Short-chain fatty acids stimulate glucagon-like peptide-1 
secretion via the G-protein–coupled receptor FFAR2." Diabetes 61(2): 364-371. 
  
177 
 
Tong, T. Y., et al. (2016). "Prospective association of the Mediterranean diet with 
cardiovascular disease incidence and mortality and its population impact in a non-
Mediterranean population: the EPIC-Norfolk study." BMC medicine 14(1): 135. 
  
Torzilli, P. A., et al. (1998). "Diffusive properties of immature articular cartilage." Journal of 
biomedical materials research 40(1): 132-138. 
  
Tou, J. C., et al. (2007). "Krill for human consumption: nutritional value and potential health 
benefits." NUTRITION REVIEWS-WASHINGTON- 65(2): 63. 
  
Triantaphyllidou, I.-E., et al. (2013). "Perturbations in the HDL metabolic pathway 
predispose to the development of osteoarthritis in mice following long-term exposure to 
western-type diet." Osteoarthritis and Cartilage 21(2): 322-330. 
  
Üçeyler, N., et al. (2006). "Reduced levels of antiinflammatory cytokines in patients with 
chronic widespread pain." Arthritis & Rheumatism 54(8): 2656-2664. 
  
Unlu, N. Z., et al. (2005). "Carotenoid absorption from salad and salsa by humans is 
enhanced by the addition of avocado or avocado oil." The Journal of nutrition 135(3): 431-
436. 
  
Van de Vijver, L., et al. (2009). "Whole-grain consumption, dietary fibre intake and body 
mass index in the Netherlands cohort study." European journal of clinical nutrition 63(1): 
31. 
  
Van Gool, F., et al. (2009). "Intracellular NAD levels regulate tumor necrosis factor protein 
synthesis in a sirtuin-dependent manner." Nature medicine 15(2): 206-210. 
  
van Leeuwen, I. M., et al. (2010). "Dynamic energy budget approaches for modelling 
organismal ageing." Philosophical Transactions of the Royal Society B: Biological Sciences 
365(1557): 3443-3454. 
  
Van Saase, J., et al. (1989). "Epidemiology of osteoarthritis: Zoetermeer survey. Comparison 
of radiological osteoarthritis in a Dutch population with that in 10 other populations." 
Annals of the rheumatic diseases 48(4): 271-280. 
  
VanDenKerkhof, E. G., et al. (2011). "Diet, lifestyle and chronic widespread pain: results 
from the 1958 British Birth Cohort Study." Pain Research & Management: The Journal of 
the Canadian Pain Society 16(2): 87. 
  
Vankemmelbeke, M. N., et al. (2003). "Selective inhibition of ADAMTS‐1,‐4 and‐5 by 
catechin gallate esters." The FEBS Journal 270(11): 2394-2403. 
  
178 
 
Veglia, F., et al. (2019). "A priori-defined Mediterranean-like dietary pattern predicts 
cardiovascular events better in north Europe than in Mediterranean countries." 
International journal of cardiology 282: 88-92. 
  
Veronese, N., et al. (2018). "Mediterranean diet and knee osteoarthritis outcomes: a 
longitudinal cohort study." Clinical nutrition. 
  
Veronese, N., et al. (2018). "The association between the Mediterranean diet and magnetic 
resonance parameters for knee osteoarthritis: data from the Osteoarthritis Initiative." 
Clinical rheumatology 37(8): 2187-2193. 
  
Veronese, N., et al. (2016). "Adherence to the Mediterranean diet is associated with better 
quality of life: data from the Osteoarthritis Initiative–3." The American journal of clinical 
nutrition 104(5): 1403-1409. 
  
Veronese, N., et al. (2017). "Adherence to a Mediterranean diet is associated with lower 
prevalence of osteoarthritis: Data from the osteoarthritis initiative." Clinical nutrition 36(6): 
1609-1614. 
  
Veronese, N., et al. (2018). "Adherence to a Mediterranean diet is associated with lower 
incidence of frailty: A longitudinal cohort study." Clinical nutrition 37(5): 1492-1497. 
  
Veronese, N., et al. (2017). "Fried potato consumption is associated with elevated 
mortality: an 8-y longitudinal cohort study." The American journal of clinical nutrition 
106(1): 162-167. 
  
Villalvilla, A., et al. (2013). "Lipid transport and metabolism in healthy and osteoarthritic 
cartilage." International journal of molecular sciences 14(10): 20793-20808. 
  
Visser, A., et al. (2015). "The relative contribution of mechanical stress and systemic 
processes in different types of osteoarthritis: the NEO study." Annals of the rheumatic 
diseases 74(10): 1842-1847. 
  
Von Mühlen, D., et al. (2002). "Postmenopausal estrogen and increased risk of clinical 
osteoarthritis at the hip, hand, and knee in older women." Journal of women's health & 
gender-based medicine 11(6): 511-518. 
  
Vos, T., et al. (2013). "Years lived with disability (YLDs) for 1160 sequelae of 289 diseases 
and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 
2010." The Lancet 380(9859): 2163-2196. 
  
Wakabayashi, I. (2015). "Light-to-moderate alcohol intake reduces lipid accumulation 
product and attenuates its relation to hypertension." Journal of human hypertension 29(6): 
359. 
179 
 
  
Wang, H. and R. H. Eckel (2009). "Lipoprotein lipase: from gene to obesity." American 
Journal of Physiology-Endocrinology and Metabolism 297(2): E271-E288. 
  
Wang, K., et al. (2015). "Serum levels of resistin and interleukin-17 are associated with 
increased cartilage defects and bone marrow lesions in patients with knee symptomatic 
osteoarthritis." Osteoarthritis and Cartilage 23: A307. 
  
Wang, P., et al. (1994). "IL-10 inhibits transcription of cytokine genes in human peripheral 
blood mononuclear cells." The Journal of Immunology 153(2): 811-816. 
  
Wang, X., et al. (2016). "Adiponectin improves NF-κB-mediated inflammation and abates 
atherosclerosis progression in apolipoprotein E-deficient mice." Lipids in health and disease 
15(1): 33. 
  
Wang, Y., et al. (2016). "No association of the single nucleotide polymorphism rs8044769 in 
the fat mass and obesity-associated gene with knee osteoarthritis risk and body mass 
index: A population-based study in China." Bone and Joint Research 5(5): 169-174. 
  
Wang, Y., et al. (2007). "Effect of antioxidants on knee cartilage and bone in healthy, 
middle-aged subjects: a cross-sectional study." Arthritis Research & Therapy 9(4): R66. 
  
Wang, Y., et al. (2016). "The APOA5 rs662799 polymorphism is associated with dyslipidemia 
and the severity of coronary heart disease in Chinese women." Lipids in health and disease 
15(1): 170. 
  
Wang, Y., et al. (2011). "Meat consumption and risk of primary hip and knee joint 
replacement due to osteoarthritis: a prospective cohort study." BMC musculoskeletal 
disorders 12(1): 17. 
  
Wang, Y., et al. (2009). "Relationship between body adiposity measures and risk of primary 
knee and hip replacement for osteoarthritis: a prospective cohort study." Arthritis Research 
& Therapy 11(2): R31. 
  
Wang, Y., et al. (2008). "Effect of fatty acids on bone marrow lesions and knee cartilage in 
healthy, middle-aged subjects without clinical knee osteoarthritis." Osteoarthritis and 
Cartilage 16(5): 579-583. 
  
Watt, F. E. (2016). "Hand osteoarthritis, menopause and menopausal hormone therapy." 
Maturitas 83: 13-18. 
  
Watt, F. E. (2018). "Musculoskeletal pain and menopause." Post reproductive health 24(1): 
34-43. 
  
180 
 
Wei, S., et al. (2011). "The associations between parity, other reproductive factors and 
cartilage in women aged 50–80years." Osteoarthritis and Cartilage 19(11): 1307-1313. 
  
Weiss, L. A., et al. (2006). "The sex-specific genetic architecture of quantitative traits in 
humans." Nature genetics 38(2): 218-222. 
  
Wieland, H. A., et al. (2005). "Osteoarthritis—an untreatable disease?" Nature reviews 
Drug discovery 4(4): 331-344. 
  
Wijnhoven, H. A., et al. (2006). "Explaining sex differences in chronic musculoskeletal pain 
in a general population." Pain 124(1-2): 158-166. 
  
Willett, W. (2012). Nutritional epidemiology, Oxford University Press. 
  
Willett, W. (2012). Nutritional epidemiology, Oxford University Press. 
  
Willett, W. and M. J. Stampfer (1986). "Total energy intake: implications for epidemiologic 
analyses." American journal of epidemiology 124(1): 17-27. 
  
Willett, W. C., et al. (1995). "Mediterranean diet pyramid: a cultural model for healthy 
eating." The American journal of clinical nutrition 61(6): 1402S-1406S. 
  
Williams, F. M., et al. (2010). "Dietary garlic and hip osteoarthritis: evidence of a protective 
effect and putative mechanism of action." BMC musculoskeletal disorders 11(1): 280. 
  
Woolf, C. J. and M. W. Salter (2000). "Neuronal plasticity: increasing the gain in pain." 
Science 288(5472): 1765-1768. 
  
Wu, C.-L., et al. (2014). "Dietary fatty acid content regulates wound repair and the 
pathogenesis of osteoarthritis following joint injury." Annals of the rheumatic diseases: 
annrheumdis-2014-205601. 
  
Wu, T., et al. (2009). "The effects of phytosterols/stanols on blood lipid profiles: a 
systematic review with meta-analysis." Asia Pacific journal of clinical nutrition 18(2): 179-
186. 
  
Xiao, Y.-F., et al. (1995). "Blocking effects of polyunsaturated fatty acids on Na+ channels of 
neonatal rat ventricular myocytes." Proceedings of the National Academy of Sciences 
92(24): 11000-11004. 
  
Xu, H., et al. (1994). "Dietary lipids modify the fatty acid composition of cartilage, isolated 
chondrocytes and matrix vesicles." Lipids 29(9): 619-625. 
  
181 
 
Yang, S.-R., et al. (2007). "Sirtuin regulates cigarette smoke-induced proinflammatory 
mediator release via RelA/p65 NF-κB in macrophages in vitro and in rat lungs in vivo: 
implications for chronic inflammation and aging." American Journal of Physiology-Lung 
Cellular and Molecular Physiology 292(2): L567-L576. 
  
Yeung, F., et al. (2004). "Modulation of NF‐κB‐dependent transcription and cell survival 
by the SIRT1 deacetylase." The EMBO journal 23(12): 2369-2380. 
  
Yin, R. X., et al. (2013). "Interactions between the apolipoprotein a1/c3/a5 haplotypes and 
alcohol consumption on serum lipid levels." Alcoholism: Clinical and Experimental Research 
37(2): 234-243. 
  
Yoshizaki, T., et al. (2009). "SIRT1 exerts anti-inflammatory effects and improves insulin 
sensitivity in adipocytes." Molecular and cellular biology 29(5): 1363-1374. 
  
Yusuf, E. (2012). "Metabolic factors in osteoarthritis: obese people do not walk on their 
hands." Arthritis Research & Therapy 14(4): 123. 
  
Yusuf, E., et al. (2011). "Association between leptin, adiponectin and resistin and long-term 
progression of hand osteoarthritis." Annals of the rheumatic diseases 70(7): 1282-1284. 
  
Yusuf, E., et al. (2010). "Association between weight or body mass index and hand 
osteoarthritis: a systematic review." Annals of the rheumatic diseases 69(4): 761-765. 
  
Zainal, Z., et al. (2009). "Relative efficacies of omega-3 polyunsaturated fatty acids in 
reducing expression of key proteins in a model system for studying osteoarthritis." 
Osteoarthritis and Cartilage 17(7): 896-905. 
  
Zembala-Szczerba, M., et al. (2017). "Low-Grade Metabolically-Induced Inflammation 
Mediators Interleukin-6, Adiponectin, and TNF-α Serum Levels in Obese Pregnant Patients 
in the Perinatal Period." Medical science monitor basic research 23: 1. 
  
Zengini, E., et al. (2016). "The genetic epidemiological landscape of hip and knee 
osteoarthritis: where are we now and where are we going?" The Journal of rheumatology 
43(2): 260-266. 
  
Zhang, Y. and J. M. Jordan (2010). "Epidemiology of osteoarthritis." Clinics in geriatric 
medicine 26(3): 355-369. 
  
Zhang, Y., et al. (2019). "Activation of mitogen-activated protein kinases in satellite glial 
cells of the trigeminal ganglion contributes to substance P-mediated inflammatory pain." 
International journal of oral science 11(3): 1-10. 
  
182 
 
Zhang, Y., et al. (2016). "Associations of cigarette smoking, betel quid chewing and alcohol 
consumption with high-sensitivity C-reactive protein in early radiographic knee 
osteoarthritis: a cross-sectional study." BMJ open 6(3): e010763. 
  
 
  
183 
 
13 Appendix 1. Dietary Exposures and Musculoskeletal Pain. 
 
Below are the results from the analysis for other musculoskeletal sites that although 
relevant when looking at OA are less commonly diagnosed as a site at which OA occurs. 
Below are the tables from the analysis within TWINS-UK looking at associations between 
dietary exposures and musculoskeletal pain. 
13.1 TWINS-UK Dietary Patterns and Other Musculoskeletal Pain 
 
Below are the results from the analysis between the dietary patterns and back pain, neck 
and shoulder pain, elbow and forearm pain and foot pain.  
TABLE 47. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND BACK PAIN IN 
TWINS-UK. 
Back Pain Model 1 (n=1943)   Model 2 (n=931)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 0.88 (0.75, 1.03) 0.83 (0.67, 1.02) 
High Alcohol 0.98 (0.79, 1.21) 1.00 (0.72, 1.38) 
Traditional English 0.97 (0.77, 1.21) 1.01 (0.76, 1.34) 
Dieting 1.09 (0.86, 1.38) 1.14 (0.84, 1.54) 
Low Meat 1.28 (0.97, 1.69) 1.31 (0.90, 1.90) 
*p<0.05 
**p<0.01 
 
TABLE 48. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND NECK AND 
SHOULDER PAIN IN TWINS-UK. 
Neck and Shoulder Pain Model 1 (n=3469)   Model 2 (801)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 0.98 (0.91, 1.06) 1.05 (0.95, 1.16) 
High Alcohol 0.94 (0.84, 1.05) 1.05 (0.89, 1.25) 
Traditional English 1.16 (1.04, 1.30)* 1.15 (1.00, 1.31) 
Dieting 0.97 (0.85, 1.10) 1.03 (0.87, 1.22) 
Low Meat 0.99 (0.86, 1.15) 1.04 (0.85, 1.27) 
*p<0.05 
**p<0.01 
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TABLE 49. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND ELBOW AND 
FOREARM PAIN IN TWINS-UK. 
Elbow and Forearm Pain Model 1 (n=3380)   Model 2 (n=765)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 0.98 (0.89, 1.08) 0.94 (0.82, 1.07) 
High Alcohol 0.96 (0.84, 1.10) 1.01 (0.82, 1.25) 
Traditional English 1.06 (0.93, 1.20) 1.11 (0.93, 1.33) 
Dieting 1.06 (0.91, 1.23) 1.17 (0.95, 1.44) 
Low Meat 1.17 (0.99, 1.39) 1.12 (0.87, 1.43) 
*p<0.05 
**p<0.01 
 
TABLE 50. OR AND 95% CI FOR ASSOCIATIONS BETWEEN DIETARY PATTERNS AND FOOT PAIN IN 
TWINS-UK. 
Foot Pain Model 1 (n=3302)   Model 2 (n=741)   
Dietary Pattern OR 95% CI OR 95% CI 
Fruit and Vegetable 1.01 (0.93, 1.10) 1.02 (0.91, 1.16) 
High Alcohol 0.97 (0.86, 1.09) 0.93 (0.76, 1.15) 
Traditional English 1.05 (0.93, 1.17) 0.98 (0.83, 1.16) 
Dieting 0.95 (0.83, 1.09) 1.06 (0.87, 1.30) 
Low Meat 1.05 (0.90, 1.22) 1.02 (0.80, 1.30) 
*p<0.05 
**p<0.01 
 
13.2 TWINS-UK Lipids and Other Musculoskeletal Pain 
 
Below are the results from the analysis between serum blood lipids and back pain, neck 
and shoulder pain, elbow and forearm pain and foot pain. 
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TABLE 51. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND BACK PAIN IN TWINS-
UK. 
Back Pain 
Model 1 
(n=800)   
Model 2 
(n=450)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 2.03 (0.74, 5.58) 2.65 (0.79, 8.88) 
Apolipoprotein B1 0.66 (0.26, 1.66) 0.38 (0.12, 1.22) 
Cholesterol 0.91 (0.70, 1.19) 0.84 (0.61, 1.14) 
High Density Lipoprotein 0.64 (0.29, 1.40) 0.79 (0.33, 1.88) 
Low Density Lipoprotein 0.90 (0.67, 1.20) 0.83 (0.58, 1.17) 
Triglycerides  1.03 (0.63, 1.67) 0.87 (0.47, 1.61) 
*p<0.05 
**p<0.01 
 
TABLE 52. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND NECK AND SHOULDER 
PAIN IN TWINS-UK. 
Neck and Shoulder Pain Model 1 (n=900)   Model 2 (n=600)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.68 (0.41, 1.14) 0.76 (0.39, 1.51) 
Apolipoprotein B1 0.61 (0.38, 0.97)* 0.47 (0.23, 0.94)* 
Cholesterol 0.90 (0.78, 1.05) 0.88 (0.72, 1.08) 
High Density Lipoprotein 0.78 (0.51, 1.20) 0.78 (0.45, 1.38) 
Low Density Lipoprotein 0.89 (0.76, 1.05) 0.84 (0.67, 1.06) 
Triglycerides  1.00 (0.77, 1.30) 1.14 (0.80, 1.62) 
*p<0.05 
**p<0.01 
 
TABLE 53. OR AND 95% CI FOR ASSOCIATIONS BETWEEN BLOOD LIPIDS AND ELBOW AND FOREARM 
PAIN IN TWINS-UK. 
Elbow and Forearm Pain 
Model 1 
(n=800)   
Model 2 
(n=550)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.76 (0.41, 1.40) 0.67 (0.30, 1.50) 
Apolipoprotein B1 0.73 (0.41, 1.31) 0.83 (0.37, 1.86) 
Cholesterol 0.90 (0.76, 1.08) 0.93 (0.74, 1.18) 
High Density Lipoprotein 0.64 (0.38, 1.08) 0.55 (0.27, 1.11) 
Low Density Lipoprotein 0.91 (0.75, 1.10) 0.91 (0.70, 1.17) 
Triglycerides  1.29 (0.95, 1.74) 1.58 (1.05, 2.37)* 
*p<0.05 
**p<0.01 
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Table 54. OR and 95% CI for associations between blood lipids and foot pain in TWINS-UK. 
 
Foot Pain 
Model 1 
(n=800)   
Model 2 
(n=500)   
Lipid OR 95% CI OR 95% CI 
Apolipoprotein A1 0.88 (0.50, 1.56) 1.51 (0.61, 3.74) 
Apolipoprotein B1 1.70 (1.02, 2.83) 1.39 (0.61, 3.17) 
Cholesterol 1.19 (1.02, 1.38)* 1.12 (0.88, 1.42) 
High Density Lipoprotein 0.70 (0.43, 1.11) 0.86 (0.42, 1.76) 
Low Density Lipoprotein 1.17 (0.99, 1.39) 1.08 (0.82, 1.43) 
Triglycerides  1.39 (1.04, 1.85)* 1.39 (0.83, 2.32) 
*p<0.05 
**p<0.01 
  
14 Appendix 2. Tables of TWINS-UK FFQ Food Groups and Items for PCA Derived Dietary Score Patterns. 
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FIGURE 16. FFQ DATA TABLES FOR PCA DERIVED DIETARY PATTERNS INSERTED FROM TEUCHER, B., ET AL. (2007). "DIETARY PATTERNS AND HERITABILITY OF FOOD CHOICE IN 
A UK FEMALE TWIN COHORT." TWIN RESEARCH AND HUMAN GENETICS 10(05): 734-748. 
